<SEC-DOCUMENT>0000886163-16-000164.txt : 20160412
<SEC-HEADER>0000886163-16-000164.hdr.sgml : 20160412
<ACCEPTANCE-DATETIME>20160412160327
ACCESSION NUMBER:		0000886163-16-000164
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20160412
FILED AS OF DATE:		20160412
DATE AS OF CHANGE:		20160412
EFFECTIVENESS DATE:		20160412

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		161567293

	BUSINESS ADDRESS:	
		STREET 1:		11119 NORTH TORREY PINES ROAD
		STREET 2:		SUITE 200
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		11119 NORTH TORREY PINES ROAD
		STREET 2:		SUITE 200
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>lgnd-2016annualmeetingprox.htm
<DESCRIPTION>DEF 14A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2016 Workiva -->
		<title>DEF 14A</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="sDC15893BB0F50E30A4A4E760CF6FBE98"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, D.C. 20549</font></div><div style="line-height:120%;padding-top:13px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SCHEDULE 14A INFORMATION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Rule 14a-101)</font></div><div style="line-height:120%;padding-top:9px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PROXY STATEMENT PURSUANT TO SECTION 14(a) OF</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Filed by the Registrant </font><font style="font-family:Wingdings;font-size:10pt;">x</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Filed by a Party other than the Registrant </font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box:  </font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:21px;text-align:left;padding-left:26px;text-indent:-27px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preliminary Proxy Statement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">x</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:5px;text-align:left;padding-left:26px;text-indent:-27px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Definitive Proxy Statement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:5px;text-align:left;padding-left:26px;text-indent:-27px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Definitive Additional Materials</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:5px;text-align:left;padding-left:26px;text-indent:-27px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting Material under 240.14a-12</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:5px;text-align:left;padding-left:26px;text-indent:-27px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:5px;text-align:left;padding-left:26px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="line-height:120%;padding-top:13px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Name of Registrant as Specified In Its Charter</font></div><div style="line-height:120%;padding-top:21px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Name of Person(s) Filing Proxy Statement, if other than the Registrant</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of Filing Fee (Check the appropriate box):</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">x</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:17px;text-align:left;padding-left:26px;text-indent:-27px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No fee required.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:17px;text-align:left;padding-left:26px;text-indent:-27px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)&#160;&#160;&#160;&#160;Title of each class of securities to which transaction applies:</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2)&#160;&#160;&#160;&#160;Aggregate number of securities to which transaction applies:</font></div><div style="padding-left:36px;text-indent:-36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)&#160;&#160;&#160;&#160;Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)&#160;&#160;&#160;&#160;Proposed maximum aggregate value of transaction:</font></div><div style="padding-bottom:1px;padding-left:36px;text-indent:-36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5)      Total fee paid:</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:17px;text-align:left;padding-left:26px;text-indent:-27px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee paid previously with preliminary materials.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:17px;text-align:left;padding-left:36px;text-indent:-36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)          Amount Previously Paid:</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2)&#160;&#160;&#160;&#160;Form, Schedule or Registration Statement No.:</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)&#160;&#160;&#160;&#160;Filing Party:</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)&#160;&#160;&#160;&#160;Date Filed:</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"><br></font></div><br><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sEC49094E6E1AF5EF71E3E760CFA775ED"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><img src="image0.jpg" style="height:77px;width:212px;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:5px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;font-weight:bold;">Notice of Annual Meeting of Stockholders</font></div><div style="padding-bottom:5px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;font-weight:bold;">to be held Monday, May 23, 2016</font></div></td></tr></table></div></div><div style="line-height:100%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dear Stockholder:</font></div><div style="line-height:100%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The annual meeting of stockholders of Ligand Pharmaceuticals Incorporated (&#8220;Ligand&#8221; or the &#8220;Company&#8221;) will be held at 11119 N. Torrey Pines Rd. Suite 200 La Jolla, CA 92037, on May 23, 2016 at 8:30 a.m. local time, for the following purposes:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:57px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:100%;font-size:10pt;padding-left:33px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To elect a board of directors for the forthcoming year. Our board of directors has nominated the following seven persons, each to serve for a one year term to expire at the 2017 annual meeting of stockholders: Jason Aryeh, Todd Davis, John Higgins, John Kozarich, John LaMattina, Sunil Patel and Stephen Sabba.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:57px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:100%;font-size:10pt;padding-left:33px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To ratify the selection of Grant Thornton LLP as the Company&#8217;s independent registered accounting firm for the fiscal year ending December 31, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:57px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:100%;font-size:10pt;padding-left:33px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To approve the amendment and restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:57px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:100%;font-size:10pt;padding-left:33px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission, or the SEC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:57px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:100%;font-size:10pt;padding-left:33px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To transact such other business as may properly come before the meeting or any adjournment(s) thereof.</font></div></td></tr></table><div style="line-height:100%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders of record at the close of business on March 29, 2016 will be entitled to vote at the annual meeting. We have elected to use the internet as our primary means of providing our proxy materials to stockholders. Most stockholders will receive only a Notice of Internet Availability of Proxy Materials with instructions for accessing the proxy materials, including our Proxy Statement and annual report, and for voting via the internet. The Notice of Internet Availability of Proxy Materials also provides information on how stockholders may obtain paper copies of our proxy materials free of charge, if they so choose. </font></div><div style="line-height:100%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The stock transfer books of the Company will remain open between the record date, March 29, 2016, and the date of the meeting. A list of stockholders entitled to vote at the annual meeting will be available for inspection at the offices of the Company and at the meeting. Whether or not you plan to attend the annual meeting in person, please vote by internet or telephone as described in the enclosed proxy materials or, if you request that the proxy materials be mailed to you, by signing, dating and returning the proxy card enclosed with those materials. If you attend the annual meeting and vote by ballot, your proxy will be revoked automatically and only your vote at the annual meeting will be counted. The prompt return of your proxy will assist us in preparing for the annual meeting.</font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:40.38461538461539%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By Order of the Board of Directors,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;C</font><font style="font-family:inherit;font-size:8pt;">HARLES</font><font style="font-family:inherit;font-size:10pt;">&#160;S. B</font><font style="font-family:inherit;font-size:8pt;">ERKMAN</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Charles S. Berkman</font></div><div style="padding-bottom:1px;text-align:center;padding-left:4px;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;font-weight:bold;font-style:italic;">Vice President, General Counsel&#160;&amp; Secretary</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">La Jolla, California</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 12, 2016</font></div><div style="line-height:120%;text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s7E2BFB81ABB577349214E760CFD3EAEB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:5px;text-align:left;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">Table of Contents</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="94%"></td><td width="6%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s82FBF1A5140C2B67915CE760D00C840F"><font style="font-family:inherit;font-size:10pt;">Introduction</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s82FBF1A5140C2B67915CE760D00C840F">1</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#s4BA1AA0E10CEE8A58721E760D0818730"><font style="font-family:inherit;font-size:11pt;">Proposal No.&#160;1: Election of Directors</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4BA1AA0E10CEE8A58721E760D0818730">5</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#sD8FC00B1A78284980544E760CF1AB04C"><font style="font-family:inherit;font-size:11pt;">Proposal No.&#160;2: Ratification of Independent Registered Public Accounting Firm</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD8FC00B1A78284980544E760CF1AB04C">10</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#sC3A352E5202C846A7064E760CEC1E001"><font style="font-family:inherit;font-size:11pt;">Proposal No. 3: Approval of the Amendment and Restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC3A352E5202C846A7064E760CEC1E001">12</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#s62B324D0D00DD2785D6AE760D220E48A"><font style="font-family:inherit;font-size:11pt;">Proposal No.&#160;4: Approval of the Compensation of the Named Executive Officers</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s62B324D0D00DD2785D6AE760D220E48A">25</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#sE58620CE2139DD2C6B8DE760D249809E"><font style="font-family:inherit;font-size:11pt;">Executive Officers</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE58620CE2139DD2C6B8DE760D249809E">25</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#s54A3D62D49B1E8A07202E760CEEB4CBC"><font style="font-family:inherit;font-size:11pt;">Security Ownership of Certain Beneficial Owners, Directors and Management</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s54A3D62D49B1E8A07202E760CEEB4CBC">26</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#s0092EA0DF5E0022C530FE760CEC079EB"><font style="font-family:inherit;font-size:11pt;">Compensation Discussion and Analysis</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s0092EA0DF5E0022C530FE760CEC079EB">29</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#sD112A73BD6B31C13DB13E760D49DFF54"><font style="font-family:inherit;font-size:11pt;">Certain Relationships and Related Transactions</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD112A73BD6B31C13DB13E760D49DFF54">53</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#s745386F0A05ED801C960E760D4ADD879"><font style="font-family:inherit;font-size:11pt;">Section&#160;16(a) Beneficial Ownership Reporting Compliance   </font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s745386F0A05ED801C960E760D4ADD879">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#s8E61B2E91F65E2F13AA5E760D4CE45F7"><font style="font-family:inherit;font-size:11pt;">Deadline for Proposals for Next Annual Meeting</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8E61B2E91F65E2F13AA5E760D4CE45F7">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#s9FCFC22F14E8770069F6E760D4EFDBFA"><font style="font-family:inherit;font-size:11pt;">Annual Report on Form 10-K</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s9FCFC22F14E8770069F6E760D4EFDBFA">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#s4E5DD85B9F23C1A4762AE760D524E88F"><font style="font-family:inherit;font-size:11pt;">Solicitation of Proxies</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4E5DD85B9F23C1A4762AE760D524E88F">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#s7E766B35A07915ABB541E760D54AA94F"><font style="font-family:inherit;font-size:11pt;">Householding of Proxy Materials</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s7E766B35A07915ABB541E760D54AA94F">54</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#sD4715622F9BBED8C0641E760D5758432"><font style="font-family:inherit;font-size:11pt;">Other Business</font></a><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD4715622F9BBED8C0641E760D5758432">55</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="font-family:inherit;font-size:11pt;" href="#sbf6b4c24e9ea4917b070a0d8dd6584e2"><font style="font-family:inherit;font-size:11pt;">Appendix A-Ligand 2002 Stock Incentive Plan as Amended Through April 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-left:4px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sbf6b4c24e9ea4917b070a0d8dd6584e2">56</a></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s82FBF1A5140C2B67915CE760D00C840F"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:5px;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">Ligand Pharmaceuticals Incorporated</font></div><div style="padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">11119 N. Torrey Pines Rd. Suite 200</font></div><div style="padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">La Jolla, CA 92037</font></div><div style="padding-left:9px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;color:#ffffff;font-weight:bold;">Proxy Statement</font></div><div style="padding-left:9px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;color:#ffffff;font-weight:bold;">For the Annual Meeting of Stockholders</font></div><div style="padding-bottom:5px;padding-left:9px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;color:#ffffff;font-weight:bold;">May 23, 2016</font></div></td></tr></table></div></div><div style="line-height:150%;padding-top:21px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On behalf of the board of directors of Ligand, we are asking for your proxy, to be used at the annual meeting of stockholders to be held on May 23, 2016. The annual meeting will be held at 8:30 a.m. local time at 11119 N. Torrey Pines Rd. Suite 200 La Jolla, CA 92037. Stockholders of record on March 29, 2016 (the &#8220;Record Date&#8221;) are entitled to notice of and to vote at the annual meeting. If you need directions to the location of the annual meeting, please contact us at (858)&#160;550-7500. On or about April 12, 2016, we will mail to stockholders a Notice of Internet Availability of Proxy Materials containing instructions on how to access our proxy statement and 2015 annual report online and how to vote online. If you receive such a Notice by mail, you will not receive a printed copy of the materials unless you specifically request one. However, the Notice contains instructions on how to request to receive printed copies of these materials and a proxy card by mail.</font></div><div style="line-height:120%;padding-top:21px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on Monday, May 23, 2016.</font></div><div style="line-height:150%;padding-top:21px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This proxy statement and the Company&#8217;s annual report are available electronically at </font><a style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#"><font style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;">www.ecdocumentview.com/LGND</font></a><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">1</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s82FBF1A5140C2B67915CE760D00C840F"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:5px;text-align:left;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">General Information about the Annual Meeting and Voting</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:13px;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="18%"></td><td width="82%"></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">What is the purpose of the annual meeting?</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At our annual meeting, stockholders will act on the items outlined in the notice of meeting that is attached to this proxy statement. These include the election of directors, the ratification of the selection of Grant Thornton LLP as the Company&#8217;s independent registered public accounting firm, the approval of the amendment and restatement of the Company's 2002 Stock Incentive Plan and the approval, on an advisory basis, of the compensation of the named executive officers as disclosed in this proxy statement. </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Who can vote at the meeting?</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Only stockholders of record as of the close of business on the Record Date are entitled to vote the shares of stock they held on that date. Stockholders may vote in person or by proxy (see &#8220;How do I vote by proxy?&#8221; below). Each holder of shares of common stock is entitled to one vote for each share of stock held on the proposals presented in this proxy statement. Our amended and restated bylaws provide that a majority of all of the shares of the stock entitled to vote, whether present in person or represented by proxy, will be a quorum for the transaction of business at the meeting.</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How many votes do I have?</font></div><div style="padding-top:18px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each share of our common stock that you own as of March 29, 2016 entitles you to one vote. The Notice of Internet Availability of Proxy Materials that is sent to you, or the proxy card or voting instruction form that is included in the proxy materials mailed to you if you have requested delivery by mail, will show the number of shares that you are entitled to vote.</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How are votes counted?</font></div><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Directors will be elected by a favorable vote of a plurality of the aggregate votes present, in person or by proxy, at the annual meeting. Accordingly, abstentions will not affect the outcome of the election of candidates for director. Absent instructions from the beneficial owner of such shares, a broker is not entitled to vote shares held for a beneficial owner on certain non-routine items, such as the election of directors, the approval, on an advisory basis, of the compensation of the named executive officers as disclosed in this proxy statement, and stockholder proposals. Thus, if the beneficial owner does not give a broker specific instructions, the beneficially owned shares may not be voted on this proposal and will not be counted in determining the number of shares necessary for approval, although they will count for purposes of determining whether a quorum exists. Stockholders are not permitted to cumulate their shares for the purpose of electing directors or otherwise.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The proposal to ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2016 requires the affirmative vote of a majority of the aggregate votes present, in person or by proxy, and entitled to vote at the annual meeting. Abstentions will have the same effect as a vote against this proposal. However, ratification of the selection of Grant Thornton LLP is considered a routine matter on which a broker or other nominee is empowered to vote. Accordingly, no broker non-votes will result from this proposal.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Approval of the amendment and restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan and the non-binding advisory resolution on our executive compensation requires the affirmative vote of a majority of the aggregate votes present, in person or by proxy, and entitled to vote at the annual meeting. Abstentions will have the same effect as a vote against these proposals. Absent instructions from the beneficial owner of such shares, a broker is not entitled to vote shares held for a beneficial owner on the resolution to approve the amendment and restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan or the compensation of our named executive officers. As a result, broker non-votes will have no effect on the outcome of the vote on these proposals.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All votes will be counted by an inspector of elections appointed for the meeting. The inspector will count separately &#8220;yes&#8221; votes, &#8220;no&#8221; votes, abstentions and broker non-votes. Shares represented by proxies that reflect abstentions or &#8220;broker non-votes&#8221; (i.e., shares held by a broker or nominee which are represented at the annual meeting, but not empowered to vote on a particular proposal) will be counted as shares that are present and entitled to vote for purposes of determining the presence of a quorum.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Voting results will be tabulated and certified by our mailing and tabulating agent, Computershare.</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">2</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s82FBF1A5140C2B67915CE760D00C840F"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="18%"></td><td width="82%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Why did I receive a one-page notice in the mail regarding the Internet availability of proxy materials instead of a full set of proxy materials?</font></div><div style="padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-top:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to rules adopted by the SEC, we have elected to provide access to our proxy materials over the internet. Accordingly, we are sending a Notice of Internet Availability of Proxy Materials to our stockholders who have not previously requested the receipt of paper proxy materials advising them that they can access this proxy statement, the 2015 annual report and voting instructions over the internet at http://www.envisionreports.com/LGND, by calling toll-free (866) 641-4276, or by sending an e-mail to investorvote@computershare.com with &#8220;Proxy Materials Ligand Pharmaceuticals&#8221; in the subject line. Include in the message your full name and address, plus the number located in the shaded bar on the reverse, and state in the email that you want a paper copy of current meeting materials. You can also state your preference to receive a paper copy for future meetings. There is no charge for you requesting a copy. Please make your request for a copy on or before May 12, 2016 to facilitate timely delivery. In addition, stockholders may request to receive proxy materials electronically by email or in printed form by mail on an ongoing basis. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice of Internet Availability of Proxy Materials or request to receive a printed set of the proxy materials. We encourage stockholders to take advantage of the availability of the proxy materials on the internet to help reduce the environmental impact of the annual meeting.</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="18%"></td><td width="6%"></td><td width="76%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How do I vote by proxy?</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you are a stockholder of record on the Record Date, you may vote in one of the following four ways:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-top:4px;padding-left:36px;text-indent:-36px;"><img src="image1a01.gif" style="height:29px;width:30px;"></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">By the internet.</font><font style="font-family:inherit;font-size:10pt;">&#160;You may go to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">www.envisionreports.com/LGND</font><font style="font-family:inherit;font-size:10pt;">&#160;24 hours a day, 7 days a week, and follow the instructions. You will need the 15-digit control number that is included in the Notice of Internet Availability of Proxy Materials, proxy card or voting instructions form that is sent to you. The internet voting system allows you to confirm that the system has properly recorded your votes. This method of voting will be available up until 11:59 p.m. EDT, on May 22, 2016.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-top:4px;padding-left:36px;text-indent:-36px;font-size:10pt;"><img src="image2.gif" style="height:30px;width:30px;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">By telephone</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">. </font><font style="font-family:inherit;font-size:10pt;">On a touch-tone telephone, you may call toll-free 1-800-652-8683, 24 hours a day, 7 days a week, and follow the instructions. You will need the 15 digit control number that is included in the Notice of Internet Availability of Proxy Materials, proxy card or voting instructions form that is sent to you. As with internet voting, you will be able to confirm that the system has properly recorded your votes. This method of voting will be available up until 11:59 p.m. EDT, on May 22, 2016.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-top:4px;padding-left:36px;text-indent:-36px;font-size:10pt;"><img src="image3.gif" style="height:30px;width:30px;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">By mail</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">. </font><font style="font-family:inherit;font-size:10pt;">If you are a stockholder of record, and you elect to receive your proxy materials by mail, you may vote by proxy by marking, dating, and signing your proxy card exactly as your name appears on the card and returning it by mail in the postage-paid envelope that will be provided to you. If you hold your shares in street name and you elect to receive your proxy materials by mail, you may vote by completing and mailing the voting instruction form that will be provided by your bank, broker or other holder of record. You should mail the proxy card or voting instruction form in plenty of time to allow delivery prior to the meeting. Do not mail the proxy card or voting instruction form if you are voting over the internet or by telephone.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;padding-top:4px;padding-left:36px;text-indent:-36px;"><img src="image4.gif" style="height:29px;width:30px;"></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">At the annual meeting</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">. </font><font style="font-family:inherit;font-size:10pt;">Whether you are a stockholder of record or a street name holder, you may vote your shares at the annual meeting if you attend in person.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Even if you plan to attend the annual meeting, we encourage you to vote over the internet or by telephone prior to the meeting. It is fast and convenient, and votes are recorded and confirmed immediately.</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">3</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s82FBF1A5140C2B67915CE760D00C840F"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="18%"></td><td width="82%"></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">May I revoke my proxy?</font></div><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you give us your proxy, you may revoke it at any time before it is exercised. You may revoke your proxy by sending in another signed proxy with a later date, by notifying our corporate secretary, Charles S. Berkman, in writing before the annual meeting that you have revoked your proxy, or by attending the annual meeting and voting in person.</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:13px;padding-bottom:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">What is the quorum requirement?</font></div><div style="padding-top:8px;padding-bottom:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:13px;padding-bottom:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if the holders of a majority in voting power of the shares of common stock issued, outstanding and entitled to vote are present in person or represented by proxy at the annual meeting. On the Record Date, there were 20,815,636 shares outstanding and entitled to vote. Accordingly, 10,407,819 shares must be represented by stockholders present at the annual meeting or by proxy to have a quorum.</font></div><div style="padding-top:8px;padding-bottom:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Your shares will be counted towards the quorum only if you submit a valid proxy vote or vote at the annual meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, either the chairperson of the annual meeting or a majority in voting power of the stockholders entitled to vote at the annual meeting, present in person or represented by proxy, may adjourn the annual meeting to another time or place.</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">I share an address with another stockholder, and we received only one paper copy of the proxy materials and annual report. How may I obtain an additional copy of these materials?</font></div><div style="padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The rules of the SEC permit us, under certain circumstances, to send a single set of the Notice of Internet Availability of Proxy Materials, proxy materials, and annual reports to any household at which two or more stockholders reside. This procedure, known as householding, reduces the volume of duplicate information you receive and helps to reduce our expenses.</font></div><div style="padding-bottom:8px;padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In order to take advantage of this opportunity, we have delivered only one Notice of Internet Availability of Proxy Materials or, if you previously requested to receive paper proxy materials by mail, one proxy statement and annual report to stockholders who share an address (unless we received contrary instructions from the affected stockholders prior to the mailing date). We will mail a separate copy of any of these documents, if requested. Requests for separate copies of any of these documents, either now or in the future, as well as requests for single copies in the future by stockholders who share an address and are currently receiving multiple copies, can be made by stockholders of record by contacting our corporate secretary at Ligand Pharmaceuticals Incorporated, 11119 N. Torrey Pines Rd. Suite 200 La Jolla CA 92037, or by telephone at (858) 550-7500. Such requests by street name holders should be made through their bank, broker or other holder of record.</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How do I obtain an Annual Report on Form 10-K?</font></div><div style="padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If you would like a copy of our annual report on Form 10-K for the fiscal year ended December&#160;31, 2015 that we filed with the SEC, we will send you one without charge. Please write to:</font></div><div style="padding-top:8px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated</font></div><div style="text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11119 N. Torrey Pines Rd. Suite 200 </font></div><div style="text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">La Jolla, CA 92037</font></div><div style="text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attn: Corporate Secretary</font></div><div style="padding-bottom:8px;padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All of our SEC filings are also available free of charge in the Investors section of our website at www.ligand.com.</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#b4b4b4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">How can I find out the results of the voting at the annual meeting?</font></div><div style="padding-top:8px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preliminary voting results will be announced at the annual meeting. Final voting results will be published in a Current Report on Form 8-K to be filed with the SEC within four business days after the annual meeting. If final voting results are not available to us in time to file a Form&#160;8-K within four business days after the meeting, we intend to file a Form&#160;8-K to publish preliminary results and, within four business days after the final results are known to us, file an amendment to the Form&#160;8-K to publish the final results.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">4</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s4BA1AA0E10CEE8A58721E760D0818730"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:5px;padding-top:5px;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">Proposal No. 1 E</font><font style="font-family:inherit;font-size:18pt;color:#ffffff;font-weight:bold;">lection</font><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:18pt;color:#ffffff;font-weight:bold;">of</font><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">&#160;D</font><font style="font-family:inherit;font-size:18pt;color:#ffffff;font-weight:bold;">irectors</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The persons named below have been nominated by our board of directors to serve as directors of the Company until the next annual meeting of stockholders and until their successors have been elected and qualified. The seven candidates receiving the highest number of affirmative votes of the shares entitled to vote at the annual meeting will be elected directors of the Company. As of the date of this proxy statement, our board of directors is not aware of any nominee who is unable to or will decline to serve as a director. If, however, any of those named are unable to serve at the time of the annual meeting, the proxyholders may exercise discretionary authority to vote for substitutes.</font></div><div style="line-height:150%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Nominees</font></div><div style="line-height:150%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td width="35%"></td><td width="1%"></td><td width="36%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td><td width="13%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Offices Held</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Year First</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Elected</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Director</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Age*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John W. Kozarich(N)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Chairman of the Board</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2003</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">66</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John L. Higgins</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Chief Executive Officer and Director</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2007</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">46</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Jason M. Aryeh(C)(N)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2006</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Todd C. Davis(C)</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Director</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2007</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John L. LaMattina(C)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">66</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Sunil Patel(A)</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Director</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2010</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">44</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stephen L. Sabba(A)(N)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2008</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56</font></div></td></tr></table></div></div><div style="line-height:150%;text-align:left;padding-left:48px;text-indent:-12px;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:2px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:150%;font-size:8pt;padding-left:36px;"><font style="font-family:inherit;font-size:8pt;">&#160;*&#160;</font></div></td><td style="vertical-align:top;"><div style="line-height:150%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#32;&#32;&#32;As of March 29, 2016</font></div></td></tr></table><div style="line-height:150%;text-align:left;padding-left:48px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(A)  Member of the audit committee</font></div><div style="line-height:150%;text-align:left;padding-left:48px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(C)  Member of the compensation committee</font></div><div style="line-height:150%;text-align:left;padding-left:48px;text-indent:-12px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(N)  Member of the nominating and corporate governance committee</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mr. David Knott, 72, has decided not to stand for reelection. Mr. Knott has served on our board of directors since 2007 and is currently a member of our audit committee, as well as our designated &#8220;audit committee financial expert.&#8221; Effective as of the 2016 annual meeting, our board will reduce the size of the board from eight to seven members and will appoint one of our remaining independent directors to the audit committee. Proxies cannot be voted for more than seven people which is the number of nominees named herein.</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Business Experience of Director Nominees</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jason M.&#160;Aryeh&#160;has served as a member of Ligand&#8217;s board of directors since September 2006. He is the founder and managing general partner of JALAA Equities, LP,&#160;a private hedge fund focused on the life sciences&#160;sector, and has served in such capacity since 1997. Mr.&#160;Aryeh&#160;serves as the Chairman of the board and a director of QLT Inc. and has served as the Chairman of both its Corporate Governance and Nominating Committee and its Strategic Action Committee. Mr.&#160;Aryeh&#160;also serves on the board of directors of&#160;CorMatrix&#160;Cardiovascular a medical device company,&#160;where he is Chairman of CorMatrix's Audit Committee and serves on its Compensation Committee,&#160; Aralez Pharmaceuticals, where he is Chairman of the Transaction Committee and serves on its Compensation Committee and the Cystic Fibrosis Foundation&#8217;s Therapeutics Board. Previously, Mr.&#160;Aryeh&#160;served as a director of both&#160;Nabi&#160;Biopharmaceuticals, prior to its merger with Biota Pharmaceuticals, Inc. in November 2012, and of&#160;Myrexis, Inc., both of which were public biotechnology companies. Mr.&#160;Aryeh&#160;earned a B.A. in economics, with honors, from Colgate University, and is a member of the&#160;Omnicron&#160;Delta Epsilon Honor Society in economics. In selecting Mr.&#160;Aryeh&#160;to serve as a director, the board considered, among other things, his valuable capital markets experience, including his service as managing general partner of a&#160;hedge fund focused on the life sciences sector. The Company also benefits from Mr.&#160;Aryeh&#8217;s&#160;involvement in the biotechnology industry through his current and former positions as a director of multiple life science organizations including: &#160;QLT Inc.,&#160;Aralez Pharmaceuticals, CorMatrix&#160;Cardiovascular, the Cystic Fibrosis Foundation's Therapeutics board,&#160;NabiBiopharmaceuticals and&#160;Myrexis, Inc.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Todd C. Davis has served as a member of Ligand&#8217;s board of directors since March 2007.  He is a Founding Managing Director of HealthCare Royalty Partners, a global healthcare investment firm. He has over 32 years of experience working in </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">5</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s4BA1AA0E10CEE8A58721E760D0818730"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and investing in the pharmaceutical and biotechnology industries. Over the course of his career, Mr. Davis has been involved in over $2 billion in healthcare deals and nearly $1 billion in royalty financings. He has also led, structured and closed over 40 additional intellectual property licenses, as well as growth equity, and debt deals. Previously, from 2004 to 2006, Mr. Davis was a partner at Paul Capital Partners, where he co-managed that firm&#8217;s royalty investments as a member of the royalty management committee. He also served as a partner responsible for biopharmaceutical growth equity investments at Apax Partners from 2001 to 2004. Prior to beginning his principal investment career in 2001, Mr. Davis held various sales and product management roles at Abbott Laboratories and worked in business development, operations and licensing at Elan Pharmaceuticals. He currently serves on the boards of Suneva Medical, Inc. and Helomics, Inc.  Mr. Davis holds a B.S. from the U.S. Naval Academy and an M.B.A. from Harvard University. In selecting Mr.&#160;Davis to serve as a director, the board considered, among other things, his valuable prior experience as a director of several public and private companies. Ligand also benefits from Mr.&#160;Davis' financial and accounting expertise and leadership experience within the biotechnology industry.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John L. Higgins is the Chief Executive Officer of Ligand Pharmaceuticals Incorporated, a position he has held since January 2007 and he has been a member of Ligand&#8217;s board of directors since March 2007.  Prior to joining Ligand, Mr. Higgins served as Chief Financial Officer at Connetics Corporation, a specialty pharmaceutical company, since 1997, and also served as Executive Vice President, Finance and Administration and Corporate Development at Connetics until its acquisition by Stiefel Laboratories, Inc. in December 2006. Before joining Connetics, he was a member of the executive management team at BioCryst Pharmaceuticals. Prior to BioCryst, Mr. Higgins was a member of the healthcare banking team of Dillon, Read &amp; Co. Inc., an investment banking firm.  Mr. Higgins serves as Chairman of CoMentis, Inc., a biopharmaceutical company and serves on the board, audit and compensation committees of BioTechne, a company with a market capitalization of over $3 billion. Mr. Higgins has served as a director of numerous public and private companies.  He graduated Magna Cum Laude from Colgate University with an A.B. in economics. In selecting Mr. Higgins to serve as a director, the board considered, among other things, his valuable experience operating and managing public biotechnology companies, his prior service on other company boards and his financial transaction experience as an investment banker. Ligand also benefits from Mr. Higgins' financial experience in leadership roles at companies within the biopharmaceutical industry.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John W. Kozarich, Ph.D., has served as a member of Ligand&#8217;s board since March 2003. Dr. Kozarich is Chairman and President of ActivX Biosciences in La Jolla. From 1992 to 2001, he was vice president at Merck Research Laboratories and previously held professorships at the University of Maryland and Yale University School of Medicine. Dr. Kozarich is also an adjunct professor of Chemical Physiology at the Scripps Research Institute and serves on boards, including QLT Inc., Retrophin, Inc. and the Board of Trustees of the Gordon Research Conferences.  Previously, Dr. Kozarich served as a director of Corium Intl. He is also a recent recipient of the Distinguished Scientist Award from the San Diego Section of the American Chemical Society. Dr. Kozarich earned his B.S. in chemistry, summa cum laude, from Boston College, his Ph.D. in biological chemistry from the Massachusetts Institute of Technology, and was an NIH Postdoctoral Fellow at Harvard. In selecting Dr.&#160;Kozarich to serve as a director, the board considered, among other things, his valuable pharmaceutical and international experience, including his service at Merck Research Laboratories, which is part of one of the world&#8217;s largest pharmaceutical companies, and his service with ActivX Biosciences, Inc., QLT Inc. and Corium Intl. Ligand also benefits from Dr.&#160;Kozarich&#8217;s financial and accounting experience in the pharmaceutical and biotechnology industries.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John L. LaMattina, Ph.D., has served as a member of Ligand&#8217;s board since February 2011.  He spent 30 years at Pfizer Inc. beginning as a medicinal chemist in 1977. During his career, he was appointed to various positions of increasing responsibility for Pfizer Central Research, including Vice President of U.S. Discovery Operations in 1993, Senior Vice President of Worldwide Discovery Operations in 1998, Senior Vice President of Worldwide Development in 1999, and President, Pfizer Global R&amp;D in 2004. Dr. LaMattina graduated with cum laude honors from Boston College with a B.S. in Chemistry. He received a Ph.D. from the University of New Hampshire in Organic Chemistry and subsequently was at Princeton University in the National Institutes of Health Postdoctoral Fellowship program. Dr. LaMattina is currently a senior partner at PureTech Ventures and serves on the board of directors of PureTech Health, Gelesis and Vedanta.  Additionally, Dr. LaMattina serves as a director of Zafgen, Inc. and is on the Scientific Advisory Board for Trevena. Dr. LaMattina is a respected commentator on the biopharmaceutical industry on Forbes.com as well as with his books, most recently Devalued &amp; Distrusted - Can the Pharmaceutical Industry Restore its Broken Image? In selecting Dr. LaMattina to serve as a director, the board considered, among other things, his valuable pharmaceutical and experience and experience as director of several biotech companies which provides the board with a broad leadership perspective. Ligand also benefits from Dr.&#160;LaMattina&#8217;s expert knowledge of the biopharmaceutical industry and his experience as strategic and scientific advisor.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sunil Patel has served as a member of Ligand&#8217;s board of directors since October 2010.  He has more than 20 years of senior management and R&amp;D experience in the biotechnology industry and is currently Chief Financial Officer, Senior Vice President Corporate Development &amp; Finance for OncoMed Pharmaceuticals, a development-stage company focused on </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">6</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s4BA1AA0E10CEE8A58721E760D0818730"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">therapeutics targeting cancer stem cells. Mr. Patel has held senior management positions in corporate development, marketing, and strategy with BiPar Sciences, Allos Therapeutics, Connetics, Abgenix and Gilead Sciences. Mr. Patel also worked at McKinsey &amp; Company serving biotech and pharmaceutical clients and has held scientific research positions at ZymoGenetics and ProCyte. Mr. Patel received his undergraduate degree in Chemistry at the University of California, Berkeley, and master&#8217;s degree in Molecular Bioengineering/Biotechnology at the University of Washington. In selecting Mr.&#160;Patel to serve as a director, the board considered, among other things, his valuable pharmaceutical and corporate development experience, including his service at OncoMed Pharmaceuticals. Ligand also benefits from Mr.&#160;Patel&#8217;s experience in serving as a senior member of management at both public and private biotechnology companies.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stephen L. Sabba, M.D., has served as a member of Ligand&#8217;s board of directors since August 2008.  Dr. Sabba has been a leading Bio/Pharma Analyst and Fund Manager for Knott Partners, L.P., an investment fund company, since November 2006. Previously he was a Partner and Director of Research with Kilkenny Capital Management, a Chicago-based biomedical hedge fund. Prior to that, Dr. Sabba was Director of Research at Sturza&#8217;s Medical Research, and previously was a gastroenterologist and internist in private practice at Phelps Memorial Hospital in North Tarrytown, New York. He received his medical degree from the New York University School of Medicine, and completed a residency in internal medicine and a fellowship in gastroenterology at the Veterans Administration Medical Center in New York City. He earned a B.S. with honors at Cornell University. Dr. Sabba has served as a member of the board of the directors for QLT Inc., a leading Canadian biotech company, since June 2012. In selecting Dr.&#160;Sabba to serve as a director, the board considered, among other things, his capital markets and accounting expertise gained from his prior experience working in the hedge fund and investment fund industries. Ligand also benefits from his background as a medical doctor and from his understanding of medicine.</font></div><div style="line-height:120%;padding-top:20px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Director Independence</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our board of directors has determined that, with the exception of Mr.&#160;Higgins, each of the directors is an independent director under the NASDAQ Global Market listing standards. The independent directors have two or more regularly scheduled executive sessions per year at which only the independent directors are present.</font></div><div style="line-height:120%;padding-top:16px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Board Meetings and Committees</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our board of directors held 2 in-person meetings and 6 telephonic meetings, and acted by unanimous written consent 4 times during the year ended December&#160;31, 2015. During such year, each incumbent director attended at least 92% of the aggregate number of meetings of our board of directors and the committees on which he served which were held during the periods in which he served. The Company does not have a policy regarding attendance of the directors at the annual meeting. At our 2015 annual meeting of stockholders, none of our then-current directors was in attendance.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our board of directors has an audit committee, a nominating and corporate governance committee and a compensation committee. Each committee is described below. Each of these committees has a written charter approved by our board of directors. A copy of each charter can be found in the &#8220;Investors&#8212;Corporate Governance&#8212;Committee Charters&#8221; section of our website at www.ligand.com. Our board of directors has determined that each member of these committees meets the applicable rules and regulations regarding independence and that each member is free of any relationship that would interfere with his or her individual exercise of independent judgment with regard to the Company.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The audit committee is primarily responsible for overseeing the Company&#8217;s accounting and financial reporting processes, auditing of financial statements, systems of internal control, and financial compliance programs. The audit committee currently consists of Messrs. Knott and Patel and Dr. Sabba (chair). Our board of directors will appoint one of our remaining independent directors to the audit committee on or prior to the 2016 annual meeting to replace Mr. Knott. The audit committee held 1 in-person meeting and 4 telephonic meetings during 2015. After reviewing the qualifications of all current committee members and any relationship they may have that might affect their independence from the Company, our board of directors has determined that (i)&#160;all current committee members are &#8220;independent&#8221; as defined under Section&#160;10A of the Securities Exchange Act of 1934, as amended, (ii)&#160;all current committee members are &#8220;independent&#8221; as defined under the applicable NASDAQ Global Market listing standards, (iii)&#160;all current committee members have the ability to read and understand financial statements and (iv)&#160;Mr.&#160;Knott qualifies as an &#8220;audit committee financial expert.&#8221; The latter determination is based on a qualitative assessment of his level of knowledge and experience based on a number of factors, including his formal education and experience.  </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">7</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s4BA1AA0E10CEE8A58721E760D0818730"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The nominating and corporate governance committee is responsible for identifying and recommending candidates for director of the Company. The nominating and corporate governance committee currently consists of Mr.&#160;Aryeh (chair) and Drs. Kozarich and Sabba. Each member of the nominating and corporate governance committee is an independent director under the NASDAQ Global Market listing standards. The nominating and corporate governance committee held 1 in-person meeting and 3 telephonic meetings during 2015.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The nominating and corporate governance committee considers nominees recommended by stockholders, if submitted in writing to the Secretary at the Company&#8217;s principal executive offices and accompanied by the author&#8217;s full name, current address and telephone number. The nominating and corporate governance committee has set no specific minimum qualifications for candidates it recommends, but considers each individual&#8217;s qualifications, such as high personal integrity and ethics, relevant expertise and professional experience, as a whole. The nominating and corporate governance committee and the board as a whole consider it beneficial to the Company to have directors with a diversity of backgrounds and skills. The nominating and corporate governance committee and the board as a whole have no formal policy with regard to the consideration of diversity in identifying director nominees. The nominating and corporate governance committee considers candidates throughout the year and makes recommendations as vacancies occur or the size of our board of directors expands. Candidates are identified from a variety of sources including recommendations by stockholders, current directors, management, and other parties. The nominating and corporate governance committee considers all such candidates in the same manner, regardless of source. Under its charter, the nominating and corporate governance committee may retain a search firm to identify and recommend candidates but has not done so to date.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation committee reviews and approves the Company&#8217;s compensation policies, sets executive officers&#8217; compensation and administers the Company&#8217;s stock option and stock purchase plans. The compensation committee consists of Messrs. Aryeh and Davis (chair) and Dr.&#160;LaMattina. Each member is an independent director under the NASDAQ Global Market listing standards. The compensation committee held 4 telephonic meetings and acted by unanimous written consent 2 times during 2015.</font></div><div style="line-height:120%;padding-top:20px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Board Leadership Structure</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our board of directors has nominated seven persons to serve as directors of the Company until the next annual meeting of stockholders, six of whom are independent. We separate the roles of chief executive officer and chairman of our board of directors in recognition of the differences between the two roles. The chief executive officer is responsible for setting the strategic direction for the Company and the day-to-day leadership and performance of the Company, while the chairman of our board of directors provides guidance to the chief executive officer and presides over meetings of the full board of directors. We believe that this separation of responsibilities provides a balanced approach to managing the board of directors and overseeing the Company.</font></div><div style="line-height:120%;padding-top:20px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Board&#8217;s Role in Risk Oversight</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our board of directors is actively involved in oversight of risks that could affect the Company. The board&#8217;s role in our risk oversight process includes receiving regular reports from members of senior management on areas of material risk to the Company, including risks associated with our operational, financial, legal and regulatory functions. The full board (or the appropriate board committee in the case of risks that are under the purview of a particular committee) receives these reports from the appropriate &#8220;risk owner&#8221; within the organization to enable it to understand our risk identification, risk management and risk mitigation strategies. When a board committee engages in a discussion related to areas of material risk to the Company, the chairperson of the relevant committee reports on the discussion to the full board during the committee reports portion of the next board meeting. This enables the board and its committees to coordinate the risk oversight role.</font></div><div style="line-height:120%;padding-top:20px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Communicating with the Board of Directors</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders may communicate with our board of directors or individual directors by mail, in care of the Secretary, at the Company&#8217;s principal executive offices. Letters are distributed to the board of directors, or to any individual director or directors as appropriate, depending on the content of the letter. However, items that are unrelated to the duties and responsibilities of the board of directors will be excluded. In addition, material that is illegal, inappropriate or similarly unsuitable will be excluded. Any letter that is filtered out under these standards, however, will be made available to any director upon request.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">8</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s4BA1AA0E10CEE8A58721E760D0818730"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:20px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Recommendation of the Board of Directors</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The board of directors unanimously recommends a vote FOR the nominees listed above.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">9</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sD8FC00B1A78284980544E760CF1AB04C"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:24px;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:5px;text-align:left;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">Proposal No. 2 Ratification of Independent Registered Public Accounting Firm</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You are being asked to ratify the selection of Grant Thornton LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2016. Neither the firm nor any of its members has any relationship with the Company or any of its affiliates, except in the firm&#8217;s capacity as the Company&#8217;s independent registered public accounting firm.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholder ratification of the selection of Grant Thornton LLP as the Company&#8217;s independent registered public accounting firm is not required by Delaware law, the Company&#8217;s certificate of incorporation, the Company&#8217;s amended and restated bylaws, or otherwise. However, the board of directors is submitting the selection of Grant Thornton LLP to the stockholders for ratification as a matter of good corporate practice. In the event the stockholders fail to ratify the selection, the board of directors will reconsider its selection. Even if the selection is ratified, the board of directors or its audit committee, in its discretion, may direct the appointment of a different independent auditing firm at any time during the year if such a change would be in the Company&#8217;s and its stockholders&#8217; best interests.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Representatives of Grant Thornton LLP are expected to be present at the annual meeting, and will have the opportunity to make a statement if they desire to do so and are expected to be available to respond to appropriate questions. The affirmative vote of the holders of a majority of the shares represented and voting at the annual meeting will be required to ratify the selection of Grant Thornton LLP.</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Independent Auditor&#8217;s Fees</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a summary of the fees incurred by the Company from Grant Thornton LLP, the Company&#8217;s independent registered public accounting firm for the fiscal years ended December&#160;31, 2015 and 2014:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td width="67%"></td><td width="1%"></td><td width="1%"></td><td width="14%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fee Category</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015 Fees</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014 Fees</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Audit Fees(1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">625,856</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">473,290</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Audit-related fees(2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70,062</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Tax Fees(3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">422,268</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">289,843</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Fees</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,118,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">763,133</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><div style="line-height:120%;padding-left:24px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;padding-top:2px;text-align:left;padding-left:36px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1)    Audit fees consist of fees for professional services rendered for the audit of the Company&#8217;s consolidated annual financial statements and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided in connection with statutory and regulatory filings or engagements. In 2015 and 2014, audit fees included fees for professional services rendered for the audits of (i)&#160;management&#8217;s assessment of the effectiveness of internal control over financial reporting and (ii)&#160;the effectiveness of internal control over financial reporting, (iii) comfort letters, consents, and assistance with and review of documents filed with the SEC, and (iv) other accounting and financial reporting consultation and research work necessary to comply with the standards of the PCAOB.</font></div><div style="line-height:130%;padding-top:2px;text-align:left;padding-left:36px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2)     Audit-related fees consist of professional services rendered for assistance with tax related due diligence work related to the acquisition of Open Monoclonal Technology, Inc.</font></div><div style="line-height:130%;text-align:left;padding-left:36px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3)    Tax fees consist of fees for professional services rendered for assistance with federal, state and international tax compliance and tax consulting projects including the  analysis of our net operating loss carryforwards, Research and Development tax credit analysis and international tax planning.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In considering the nature of the services provided by Grant Thornton LLP during the 2015 fiscal year, the audit committee determined that such services are compatible with the provision of independent audit services.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The audit committee discussed these services with Grant Thornton LLP and the Company&#8217;s management to determine that they are permitted under the rules and regulation concerning auditor independence promulgated by the SEC to implement the Sarbanes-Oxley Act of 2002, as well as the American Institute of Certified Public Accountants.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All services performed by Grant Thornton LLP in 2015 and 2014 were pre-approved in accordance with the requirements of the audit committee charter.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">10</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sD8FC00B1A78284980544E760CF1AB04C"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Except as stated above, there were no other fees charged by Grant Thornton for 2015 and 2014. The audit committee considers the provision of these services to be compatible with maintaining the independence of Grant Thornton LLP. None of the fees paid to Grant Thornton LLP under the category &#8220;Tax Fees&#8221; described above were approved by the audit committee after services were rendered pursuant to the de minimis exception established by the SEC.</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Audit Committee Policy Regarding Pre-Approval of Audit and Permissible Non-Audit Services of Our Independent Registered Public Accounting Firm</font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our audit committee has established a policy that all audit and permissible non-audit services provided by our independent registered public accounting firm will be pre-approved by the audit committee. These services may include audit services, audit-related services, tax services and other services. The audit committee considers whether the provision of each non-audit service is compatible with maintaining the independence of our auditors. Pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget. Our independent registered public accounting firm and management are required to periodically report to the audit committee regarding the extent of services provided by the independent registered public accounting firm in accordance with this pre-approval, and the fees for the services performed to date.</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Recommendation of the Board of Directors</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our board of directors unanimously recommends that stockholders vote </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FOR</font><font style="font-family:inherit;font-size:10pt;">&#32;the ratification of the selection of Grant Thornton LLP to serve as the Company&#8217;s independent registered public accounting firm for the year ending December&#160;31, 2016.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">11</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:24px;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:5px;padding-top:5px;text-align:left;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">Proposal No. 3 Approval of the Amendment and Restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are asking our stockholders to approve the amendment and restatement of the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan, or the 2002 Plan. The amended and restated 2002 Plan is referred to herein as the Restated Equity Plan. The Restated Equity Plan was adopted by our board on April 5, 2016, subject to stockholder approval. The Restated Equity Plan will become effective if it is approved by the stockholders at the annual meeting. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The proposed amendments to the 2002 Plan would: </font></div><div style="line-height:120%;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Increase the Share Reserve</font><font style="font-family:inherit;font-size:10pt;">. We are asking our stockholders to approve an increase of 900,000 in the number of shares available for issuance under the Restated Equity Plan over the existing share reserve under the 2002 Plan. Accordingly, the Restated Equity Plan authorizes the issuance of an aggregate of 5,479,254 shares of common stock. As of March 29, 2016, awards covering a total of 2,228,738 shares were subject to outstanding awards under the 2002 Plan and 41,808 shares remained available for future grants under the 2002 Plan. </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the terms of the Restated Equity Plan, the shares available for issuance may be used for all types of awards under a fungible pool formula. Pursuant to this fungible pool formula, the authorized share limit will be reduced by one share of common stock for every one share subject to an option or stock appreciation right, or SAR, outstanding under the Restated Equity Plan and 1.5 shares of common stock for every one share subject to a &#8220;full-value award&#8221; under the Restated Equity Plan. For purposes of the Restated Equity Plan, a full-value award is an award pursuant to which shares of our common stock are issuable that is granted with a per-share exercise or purchase price less than 100% of the fair market value of a share of our common stock on the date of grant. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The proposed increase in shares available for issuance under the Restated Equity Plan (over the existing share reserve under the 2002 Plan) has been reviewed and approved by our board. In the process, the board determined that the existing number of shares available for issuance under the 2002 Plan was insufficient to meet our ongoing needs to provide long-term incentive grants on an ongoing and regular basis to motivate, reward and retain key employees who create stockholder value. The increase in shares has been necessitated by the hiring of new employees, and by granting additional stock awards to current employees as long-term incentives. The increase will enable us to continue our policy of equity ownership by employees and directors as an incentive to contribute to our continued success. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Extend the Term</font><font style="font-family:inherit;font-size:10pt;">. The Restated Equity Plan will have a term of ten years from the date it was adopted by our board. </font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Limit on Director Compensation</font><font style="font-family:inherit;font-size:10pt;">. The Restated Equity Plan establishes an annual limit on the compensation that may be paid to a non-employee director in any one calendar year. </font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Clawback Policy</font><font style="font-family:inherit;font-size:10pt;">.  Under the Restated Equity Plan, all awards are subject to the provisions of any claw-back policy implemented by the Company, including, without limitation, any claw-back policy adopted to comply with the requirements of applicable laws, including, without limitation, the Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules or regulations promulgated thereunder.</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">162(m) Approval and Approval of Material Terms of Performance Goals</font><font style="font-family:inherit;font-size:10pt;">. We are also seeking stockholder approval of the Restated Equity Plan to satisfy the stockholder approval requirements of Section 162(m) of the Code, or Section 162(m), and to approve the material terms of the performance goals for awards that may be granted under the Restated Equity Plan as required under Section 162(m). In general, Section 162(m) places a limit on the deductibility for federal income tax purposes of the compensation paid to our Chief Executive Officer or any of our three other most highly compensated executive officers (other than our Chief Financial Officer). Under Section 162(m), compensation paid to such persons in excess of $1 million in a taxable year generally is not deductible. However, compensation that qualifies as &#8220;performance-based&#8221; under Section 162(m) does not count against the $1 million deduction limitation. One of the requirements of &#8220;performance-based&#8221; compensation for purposes of Section 162(m) is that the material terms of the plan under which compensation may be paid be disclosed to and approved by our public stockholders. For purposes of Section 162(m), the material terms include (1) the employees eligible to receive compensation, (2) a description of the business criteria on which the performance goals may be based and (3) the maximum amount of compensation that can be paid to an employee under the performance goals. Each of these </font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">12</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">aspects of the Restated Equity Plan is discussed below, and stockholder approval of this Proposal 3 is intended to constitute approval of the material terms of the Restated Equity Plan for purposes of the stockholder approval requirements of Section 162(m).  </font></div><div style="line-height:120%;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholder approval of the Restated Equity Plan is only one of several requirements under Section 162(m) that must be satisfied for amounts realized under the Restated Equity Plan to qualify for the &#8220;performance-based&#8221; compensation exemption under Section 162(m), and submission of the material terms of the Restated Equity Plan performance goals for stockholder approval should not be viewed as a guarantee that we will be able to deduct all compensation under the Restated Equity Plan. Nothing in this proposal precludes us or the plan administrator from making any payment or granting awards that do not qualify for tax deductibility under Section 162(m).</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Restated Equity Plan is not being materially amended in any respect other than to reflect the changes described above. </font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Why the Stockholders Should Vote to Approve the Restated Equity Plan </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Incentive Awards Are an Important Part of Our Compensation Philosophy</font><font style="font-family:inherit;font-size:10pt;">.  Our equity compensation plans are critical to our ongoing effort to build stockholder value. As discussed in the Compensation Discussion and Analysis section of this proxy statement, equity incentive awards are central to our compensation program. Our board and its compensation committee believe that our ability to grant equity incentive awards to new and existing employees, directors and eligible consultants has helped us attract, retain and motivate world-class talent. Historically, we have primarily issued stock options and restricted stock units because these forms of equity compensation provide a strong retention value and incentive for employees to work to grow the business and build stockholder value, and are attractive to employees who share the entrepreneurial spirit that has made us a success. </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Also, our equity incentive programs are broad-based. The equity incentive programs we have in place have worked to build stockholder value by attracting and retaining talented employees. We believe we must continue to offer a competitive equity compensation plan in order to attract and motivate the talent necessary for our continued growth and success. As of March 29, 2016, all of our 21 employees and all of our eight non-employee directors held outstanding equity awards. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The 2002 Plan Will No Longer Have Shares Available for Grant</font><font style="font-family:inherit;font-size:10pt;">. Under our current forecasts, the 2002 Plan will run out of shares available for grant within the next 12 months, and we will not be able to continue to issue equity to our employees and directors unless our stockholders approve the Restated Equity Plan. This assumes we continue to grant awards consistent with our historical usage and current practices, as reflected in our historical burn rate discussed below, and noting that future circumstances may require us to change our current equity grant practices. While we could increase cash compensation if we are unable to grant equity incentives, we anticipate that we will have difficulty attracting, retaining and motivating our employees and directors if we are unable to make equity grants to them.</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">We Manage Our Equity Incentive Award Use Carefully</font><font style="font-family:inherit;font-size:10pt;">. We manage our long-term stockholder dilution by limiting the number of equity awards granted annually. Our compensation committee carefully monitors our total dilution and equity expense to ensure that we maximize stockholder value by granting only the appropriate number of equity awards necessary to attract, reward and retain employees. The following table summarizes the awards outstanding and shares available for grant under the 2002 Plan as of March 29, 2016, and the proposed increase in shares authorized for issuance under the Restated Equity Plan:</font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">13</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="58%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="14%"></td><td width="1%"></td><td width="13%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">of Shares </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As a % of Shares</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Dollar</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,880,327</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0%</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$197,152</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Weighted average exercise price of outstanding options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.50</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Weighted average remaining term (in years) of outstanding options</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.66</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">348,411</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$36,531</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares available for grant</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,808</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2%</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4,384</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proposed increase in shares available for issuance under Restated Equity Plan (over existing share reserve under 2002 Plan)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">900,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$94,365</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)   Excludes the shares available for grant under our Employee Stock Purchase Plan, as amended and restated.</font></div><div style="line-height:120%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2)   Based on 20,815,636 shares of our common stock outstanding as of March 29, 2016. </font></div><div style="line-height:120%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)   Based on the closing price of our common stock on March 29, 2016, of $104.85 per share (in thousands). </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units that are subject to performance-based vesting are reflected assuming &#8220;maximum&#8221; performance.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In determining whether to approve the Restated Equity Plan, including the proposed increase to the share reserve under the Restated Equity Plan over the share reserve under the existing 2002 Plan, our board considered the following: </font></div><div style="line-height:120%;text-align:justify;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;The 5,479,254 shares to be reserved for issuance under the Restated Equity Plan will represent an increase of 900,000 shares from the aggregate number of shares reserved for issuance and that remain available for future grant under the 2002 Plan as of March 29, 2016.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In determining the size of the share reserve under the Restated Equity Plan, our board considered the number of equity awards we granted during the past three calendar years.  In calendar years 2013, 2014 and 2015, our annual equity burn rates (calculated by dividing (1) the number of shares subject to equity awards granted during the year by (2) the weighted-average number of diluted shares outstanding at the end of the applicable year) under the 2002 Plan were 2.6%, 2.1% and 1.9%, respectively. If each &#8220;full-value award&#8221; is multiplied by 1.5 (consistent with the methodology employed pursuant to the fungible share ratio in the Restated Equity Plan), the &#8220;adjusted&#8221; annual burn rate under the 2002 Plan would be 4.0%, 3.2% and 2.8% for calendar years 2013, 2014 and 2015, respectively. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We expect the proposed aggregate share reserve under the Restated Equity Plan to provide us with enough shares for awards for approximately two years, assuming we continue to grant awards consistent with our current practices and historical usage, as reflected in our historical burn rate, and further dependent on the price of our shares and hiring activity during the next few years, forfeitures of outstanding awards under the 2002 Plan, and noting that future circumstances may require us to change our current equity grant practices. We cannot predict our future equity grant practices, the future price of our shares or future hiring activity with any degree of certainty at this time, and the share reserve under the Restated Equity Plan could last for a shorter or longer time. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In calendar years 2013, 2014 and 2015, the end of year overhang rate (calculated by dividing (1) the sum of the number of shares subject to equity awards outstanding at the end of the calendar year plus shares remaining available for issuance for future awards at the end of the calendar year by (2) the number of shares outstanding at the end of the calendar year) was 16.2%, 15.1%, and 12.9%, respectively. If the Restated Equity Plan is approved, we expect our overhang at the end of 2016 will be approximately 14.9% (excluding the 72,367 shares that remain available for issuance under the Employee Stock Purchase Plan as of March 29, 2016).</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Analysis by our compensation consultant, which was based on generally accepted evaluation methodologies used by proxy advisory firms, that the additional number of shares to be reserved under the Restated Equity Plan is within generally accepted standards as measured by an analysis of the Restated Equity Plan cost relative to industry standards.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:76px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In light of the factors described above, and the fact that the ability to continue to grant equity compensation is vital to our ability to continue to attract and retain highly qualified individuals in the extremely competitive labor markets in which we compete, our board has determined that the size of the share reserve under the Restated Equity Plan is reasonable and </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">14</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">appropriate at this time. Our board will not create a subcommittee to evaluate the risk and benefits for issuing shares under the Restated Equity Plan.</font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Restated Equity Plan Contains Equity Compensation Best Practices </font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Restated Equity Plan authorizes the issuance of equity-based compensation in the form of stock options, SARs, restricted shares, restricted stock units, dividend equivalents, stock payments and performance-based awards structured by the compensation committee within parameters set forth in the Restated Equity Plan, for the purpose of providing our directors, officers, employees and consultants equity compensation, incentives and rewards for superior performance. Some of the key features of the Restated Equity Plan that reflect our commitment to effective management of incentive compensation and that are consistent with best practices in equity compensation to protect our stockholders&#8217; interests are as follows:</font></div><div style="line-height:120%;text-align:left;padding-left:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Broad-based eligibility for equity awards</font><font style="font-family:inherit;font-size:10pt;">. We grant equity awards to all of our full-time employees. By doing so, we link employee interests with stockholder interests throughout the organization and motivate our employees to act as owners of the business. As of March 29, 2016, all of our 21 employees and all of our eight non-employee directors received grants of equity awards.  No consultants held any equity awards.</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stockholder approval is required for additional shares</font><font style="font-family:inherit;font-size:10pt;">. The Restated Equity Plan does not contain an annual &#8220;evergreen&#8221; provision. The Restated Equity Plan authorizes a fixed number of shares, so that stockholder approval is required to increase the maximum number of securities which may be issued under the Restated Equity Plan. </font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">No Re-pricing or Replacement of Options or Stock Appreciation Rights</font><font style="font-family:inherit;font-size:10pt;">. The Restated Equity Plan prohibits, without stockholder approval: (1) the amendment of awards to reduce the exercise price, and (2) the replacement of an option or SAR with cash, any other award or an option or SAR with an exercise price that is less than the exercise price per share of the original option or SAR. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">No In-the-Money Option or Stock Appreciation Right Grants</font><font style="font-family:inherit;font-size:10pt;">. The Restated Equity Plan prohibits the grant of options or SARs with an exercise or base price less than the fair market value of our common stock, generally the closing price of our common stock, on the date of grant. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Section 162(m) Qualification</font><font style="font-family:inherit;font-size:10pt;">. The Restated Equity Plan is designed to allow awards made under the Restated Equity Plan to qualify as performance-based compensation under Section 162(m) of the Code. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Limitations on Dividend Payments on Performance Awards</font><font style="font-family:inherit;font-size:10pt;">. Dividends and dividend equivalents may be paid on awards subject to performance vesting conditions only to the extent such conditions are met.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Limitations on Grants</font><font style="font-family:inherit;font-size:10pt;">. No one person participating in the Restated Equity Plan may receive awards for more than 1,000,000 shares of common stock in the aggregate per calendar year.</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Non-Employee Director Compensation Limit</font><font style="font-family:inherit;font-size:10pt;">.  The sum of any cash compensation, or other compensation, and the grant date fair value of awards granted to a non-employee director for services as a non-employee director during any calendar year, generally may not exceed $550,000 (which limit will be increased to $850,000 in the calendar year of his or her initial service as a non-employee director).</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">No Tax Gross-Ups</font><font style="font-family:inherit;font-size:10pt;">.  The Restated Equity Plan does not provide for any tax gross-ups.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Independent Administration</font><font style="font-family:inherit;font-size:10pt;">. The compensation committee of the board, which consists of only independent directors, will administer the Restated Equity Plan if it is approved by stockholders. </font></div></td></tr></table><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholder Approval Requirement</font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholder approval of the Restated Equity Plan is necessary in order for us to (1) meet the stockholder approval requirements of Nasdaq, (2) take tax deductions for certain compensation resulting from awards granted thereunder intended to qualify as performance-based compensation under Section 162(m), and (3) grant incentive stock options, or ISOs, thereunder. </font></div><div style="line-height:120%;text-align:left;padding-left:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Specifically, approval of the Restated Equity Plan will constitute approval of the material terms of the Restated Equity Plan pursuant to the stockholder approval requirements of Section 162(m), as discussed above, which will enable (but not require) </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">15</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">us to award performance-based compensation within the meaning of Section 162(m) under the Restated Equity Plan, preserving the deductibility of these awards for federal income tax purposes. In addition, approval of the Restated Equity Plan will constitute approval pursuant to the stockholder approval requirements of Section 422 of the Code relating to ISOs.</font></div><div style="line-height:120%;text-align:left;padding-left:28px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If the Restated Equity Plan is not approved by our stockholders, the Restated Equity Plan will not become effective, the existing 2002 Plan will continue in full force and effect, and we may continue to grant awards under the existing 2002 Plan, subject to its terms, conditions and limitations, using the shares available for issuance thereunder.</font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Summary of the Restated Equity Plan </font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a summary of the principal features of the Restated Equity Plan, assuming approval of this proposal. The summary, however, is not a complete description of all the provisions of the Restated Equity Plan. The proposed Restated Equity Plan is attached to this proxy statement as </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Appendix A</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Plan Structure </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Restated Equity Plan contains three separate equity programs; the Discretionary Option Grant Program, the Stock Issuance Program and the Other Stock Awards Program. </font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Administration </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Restated Equity Plan will be administered by the compensation committee of the board. This committee has complete discretion, subject to the provisions of the Restated Equity Plan, to authorize awards under the Restated Equity Plan to all eligible persons other than non-employee members of our board. However, the board may also appoint a secondary committee of one or more members of our board of directors to have separate but concurrent authority to make awards under those programs to all eligible individuals other than our executive officers and non-employee members of our board of directors. The full board will administer the Restated Equity Plan with respect to awards to the non-employee members of our board of directors. The term &#8220;Plan Administrator,&#8221; as used in this proxy statement, will mean the board, the compensation committee or any secondary committee, to the extent each such entity is acting within the scope of its duties under the Restated Equity Plan. </font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Eligibility </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Officers and employees of Ligand and its subsidiaries, whether now existing or subsequently established, non-employee members of our board of directors and consultants and independent contractors of Ligand and its parent and subsidiaries are eligible to participate in the Restated Equity Plan. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of March 29, 2016, all 21 of our employees and all eight non-employee members of our board of directors were eligible to receive awards under the 2002 Plan, and would have been eligible to receive awards under the Restated Equity Plan had it been in effect on such date.  No consultants held equity awards.</font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Shares Available</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are asking our stockholders to approve an increase of 900,000 in the number of shares available for issuance under the Restated Equity Plan over the share reserve under the existing 2002 Plan. The Restated Equity Plan will authorize the issuance of an aggregate of 5,479,254 shares of common stock, reduced by (1) one share for each share subject to a stock option or SAR and (2) 1.5 shares for each share subject to a full-value award. As of March 29, 2016, 41,808 shares of common stock remained available for future issuance under the 2002 Plan and 2,228,738 shares were subject to outstanding awards under the 2002 Plan.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If (1) any award is forfeited or expires or such award is settled for cash, (2) any shares subject to a full-value award are forfeited by the holder or repurchased by us at a price not greater than the price paid by the holder of such shares, or (3) any shares are tendered or withheld to satisfy any tax withholding obligation with respect to a full-value award, then the shares subject to such award may, to the extent of such forfeiture, expiration, cash settlement or repurchase, be used again for new grants under the Restated Equity Plan. Any shares that again become available for grant will be added back as (1) one share if such shares were subject to an option or SAR, and (2) as 1.5 shares if such shares were subject to full-value </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">16</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">awards. The payment of dividend equivalents in cash in conjunction with any outstanding awards will not be counted against the shares available for issuance under the Restated Equity Plan. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notwithstanding the foregoing, the following shares will not be added to the shares authorized for grant under the Restated Equity Plan: (1) any shares tendered or withheld to satisfy the exercise price of an option or any tax withholding obligation with respect to an option or SAR, (2) any shares subject to a SAR that are not issued in connection with the stock settlement of the SAR on its exercise, and (3) any shares purchased on the open market with the cash proceeds from the exercise of options. </font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adjustments </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Should any change be made to the common stock issuable under the Restated Equity Plan by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding common stock as a class without our receipt of consideration, or as a result of a change in ownership or control of Ligand, then appropriate adjustments will be made to: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the maximum number and/or class of securities issuable under the Restated Equity Plan;</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the maximum number and/or class of securities for which any one person may be granted awards per calendar year under the Restated Equity Plan;</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the number and/or class of securities for which grants are subsequently to be made under an automatic option grant program to new and continuing non-employee members of the board of directors;</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the number and/or class of securities and price per share in effect under each outstanding award; and</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">terms and conditions of any outstanding awards (including, without limitation, any applicable performance targets or criteria with respect thereto).</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, equitable adjustments will be made to outstanding awards in the event a large non-recurring cash dividend is paid to our stockholders, which affects the common stock or share price of the common stock underlying the awards subject to the Restated Equity Plan. Such adjustments to the outstanding awards will be effected in a manner which will preclude the enlargement or dilution of rights and benefits under those awards. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Valuation </font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair market value per share of common stock on any relevant date under the Restated Equity Plan will be deemed to be equal to the closing selling price per share on that date on the NASDAQ Global Market. If there is no reported selling price for such date, then the fair market value per share will be the closing selling price on the last preceding date for which such quotation exists. On March 29, 2016, the closing selling price per share was $104.85. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Discretionary Grant Program </font></div><div style="line-height:120%;padding-top:16px;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Grants </font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Plan Administrator has complete discretion under the Discretionary Option Grant Program to determine which eligible individuals are to receive option grants, the time or times when those grants are to be made, the number of shares subject to each such grant, the status of any granted option as either an ISO or a non-statutory option under the federal tax laws, the time or times when each option is to become exercisable, the vesting schedule (if any) to be in effect for the option grant and the maximum term (up to 10 years) for which any granted option is to remain outstanding. </font></div><div style="line-height:120%;padding-top:16px;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Price and Exercisability </font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each granted option will have an exercise price per share not less than 100% of the fair market value per share of common stock on the option grant date, and no granted option will have a term in excess of 10 years. The shares subject to each option will generally become exercisable for fully-vested shares in a series of installments over a specified period of service measured from the grant date. However, one or more options may be structured so that </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">17</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">they are immediately exercisable for any or all of the option shares. The shares acquired under such immediately-exercisable options will normally be unvested and subject to repurchase by us, at the lower of (1) the exercise price paid per share or (2) the fair market value per share of common stock at the time of cessation of service if the optionee ceases service with us prior to vesting in those shares. </font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The exercise price may be paid in cash or check, in shares of common stock or, in the Plan Administrator&#8217;s discretion, by issuance of a promissory note. Outstanding options may also be exercised through a same-day sale program pursuant to which a designated brokerage firm is to effect an immediate sale of the shares purchased under the option and pay to us, out of the sale proceeds available on the settlement date, sufficient funds to cover the exercise price for the purchased shares plus all applicable withholding taxes. </font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No optionee has any stockholder rights with respect to the option shares until such optionee has exercised the option and paid the exercise price for the purchased shares. Options are generally not assignable or transferable other than by will or the laws of inheritance and, during the optionee&#8217;s lifetime, the option may be exercised only by such optionee. However, the Plan Administrator may allow non-statutory options to be transferred or assigned during the optionee&#8217;s lifetime to one or more members of the optionee&#8217;s immediate family or to a trust established exclusively for one or more such family members or to the optionee&#8217;s former spouse, to the extent such transfer or assignment is in furtherance of the optionee&#8217;s estate plan or pursuant to a domestic relations order. The optionee may also designate one or more beneficiaries to automatically receive his or her outstanding options at death. </font></div><div style="line-height:120%;padding-top:16px;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Termination of Service </font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon cessation of service, the optionee will have a limited period of time in which to exercise his or her outstanding options for any shares in which the optionee is vested at that time. The Plan Administrator has discretion to extend the period following the optionee&#8217;s cessation of service during which his or her outstanding options may be exercised, up to the date of the option&#8217;s expiration and/or to accelerate the exercisability or vesting of such options in whole or in part. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Issuance Program </font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares may be issued under the Stock Issuance Program at a price per share, if any, determined by the Plan Administrator. The Plan Administrator has complete discretion under this program to determine which eligible individuals are to receive such stock issuances, the time or times when such issuances or awards are to be made, the number of shares subject to each such issuance or award and the vesting schedule, if any, to be in effect for the stock issuance. </font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The shares issued may be fully and immediately vested upon issuance or may vest upon the recipient&#8217;s completion of a designated service period or upon our attainment of pre-established performance goals. The Plan Administrator has, however, the discretionary authority at any time to accelerate the vesting of any and all unvested shares outstanding under the Stock Issuance Program. </font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any unvested shares for which the requisite service requirement or performance objective is not obtained must be surrendered to us for cancellation or repurchase, and the participant will not have any further stockholder rights with respect to those shares. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Stock Awards Program </font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Plan Administrator has complete discretion under the Other Stock Awards Program to make awards of stock appreciation rights, restricted stock units or dividend equivalents to eligible persons under the Plan. </font></div><div style="line-height:120%;padding-top:16px;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Appreciation Rights </font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SARs may be granted in connection with stock options or other awards, or separately. SARs granted by the Plan Administrator in connection with stock options or other awards typically will provide for payments to the holder based upon increases in the price of our common stock over the exercise price of the SAR or a related option or other awards. Each granted SAR will have an exercise or base price per share not less than 100% of the fair market value per share of common stock on the SAR grant date, and no granted SAR will have a term in excess of 10 years. Except as required by Section 162(m) of the Code with respect to a SAR intended to qualify as performance-based compensation as described in Section 162(m) of the Code, there are no restrictions specified in the plan on the exercise of SARs or the amount of gain realizable therefrom, although restrictions may be imposed by the Plan </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">18</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Administrator in the SAR agreements. The Plan Administrator may elect to pay SARs in cash or in shares of our common stock or in a combination of both. </font></div><div style="line-height:120%;padding-top:16px;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted Stock Units</font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units may be awarded to participants, typically without payment of consideration, but subject to vesting conditions based on continued employment or on performance criteria established by our compensation committee. Like stock issuances that are subject to vesting, restricted stock units may not be sold, or otherwise transferred or hypothecated, until vesting conditions are removed or expire. Unlike stock issuances, shares issuable pursuant to a restricted stock unit award will not be issued until the restricted stock unit award has vested, and recipients of restricted stock unit awards generally will have no voting or dividend rights prior to the time when vesting conditions are satisfied. </font></div><div style="line-height:120%;padding-top:16px;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Dividend Equivalents </font></div><div style="line-height:120%;padding-top:16px;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend equivalents represent the value of the dividends, if any, per share paid by us, calculated with reference to the number of shares covered by the stock options, SARs or other awards held by the participant. Dividend and dividend equivalents may not be paid on awards subject to performance vesting conditions unless and until such conditions are met.</font></div><div style="line-height:120%;padding-top:21px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Awards to Non-Employee Directors </font></div><div style="line-height:120%;padding-top:21px;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-employee members of our board of directors are eligible for automatic equity awards under the Restated Equity Plan pursuant to the terms of our Director Compensation Policy, which is described below under &#8220;Compensation Discussion and Analysis&#8212;Narrative to Director Compensation Table.&#8221; </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the Restated Equity Plan, the sum of any cash compensation, or other compensation, and the</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">grant date fair value of awards granted to a non-employee director for services as a non-employee</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">director during any calendar year, generally may not exceed $550,000 (which limit will be increased to $850,000 in the calendar year of his or her initial service as a non-employee director). The plan administrator may make exceptions to this limit for individual non-employee directors in extraordinary circumstances, as the plan administrator may determine in its discretion, provided that the non-employee director receiving such additional compensation may not participate in the decision to award such compensation or in other contemporaneous compensation decisions involving non-employee directors.</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">General Plan Provisions </font></div><div style="line-height:120%;text-align:left;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Change in Ownership or Control </font></div><div style="line-height:120%;text-align:left;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event that we are acquired by merger or asset sale, or if there is a change in ownership or control, the Plan Administrator may provide for any or all of the following alternatives: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">require participants to surrender their outstanding awards for a cash payment;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">replace outstanding awards with other rights or property; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">accelerate the vesting of all or a portion of the awards; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">require that the successor or survivor corporation assume the awards or replace them with equivalent awards; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">adjust the terms and conditions of outstanding awards. </font></div></td></tr></table><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, in the event that we are acquired by merger or asset sale, or if there is a change in ownership or control, then awards granted under the Restated Equity Plan may: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">vest or accelerate in full when such awards are not to be assumed by any successor corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">vest or accelerate in full when such awards are to be assumed by any successor corporation; or </font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">19</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">vest or accelerate in full when such awards are to be assumed by any successor corporation and the employee holding such options is involuntarily terminated. </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Special Tax Election </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Plan Administrator may provide holders of awards under the Restated Equity Plan with the right to have us withhold a portion of the shares otherwise issuable to such individuals in satisfaction of the withholding taxes to which such individuals may become subject in connection with the exercise or vesting of those awards. Alternatively, the Plan Administrator may allow such individuals to deliver previously acquired shares of common stock in payment of such withholding tax liability. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amendment and Termination </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The board may amend or modify the Restated Equity Plan at any time, subject to any required stockholder approval pursuant to applicable laws and regulations. Unless sooner terminated by the board, the Restated Equity Plan will terminate on the earliest of: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 4, 2026; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the termination of all outstanding options in connection with certain changes in control or ownership of the Company. </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Repricing Prohibited </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Restated Equity Plan prohibits, without stockholder approval: (1) the amendment of awards to reduce the exercise price, and (2) the replacement of an option or SAR with cash, any other award or an option or SAR with an exercise price that is less than the exercise price per share of the original option or SAR. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Performance-Based Awards</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Performance awards may also be granted pursuant to the Restated Equity Plan. The value of performance awards may be linked to any one or more of the performance criteria listed below, or other specific criteria determined by the Plan Administrator, in each case on a specified date or dates or over any period or periods determined by the Plan Administrator. The goals are established and evaluated by the Plan Administrator and may relate to performance over any periods as determined by the Plan Administrator. The Plan Administrator will determine whether performance awards are intended to be performance-based compensation within the meaning of Section 162(m) of the Code. Following is a brief discussion of the requirements for awards to be treated as performance-based compensation within the meaning of Section 162(m) of the Code. </font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation committee may grant awards to employees who are or may be &#8220;covered employees,&#8221; as defined in Section 162(m) of the Code, that are intended to be performance-based compensation within the meaning of Section 162(m) of the Code in order to preserve the deductibility of these awards for federal income tax purposes. Participants are only entitled to receive payment for a Section 162(m) performance-based award for any given performance period to the extent that pre-established performance goals set by the compensation committee for the period are satisfied. These pre-established performance goals must be based on one or more of the following performance criteria: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">net earnings (either before or after interest, taxes, depreciation and amortization); </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">gross or net sales or revenue; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">adjusted net income;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">operating earnings or profit; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">cash flow (including, but not limited to, operating cash flow and free cash flow); </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">return on assets; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">return on capital; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">return on stockholders&#8217; equity; </font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">20</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">total stockholder return; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">return on sales; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">gross or net profit or operating margin; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">expenses; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">working capital; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">earnings per share or adjusted earnings per share </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">price per share of our common stock; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">regulatory body approval for commercialization of a product; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">implementation or completion of critical projects; </font></div></td></tr></table><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any of which may be measured with respect to us, or any subsidiary, affiliate or other business unit, either in absolute terms, terms of growth or as compared to any incremental increase or decrease or as compared to results of a peer group or to market performance indicators or indices. The compensation committee will define in an objective fashion the manner of calculating the performance criteria it selects to use for such awards. With regard to a particular performance period, the compensation committee will have the discretion to select the length of the performance period, the type of performance-based awards to be granted, and the goals that will be used to measure the performance for the period. In determining the actual size of an individual performance-based award for a performance period, the compensation committee may reduce or eliminate (but not increase) the initial award. Generally, a participant will have to be employed by or providing services to us or any of our subsidiaries or affiliates on the date the performance-based award is paid to be eligible for a performance-based award for any period. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation committee may, in its sole discretion, provide that one or more objectively determinable adjustments shall be made to one or more of the performance goals. Such adjustments may include one or more of the following:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items related to a change in accounting principle; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items relating to financing activities; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">expenses for restructuring or productivity initiatives; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">other non-operating items; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items related to acquisitions; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items attributable to the business operations of any entity acquired by us during the performance period;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items related to the disposal of a business or segment of a business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items related to discontinued operations that do not qualify as a segment of a business under applicable accounting standards; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items attributable to any stock dividend, stock split, combination or exchange of stock occurring during the performance period; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">other items of significant income or expense which are determined to be appropriate adjustments; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items relating to unusual or extraordinary corporate transactions, events or developments; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items related to amortization of acquired intangible assets; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items that are outside the scope of our core, on-going business activities; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items related to acquired in-process research and development; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items relating to changes in tax laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items relating to major licensing or partnership arrangements; </font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">21</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items relating to asset impairment charges;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items relating to gains or losses for litigation, arbitration and contractual settlements; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">items relating to any other unusual or nonrecurring events or changes in applicable laws, accounting principles or business conditions. </font></div></td></tr></table><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For all awards intended to qualify as performance-based compensation, such determinations will be made by the compensation committee within the time prescribed by, and otherwise in compliance with, Section 162(m) of the Code. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The maximum number of shares which may be subject to awards granted under the Restated Equity Plan to any individual in any calendar year may not exceed 1,000,000 shares of common stock. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Material U.S. Federal Income Tax Consequences </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a general summary under current law of the material federal income tax consequences to an employee, consultant or non-employee director granted an award under the Restated Equity Plan. This summary deals with the general federal income tax principles that apply and is provided only for general information. Some kinds of taxes, such as state, local and foreign income taxes and federal employment taxes, are not discussed. Tax laws are complex and subject to change and may vary depending on individual circumstances and from locality to locality. The summary does not discuss all aspects of federal income taxation that may be relevant in light of a holder&#8217;s personal circumstances. This summarized tax information is not tax advice and a holder of an award should rely on the advice of his or her legal and tax advisors. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Option Grants </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options granted under the Restated Equity Plan may be either ISOs which satisfy the requirements of Section 422 of the Code or non-statutory options which are not intended to meet such requirements. The Federal income tax treatment for the two types of options differs as follows: </font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Incentive Options</font><font style="font-family:inherit;font-size:10pt;">. The optionee recognizes no taxable income at the time of the option grant, and no taxable income is generally recognized at the time the option is exercised. However, the amount by which the fair market value (at the time of exercise) of the purchased shares exceeds the exercise price will be included in the optionee&#8217;s income for purposes of the alternative minimum tax. The optionee will, however, recognize taxable income in the year in which the purchased shares are sold or otherwise made the subject of a taxable disposition. For Federal tax purposes, dispositions are divided into two categories: (1) qualifying and (2) disqualifying. A qualifying disposition occurs if the sale or other disposition is made after the optionee has held the shares for more than two years after the option grant date and more than one year after the exercise date. If either of these two holding periods is not satisfied, then a disqualifying disposition will result. </font></div></td></tr></table><div style="line-height:120%;padding-left:78px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:78px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon a qualifying disposition, the optionee will recognize long-term capital gain in an amount equal to the excess of (1) the amount realized upon the sale or other disposition of the purchased shares over (2) the exercise price paid for the shares. If there is a disqualifying disposition of the shares, then the excess of (1) the lesser of the fair market value of those shares on the exercise date or the sale date over (2) the exercise price paid for the shares will be taxable as ordinary income to the optionee. Any additional gain or loss recognized upon the disposition will be recognized as a capital gain or loss by the optionee. </font></div><div style="line-height:120%;padding-left:78px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:78px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If the optionee makes a disqualifying disposition of the purchased shares, then we will be entitled to an income tax deduction, for the taxable year in which such disposition occurs, equal to the excess of (1) the fair market value of such shares on the option exercise date or the sale date, if less, over (2) the exercise price paid for the shares. In no other instance will we be allowed a deduction with respect to the optionee&#8217;s disposition of the purchased shares. </font></div><div style="line-height:120%;padding-left:78px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Non-Statutory Options</font><font style="font-family:inherit;font-size:10pt;">. No taxable income is recognized by an optionee upon the grant of a non-statutory option. The optionee will in general recognize ordinary income in the year in which the option is exercised, equal to the excess of the fair market value of the purchased shares on the exercise date over the exercise price paid for the shares, and the optionee will be required to satisfy the tax withholding requirements applicable to such income. </font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">22</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:78px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are entitled to an income tax deduction equal to the amount of ordinary income recognized by the optionee with respect to the exercised non-statutory option. The deduction is in general allowed for the taxable year of Ligand in which such ordinary income is recognized by the optionee. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Appreciation Rights </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No taxable income is recognized upon receipt of a SAR. The holder recognizes ordinary income, in the year in which the SAR is exercised, in an amount equal to the excess of the fair market value of the underlying shares of common stock on the exercise date over the base price in effect for the exercised right, and the holder is required to satisfy the tax withholding requirements applicable to such income. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are entitled to an income tax deduction equal to the amount of ordinary income recognized by the holder in connection with the exercise of the SAR. The deduction generally is allowed for the taxable year in which such ordinary income is recognized. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Direct Stock Issuance </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">An employee to whom unvested shares are issued generally will not recognize taxable income upon such issuance and we generally will not then be entitled to a deduction unless an election is made by the participant under Section 83(b) of the Code. However, when the restrictions on the shares of stock lapse, such that the shares are no longer subject to a substantial risk of forfeiture, the employee generally will recognize ordinary income and we generally will be entitled to a deduction for an amount equal to the excess of the fair market value of the shares at the date such restrictions lapse over the purchase price. If a timely election is made under Section 83(b) with respect to unvested stock, the participant generally will recognize ordinary income on the date of the issuance equal to the excess, if any, of the fair market value of the shares at that date over the purchase price therefore, and we will be entitled to a deduction for the same amount. A participant who receives stock in lieu of a cash payment that would otherwise have been made will generally be taxed as if the cash payment has been received, and we generally will be entitled to a deduction for the same amount. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted Stock Units </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">An individual to whom restricted stock units are issued will not have taxable income upon issuance and we will not then be entitled to a deduction. An individual to whom restricted stock units are issued will generally realize ordinary income at the time the shares issuable with respect to the restricted stock unit award are distributed to the individual in an amount equal to the fair market value of such shares (less any purchase price), and we will be entitled to a corresponding deduction. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Dividend Equivalents </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A recipient of a dividend equivalent award generally will not recognize taxable income at the time of grant, and we will not be entitled to a deduction at that time. When a dividend equivalent is paid, the participant generally will recognize ordinary income, and we will be entitled to a corresponding deduction. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Section 162(m) of the Code </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Section 162(m) of the Code denies a deduction to any publicly held corporation for compensation paid to certain &#8220;covered employees&#8221; in a taxable year to the extent that compensation to such covered employee exceeds $1 million. It is possible that compensation attributable to awards under the Restated Equity Plan, when combined with all other types of compensation received by a covered employee from us, may cause this limitation to be exceeded in any particular year. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain kinds of compensation, including qualified &#8220;performance-based compensation,&#8221; are disregarded for purposes of the deduction limitation. In accordance with Treasury Regulations issued under Section 162(m), compensation attributable to stock awards will generally qualify as performance-based compensation if (1) the award is granted by a compensation committee composed solely of two or more &#8220;outside directors,&#8221; (2) the plan contains a per-employee limitation on the number of awards which may be granted during a specified period, (3) the plan is approved by the stockholders, and (4) under the terms of the award, the amount of compensation an employee could receive is based solely on an increase in the value of the stock after the date of the grant (which requires that the exercise price of the option is not less than the fair market value of the stock on the date of grant), and for awards other than options, established performance criteria that must be met before the award actually will vest or be paid. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">23</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sC3A352E5202C846A7064E760CEC1E001"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Restated Equity Plan is designed to meet the requirements of Section 162(m); however, full-value awards granted under the Restated Equity Plan will only be treated as qualified performance-based compensation under Section 162(m) if the full-value awards and the procedures associated with them comply with all other requirements of Section 162(m). There can be no assurance that compensation attributable to awards granted under the Restated Equity Plan will be treated as qualified performance-based compensation under Section 162(m) and thus be deductible to us. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Section 409A of the Code </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain awards under the Restated Equity Plan may be considered &#8220;nonqualified deferred compensation&#8221; subject to Section 409A of the Code, which imposes additional requirements on the payment of deferred compensation. Generally, if at any time during a taxable year a nonqualified deferred compensation plan fails to meet the requirements of Section 409A, or is not operated in accordance with those requirements, all amounts deferred under the nonqualified deferred compensation plan for the current taxable year and all preceding taxable years, by or for any participant with respect to whom the failure relates, are includible in the gross income of the participant for the taxable year to the extent not subject to a substantial risk of forfeiture and not previously included in gross income. If a deferred amount is required to be included in income under Section 409A, the amount will be subject to income tax at regular income tax rates plus an additional 20 percent tax, as well as potential premium interest tax. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Plan Benefits </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below shows, as to our named executive officers and the various indicated groups, the number of shares of common stock subject to awards granted under the existing 2002 Plan to date that were outstanding as of March 29, 2016: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td width="67%"></td><td width="15%"></td><td width="1%"></td><td width="1%"></td><td width="15%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name and Position</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares Subject to Stock Option Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares Subject to Restricted Stock Awards/RSUs</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John L. Higgins, President and Chief Executive Officer</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">736,639</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52,463</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Matthew W. Foehr, Executive VP and Chief Operating Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335,552</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,871</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Matthew Korenberg, Vice President, Finance and Chief Financial Officer</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,464</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,740</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charles S. Berkman, Vice President, General Counsel and Secretary</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,108</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,812</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Melanie J. Herman, Chief Accounting Officer</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,937</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,299</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Officers, as a group</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,184,763</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,886</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-Employee Directors, as a group</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172,253</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,550</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employees other than Executive Officers, as a group</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">523,311</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">204,511</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) Excludes shares subject to awards held by Ms. Herman and Dr. de Silva who were not executive officers as  of March 29, 2016. </font></div><div style="line-height:120%;padding-top:8px;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2) All of the non-employee members of our board of directors will, upon re-election to the board at the Annual Meeting, receive an automatic award of shares of restricted stock and options to purchase shares of common stock under the Restated Equity Plan pursuant to our Director Compensation Policy, as described below under &#8220;Compensation Discussion and Analysis&#8212;Narrative to Director Compensation Table.&#8221; Each option will have an exercise price per share equal to the fair market value per share of common stock on the grant date.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All other future grants under the Restated Equity Plan are within the discretion of the Plan Administrator and the benefits of such grants are, therefore, not determinable. </font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Recommendation of the Board of Directors</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our board believes that the Restated Equity Plan is necessary in order to continue to provide equity incentives to attract and retain the services of high quality employees. Our board unanimously recommends that the stockholders vote FOR this proposal. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">24</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s62B324D0D00DD2785D6AE760D220E48A"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:24px;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:5px;text-align:left;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">Proposal No. 4 Approval of Compensation of the Named Executive Officers</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the Dodd-Frank Act, our stockholders are entitled to vote at the annual meeting to provide advisory approval of the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the SEC. Pursuant to the Dodd-Frank Act, the stockholder vote on executive compensation is an advisory vote only, and it is not binding on us or our board of directors.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although the vote is non-binding, our compensation committee and board of directors value the opinions of the stockholders and will consider the outcome of the vote when making future compensation decisions. As described more fully in the Compensation Discussion and Analysis section of this proxy statement, our executive compensation program is designed to attract, retain and motivate individuals with superior ability, experience and leadership capability to deliver on our annual and long-term business objectives necessary to create stockholder value. We urge stockholders to read the Compensation Discussion and Analysis section of this proxy statement, which describes in detail how our executive compensation policies and procedures operate and are intended to operate in the future. The compensation committee and the board of directors believe that our executive compensation program fulfills these goals and is reasonable, competitive and aligned with our performance and the performance of our executives.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are asking our stockholders to indicate their support for our named executive officer compensation as described in this proxy statement. This proposal, commonly known as a &#8220;say-on-pay&#8221; proposal, gives our stockholders the opportunity to express their views on our named executive officers&#8217; compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement. Accordingly, we ask that our stockholders vote &#8220;FOR&#8221; the following resolution:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8220;RESOLVED, that Ligand Pharmaceuticals Incorporated stockholders approve, on an advisory basis, the compensation of the named executive officers, as disclosed in Ligand Pharmaceuticals Incorporated&#8217;s Proxy Statement for the 2016 annual meeting of stockholders, pursuant to the compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the 2015 Summary Compensation Table and the other related tables and disclosure.&#8221;</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Recommendation of the Board of Directors</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our board of directors unanimously recommends that stockholders vote FOR the approval, on an advisory basis, of the compensation of the named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the SEC.</font></div><a name="sE58620CE2139DD2C6B8DE760D249809E"></a><div style="line-height:120%;padding-top:24px;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:5px;text-align:left;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">Executive Officers</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The names of the executive officers of the Company and their ages, titles and biographies as of March 29, 2016 are set forth below.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">John L. Higgins,</font><font style="font-family:inherit;font-size:10pt;">&#32;46, is being considered for the position of director of the Company. See &#8220;Election of Directors&#8221; for a discussion of Mr.&#160;Higgins' business experience.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Charles S. Berkman, J.D.,</font><font style="font-family:inherit;font-size:10pt;">&#32;47, has served as our Vice President, General Counsel and Secretary since April 2007. Mr. Berkman joined the Company in November 2001 and previously served as Associate General Counsel and Chief Patent Counsel for the Company (and Secretary since March 2007). Prior to joining the Company, Mr. Berkman was an attorney at the international law firm of Baker &amp; McKenzie from November 2000 to November 2001. Before that he served as an attorney at the law firm of Lyon &amp; Lyon from 1993 to November 2000, where he specialized in intellectual property law. Mr. Berkman earned a B.S. in chemistry from the University of Texas and a J.D. from the University of Texas School of Law.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">25</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Matthew W. Foehr,</font><font style="font-family:inherit;font-size:10pt;">&#32;43, has been our President and Chief Operating Officer since January 2015.  Prior to that time, Mr. Foehr served as our Executive Vice President and Chief Operating Officer since 2011, and has more than 20 years of experience managing global research and development programs. Prior to joining Ligand in 2011, he was Vice President and Head of Consumer Dermatology R&amp;D, as well as Acting Chief Scientific Officer of Dermatology, in the Stiefel division of GlaxoSmithKline (GSK). Following GSK's $3.6 billion acquisition of Stiefel in 2009, Mr. Foehr led the R&amp;D integration of Stiefel into GSK. At Stiefel Laboratories, Inc., Mr. Foehr served as Senior Vice President of Global R&amp;D Operations, Senior Vice President of Product Development &amp; Support, and Vice President of Global Supply Chain Technical Services. Prior to Stiefel, Mr. Foehr held various executive roles at Connetics Corporation including Senior Vice President of Technical Operations and Vice President of Manufacturing. Mr. Foehr serves on the Board of Directors of Viking Therapeutics, Inc. and Ritter Pharmaceuticals, Inc.  Mr. Foehr is the author of multiple scientific publications and is named on numerous U.S. patents. He received his B.S. degree in biology from Santa Clara University.</font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Matthew Korenberg,</font><font style="font-family:inherit;font-size:10pt;">&#32;41, has served as our Vice President, Finance and Chief Financial Officer since August 2016.  Prior to joining Ligand, commencing in September 2013, Mr. Korenberg was the founder, Chief Executive Officer and a director of NeuroCircuit Therapeutics, a company focused on developing drugs to treat genetic disorders of the brain with an initial focus on Down syndrome. Prior to founding NeuroCircuit Therapeutics, Mr. Korenberg was a Managing Director and member of the healthcare investment banking team at Goldman Sachs from July 1999 through August 2013. During his 14 year tenure at Goldman Sachs, Mr. Korenberg was focused on advising and financing companies in the biotechnology and pharmaceutical sectors and was based in New York, London and San Francisco. Prior to Goldman Sachs, Mr. Korenberg was a healthcare investment banker at Dillon, Read &amp; Co. Inc. where he spent two years working with healthcare companies in the biotechnology and pharmaceutical sectors and industrial companies. Mr. Korenberg holds a B.B.A. in Finance and Accounting from The University of Michigan.</font></div><a name="s54A3D62D49B1E8A07202E760CEEB4CBC"></a><div style="line-height:174%;padding-top:24px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Security Ownership of Certain Beneficial Owners, Directors and Management</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows, based on information we have, the beneficial ownership of our common stock as of  March 29, 2016, by:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">all persons who are beneficial owners of 5% or more of our outstanding common stock;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">each of our current directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">each of our named executive officers (as defined below in &#8220;Compensation Discussion and Analysis &#8211; Summary Compensation Table&#8221;);&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">all of our executive officers and directors as a group.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless otherwise indicated, each of the stockholders has sole voting and investment power with respect to the shares beneficially owned, subject to community property laws, where applicable. Percentage of ownership is based on approximately 20,815,636 shares of common stock outstanding on March 29, 2016. Shares of common stock underlying options include options which are currently exercisable or will become exercisable within 60&#160;days after March 29, 2016, are deemed outstanding for computing the percentage of the person or group holding such options, but are not deemed outstanding for computing the percentage of any other person or group. The address for individuals for whom an address is not otherwise indicated is 11119 N. Torrey Pines Rd. Suite 200 La Jolla, CA 92037.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">26</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="49%"></td><td width="15%"></td><td width="1%"></td><td width="1%"></td><td width="16%"></td><td width="1%"></td><td width="1%"></td><td width="16%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beneficial Owner</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of</font></div><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares</font></div><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beneficially</font></div><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Owned</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares Beneficially</font></div><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Owned via Options,</font></div><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrants or</font></div><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percent of</font></div><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Owned</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">BlackRock, Inc.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div><div style="padding-top:1px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55 East 52</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">nd</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;Street</font></div><div style="padding-top:1px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New York, NY 10055</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,958,105</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.4%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Vanguard Group</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div><div style="padding-top:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100 Vanguard Blvd.</font></div><div style="padding-top:1px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Malvern, PA 19355</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,348,453</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FMR LLC</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div><div style="padding-top:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">245 Summer Street</font></div><div style="padding-top:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boston, MA 02210</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,110,624</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RS Investment Management Co. LLC</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div><div style="padding-top:1px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">One Bush Street, Suite 900</font></div><div style="padding-top:1px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">San Francisco, CA 94104</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,089,730</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Directors and Executive Officers</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jason M. Aryeh</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(5)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299,069</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,399</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charles S. Berkman</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,647</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,107</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Todd C. Davis</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,399</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,734</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nishan de Silva</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,282</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Matthew W. Foehr</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,912</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246,145</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Melanie J. Herman</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,631</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,688</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John L. Higgins</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125,664</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">589,738</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.4%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David M. Knott</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,265,918</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,404</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Matthew Korenberg</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,870</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John W. Kozarich</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,711</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,237</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John L. LaMattina</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,480</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,071</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sunil Patel</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,025</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,071</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stephen L. Sabba</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,622</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,071</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Directors and executive officers as a group (12 persons)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(7)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,998,317</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,059,977</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.7%</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">27</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="5%"></td><td width="95%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;*</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than one percent.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents shares of common stock owned by funds affiliated with BlackRock, Inc. at December 31, 2015, as indicated in the entity&#8217;s Schedule 13G/A filed with the SEC on January 26, 2016. BlackRock, Inc. reports shared voting and investment power with respect to all 2,025,768 shares.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents shares of common stock beneficially owned by The Vanguard Group at December 31, 2015 as indicated in the entity&#8217;s Schedule 13G/A filed with the SEC on February 10, 2016.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents shares of common stock beneficially owned by FMR LLC at December 31, 2015 as indicated in the entity&#8217;s Schedule 13G filed with the SEC on February 12, 2016.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents shares of common stock beneficially owned by RS Investment Management Co. LLC at December 31, 2015 as indicated on the entity&#8217;s Schedule 13G/A filed with the SEC on February 12, 2016.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares held by David M. Knott include shares held by Dorset Management Corporation (&#8220;Dorset&#8221;).  Mr. Knott is the sole director and President of Dorset, which provides investment management services to a limited number of foreign and domestic individuals and entities (the &#8220;Managed Accounts&#8221;). Mr. Knott is the sole member of Mabon Capital Management, LLC, a New York limited liability company, that is the sole general partner of Mulsanne Partnership, L.P., a Delaware limited partnership (&#8220;Mulsanne&#8221;).  Mr. Knott is the managing member of Knott Partners Management, LLC, a New York limited liability company, which is the sole general partner of Shoshone Partners, L.P., a Delaware limited partnership (&#8220;Shoshone&#8221;), the sole general partner of Knott Offshore Master Fund, L.P., a limited partnership (&#8220;Knott Offshore&#8221;) and managing general partner of Knott Partners, L.P., a New Jersey limited partnership (together with Shoshone, Knott Offshore and Mulsanne, the &#8220;Partnerships&#8221;). Mr. Knott individually has the sole power to vote 1,265,918 shares and dispose of 1,264,075 shares beneficially owned by Mr. Knott, the Partnerships and the Managed Accounts. As President of Dorset, Mr. Knott shares with certain of Dorset&#8217;s clients the power to vote 1,666 shares of Common Stock beneficially owned, in the aggregate, by such clients.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares held by Jason Aryeh are owned by certain funds managed by JALAA Equities, LP (&#8220;JALAA&#8221;), JLV Investments, LP (&#8220;JLV&#8221;) and affiliates (collectively, the &#8220;Funds&#8221;).  Mr. Aryeh  is the general partner of JALAA and a partner of JLV.  Mr. Aryeh individually has the sole power to vote 299,069 shares and dispose of 299,069 shares beneficially owned by Mr. Aryeh and the Funds.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Excludes shares held by Ms. Herman and Dr. de Silva who were not executive officers as of March 29, 2016.  They are included in the table because each served as our principal financial officer during some portion of 2015 making them named executive officers.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">28</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:174%;padding-top:20px;text-align:left;padding-left:30px;text-indent:-30px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Compensation Discussion and Analysis</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Compensation Discussion and Analysis (&#8220;CD</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&amp;A</font><font style="font-family:inherit;font-size:10pt;">&#8221;) describes our compensation philosophy and programs, the compensation decisions the compensation committee made under those programs, and the factors considered in making those decisions.  This CD&amp;A focuses on the compensation of our named executive officers or &#8220;NEOs&#8221;, who for 2015 were: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="35%"></td><td width="65%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Name</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Title</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John L. Higgins</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Matthew W. Foehr</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President and Chief Operating Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charles S. Berkman</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President and General Counsel</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Melanie J. Herman</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Accounting Officer and former Interim Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Matthew Korenberg</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President, Finance and Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nishan de Silva</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President, Finance and Strategy and Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:21px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ms. Herman and Dr. de Silva are included as NEOs because each served as our Chief Financial Officer for a portion of 2015.  Ms. Herman and Dr. de Silva are not currently executive officers of the Company.</font></div><div style="line-height:120%;padding-top:20px;text-align:left;padding-left:30px;text-indent:-30px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Executive Summary</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Overview and Objectives of Our Executive Compensation Program</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation committee has designed our executive compensation program to provide compensation opportunities that:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">attract, motivate and retain individuals of superior ability and managerial talent critical to its long-term success;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">align executives&#8217; interests with the Company&#8217;s corporate strategies, business objectives and the long-term interests of the Company&#8217;s stockholders;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">create incentives to achieve key strategic and corporate performance objectives; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">enhance the executives&#8217; incentive to increase the Company&#8217;s stock price and maximize stockholder value.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Within this framework our compensation program has been developed with the following key principles in mind: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We Intend to Pay for Performance. The majority of our named executive officers&#8217; total compensation as shown in our Summary Compensation Table below ties compensation directly to the achievement of corporate objectives, increases in our stock price or both. We emphasize pay for performance in order to align executive compensation with our business strategy and the creation of long-term stockholder value.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Compensation Program Supports Our Corporate Objectives and Stockholder Interests. Our compensation program is designed to align executive officer compensation with our corporate strategies, business objectives and the long-term interests of our stockholders by rewarding successful execution of our business plan and tying a significant portion of total compensation opportunities to equity incentives.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Key Elements of Our Compensation Program. Our compensation program is designed to achieve these objectives through a combination of the following types of compensation:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:20px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">base salary;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">annual variable performance bonus awards payable in cash;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">long-term stock-based incentive awards; and</font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">29</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">employee benefits and perquisites, including change in control severance arrangements.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each element of our executive compensation program is discussed in greater detail below.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Ligand's Strong 2015 Corporate Performance</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Company&#8217;s fiscal year 2015 accomplishments, guided by our named executive officers, illustrate the success of our executive compensation program, and included, among other things, the following: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:42px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Successful Business Development:  The Company's Shots-on-Goal portfolio increased from 111 to over 125 during 2015.   In addition, the Company signed a merger agreement with Open Monoclonal Technologies, Inc. in 2015 which closed in January 2016, adding an additional 16 Shots-on-Goal in a new line of business. </font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:42px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continued Optimization of Captisol Business: In 2015, the Company entered into 94 new Captisol research contracts and had significant year-over-year increases in Captisol material sales and sample requests from prospective partners.  The Company also expanded its Captisol intellectual property portfolio with 45 new patent filings and by adding 40 new countries to its intellectual property footprint. </font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:42px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and Development: In 2015, the Company continued to advance its product pipeline, including the receipt of positive Phase 1b Glucagon data.   Additionally, the Company completed a licensing agreement for oral lasofoxifene to Sermonix and acquired rights to more than 15 biologic Shots-on-Goal from proof of concept studies completed by Selexis.</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-indent:-6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:42px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operational Achievements: During 2015, the Company had its third consecutive year of being sustainably profitable and cash flow positive, with solid financial growth.   The Company successfully contained costs while implementing various internal organizational changes.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Performance Graph</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The graph below shows the five-year cumulative total stockholder return assuming the investment of $100 and is based on the returns of the component companies weighted monthly according to their market capitalizations. The graph compares total stockholder returns of our common stock, of all companies traded on the NASDAQ Stock market, as represented by the NASDAQ Composite&#174; Index, and of the NASDAQ Biotechnology Stock Index, as prepared by The NASDAQ Stock Market Inc. The NASDAQ Biotechnology Stock Index tracks approximately 151 domestic biotechnology stocks.</font></div><div style="line-height:150%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The stockholder return shown on the graph below is not necessarily indicative of future performance and we will not make or endorse any predictions to future stockholder returns.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">30</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:2px;text-align:center;padding-left:29px;"><img src="image5.jpg" style="height:325px;width:624px;"></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">2015 Compensation Programs and Decisions </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In line with our executive compensation program&#8217;s emphasis on pay for performance, compensation awarded to our named executive officers for 2015 reflected our financial results and overall compensation philosophy:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Base Salary Adjustments:</font><font style="font-family:inherit;font-size:10pt;">&#32;During 2015, our named executive officers received increases to their base salaries of between 7% and 10%.  The Company provides its named executive officers with a base salary that approximates the 25th percentile for similar positions at our peer group, and these increases were determined to be appropriate by our compensation committee to ensure that the base salaries of our named executive officers continued to be generally consistent with this pay positioning philosophy.  Ms. Herman received a 3.5% merit based base salary increase for 2015, consistent with the base salary increases for all of our non-executive employees.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Pay-for-Performance Annual Incentive Bonuses:</font><font style="font-family:inherit;font-size:10pt;">&#32;For 2015, our Company focused on certain key business development objectives and objectives related to the optimization of the Captisol business, business development, research and development related to the Glucagon product and operational goals. Our compensation program for 2015 was designed to support the Company&#8217;s focus on these areas and together achievement in these areas represented 100% of our named executive officers&#8217; total bonus opportunity.  Based on corporate performance in these four areas during 2015, as summarized above, our compensation committee determined that our executive officers should be paid their bonuses at the 95.5% of targeted levels (with the exception of Mr. Korenberg, whose bonus was paid at the targeted level due to his commencement of employment late in 2015).  The annual bonuses awarded to our named executive officers for 2015 are discussed below under &#8220;Annual Bonuses.&#8221; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Emphasis on Performance-Based Equity Awards:</font><font style="font-family:inherit;font-size:10pt;">&#160;Our compensation committee continued its practice of ensuring that a substantial portion of our named executive officers&#8217; total compensation is awarded in the form of long-term equity incentive awards.  In 2015, at least 25% of each named executive officer&#8217;s equity awards were granted in the form of performance-based stock awards.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Options:</font><font style="font-family:inherit;font-size:10pt;">&#32;Fifty percent of each named executive officer&#8217;s annual awards was granted in the form of stock options (other than Ms. Herman, who received approximately 90% of her annual equity awards in the form of stock options), which we consider to be performance based awards as they provide value to our executives only if our stock price increases.  These stock options are subject to our standard four year vesting schedule.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Performance-Based Restricted Stock Units:</font><font style="font-family:inherit;font-size:10pt;">&#160; In 2015, the compensation committee also awarded performance-based restricted stock units to our named executive officers (other than Ms. Herman, who did not receive any performance-based restricted stock units), which awards represented approximately 25% of the total value of the long-term equity incentive awards granted to our named executive officers in 2015.  These performance-based restricted stock units </font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">31</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-left:48px;padding-top:12px;"><font style="font-family:inherit;font-size:10pt;">will vest based on objectives related to our non-GAAP earnings per share growth for the two year performance period commencing January 1, 2015 and ending December 31, 2016 and our new Shots-on-Goal transactions during the three year performance period commencing January 1, 2015 and ending December 31, 2017, with each such objective equally weighted.&#160; The compensation committee selected the foregoing performance measures because they represent the key financial and operational performance metrics for which the executives are responsible, thereby creating the clearest link between executive actions, corporate results and continued long-term success for the Company.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The remainder of the long-term equity incentive awards granted to our named executive officers was granted in the form of restricted stock units that are subject to our standard three year vesting schedule.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In light of the Company&#8217;s overall performance during 2015, the compensation committee believes that the named executive officers&#8217; 2015 compensation was appropriate.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;padding-left:30px;text-indent:-30px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Ligand's Executive Compensation Best Practices</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We regularly review and refine our executive compensation program to ensure that it continues to reflect practices and policies that are aligned with our pay-for-performance philosophy.  The following practices and policies we believe are in line with current best practices for aligning executive and shareholder interests and sound corporate governance practices:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="24%"></td><td width="5%"></td><td width="71%"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Compensation Practice</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Ligand Policy</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Pay for Performance</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#008000;font-weight:bold;">YES</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A majority of our executives&#8217; total direct compensation is performance-based</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Annual &#8220;Say on Pay&#8221; Vote</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#008000;font-weight:bold;">YES</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We seek an annual non-binding advisory vote from our shareholders to approve the executive compensation programs disclosed in our CD&amp;A, tabular disclosure and related narrative in our proxy</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Independent Compensation Consultant</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#008000;font-weight:bold;">YES</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation committee retains an independent compensation consultant</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Annual Compensation Risk Assessment</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#008000;font-weight:bold;">YES</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each year we perform an assessment of any risks that could result from our compensation plans and programs</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Ownership Guidelines for Directors</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#008000;font-weight:bold;">YES</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have stock ownership guidelines for non-employee directors of 3.0 times their annual retainer</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Limited Perquisites</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#008000;font-weight:bold;">YES</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We provided very limited perquisites to our NEOs in 2015</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Employment Agreements</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#ff0000;font-weight:bold;">NO</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not provide our executive officers with employment agreements</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Tax Gross-ups</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#ff0000;font-weight:bold;">NO</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not provide tax gross ups to our executives for "excess parachute payments"</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Repricing or Exchange of Underwater Stock Options</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#ff0000;font-weight:bold;">NO</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We prohibit option repricing without stockholder approval</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Single Trigger Change in Control Vesting/Benefits</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#ff0000;font-weight:bold;">NO</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:8px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not allow for single-trigger vesting or payment of benefits upon a change in control.  Rather, we require double-trigger (or both a change in control and termination of executive&#8217;s employment) before vesting is accelerated</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:21px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Response to 2015 Say on Pay Vote</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, we held a stockholder advisory vote on the compensation of our named executive officers, commonly referred to as a say-on-pay vote. Our stockholders overwhelmingly approved the compensation of our named executive officers, with over 98% of stockholder votes cast in favor of our 2015 say-on-pay resolution (excluding abstentions and broker non-votes). As we evaluated our compensation practices and talent needs throughout 2015, we were mindful of the strong support our stockholders expressed for our compensation philosophy. As a result, following our annual review of our executive compensation philosophy, the compensation committee decided to generally retain our existing approach to executive compensation for our continuing executives, with an emphasis on short- and long-term incentive compensation that rewards our senior executives when they deliver value for our stockholders. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, when determining how often to hold a stockholder advisory vote on executive compensation, the board of directors took into account the strong preference for an annual vote expressed by our stockholders at our 2011 annual </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">32</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">meeting. Accordingly, the board of directors determined that we will hold an advisory stockholder vote on the compensation of our named executive officers every year until the next say-on-pay frequency vote.</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">The Role of the Compensation Committee and Executive Officers in Setting Compensation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation committee has the primary authority to determine the Company&#8217;s compensation philosophy and to establish compensation for the Company&#8217;s executive officers. In determining each level of compensation and the total package, the compensation committee reviewed a variety of sources, to determine and set compensation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The chief executive officer aids the compensation committee by providing annual recommendations regarding the compensation of all executive officers, other than himself. Each named executive officer and senior executive management team member, in turn, participates in an annual performance review with the chief executive officer to provide input about his contributions to the Company&#8217;s success for the period being assessed. The performance of our chief executive officer and senior executive management team as a group is reviewed annually by the compensation committee.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2015, the compensation committee retained Radford, an AonHewitt Company and an independent compensation consulting firm, to assist it in the formulation of the peer group used to determine executive equity compensation during 2015 and to advise regarding the determination of the other key elements of the executive compensation program. Radford reports to and is accountable to the compensation committee, and may not conduct any other work for us without the authorization of the compensation committee. Radford did not provide any services to us in 2015 beyond its engagement as an advisor to the compensation committee on compensation matters. After review and consultation with Radford, the compensation committee has determined that Radford is independent and there is no conflict of interest resulting from retaining Radford currently or during the year ended December 31, 2015. In reaching these conclusions, the compensation committee considered the factors set forth in Exchange Act Rule 10C-1 and NASDAQ listing standards.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As in prior years, the compensation committee and the Company&#8217;s management also consulted several independent compensation surveys to assist them in determining market pay practices for compensating executive officers. These surveys were reviewed to compare the Company&#8217;s compensation levels to the market compensation levels, taking into consideration the other companies&#8217; size, the industry, the individual executive&#8217;s level of responsibility and his years of experience. For 2015, the current executive salaries were evaluated against the Radford Global Life Sciences Compensation Report using data from comparable companies.  These surveys were used due to the competitiveness in hiring employees within the biotechnology industry as well as in our geographic location and we believe they represent the types of companies with which we compete for executive talent. With respect to the foregoing survey data, the identities of the individual companies included in the surveys were not provided to the compensation committee, and the compensation committee did not refer to individual compensation information for such companies. Instead, the compensation committee only referred to the statistical summaries of the compensation information for the companies included in such surveys.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, the compensation committee worked with Radford to confirm a peer group of companies in the United States for which compensation information can be provided to the compensation committee. This is necessary so the Company can offer compensation that is competitive within that group of companies. The peer group companies for 2015 compensation included ACADIA Pharmaceuticals, Acorda Therapeutics, AMAG Pharmaceuticals, Anacor Pharmaceuticals, ARIAD Pharmaceuticals, Array BioPharma, Depomed, Dyax, Dynavax Technologies, Exelixis, Halozyme Therapeutics, Halozyme Therapeutics, ImmunoGen, Ironwood Pharmaceuticals, Isis Pharmaceuticals, Momenta Pharmaceuticals, Nektar Therapeutics, Neurocrine Biosciences, PDL BioPharma, Repligen and Theravance.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The selected companies in our peer group are companies that fall within a reasonable range of comparison factors and/or that we may compete with for executive talent. In addition to the criteria related to finding companies with similar business models and at a similar stage of development as Ligand, the other criteria used in the identification and selection of the peer group included business/labor market competitors in the biotechnology industry similar in size and complexity to us, companies with market values between $560 million and $5.1 billion and companies with products in comparable stages of development to our products. We also focused on companies with multiple product candidates, as opposed to single product companies. The peer group was not selected on the basis of executive compensation levels.  The peer group revisions from the 2014 peer group were intended to ensure that the peer group more accurately reflects companies that are our peers in terms of our current business model and stage of development, including the number of programs maintained by the Company and the importance of licensing to the Company's business model.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">33</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The peer group compensation data is limited to publicly available information and therefore does not provide precise comparisons by position as offered by more comprehensive survey data. The survey data, however, can be used to provide pooled compensation data for positions closely akin to those held by each named executive officer. In addition, the pool of senior executive talent from which we draw and against which we compare ourselves extends beyond the limited community of our immediate peer group and includes a wide range of other organizations outside of our traditional competitors, which range is represented by such surveys. As a result, the compensation committee uses peer group data to analyze the overall competitiveness of our compensation with our direct publicly traded peers in the United States and our general compensation philosophy, and to determine equity award levels for the named executive officers, but also relies on industry survey data in determining actual executive compensation. For purposes of this compensation discussion and analysis, references to our &#8220;peer group&#8221; include both the peer group of companies listed above and the survey data reviewed by our compensation committee.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation committee has adopted a compensation philosophy that places a greater emphasis on long-term equity incentive compensation for our named executive officers than cash compensation.&#160; As a result, the compensation committee generally sets target total cash compensation below the median (e.g., at approximately the 25th percentile) of executive officers performing similar job functions at companies in our peer group.&#160; At the same time, the compensation committee emphasizes long-term equity incentive compensation by setting target equity compensation above the median of executive officers performing similar job junctions at companies in our peer group.&#160; However, we strongly believe in retaining the best talent among our senior executive management team and while we believe that comparisons to market data are a useful tool, we do not believe that it is appropriate to establish executive compensation levels based solely on a comparison to data from these companies.&#160; Therefore, the compensation committee may approve total compensation packages for senior executive management that vary from the foregoing positioning based on several factors, including overall experiences, accumulated years of service with us, level of responsibilities and/or performance ratings.&#160; Our 2015 total compensation for our named executive officers was generally consistent with the foregoing compensation philosophy. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the mix of compensation paid to our named executive officers is intended to ensure that total compensation reflects our overall success or failure and to motivate executive officers to meet appropriate performance measures. In determining each element of compensation for any given year, our compensation committee considers and determines each element individually and then reviews the resulting total compensation and determines whether it is reasonable and competitive. We do not have a pre-established policy or target for the allocation between either cash and non-cash or short-term and long-term incentive compensation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation levels of our named executive officers reflect to a significant degree their varying roles and responsibilities. Mr.&#160;Higgins, in his role as chief executive officer, has the greatest level of responsibility among our named executive officers and, therefore, receives the highest level of pay. This is also consistent with the practices of the companies in our peer group and the summary compensation data included in the summaries of comparable companies reviewed by our compensation committee.</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Base Compensation</font></div><div style="line-height:150%;padding-top:21px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As discussed above, the Company provides its named executive officers with a base salary that approximates the 25</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;percentile for similar positions at our peer group, but may vary from such level based on:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">industry experience, knowledge and qualifications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the salary levels in effect for comparable positions within the Company&#8217;s principal industry marketplace competitors; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">internal comparability considerations.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a general matter, the base salary for each executive officer is initially established through negotiation at the time the officer is hired, taking into account the officer&#8217;s qualifications, experience, prior salary and competitive salary information. Increases in base salary from year to year are based upon the performance of the executive officers as well as market positioning considerations, as assessed by the chief executive officer (for executives other than himself) and approved by the compensation committee. The compensation committee assesses these factors with respect to the chief executive officer.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">34</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2015, our named executive officers received increases to their base salaries of between 7% and 10%, as follows:  Mr. Higgins, 7.6% increase; Mr. Foehr, 10% increase; Mr. Berkman, 7.1% increase; Ms. Herman, 3.5% increase; and Mr. de Silva, 9.6% increase.  These increases were determined to be appropriate by our compensation committee to ensure that the base salaries of our named executive officers continued to be generally consistent with our pay positioning philosophy, as described above.  Ms. Herman&#8217;s 3.5% merit based base salary increase for 2015 was consistent with the base salary increases for all of our non-executive employees.  Mr. Korenberg&#8217;s initial base salary was determined in connection with his commencement of employment in August 2015.  Base salaries paid to our named executive officers for 2015 are disclosed below in the table entitled &#8220;Summary Compensation Table.&#8221;</font></div><div style="line-height:120%;padding-top:21px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Performance-Based Compensation</font></div><div style="line-height:120%;padding-top:21px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Annual Performance-Based Cash Compensation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is the compensation committee&#8217;s objective to have a substantial portion of each named executive officer&#8217;s compensation contingent upon the Company&#8217;s performance. For each of our named executive officers (other than Ms. Herman), all of his annual bonus compensation is dependent on the Company&#8217;s performance relative to specified performance objectives.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The annual performance-based bonus program consists of a cash award if certain corporate performance objectives are satisfied. The Company sets annual incentive targets so that each executive&#8217;s total target cash compensation (inclusive of base salary) approximates the 25th percentile of target total cash opportunities offered by our peer group. Under the Company&#8217;s 2015 program, the potential performance bonus for the chief executive officer is up to 75% of base salary, 50% of base salary for Mr.&#160;Foehr, and 40% of base salary for the other named executive officers. For 2015, Ms. Herman was eligible for a target bonus of  20% of her base salary, the payout of which was determined by Mr. Higgins, in his sole discretion.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In determining the performance compensation awarded to each named executive officer, the Company evaluates the Company&#8217;s performance in a number of areas. At the beginning of each year, our board of directors sets corporate objectives for the year. These objectives are set by the board of directors after considering management input and our overall strategic objectives. These objectives generally relate to factors such as strategic objectives, achievement of product development objectives, establishment of new collaborative arrangements and general operational goals. Following the conclusion of each year, the compensation committee determines the level of achievement for each year relative to these corporate objectives. This achievement level is then applied to each named executive officer&#8217;s target bonus to determine that year&#8217;s total annual bonus. The compensation committee retains the discretion to reduce the final bonus payout to a named executive officer.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the beginning of 2015, our board of directors, with input provided by our named executive officers, established our Company goals for the year. The compensation committee then reviewed and considered a proposed Company-wide (including named executive officers) bonus program in view of the Company goals, including the proportional emphasis to be placed on each objective annual bonus determination purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company goals approved by the compensation committee for 2015 for purposes of annual bonus achievement included:</font></div><div style="line-height:120%;padding-top:21px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goals Related to Optimization of Captisol Business (30% Weighting)</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manage current business to maintain and maximize revenue and manage competitive threats</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expand existing relationships and generate at least 45 new research contracts, expand customer sample requests to new annual highs</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expand manufacturing capacity to meet growing demand</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expand intellectual portfolio to further leverage additional uses and expand geographic coverage </font></div></td></tr></table><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Development Goals (30% Weighting)</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Complete at least five licensing deals </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Complete one LTP deal or one novel R&amp;D asset deal</font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">35</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:21px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Strategic Initiatives (25% Weighting)</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Complete an acquisition, major alliance or other strategic initiative </font></div></td></tr></table><div style="line-height:120%;padding-top:21px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operational Goals (15% Weighting)</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Engage with major partners to impact planning for long-term commercial success</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deliver superior partner customer service focused on information timeliness, technical support and issue resolution</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Successful project management of our research and development projects related to granulocyte colony stimulating factor (&#8220;GCSF&#8221;), lasofoxifene (&#8220;Laso&#8221;), LTP and Captisol-enabled development programs</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective financial and administrative management</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Enter sublease agreement for unused space</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In evaluating management&#8217;s performance against our 2015 corporate objectives in January 2016, our compensation committee determined to award a corporate achievement level of 95.5% relative to those objectives. This determination was made in the discretion of the compensation committee after its review of our overall corporate performance relative to each of the objectives listed above. In general, quantitative objectives were not established for most of the corporate objectives during 2015. Instead these performance objectives were used as a guide by the compensation committee in determining overall corporate performance as they represented those areas in which the named executive officers and our employees generally were expected to focus their efforts.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to the goals related to the optimization of our Captisol business, the compensation committee awarded full credit, for an achievement level of 90%, noting the Company entered into 94 new Captisol research contracts.  The Company had sharp year-over-year increases in Captisol material sales and Captisol sample requests from new prospective partners.  The Company also expanded manufacturing capacity to meet growing demand and expanded the intellectual property portfolio to further leverage additional uses for Captisol and increase and continued the globalization of the Company&#8217;s Captisol customer base.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to the business development goals, the compensation committee awarded full credit, for an achievement level of 100%, noting that in 2015, the Company completed eight new Captisol licensing deals that increased the Company&#8217;s Shots-on-Goal portfolio by at least ten.  The Company also completed the licensing of oral lasofoxifene, creating the potential for $32 million in potential future milestones.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to the strategic initiatives goal, the compensation committee awarded full credit, for an achievement level of 100%, noting that completion of the Viking initial public offering in May 2015, the acquisition of over 15 biologic Shots-on-Goal from Selexis and the completion of the OMT acquisition.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to the operational goals, which were entirely qualitative goals and not objectively determinable, the compensation committee determined an overall achievement level of 90% was appropriate given its subjective determination of the Company&#8217;s overall performance in this area during 2015. The compensation committee noted that in 2015, the Company was profitable and cash-flow positive for the second consecutive year.  The Company effectively managed the research and development projects related to the glucagon receptor antagonist, GCSF, Laso, LTP and Captisol-enabled programs, signed a sub-lease agreement and successfully implemented several internal organizational changes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of the foregoing determinations, all of our named executive officers, other than Mr. Korenberg and Mr. de Silva, received bonus awards equal to 95.5% of their target awards. Mr. Korenberg received a bonus award equal to 100% of his target award, prorated for the portion of 2015 he was employed by the Company, due to his commencement of employment late in 2015. Mr. de Silva was not eligible for a bonus award for 2015 due to his resignation in May 2015.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ms. Herman received a bonus equal to 100% of her target bonus, which amount was determined by Mr. Higgins in his sole discretion, and based on his assessment of her individual performance during 2015.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">36</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The actual bonus awards paid to our named executive officers for 2015 are disclosed below in the table entitled &#8220;Summary Compensation Table.&#8221;</font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-Term Performance-Based Equity Incentive Program </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with our compensation philosophy, the Company&#8217;s longer-term performance-based compensation is based on equity ownership. The Company believes that equity ownership in the Company is important to tie the ultimate level of an executive officer&#8217;s compensation to the performance of the Company&#8217;s stock and stockholder gains while creating an incentive for sustained growth.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We generally provide equity compensation to our named executive officers through grants of stock options, performance stock units and restricted stock units. The grants are designed to align the interests of our named executive officers with those of the stockholders and provide each individual with a significant incentive to manage the Company from the perspective of an owner with an equity stake in the business. The compensation committee views granting options and restricted stock unit awards as a retention device and therefore also reviews the status of vesting and number of vested verses unvested options and restricted stock unit awards at the time of grant. Guidelines for the number of stock options and restricted stock unit awards granted to each executive officer are determined using a procedure approved by the compensation committee based upon several factors, including the executive officer&#8217;s level of responsibility, salary grade, performance and the value of the stock option and restricted stock unit awards at the time of grant. With respect to our named executive officers, we generally make awards to such officers at the time of initial hire based on an evaluation of the foregoing factors. Additional grants, other than the annual awards to executives, may be made following a significant change in job responsibility or in recognition of a significant achievement. Annual awards are made to our named executive officers when such awards are deemed appropriate by the compensation committee based on an evaluation of the foregoing factors.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Time-based stock options granted under our 2002 Stock Incentive Plan, or the 2002 Plan, generally have a four-year vesting schedule designed to provide an incentive for continued employment. The options generally expire ten years from the date of the grant. This provides a reasonable time frame during which executive officers and other employees who receive grants can benefit from the appreciation of the Company&#8217;s shares. The exercise price of options granted under our 2002 Plan, is equal to 100% of the fair market value of the underlying stock on the date of grant. Accordingly, the option will provide a return to the executive officer only if the market price of the shares appreciates over the option term. Time-based restricted stock unit awards generally vest in equal installments over three years. We also grant performance-based equity awards to certain of our named executive officers.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commencing in 2015, the compensation committee introduced performance-based restricted stock units as a component of our annual long-term equity incentive awards for our named executive officers.&#160; The &#8220;target&#8221; number of performance-based restricted stock units represented approximately 25% of the total value of the long-term equity incentive awards granted to our named executive officers in February 2015 (other than Ms. Herman).&#160; Of the remainder of the long-term equity incentive awards granted to our named executive officers (other than Ms. Herman), 50% of the total value of the long-term incentive awards was granted in the form of stock options that are subject to our standard four year vesting schedule, as described above, and 25% of the total value of the long-term incentive awards was granted in the form of restricted stock units that are subject to our standard three year vesting schedule, as described above. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A named executive officer may earn up to 137.5% of the &#8220;target&#8221; number of performance-based restricted stock units based on performance relative to the performance objectives established for these awards.  The performance-based restricted stock units will vest based on objectives related to our non-GAAP earnings per share growth for the two year performance period commencing January 1, 2015 and ending December 31, 2016 and our new Shots-on-Goal transactions during the three year performance period commencing January 1, 2015 and ending December 31, 2017, with each such objective equally weighted (and a possible performance multiplier of 150% for &#8220;maximum&#8221; performance relative to the non-GAAP earnings per share growth objectives and a possible performance multiplier of 125% for &#8220;maximum&#8221; performance relative to the Shots-on-Goal transactions objectives). Threshold performance levels, below which no vesting will be awarded, were also established for each performance objective.  The compensation committee selected the foregoing performance measures because they represent the key financial and operational performance metrics for which the executives are responsible, thereby creating the clearest link between executive actions, corporate results and continued long-term success for the Company.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ms. Herman received approximately 90% of her annual equity awards in the form of stock options and the remainder in the form of time-based restricted stock units.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">37</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Given the position of executive cash compensation relative to market, our compensation committee has emphasized long-term equity incentive compensation to ensure total compensation is competitive.  The long-term equity incentive awards to the named executive officers in 2015 were set at approximately the 75th percentile level of equity awards for similar positions at our peer group companies, adjusted using the above factors and taking into consideration such equivalency factors as our number of shares outstanding and market capitalization, compared to the peer group companies.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All of the equity awards granted to our named executive officers are disclosed below in the table entitled &#8220;Grants of Plan-Based Awards in Fiscal Year 2015.&#8221;</font></div><div style="line-height:120%;padding-top:24px;text-align:left;padding-left:30px;text-indent:-30px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Other Elements of Compensation and Perquisites</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We also provide our named executive officers and other employees the following benefits and perquisites.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Medical Insurance.</font><font style="font-family:inherit;font-size:10pt;">&#32;The Company provides to each named executive officer, the named executive officer&#8217;s spouse and children such health, dental and vision insurance coverage as the Company may from time to time make available to its other executives of the same level of employment. The Company pays a portion of the premiums for this insurance for all employees.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Life and Disability Insurance.</font><font style="font-family:inherit;font-size:10pt;">&#32;The Company provides each named executive officer such disability and/or life insurance as the Company in its sole discretion may from time to time make available to its other executive employees of the same level of employment.  The Company pays the premiums for this life insurance coverage for the named executive officers.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Defined Contribution Plan.</font><font style="font-family:inherit;font-size:10pt;">&#32;The Company and its designated affiliates offer the Section&#160;401(k) Savings/Retirement Plan, or the 401(k) Plan, a tax-qualified retirement plan, to their eligible employees. The 401(k) Plan permits eligible employees to defer from 1% to 90% of their annual eligible compensation, subject to certain limitations imposed by the Internal Revenue Code. The employees&#8217; elective deferrals are immediately vested and non-forfeitable in the 401(k) Plan.  The Company also makes matching contributions to the 401(k) Plan.  In 2015, the match was equal to $0.40 per each $1.00 contributed by an employee up to an annual maximum of $4,800 per year.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Employee Stock Purchase Plan.</font><font style="font-family:inherit;font-size:10pt;">&#32;The Company&#8217;s 2002 Employee Stock Purchase Plan, which is intended to qualify under Section&#160;423 of the Internal Revenue Code, permits participants to purchase Company stock on favorable terms. Plan participants are granted a purchase right to acquire shares of common stock at a price that is 85% of the stock price on either the first day of the six month offering period or the stock price on the last day of the six month offering period, whichever is lower. The purchase dates occur on the last business days of December and June of each year. To pay for the shares, each participant may authorize periodic payroll deductions from 1% to 10% of his or her cash compensation, subject to certain limitations imposed by the Internal Revenue Code. All payroll deductions collected from the participant in an offering period are automatically applied to the purchase of common stock on that offering period&#8217;s purchase date provided the participant remains an eligible employee and has not withdrawn from the employee stock purchase plan prior to that date.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other.</font><font style="font-family:inherit;font-size:10pt;">&#32;The Company makes available certain other perquisites or fringe benefits to executive officers and other employees, such as tuition reimbursement, professional society dues and food and recreational fees incidental to official company functions, including board meetings.  The aggregate of these other benefits was less than $10,000 for each executive officer in the last fiscal year.</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Severance and Change in Control Arrangements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that reasonable severance benefits for our named executive officers are important because it may be difficult for our executive officers to find comparable employment within a short period of time following an involuntary termination of employment. We also believe that it is important to protect our named executive officers in the event of a change in control transaction involving us. In addition, it is our belief that the interests of stockholders will be best served if the interests of our senior management are aligned with them, and providing change in control severance benefits should eliminate, or at least reduce, the reluctance of senior management to pursue potential change in control transactions that may be in the best interests of stockholders. Accordingly, the severance arrangements we have entered into with each of our executive officers provide for severance benefits in specified circumstances, as well as benefits in connection with an involuntary termination following a change in control.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">38</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in Control Arrangements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a change in control severance agreement with each of the named executive officers (other than Ms. Herman, who is not a party to one of these agreements). In the event a named executive officer&#8217;s employment is terminated by us without cause or he or she resigns for good reason within 24 months following a change in control of the Company, he or she will be eligible to receive a severance benefit equal to:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">one times (two times for Mr.&#160;Higgins) the annual rate of base salary in effect for such officer at the time of involuntary termination; plus</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">one times (two times for Mr.&#160;Higgins) the greater of: (a)&#160;the maximum target bonus for the fiscal year in which the termination occurs; or (b)&#160;the maximum target bonus for the fiscal year in which the change in control occurs, if different; plus</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">twelve (twenty-four for Mr.&#160;Higgins) multiplied by the monthly premium the executive would be required to pay for continued health coverage for himself or herself and his or her eligible dependents.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing severance amount will be payable in a lump sum following the officer&#8217;s termination of employment, subject to the officer&#8217;s execution of a general release of claims acceptable to us.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The change in control severance agreements also provide that all of a named executive officer&#8217;s outstanding stock awards will vest in the event of such a termination. In addition, the post-termination exercise period of a named executive officer&#8217;s stock options will be extended from three&#160;months to the date that is nine months following the date of termination (but in no event beyond the original expiration date of such options).</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For purposes of the change in control severance agreements, an involuntary termination is either a termination of a named executive officer&#8217;s employment by us without cause or his resignation for good reason. &#8220;Cause&#8221; is generally defined as an officer&#8217;s conviction of, or plea of &#8220;guilty&#8221; or &#8220;no contest&#8221; to, a felony under the laws of the United States or any state thereof, an officer&#8217;s willful and material breach of any obligation or duty under the employment agreement, the Company&#8217;s confidentiality and proprietary rights agreement or the Company&#8217;s written employment or other written policies that have previously been furnished to the officer, which breach is not cured within 30 days after written notice thereof is received by the officer, if such breach is capable of cure, the officer&#8217;s gross negligence or willful misconduct, including without limitation, fraud, dishonesty or embezzlement, in the performance of his duties, or the officer&#8217;s continuing failure or refusal to perform his assigned duties or to comply with reasonable directives of the board of directors that are consistent with the officer&#8217;s job duties (which directives are not in conflict with applicable law), which failure is not cured within 30 days after written notice thereof is received by the officer.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For purposes of the change in control severance agreements, &#8220;good reason&#8221; is generally defined as a material diminution in the officer&#8217;s authority, duties or responsibilities, a material diminution in the officer&#8217;s base compensation, a material change in the geographic location at which the officer must perform his duties, or any other action or inaction that constitutes a material breach by the Company or any successor or affiliate of its obligations to the officer under the employment agreement. An officer must provide written notice to the Company of the occurrence of any of the foregoing events or conditions without his written consent within 90 days of the occurrence of such event. The Company will have a period of 30 days to cure such event or condition after receipt of written notice of such event from the officer. Any voluntary termination of an officer&#8217;s employment for &#8220;good reason&#8221; must occur no later than the date that is six months following the initial occurrence of one of the foregoing events or conditions.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For purposes of the change in control severance agreements, a &#8220;change in control&#8221; has generally the same definition as given to such term under our 2002 Plan, as described below.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amended and Restated Severance Plan</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We maintain the Ligand Pharmaceuticals Incorporated Amended and Restated Severance Plan to provide severance payments to our employees and the employees of our subsidiaries upon an involuntary termination of employment without cause. Each of the named executive officers is eligible to participate in the severance plan, provided that he or she is not subject to disciplinary action or a formal performance improvement plan at the time of termination. However, if, as a result of his or her involuntary termination by us without &#8220;cause,&#8221; a named executive officer would be eligible to receive severance under any </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">39</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">individual change in control severance agreement, employment agreement or other arrangement providing severance benefits, as approved by our board of directors or a committee thereof, such named executive officer will not be eligible for benefits under the severance plan.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the terms of the severance plan, a named executive officer will be eligible to receive (1)&#160;a lump sum payment in cash for his fully earned but unpaid base salary and accrued but unused vacation through the date of termination, (2)&#160;an amount equal to his base salary for the severance period, which period will be equal to (a)&#160;two months plus (b)&#160;one week for each year of service as of the date of termination and (c)&#160;continued health coverage at the same cost as was in effect for the named executive officer at the date of termination throughout such severance period, provided that such named executive officer elects continued coverage under COBRA. The foregoing cash severance benefit will be payable in a lump sum following the officer&#8217;s termination of employment, subject to the officer&#8217;s execution of a general release of claims acceptable to us.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For purposes of the severance plan, &#8220;cause&#8221; is generally defined as an officer&#8217;s conviction of (or entry of a plea of no contest to) any felony or any other criminal act, an officer&#8217;s commission of any act of fraud or embezzlement, an officer&#8217;s unauthorized use or disclosure of confidential or proprietary information or trade secrets of the Company or our subsidiaries, or an officer&#8217;s commission of any material violation of the Company&#8217;s policies, or an officer&#8217;s commission of any other intentional misconduct which adversely affects the business or affairs of the Company in a material manner.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in Control Acceleration of Equity Awards</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity awards granted under the 2002 Plan to the named executive officers may be subject to accelerated vesting in the event of a &#8220;change in control.&#8221;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity award agreements under the 2002 Plan, which cover each of the named executive officers, provide that such equity awards will automatically vest in the event of a &#8220;change in control&#8221; where the option is not assumed or replaced by a successor.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the 2002 Plan, a &#8220;change in control&#8217; is generally defined as:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a merger, consolidation or reorganization of the Company in which 50% or more of its voting securities change ownership;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the sale, transfer or other disposition of all or substantially all of the Company&#8217;s assets in complete liquidation or dissolution of the Company; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a change in control of the Company effected through a successful tender offer for more than 50% of the Company&#8217;s outstanding common stock or through a change in the majority of our board of directors as a result of one or more contested elections for board membership.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the performance-based restricted stock units granted to the named executive officers in 2015 contain additional vesting provisions that will apply in the event of a change in control.  In the event of a change in control prior to December 31, 2016, the number of performance-based restricted stock units in which a named executive will be eligible to vest under each performance-based restricted stock unit will be set at the &#8220;target&#8221; number of restricted stock units, which &#8220;target&#8221; restricted stock units will continue to be eligible to vest based solely on the participant&#8217;s continued employment or service, with 50% of such &#8220;target&#8221; units vesting on December 31, 2016 and 50% of such &#8220;target&#8221; units vesting on December 31, 2017. In the event of a change in control after December 31, 2016 but prior to December 31, 2017, the remaining number of restricted stock units in which a participant will be eligible to vest under each performance-based restricted stock unit will be set at 50% of the &#8220;target&#8221; number of restricted stock units, which &#8220;target&#8221; restricted stock units will continue to be eligible to vest based solely on the participant&#8217;s continued employment or service through December 31, 2017.   </font></div><div style="line-height:120%;padding-top:20px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Policies Regarding Tax Deductibility of Compensation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Section&#160;162(m) of the Internal Revenue Code restricts the ability of publicly held companies to take a federal income tax deduction for compensation paid to certain of their executive officers to the extent that compensation exceeds $1.0&#160;million per covered officer in any fiscal year. However, this limitation does not apply to compensation that is &#8220;qualified performance-based compensation&#8221; under Section 162(m) of the Internal Revenue Code.  While we consider the tax deductibility of each element of executive compensation as a factor in our overall compensation program, the compensation committee retains the </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">40</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">discretion to approve compensation that may not qualify for the compensation deduction if, in light of all applicable circumstances, it would be in our best interest for such compensation to be paid without regard to whether it may be tax deductible.</font></div><div style="line-height:120%;padding-top:20px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Risk Assessment of Compensation Policies and Programs</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, management and Radford assessed our compensation policies and programs for all employees for purposes of determining the relationship of such policies and programs and the enterprise risks faced by the Company and presented its assessment to our compensation committee. Based on these assessments, management recommended, and the compensation committee concluded, that none of our compensation policies or programs create risks that are reasonably likely to have a material adverse effect on the Company. In connection with their review, management and the compensation committee noted certain key attributes of our compensation policies and programs that help to reduce the likelihood of excessive risk taking, including:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The program design provides a balanced mix of cash and equity compensation, fixed and variable compensation and annual and long-term incentives.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate performance objectives are designed to be consistent with the Company&#8217;s overall business plan and strategy, as approved by the board of directors.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of executive incentive awards is based on a review of a variety of indicators of performance, reducing the risk associated with any single indicator of performance.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s equity awards generally vest over multi-year periods.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation committee has the right to exercise negative discretion over executive annual incentive plan payments.</font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">41</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Summary Compensation Table</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides information regarding the compensation earned by our named executive officers during the fiscal years ended December&#160;31, 2015, 2014 and 2013</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="22%"></td><td width="1%"></td><td width="5%"></td><td width="1%"></td><td width="9%"></td><td width="1%"></td><td width="10%"></td><td width="1%"></td><td width="10%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td><td width="1%"></td><td width="14%"></td><td width="1%"></td><td width="9%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Name and Principal Position</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Salary($)</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Awards ($)</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Option</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Awards ($)</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Equity</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Incentive Plan</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Compensation ($)</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">All Other</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Compensation ($)</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John L. Higgins,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">547,336</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,794,131</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,810,851</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">392,029</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,369</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,550,716</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:14px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">President and Chief Executive Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">510,198</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">595,360</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,552,951</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">383,097</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,650</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,047,256</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">500,331</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">559,360</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,567,129</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">375,248</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,843</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,004,911</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew W. Foehr,</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2015</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">410,472</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,250,322</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,356,995</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">196,000</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">143,501 (4)</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,357,290</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:14px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Executive VP and Chief Operating Officer</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2014</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">375,360</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">372,100</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,115,177</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">187,900</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,400</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,055,937</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">368,101</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">398,176</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,012,371</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">184,050</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,767</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,965,465</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew Korenberg,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">140,673</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,255,080</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,340,490</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56,269</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,464</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,797,976</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:14px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Vice President, Finance and Chief Financial Officer (5)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charles S. Berkman,</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2015</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">308,592</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">512,641</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">517,400</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">117,882</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,937</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,462,452</font></div></td></tr><tr><td rowspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;padding-left:14px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Vice President and General Counsel</font></div><div style="padding-top:1px;padding-left:14px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2014</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">288,938</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">186,050</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">958,516</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">115,711</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,700</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,554,915</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">283,351</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">54,800</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">277,362</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">113,340</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,908</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">731,761</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Melanie J. Herman,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">191,035</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67,512</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">290,004</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38,207</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45,857</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">632,615</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:14px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Chief Accounting Officer and former Interim Chief Financial Officer (6)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nishan de Silva,</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2015</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">137,903</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">666,456</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">672,584</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,050</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,481,993</font></div></td></tr><tr><td rowspan="2" style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:left;padding-left:14px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Former VP, Finance and Strategy and Chief Financial Officer(7) </font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2014</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">300,547</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">223,260</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,156,661</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">120,360</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,700</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,806,528</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">294,583</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">109,600</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">624,065</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">94,267</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,616</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,125,131</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><div style="line-height:120%;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:2px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reflects the grant date fair value for stock and option awards granted in 2013, 2014 and 2015, calculated in accordance with FASB ASC Topic 718. The assumptions used to calculate the value of stock and option awards are set forth under Note 8 of the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December&#160;31, 2015, filed with the SEC on February 26, 2016. With respect to the restricted stock unit awards included in the Summary Compensation Table that were granted during 2015 with performance-based vesting conditions, these amounts include the grant date fair values attributable to performance-based restricted stock units granted to each of the named executive officers based on the estimated probable outcome of  the performance based objectives applicable to such awards on the grant date.  The full grant date fair value of the performance-based restricted stock units awarded to our named executive officers during fiscal year 2015, assuming maximum achievement of the applicable performance objectives is as follows: Mr. Higgins $1,233,465, Mr. Foehr $704,882, Mr. Korenberg $862,868, Mr. Berkman $352,440, and Dr. de Silva $458,188.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents performance bonus awards under the management bonus plan earned in 2013, 2014 and 2015, but paid in the subsequent year.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">With the exception of Mr. Higgins in 2014 and Mr. Foehr in 2015, represents life insurance premiums paid by the Company for each year represented in the table and $4,800 in 401(k) matching funds paid by the Company for each named executive officer (which 401 (k) matching funds were $2,400 for 2013 and $4,800 for 2014 and 2015). </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pursuant to the management rights letter between Viking Therapeutics, Inc., or Viking, and the Company dated May 21, 2014, the Company nominated Mr. Foehr to serve as a member of Viking&#8217;s board of directors.  During 2015, in connection with such nomination and Mr. Foehr&#8217;s service as a director of Viking, Mr. Foehr received (1) $22,113 in cash payments and (2) $115,569 in option awards (representing the aggregate grant date fair value of the option awards as reported by Viking, computed in accordance with authoritative accounting guidance).  Additionally, Mr. Foehr received life insurance premiums paid by the Company for 2015 of $600, taxable fringe benefits of $419 and $4,800 in 401(k) matching funds paid by the Company in 2015.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Mr. Korenberg joined the Company on August 6, 2015.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Ms. Herman served as interim Chief Financial Officer from April 23, 2015 through August 6, 2015.  Included in other compensation, Ms. Herman received $40,000 additional compensation for serving as the interim Chief Financial Officer.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effective May 20, 2015, Mr. de Silva resigned his positions with the Company.  The amount in the "Salary" column includes his prorated base salary for 2015 plus $12,595 of vacation payout in connection with his termination of employment.</font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">42</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:24px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Grants of Plan-Based Awards in Fiscal Year 2015</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes plan-based awards granted to our named executive officers during the last fiscal year.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="23"></td></tr><tr><td width="7%"></td><td width="6%"></td><td width="8%"></td><td width="7%"></td><td width="1%"></td><td width="6%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="6%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="6%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Name</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Grant Date</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Date&#160;of Board&#160;</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Action </font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">approving</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Award</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Estimated Future Payouts Under</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-Equity Incentive Plan</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Awards </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="6" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Estimated Future Payouts Under Equity Incentive Plan Awards </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">All Other</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Awards:</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Number of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shares of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock or</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Units </font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(#)</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">All&#160;Other</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Option</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Awards:</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Number of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Securities</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Underlying</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Options </font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(#)</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercise&#160;or</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Base&#160;Price</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">of&#160;Option</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Awards</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">($/Sh)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Grant&#160;Date</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value </font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock and</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Option</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Awards </font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">($) ($)</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Threshold ($)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Target ($)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Maximum ($)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Threshold (#)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Target (#)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Maximum (#)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John&#160;L.&#160;</font></div><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Higgins</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/27/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/27/15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">412,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/23/14</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,965</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,945</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21,925</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">897,066</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/23/14</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,945</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">897,066</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/23/14</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56,198</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,810,851</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew&#160;</font></div><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">W. Foehr</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/27/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/23/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">206,500</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/6/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,695</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,112</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12,529</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">512,641</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/6/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13,112</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">737,681</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/6/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42,113</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.26</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,356,995</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew Korenberg</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7/22/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8/6/15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56,269</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7/22/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8/6/15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,750</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,250</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">627,540</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7/22/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8/6/15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">627,540</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7/22/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8/6/15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">104.59</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,340,490</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charles S. Berkman</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/27/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/23/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">124,000</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/6/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,847</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,556</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,265</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">256,320</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/6/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,556</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">256,321</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/6/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,057</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.26</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">517,400</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Melanie Herman</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/27/15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">38,207</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,200</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">67,512</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/27/15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">290,004</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nishan </font></div><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">de Silva</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/27/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1/23/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">132,000</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/6/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,702</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,923</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,144</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">333,227</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/6/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,923</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">333,228</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/15</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:1px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/6/14</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20,873</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.26</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">672,456</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><div style="line-height:120%;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:3pt;">&#32;</font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents the target cash bonus awards granted under our annual performance bonus program. Actual bonus amounts paid are reflected in the Summary Compensation Table above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The performance-based restricted stock units will vest based on objectives related to our non-GAAP earnings per share growth for the two year performance period commencing January 1, 2015 and ending December 31, 2016 and our new Shots-on-Goal transactions during the three year performance period commencing January 1, 2015 and ending December 31, 2017, with each such objective equally weighted (and a possible performance multiplier of 150% for &#8220;maximum&#8221; performance relative to the non-GAAP earnings per share growth objectives and a possible performance multiplier of 125% for &#8220;maximum&#8221; performance relative to the Shots-on-Goal transactions objectives).  Threshold performance levels, below which no vesting will be awarded, were also established for each performance </font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">43</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:130%;padding-left:53px;text-align:left;"><font style="font-family:inherit;font-size:8pt;">objective.  For a description of the change in control provisions applicable to the foregoing equity award, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The restricted stock unit awards granted to the named executive officers vest in equal installments over a three year period. For a description of the change in control provisions applicable to the foregoing equity awards, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Each option grant to the named executive officers vests 12.5% after six months from grant and the remainder in 42 equal monthly installments. For a description of the change in control provisions applicable to the foregoing equity awards, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents the fair value of the stock option or stock award at the time of grant as determined in accordance with the provisions of FASB ASC Topic 718. The assumptions used to calculate the value of stock and option awards are set forth under Note 8 of the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December&#160;31, 2015, filed with the SEC on February 26, 2016. With respect to awards, the vesting of which is performance-based, the grant date fair value is based on the estimated probable outcome of the performance objectives applicable to such awards on the grant date.</font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">44</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:21px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Outstanding Equity Awards at Fiscal Year-End</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides information on all stock and option awards held by the named executive officers of the Company as of December&#160;31, 2015. All outstanding equity awards are in shares of the Company&#8217;s common stock. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td width="9%"></td><td width="9%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="9%"></td><td width="1%"></td><td width="7%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="1%"></td><td width="9%"></td><td width="1%"></td><td width="9%"></td><td width="1%"></td><td width="8%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option Awards</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock Awards</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Name</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Securities</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Underlying</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unexercised</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options (#)</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercisable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Securities</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Underlying</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unexercised</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options (#)</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unexercisable</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Equity</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Incentive Plan</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Awards:</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Securities</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Underlying</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unexercised</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unearned</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options&#160;(#)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option Exercise Price</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Expiration</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number&#160;of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares or</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Units of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock That</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Have Not</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Vested&#160;(#)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Market&#160;</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value&#160;of Shares or&#160;Units of&#160;Stock That</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Have Not</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Vested&#160;($)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Equity</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Incentive</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Awards:</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number&#160;of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unearned</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares,</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unit&#160;or&#160;</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Rights&#160;That</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Have Not</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Vested&#160;(#)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Equity</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">incentive</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Awards:</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">or Payout</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unearned</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares,</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Units&#160;or&#160;Other</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Rights&#160;That</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Have Not</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Vested&#160;($)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John&#160;L.&#160;</font></div><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Higgins</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33,149</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.00</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/22/2018</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">62,444</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/14/2019</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48,125</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.96</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/14/2020</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">110,332</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.05</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/16/2021</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">154,057</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,609</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.47</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/8/2022</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">75,792</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31,208</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.92</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/15/2023</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13,438</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">896 </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6/3/2023</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">54,375</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20,625</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.42</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/2024</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.42</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/2024</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,708</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">44,490</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/10/2025</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23,944 </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(7)</sup></font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,596,008</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,945</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(4)</sup></font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,728,757</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew W. Foehr</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77,009</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.97</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4/17/2021</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57,500</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,500</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.47</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/8/2022</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">51,708</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21,292</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.92</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/15/2023</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40,625</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24,375</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.42</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/2024</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,774</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">33,339</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.26</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/10/2025</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,445 </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(8)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,782,967</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,112</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(4)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">987,923</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew Korenberg</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">104.59</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8/5/2025</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,000 </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(9)</sup></font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">650,520</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,000 </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">650,520</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charles S. Berkman</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,333</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40.86</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4/29/2017</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,947</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42.90</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6/19/2017</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">625</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.05</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/16/2021</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,646</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,042</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.47</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/8/2022</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,787</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,833</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.92</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/15/2023</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,167</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,833</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.42</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/11/2024</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,346</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12,711</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.26</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/10/2025</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,055</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(10)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">764,903</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,556 </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">493,962</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Melanie Herman</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">187</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,125</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56.26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2/10/2025</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,652</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">287,530</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><div style="line-height:120%;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">45</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Each option grant to the named executive officers has a ten year term from the date of grant. Except as described below, each option vests 12.5% after six months from grant and the remainder in 42 equal monthly installments. Exercise prices for awards granted prior to April 2007 reflect the $2.50 downward adjustment made to such exercise prices in April 2007 to reflect the Company&#8217;s one-time special cash dividend paid in April 2007. With respect to Mr. Foehr, 65,000 of the options granted in February 2011 were subject to performance-based vesting and were scheduled to vest as follows: 15,000 options would vest if and when cumulative CyDex revenue for 2011 and 2012 exceeded certain pre-determined levels; 25,000 options would vest if we completed a strategic partnership with a commercial partner by June 30, 2012; and 25,000 options would vest if we completed a multi-product CyDex technology-based platform transaction with a pharmaceutical company by June 30, 2012. Mr. Foehr vested in 25,000 of these options in January 2012 as a result of the CyDex technology-based platform transaction consummated with Eli Lilly, and in an additional 25,000 of these options in June 2012 as a result of our strategic partnership with Hovione. CyDex revenue for 2011 and 2012 did not exceed the necessary levels and, accordingly, 15,000 of these options were automatically forfeited after the end of 2012 and are no longer outstanding. For a description of the change in control provisions applicable to the stock option awards, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Except as described below, the restricted stock unit awards granted to the named executive officers vest in equal installments over a three year period following the date of grant. For a description of the change in control provisions applicable to the stock awards, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Computed by multiplying the closing market price of our common stock on December&#160;31, 2015 $108.42 by the number of shares of common stock subject to such award.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents the &#8220;target&#8221; number of performance-based restricted stock units granted to the named executive officer.  A named executive officer may earn up to 137.5% of the &#8220;target&#8221; number of performance-based restricted stock units based on performance relative to the performance objectives established for these awards.  The performance-based restricted stock units will vest based on objectives related to our non-GAAP earnings per share growth for the two year performance period commencing January 1, 2015 and ending December 31, 2016 and our new Shots-on-Goal transactions during the three year performance period commencing January 1, 2015 and ending December 31, 2017, with each such objective equally weighted (and a possible performance multiplier of 150% for &#8220;maximum&#8221; performance relative to the non-GAAP earnings per share growth objectives and a possible performance multiplier of 125% for &#8220;maximum&#8221; performance relative to the Shots-on-Goal transactions objectives).  Threshold performance levels, below which no vesting will be awarded, were also established for each performance objective.  For a description of the change in control provisions applicable to the foregoing equity award, see &#8220;Severance and Change in Control Arrangements&#8221; above</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The option grant was vested as to 4,473 shares on the date of grant, and the remaining shares subject to the option will vest in 33 equal monthly installments on the ninth day of each calendar month following the date of grant, commencing June 9, 2013 and continuing through February 9, 2016. For a description of the change in control provisions applicable to this stock option award, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(6) </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The performance stock options vested upon the attachment of business development goals, with 50% of the shares subject to the options vesting on the date the Company signed a licensing deal for a major asset, so long as such goal was achieved prior to December 31, 2015, and 50% of the shares subject to the options vesting on the date that the Company's Shots-on-Goal portfolio exceeded 102 Shots-on-Goal, so long as such goal was achieved prior to December 31, 2015.  In September 2014, the compensation committee determined that the Shots-on-Goal portfolio exceeded 102 Shots-on-Goal and awarded vesting credit for 50% of these awards.  In May of 2015, the compensation committee determined upon the initial public offering of Viking Therapeutics, the Viking master license agreement qualified as a licensing agreement for a major asset.  For a description of the change in control provisions applicable to the stock awards, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The table above reflects the remaining unvested restricted stock units from the following grants of restricted stock units to Mr. Higgins, which vest in equal installments over a three year period: 8,000 restricted stock units granted on February 15, 2013, 8,000 restricted stock units granted on February 12, 2014, and 31,890 restricted stock units granted on February 10, 2015.  For a description of the change in control provisions applicable to the stock awards, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(8)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The table above reflects the remaining unvested restricted stock units from the following grants of restricted stock units to Mr. Foehr, which vest in equal installments over a three year period: 6,000 restricted stock units granted on February 15, 2013, 5,000 restricted stock units granted on February 12, 2014 and 22,224 restricted stock units granted on February 10, 2015.  For a description of the change in control provisions applicable to the stock awards, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(9)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The restricted stock unit award of 12,000 shares was granted on February 11, 2015. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:29px;"><font style="font-family:inherit;font-size:8pt;">(10)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The table above reflects the remaining unvested restricted stock units from the following grants of restricted stock units to Mr. Berkman, which vest in equal installments over a three year period: 2,500 restricted stock units granted on February 15, 2013, 2,500 restricted stock units granted on February 12, 2014 and 9,112 restricted stock units granted on February 10, 2015. For a description of the change in control provisions applicable to the stock awards, see &#8220;Severance and Change in Control Arrangements&#8221; above.</font></div></td></tr></table><div style="line-height:130%;text-align:left;padding-left:53px;text-indent:-24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">46</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:21px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Option Exercises and Stock Vested During Fiscal Year 2015</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides information on stock option exercises and stock vesting in fiscal 2015 by the named executive officers of the Company.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td width="31%"></td><td width="17%"></td><td width="1%"></td><td width="1%"></td><td width="14%"></td><td width="1%"></td><td width="1%"></td><td width="17%"></td><td width="1%"></td><td width="1%"></td><td width="14%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option Awards</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock Awards</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Name</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">No. of Shares</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Acquired&#160;on&#160;Exercise&#160;(#)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value&#160;Realized&#160;Upon</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise&#160;($)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number&#160;of&#160;Shares</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Acquired&#160;on&#160;Vesting&#160;(#)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value&#160;Realized&#160;on</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Vesting&#160;($)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John L. Higgins</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,334</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">633,684</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew W. Foehr</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">40,046</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,525,256</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,000</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">391,370</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew Korenberg</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charles S. Berkman</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20,331</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,549,735</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,333</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">186,348</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Melanie Herman</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,844</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">643,186</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">958</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60,756</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Nishan de Silva</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">91,972</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,097,198</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,000</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">335,460</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><div style="line-height:120%;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The value realized upon exercise of stock options reflects the price at which shares acquired upon exercise of the stock options were sold or valued for income tax purposes, net of the exercise price for acquiring the shares.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Computed by multiplying the closing market price of our restricted stock on the vesting date by the number of shares of restricted stock subject to such award vesting on the applicable vesting date.</font></div></td></tr></table><div style="line-height:120%;padding-top:21px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Potential Payments Upon Termination or Change in Control</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes potential change in control and severance payments to each named executive officer as of December 31, 2015. The three right-hand columns describe the payments that would apply in three different potential scenarios&#8212;a termination without cause prior to a change in control or more than 24 months following a change in control; a change in control without a termination of employment; or a termination of employment as a result of the named executive officer&#8217;s resignation for good reason or termination of employment by us other than for cause, in each case within 24 months following a change in control. The table assumes that the termination or change in control occurred on December&#160;31, 2015. Nishan de Silva, our former Vice President, Finance and Strategy and Chief Financial Officer, was not eligible for payments upon a change of control or severance because his employment terminated prior to December 31, 2015.  For purposes of estimating the value of accelerated equity awards to be received in the event of a termination of employment or change in control, we have assumed a price per share of our common stock of $108.42, which represents the closing market price of our common stock as reported on the NASDAQ Global Market on December&#160;31, 2015, the last trading day of 2015. All cash severance benefits will be paid in a lump sum.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">47</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td width="22%"></td><td width="1%"></td><td width="20%"></td><td width="1%"></td><td width="15%"></td><td width="1%"></td><td width="1%"></td><td width="15%"></td><td width="1%"></td><td width="1%"></td><td width="21%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination Without Cause; No Change of Control ($)</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change of Control; No&#160;Termination ($)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Termination&#160;Without Cause&#160;or&#160;Resignation for Good Reason within 24 Months Following a Change&#160;of&#160;Control ($)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John L. Higgins</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Salary</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">185,954</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,094,672</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Bonus</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">821,004</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Option acceleration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,090,728</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,090,728</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock Award acceleration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,324,765</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4,324,765</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits continuation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8,461</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">56,363</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total value:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">194,415</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11,415,493</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13,387,532</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew W. Foehr</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Salary</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">106,302</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">410,472</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Bonus</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">205,236</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Option acceleration</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,996,924</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,996,924</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock Award acceleration</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,770,890</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,770,890</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits continuation</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,077</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28,181</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total value:</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">111,379</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,767,814</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,411,703</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Matthew Korenberg</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Salary</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">61,699</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">350,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Bonus</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">140,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Option acceleration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95,750</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">95,750</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock Award acceleration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,301,040</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,301,040</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits continuation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,384</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28,181</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total value:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">65,083</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,396,790</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,914,971</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charles S. Berkman</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Salary</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">135,701</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">308,592</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Bonus</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">123,437</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Option acceleration</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,633,778</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,633,778</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock Award acceleration</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,258,865</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,258,865</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits continuation</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10,153</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28,181</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total value:</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">145,854</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2,892,643</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,352,853</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Melanie J. Herman</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Salary</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">54,616</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">54,616</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Bonus</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Option acceleration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock Award acceleration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits continuation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,143</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,143</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total value:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60,759</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60,759</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><div style="line-height:120%;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The 2002 Plan provides that options or restricted stock units will vest in the event of a change in control and the options or restricted stock units are not assumed or replaced by a successor. This disclosure assumes that the successor does not assume or replace the options or restricted stock units.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The change in control severance agreements with each of our named executive officers provide that all of a named executive officer&#8217;s outstanding stock awards will vest in the event of an involuntary termination.  Ms. Herman is not a party to a change in control severance agreement and the benefits reflected in this column for her represent the severance benefits to which she would be entitled upon a termination without cause under our severance plan.</font></div></td></tr></table><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Compensation of Directors</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides information related to the compensation of each of our non-employee directors for fiscal 2015.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td width="39%"></td><td width="13%"></td><td width="1%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td><td width="1%"></td><td width="15%"></td><td width="1%"></td><td width="1%"></td><td width="13%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Name</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Fees ($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock Awards ($)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(8)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Option Awards ($)</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(8)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total ($)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Jason M. Aryeh(1)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">62,564</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">83,019</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139,946</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">285,529</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Todd Davis(2)</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15,000</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">127,984</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139,946</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">282,930</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">David Knott(3)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55,064</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">83,019</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139,946</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">278,029</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John W. Kozarich(4)</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">80,064</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">83,019</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139,946</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">303,029</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Sunil Patel(5)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">55,064</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">83,019</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139,946</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">278,029</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stephen L. Sabba(6)</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">70,064</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">83,019</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139,946</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">293,029</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">John L. LaMattina(7)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52,564</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">83,019</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139,946</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-top:1px;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">275,529</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><div style="line-height:120%;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December&#160;31, 2015, Mr.&#160;Aryeh held options to purchase 9,399 shares of our common stock and 925 restricted stock units. During 2015, Mr.&#160;Aryeh received 925 restricted stock units with a grant date fair value of $83,019 and 2,754 stock options with a grant date fair value of $139,946. </font></div></td></tr></table><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">48</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December&#160;31, 2015, Mr.&#160;Davis held options to purchase 16,734 shares of our common stock and 925 restricted stock units. During 2015, Mr.&#160;Davis received 925 restricted stock units with a grant date fair value of $83,019 and 1,426 stock options with a grant date fair value of $127,984. Mr. Davis elected to receive 501 shares of fully vested stock in lieu of $45,000 of his 2015 cash retainer for his services as a non-employee director.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December&#160;31, 2015, Mr.&#160;Knott held options to purchase 36,404 shares of our common stock and 925 restricted stock units. During 2015, Mr.&#160;Knott received 925 restricted stock units with a grant date fair value of $83,019 and 2,754 stock options with a grant date fair value of $139,946. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December&#160;31, 2015, Dr.&#160;Kozarich held options to purchase 33,903 shares of our common stock and 925 restricted stock units. During 2015, Dr. Kozarich received 925 restricted stock units with a grant date fair value of $83,019 and 2,754 stock options with a grant date fair value of $139,946. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December&#160;31, 2015, Mr.&#160;Patel held options to purchase 33,071shares of our common stock and 925 restricted stock units. During 2015, Mr. Patel received 925 restricted stock units with a grant date fair value of $83,019 and 2,754 stock options with a grant date fair value of $139,946. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December&#160;31, 2015, Dr.&#160;Sabba held options to purchase 33,071 shares of our common stock and 925 restricted stock units. During 2015, Dr. Sabba received 925 restricted stock units with a grant date fair value of $83,019 and 2,754 stock options with a grant date fair value of $139,946. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December&#160;31, 2015, Dr.&#160;LaMattina held options to purchase 28,071 shares of our common stock and 925 restricted stock units. During 2015, Dr. LaMattina received 925 restricted stock units with a grant date fair value of $83,019 and 2,754 stock options with a grant date fair value of $139,946. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(8)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reflects the grant date fair value for stock and option awards granted in 2015, calculated in accordance with FASB ASC Topic 718. The assumptions used to calculate the value of stock and option awards are set forth under Note 8 of the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December&#160;31, 2015, filed with the SEC on February 26, 2016. With the exception of Todd Davis, each director received 925 restricted stock units and 2,754 options. </font></div></td></tr></table><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Narrative to Director Compensation Table</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-employee members of our board of directors are paid fees for their service as a director and are reimbursed for expenses incurred in connection with such service.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under our director compensation policy, each director is eligible to receive an annual retainer of $45,000. No meeting fees will be paid. In addition, the chairperson of the board will receive an additional annual retainer of $30,000, the chairperson of the audit committee will receive an additional annual retainer fee of $20,000, the chairperson of the compensation committee will receive an additional annual retainer of $15,000 and the chairperson of the nominating and corporate governance committees will receive an additional annual retainer fee of $10,000. Members of the audit committee will receive an additional annual retainer of $10,000, members of the compensation committee will receive an additional annual retainer of $7,500 and members of the nominating and corporate governance committee will receive an additional annual retainer of $5,000.  Directors may elect to receive their retainers in cash or vested shares of our common stock, which shares will be issued under our 2002 Plan.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At each annual meeting, non-employee directors will automatically be granted (i) that number of restricted stock units determined by dividing (a) $75,000, by (b) the average closing price per share of the Company&#8217;s common stock on the Nasdaq Global Market (or such other established stock exchange or national quotation system on which the stock is quoted) for the 30-calendar day period prior to the date of grant, and (ii) that number of stock options having a value of $140,000, calculated on the grant date in accordance with the Black-Scholes option pricing model (utilizing the same assumptions that the Company utilizes in preparation of its financial statements).  The foregoing awards will vest in full on the earlier of (i) the date of the annual meeting of the Company&#8217;s stockholders next following the grant date, and (ii) on the first anniversary of the date of grant.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon initial election to the board of directors, each non-employee director will automatically be granted (i) that number of restricted stock units determined by dividing (a) $113,000, by (b) the average closing price per share of the Company&#8217;s common stock on the Nasdaq Global Market (or such other established stock exchange or national quotation system on which the stock is quoted) for the 30-calendar day period prior to the date of grant, and (ii) that number of stock options having a value of $205,000, calculated on the grant date in accordance with the Black-Scholes option pricing model (utilizing the same assumptions that the Company utilizes in preparation of its financial statements). The foregoing awards will vest in three equal annual installments on each of the first three anniversaries following the date of grant.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All awards will vest in full in the event of a change in control or a hostile take-over, each as defined under our 2002 Plan. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">49</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Non-Employee Director Ownership Guidelines</font><font style="font-family:inherit;font-size:10pt;">. In addition, the director compensation policy contains an ownership guideline so that members of the board are required to own shares with a value of at least three times the then-current annual retainer after they had completed three years of board service.  </font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Compensation Committee Interlocks and Insider Participation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Relationships and Independence of the Compensation Committee Members</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal 2015, the compensation committee was composed of Messrs. Aryeh and Davis and Dr.&#160;LaMattina. No executive officer of the Company served on the board of directors or compensation committee of any entity which has one or more executive officers serving as members of the Company&#8217;s board of directors or compensation committee.</font></div><div style="line-height:150%;padding-top:21px;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;padding-top:21px;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">50</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:5px;text-align:left;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">Compensation Committee Report</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The compensation committee of the Company&#8217;s board of directors has submitted the following report for inclusion in this proxy statement:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation committee reviewed this Compensation Discussion and Analysis and discussed its contents with the Company&#8217;s management. Based on the review and discussions, the compensation committee has recommended to the board of directors that this Compensation Discussion and Analysis be included in this proxy statement and our annual report for the year ended December&#160;31, 2015.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This report of the compensation committee shall not be deemed incorporated by reference by any general statement incorporating by reference this proxy statement into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that we specifically incorporate this information by reference, and shall not otherwise be deemed filed under such acts.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing report has been furnished by the compensation committee.</font></div><div style="line-height:150%;padding-top:21px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Todd C. Davis, Chairperson of the Compensation Committee</font></div><div style="line-height:150%;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jason M. Aryeh</font></div><div style="line-height:150%;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John L. LaMattina, Ph.D.</font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:150%;text-align:left;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">51</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:20pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;background-color:#727272;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:5px;text-align:left;padding-left:9px;font-size:20pt;"><font style="font-family:inherit;font-size:20pt;color:#ffffff;font-weight:bold;">Audit Committee Report</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The following is the report delivered by the audit committee of the Company&#8217;s board of directors with respect to the principal factors considered by such committee in its oversight of the accounting, auditing and financial reporting practices of the Company for 2015.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The audit committee oversees the Company&#8217;s financial reporting process on behalf of the board of directors. Management has the primary responsibility for the financial statements and the reporting process including the systems of internal controls. In fulfilling its oversight responsibilities, the audit committee reviewed and discussed the audited financial statements in the Company&#8217;s annual report with management, including a discussion of any significant changes in the selection or application of accounting principles, the reasonableness of significant judgments, the clarity of disclosures in the financial statements and the effect of any new accounting initiatives.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The audit committee reviewed and discussed with Grant Thornton LLP, who is responsible for expressing an opinion on the conformity of the Company&#8217;s audited consolidated financial statements with generally accepted accounting principles, their judgments as to the quality, not just the acceptability, of the Company&#8217;s accounting principles and such other matters as are required to be discussed with the audit committee under generally accepted auditing standards, including those matters required under Auditing Standard No. 16 (Communications with Audit Committees). In addition, the audit committee has discussed with Grant Thornton LLP their independence from management and the Company, and has received from Grant Thornton LLP the written disclosures and the letter required by the Public Company Accounting Oversight Board Rule 3526.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The audit committee met with Grant Thornton LLP to discuss the overall scope of their services, the results of their audit and reviews, its evaluation of the Company&#8217;s internal controls and the overall quality of the Company&#8217;s financial reporting. Grant Thornton LLP, as the Company&#8217;s independent registered public accounting firm, also periodically updates the audit committee about new accounting developments and their potential impact on the Company&#8217;s reporting. The audit committee&#8217;s meetings with Grant Thornton LLP were held with and without management present. The audit committee is not employed by the Company, nor does it provide any expert assurance or professional certification regarding the Company&#8217;s financial statements. The audit committee relies, without independent verification, on the accuracy and integrity of the information provided, and representations made, by management and the Company&#8217;s independent registered public accounting firm.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In reliance on the reviews and discussions referred to above, the audit committee has recommended to the Company&#8217;s board of directors that the audited consolidated financial statements be included in this proxy statement and in our annual report for the year ended December&#160;31, 2015.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This report of the audit committee shall not be deemed incorporated by reference by any general statement incorporating by reference this proxy statement into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that we specifically incorporate this information by reference, and shall not otherwise be deemed filed under such acts.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing report has been furnished by the audit committee.</font></div><div style="line-height:150%;padding-top:21px;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stephen L. Sabba, M.D., Chairperson of the Audit Committee</font></div><div style="line-height:150%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David M. Knott</font></div><div style="line-height:150%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sunil Patel</font></div><div style="line-height:120%;padding-top:20px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Compensation Plans</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have two compensation plans approved by our stockholders under which our equity securities are authorized for issuance to employees and directors for goods or services, the 2002 Plan and the Employee Stock Purchase Plan.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes information about our equity compensation plans as of December 31, 2015:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">52</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s0092EA0DF5E0022C530FE760CEC079EB"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td width="55%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="12%"></td><td width="1%"></td><td width="1%"></td><td width="15%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(a)</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">securities to be</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">issued upon</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">exercises of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">outstanding</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">options,</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">warrants</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">and rights</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(b)</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">average</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">exercise&#160;price&#160;of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">outstanding</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">options,</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">warrants</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">and rights</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(c)</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">securities</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">remaining available</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for future issuance</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">under equity</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">compensation</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">plans</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(excluding</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">securities</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">reflected in</font></div><div style="padding-top:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">column(a))</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity compensation plans approved by security holders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,683,341</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.23</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">760,032</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="text-align:left;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity compensation plans not approved by security holders(2)</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#bfbfbf;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,683,341</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.23</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">760,032</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;"><br></font></div><div style="line-height:120%;padding-left:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">At December 31, 2015, 760,032 and 75,741 shares were available under the 2002 Plan and the Employee Stock Purchase Plan, respectively, for future grants of awards.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:8pt;padding-left:30px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">There are no equity compensation plans (including individual compensation arrangements) not approved by the Company&#8217;s security holders.</font></div></td></tr></table><a name="sD112A73BD6B31C13DB13E760D49DFF54"></a><div style="line-height:120%;padding-top:24px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Certain Relationships and Related Transactions</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We describe below transactions and series of similar transactions, since the beginning of fiscal year 2015, with respect to which we were a party, will be a party, or otherwise benefited, in which:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the amounts involved exceeded or will exceed $120,000; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a director, nominee for director, executive officer, holder of more than 5% of our common stock or any member of their immediate family had or will have a direct or indirect material interest.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to our audit committee charter, the audit committee of our board of directors is responsible for reviewing and approving all transactions with related parties. We have not adopted written procedures for review of, or standards for approval of, these transactions, but instead the audit committee of our board of directors intends to review such transactions on a case by case basis. In addition, the compensation committee of our board of directors and/or our board of directors will review approve all compensation-related policies involving our directors and executive officers.</font></div><div style="line-height:120%;padding-top:24px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Transactions with Related Parties</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The severance arrangements we have entered into with each of our executive officers provide for severance benefits in specified circumstances, as well as benefits in connection with a change in control. See &#8220;Compensation Discussion and Analysis&#8212;Severance and Change in Control Arrangements.&#8221;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our certificate of incorporation and our amended and restated bylaws provide that we will indemnify each of our directors and officers to the fullest extent permitted by the Delaware General Corporation Law. Further, we have entered into indemnification agreements with each of our directors and officers, and we have purchased a policy of directors&#8217; and officers&#8217; liability insurance that insures our directors and officers against the cost of defense, settlement or payment of a judgment under certain circumstances.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the management rights letter between Viking Therapeutics, Inc., or Viking, and the Company dated May 21, 2014, the Company nominated Mr. Foehr to serve as a member of Viking&#8217;s board of directors.  During 2015, in connection with such nomination and Mr. Foehr&#8217;s service as a director of Viking, Mr. Foehr received (1) $22,113 in cash payments and (2) $115,569 in option awards (representing the aggregate grant date fair value of the option awards as reported by Viking, computed in accordance with authoritative accounting guidance).</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All future transactions between the Company and its officers, directors, principal stockholders and affiliates will be approved by the audit committee or a majority of the independent and disinterested members of the board of directors.</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">53</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s745386F0A05ED801C960E760D4ADD879"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:24px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Section 16(a) Beneficial Ownership Reporting Compliance</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Section&#160;16(a) of the Securities Exchange Act of 1934, as amended, requires the Company&#8217;s executive officers and directors, and persons who own more than 10% of a registered class of the Company&#8217;s equity securities, to file reports of ownership and changes in ownership with the SEC. Executive officers, directors and greater than 10% stockholders are required by SEC regulation to furnish the Company with copies of all Section&#160;16(a) forms they file.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based solely on review of the copies of such forms furnished to the Company, or written representations from certain reporting persons, we have determined that all Section&#160;16(a) filing requirements applicable to its officers, directors and greater than 10% beneficial owners were satisfied during the fiscal year ended December&#160;31, 2015.</font></div><a name="s8E61B2E91F65E2F13AA5E760D4CE45F7"></a><div style="line-height:120%;padding-top:24px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Deadline For Proposals For Next Annual Meeting</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The deadline for submitting a stockholder proposal for inclusion in our proxy statement and form of proxy for the 2016 annual meeting of stockholders is December 13, 2016 (120 calendar days in advance of the anniversary of the date of this proxy statement). Stockholders wishing to submit proposals or director nominations that are to be included in such proxy statement and proxy must also do so by December 13, 2016. Stockholders are advised to review our amended and restated bylaws, which contain additional requirements with respect to advance notice of stockholder proposals and director nominations. Our current amended and restated bylaws are available at the SEC&#8217;s website, www.sec.gov, or upon written request to our Corporate Secretary at the address listed below. Stockholder proposals and director nominations should be directed to Corporate Secretary, Ligand Pharmaceuticals Incorporated, 11119 N. Torrey Pines Rd. Suite 200 La Jolla CA, 92037.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the proxy solicited by the board of directors for the next annual meeting of stockholders will confer discretionary authority to vote on any stockholder proposal presented at that meeting, unless the Company receives notice of such proposal no later than a reasonable period of time prior to the mailing of proxy materials for such annual meeting.</font></div><a name="s9FCFC22F14E8770069F6E760D4EFDBFA"></a><div style="line-height:120%;padding-top:24px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Annual Report on Form 10-K</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders that received the Notice of Internet Availability of Proxy Materials can access this Proxy Statement and our fiscal 2015 Annual Report at http://www.envisionreports.com/LGND, which does not have cookies that identify visitors to the site. A copy of the Annual Report of the Company on Form 10-K for the 2015 fiscal year has been mailed concurrently with this proxy statement to all stockholders that received a copy of the proxy materials in the mail. The Annual Report is not incorporated into this proxy statement and is not considered proxy solicitation material. Written requests for copies of our Annual Report to stockholders may also be directed to our Corporate Secretary, Ligand Pharmaceuticals Incorporated, 11119 N. Torrey Pines Rd. Suite 200 La Jolla, CA 92037.</font></div><a name="s4E5DD85B9F23C1A4762AE760D524E88F"></a><div style="line-height:120%;padding-top:24px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Solicitation of Proxies</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company will bear the entire cost of solicitation, including the preparation, assembly, printing and mailing of this proxy statement, the proxy and any additional solicitation material furnished to stockholders. Copies of solicitation material will be furnished to brokerage houses, fiduciaries and custodians holding shares in their names that are beneficially owned by others so that they may forward this solicitation material to such beneficial owners. In addition, the Company may reimburse such persons for their costs of forwarding the solicitation materials to such beneficial owners. The original solicitation of proxies by mail may be supplemented by solicitation by telephone, telegram or other means by directors, officers, employees or agents of the Company. No additional compensation will be paid to directors, officers or employees of the Company for any such services. Except as described above, the Company does not presently intend to solicit proxies other than by internet.</font></div><a name="s7E766B35A07915ABB541E760D54AA94F"></a><div style="line-height:174%;padding-top:24px;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Householding of Proxy Materials</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The SEC has adopted rules that permit companies and intermediaries (such as brokers) to satisfy the delivery requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a </font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">54</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">single proxy statement addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially results in a reduced usage of natural resources and cost savings for companies.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A number of brokers with account holders who are our stockholders will be &#8220;householding&#8221; our proxy materials. A single proxy statement and one annual report will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. Any stockholder at a shared address to which a single copy of the documents was delivered and who wishes to receive a separate copy of the documents can request a copy of the documents by sending a written request to our Corporate Secretary, Ligand Pharmaceuticals Incorporated, 11119 N. Torrey Pines Rd. Suite 200 La Jolla, CA 92037, or contact our Corporate Secretary at (858)&#160;550-7500. Also, if you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate proxy statement and annual report in the future, please notify your broker or direct your written request to Corporate Secretary, Ligand Pharmaceuticals Incorporated, 11119 N. Torrey Pines Rd. Suite 200 La Jolla CA, 92037, or contact our Corporate Secretary at (858)&#160;550-7500. Stockholders who currently receive multiple copies of the proxy statement at their address and would like to request &#8220;householding&#8221; of their communications should contact their broker.</font></div><a name="sD4715622F9BBED8C0641E760D5758432"></a><div style="line-height:120%;padding-top:24px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">Other Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of the date of this proxy statement, the board of directors knows of no other business that will be presented for consideration at the annual meeting. If other matters are properly brought before the annual meeting, however, it is the intention of the persons named in the accompanying proxy to vote the shares represented thereby on such matters in accordance with their best judgment.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:45.63492063492063%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By Order of the Board of Directors,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;C</font><font style="font-family:inherit;font-size:8pt;">HARLES</font><font style="font-family:inherit;font-size:10pt;">&#160;S. B</font><font style="font-family:inherit;font-size:8pt;">ERKMAN</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Charles S. Berkman</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;font-style:italic;font-weight:bold;">Vice President, General Counsel&#160;&amp; Secretary</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:21px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 12, 2016</font></div><br><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated 2016 Proxy Statement </font><font style="font-family:Wingdings;font-size:8pt;">l</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">55</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Appendix A to Ligand Pharmaceuticals Incorporated 2016 Proxy Statement</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2002 STOCK INCENTIVE PLAN</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">(AS AMENDED AND RESTATED EFFECTIVE MAY 23, 2016)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ARTICLE ONE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">GENERAL PROVISIONS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">I.    PURPOSE OF THE PLAN</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;This 2002 Stock Incentive Plan is intended to promote the interests of Ligand Pharmaceuticals Incorporated, a Delaware corporation, by providing eligible persons in the Corporation&#8217;s and its Subsidiaries&#8217; service with the opportunity to acquire a proprietary interest, or otherwise increase their proprietary interest, in the Corporation as an incentive for them to remain in such service. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Capitalized terms shall have the meanings assigned to such terms in the attached Appendix.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">II.   </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">STRUCTURE OF THE PLAN</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan shall be divided into three separate equity incentives programs:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">1.     </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">the Discretionary Option Grant Program under which eligible persons may, at the discretion of the Plan Administrator, be granted options to purchase shares of Common Stock,</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">2.     </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">the Stock Issuance Program under which eligible persons may, at the discretion of the Plan Administrator, be issued shares of Common Stock, and</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">the Other Stock Award Program under which eligible persons may, at the discretion of the Plan Administrator, be granted restricted stock units, stock appreciation rights and dividend equivalents. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The provisions of Articles One, Five and Six shall apply to all equity programs under the Plan and shall govern the interests of all persons under the Plan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">III.  </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ADMINISTRATION OF THE PLAN</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Primary Committee shall have sole and exclusive authority to administer the Plan with respect to Section 16 Insiders (other than non-employee Board members, whose Awards shall be administered by the full Board, as provided below). Administration of the Plan with respect to all other persons eligible to participate in those programs may, at the Board&#8217;s discretion, be vested in the Primary Committee or a Secondary Committee, or the Board may retain the power to administer those programs with respect to all such persons. However, any discretionary Awards for members of the Primary Committee must be authorized by a disinterested majority of the Board. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Members of the Primary Committee or any Secondary Committee shall serve for such period of time as the Board may determine and may be removed by the Board at any time. The Board may also at any time </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">terminate the functions of any Secondary Committee and reassume all powers and authority previously delegated to such committee.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;C. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Each Plan Administrator shall, within the scope of its administrative functions under the Plan, have full power and authority (subject to the provisions of the Plan) to establish such rules and regulations as it may deem appropriate for proper administration of the Plan and to make such determinations under, and issue such interpretations of, the provisions of those programs and any outstanding Awards thereunder as it may deem necessary or advisable. Decisions of the Plan Administrator within the scope of its administrative functions under the Plan shall be final and binding on all parties who have an interest in the equity incentive programs under its jurisdiction or any Award thereunder.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;D. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Service on the Primary Committee or the Secondary Committee shall constitute service as a Board member, and members of each such committee shall accordingly be entitled to full indemnification and reimbursement as Board members for their service on such committee. No member of the Primary Committee or the Secondary Committee shall be liable for any act or omission made in good faith with respect to the Plan or any Awards under the Plan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;E. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Notwithstanding the foregoing, the full Board shall administer the Plan with respect to any Awards to the non-employee members of the Board.  In addition, in its sole discretion, the Board may at any time and from time to time exercise any and all rights and duties of the Primary Committee or any Secondary Committee under the Plan except with respect to matters which under Rule 16b&#8209;3 under the Exchange Act or Section 162(m) of the Code, or any regulations or rules issued thereunder, are required to be determined in the sole discretion of the Primary Committee.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">IV.   </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ELIGIBILITY</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The persons eligible to participate in the Discretionary Option Grant, Stock Issuance and Other Stock Award Programs are as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;(i) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Employees,</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;(ii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">non-employee members of the Board or the board of directors of any Parent or Subsidiary, and</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;(iii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">consultants and other independent advisors who provide services to the Corporation (or any Parent or Subsidiary). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Each Plan Administrator shall, within the scope of its administrative jurisdiction under the Plan, have full authority to determine, (i) with respect to the option grants under the Discretionary Option Grant Program, which eligible persons are to receive such grants, the time or times when those grants are to be made, the number of shares to be covered by each such grant, the status of the granted option as either an Incentive Option or a Non-Statutory Option, the time or times when each option is to become exercisable, the vesting schedule (if any) applicable to the option shares, the maximum term for which the option is to remain outstanding and such other terms and conditions of such option as the Plan Administrator determines are appropriate, (ii) with respect to stock issuances under the Stock Issuance Program, which eligible persons are to receive such issuances, the time or times when the issuances are to be made, the number of shares to be issued to each Participant, the vesting schedule (if any) applicable to the issued shares, the purchase price, if any, and consideration for such shares and such other terms and conditions of such issued shares as the Plan Administrator determines are appropriate, and (iii) with respect to other Awards under the Other Stock Awards Program, which eligible persons are to receive such Awards, the type of Award, the time or times when the issuances are to be made, the number of shares subject to such Award to be issued to each Participant, the vesting schedule (if any) applicable to the Awards, the consideration for such Awards and such other terms and conditions of such Awards as the Plan </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Administrator determines are appropriate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">V.    </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">STOCK SUBJECT TO THE PLAN</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Subject to adjustment pursuant to this Section V, the number of shares of Common Stock which may be issued or transferred pursuant to Awards under the Plan is 5,479,254 shares, which number shall be reduced at any time by (i) one share for each share subject to any outstanding Award that is not a Full Value Award, and (ii) 1.5 shares for each share subject to any outstanding Award that is a Full Value Award.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">No one person participating in the Plan may receive Awards for more than 1,000,000 shares of Common Stock in the aggregate per calendar year.  In addition, notwithstanding any provision to the contrary in the Plan,  the sum of any cash compensation, or other compensation, and the value (determined as of the grant date in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, or any successor thereto) of Awards granted to a non-employee member of the Board as compensation for services as a non-employee member of the Board during any calendar year of the Corporation may not exceed $550,000, increased to 850,000 in the calendar year of his or her initial service as a non-employee member of the Board.  The Plan Administrator may make exceptions to this limit for individual non-employee members of the Board in extraordinary circumstances, as the Plan Administrator may determine in its discretion, provided that the non-employee member of the Board receiving such additional compensation may not participate in the decision to award such compensation or in other contemporaneous compensation decisions involving non-employee members of the Board.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:left;text-indent:48px;"><font style="text-align:left;font-family:inherit;font-size:10pt;padding-right:48px;">A.</font><font style="font-family:inherit;font-size:11pt;">To the extent all or a portion of an Award is forfeited, expires or such Award or portion thereof is settled for cash (in whole or in part), the shares of Common Stock subject to such Award or portion thereof, shall, to the extent of such forfeiture, expiration or cash settlement, again be available for future grants of Awards under the Plan in an amount corresponding to the reduction in the share reserve previously made in accordance with Section V.A above.  Notwithstanding anything to the contrary contained herein, the following shares of Common Stock shall not be added to the shares of Common Stock authorized for grant under Section V.A and will not be available for future grants of Awards: (i) shares of Common Stock tendered by an Optionee or withheld by the Company in payment of the exercise price of an option; (ii) shares of Common Stock tendered by the Optionee or Participant or withheld by the Company to satisfy any tax withholding obligation with respect to an option or stock appreciation right; (iii) shares of Common Stock subject to a stock appreciation right that are not issued in connection with the stock settlement of the stock appreciation right on exercise thereof; and (iv) shares of Common Stock purchased on the open market with the cash proceeds from the exercise of options.  Shares of Common Stock tendered by the Participant or withheld by the Company to satisfy any tax withholding obligation with respect to a Full Value Award shall be available for future grants of Awards under the Plan in an amount corresponding to the reduction in the share reserve previously made in accordance with Section V.A. above. Any shares of Common Stock forfeited by the Participant or repurchased by the Company under Article Three, Section I.C at a price not greater than the price originally paid by the Participant so that such shares are returned to the Company will again be available for Awards in an amount corresponding to the reduction in the share reserve previously made in accordance with Section V.A. above.  The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards shall not be counted against the shares available for issuance under the Plan.  Notwithstanding the provisions of this Section V.C, no shares of Common Stock may again be optioned, granted or awarded if such action would cause an Incentive Option to fail to qualify as an incentive stock option under Section 422 of the Code. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;D. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">If any change is made to the Common Stock by reason of any stock split, stock or cash dividend (other than normal cash dividends), recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without the Corporation&#8217;s receipt of consideration, equitable adjustments shall be made by the Plan Administrator to (i) the maximum number and/or class of securities issuable under the Plan, (ii) the maximum number and/or class of securities for which any one person may be </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">granted Awards under the Plan per calendar year, (iii) the number and/or class of securities for which grants are subsequently to be made under the Automatic Option Grant Program to new and continuing non-employee Board members, (iv) the number and/or class of securities and the exercise or purchase price per share in effect under each outstanding Award under the Plan, and (v) the terms and conditions of any outstanding Awards (including, without limitation, any applicable performance targets or criteria with respect thereto). Such adjustments to the outstanding Awards are to be effected in a manner which shall preclude the enlargement or dilution of rights and benefits under such Awards. The adjustments determined by the Plan Administrator shall be final, binding and conclusive.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">E.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Subject to Article Two, Section III, Article Three, Section II and Article Four, Section V, in the event of any transaction or event described in Section V.D or any unusual or nonrecurring transactions or events affecting the Corporation, any affiliate of the Corporation, or the financial statements of the Corporation or any affiliate, or of changes in applicable laws, regulations or accounting principles, including, without limitation, a Change in Control or a Hostile Take-Over, the Plan Administrator, in its sole and absolute discretion, and on such terms and conditions as it deems appropriate, either by the terms of the Award or by action taken prior to the occurrence of such transaction or event and either automatically or upon the Optionee&#8217;s or Participant&#8217;s request, is hereby authorized to take any one or more of the following actions whenever the Plan Administrator determines that such action is appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan or with respect to any Award under the Plan, to facilitate such transactions or events or to give effect to such changes in laws, regulations or principles:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">1.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">To provide for either (A) termination of any such Award in exchange for an amount of cash, if any, equal to the amount that would have been attained upon the exercise of such Award or realization of the Optionee&#8217;s or Participant&#8217;s rights (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction or event described in this Section V.E the Plan Administrator determines in good faith that no amount would have been attained upon the exercise of such Award or realization of the Optionee&#8217;s or Participant&#8217;s rights, then such Award may be terminated by the Corporation without payment) or (B) the replacement of such Award with other rights or property selected by the Plan Administrator in its sole discretion;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">To provide that such Award be assumed by the successor or survivor corporation, or a parent or subsidiary thereof, or shall be substituted for by similar Awards covering the stock of the successor or survivor corporation, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and prices; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">To make adjustments in the number and type of shares of Common Stock (or other securities or property) subject to outstanding Awards, and in the number and/or in the terms and conditions of (including the grant or exercise price), and the criteria included in, outstanding Awards;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">4.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">To provide that such Award shall be exercisable or payable or fully vested with respect to all shares covered thereby, notwithstanding anything to the contrary in the Plan or the applicable award agreement; and</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">5.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">To provide that the Award cannot vest, be exercised or become payable after such event.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">F.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">In the event of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Corporation assets to stockholders, or any other change affecting the shares of Common Stock or the share price of the Common Stock, for reasons of administrative convenience, the Corporation in its sole discretion may refuse to permit the exercise of any Award during a period of thirty (30) days prior to the consummation of any such transaction.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ARTICLE TWO</font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">DISCRETIONARY OPTION GRANT PROGRAM</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">I.   </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">OPTION TERMS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;Each option shall be evidenced by one or more documents in the form approved by the Plan Administrator; provided, however, that each such document shall comply with the terms specified below. Each document evidencing an Incentive Option shall, in addition, be subject to the provisions of the Plan applicable to such options.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">EXERCISE PRICE.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">1. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The exercise price per share shall be fixed by the Plan Administrator but shall not be less than one hundred percent (100%) of the Fair Market Value per share of Common Stock on the option grant date. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">2. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The exercise price shall become immediately due upon exercise of the option and shall, subject to the provisions of the documents evidencing the option, be payable in one or more of the forms specified below:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(i) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">cash or check made payable to the Corporation, </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(ii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">shares of Common Stock held by the Optionee or otherwise issuable upon exercise of the option and valued at Fair Market Value on the Exercise Date, </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(iii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">to the extent the option is exercised for vested shares, through a special sale and remittance procedure pursuant to which the Optionee shall concurrently provide irrevocable instructions to (a) a Corporation-designated brokerage firm to effect the immediate sale of the purchased shares and remit to the Corporation, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate exercise price payable for the purchased shares plus all applicable income and employment taxes required to be withheld by the Corporation by reason of such exercise and (b) the Corporation to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale, or</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:144px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">(iv)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">with the consent of the Plan Administrator, a promissory note bearing interest at no less than such rate as shall then preclude the imputation of interest under the Code.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;Except to the extent such sale and remittance procedure is utilized, payment of the exercise price for the purchased shares must be made on the Exercise Date.  Notwithstanding any other provision of the Plan to the contrary, no Optionee who is a member of the Board or an &#8220;executive officer&#8221; of the Corporation within the meaning of Section 13(k) of the Exchange Act shall be permitted to pay the exercise price of an option, or continue any extension of credit with respect to the exercise of an option, with a loan from the Corporation or a loan arranged by the Corporation in violation of Section 13(k) of the Exchange Act.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">EXERCISE AND TERM OF OPTIONS. Each option shall be exercisable at such time or times, during such period and for such number of shares as shall be determined by the Plan Administrator and set forth in the documents evidencing the option. However, no option shall have a term in excess of ten (10) years measured from the option grant date.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;C. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">EFFECT OF TERMINATION OF SERVICE.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">1. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The following provisions shall govern the exercise of any options held by the Optionee at the time of cessation of Service or death: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(i) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Any option outstanding at the time of the Optionee&#8217;s cessation of Service for any </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">reason shall remain exercisable for such period of time thereafter as shall be determined by the Plan Administrator and set forth in the documents evidencing the option, but no such option shall be exercisable after the expiration of the option term. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:144px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">(ii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Any option held by the Optionee at the time of death and exercisable in whole or in part at that time may be subsequently exercised by the personal representative of the Optionee&#8217;s estate or by the person or persons to whom the option is transferred pursuant to the Optionee&#8217;s will or the laws of inheritance or by the Optionee&#8217;s designated beneficiary or beneficiaries of that option. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(iii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">During the applicable post-Service exercise period, the option may not be exercised in the aggregate for more than the number of vested shares for which the option is exercisable on the date of the Optionee&#8217;s cessation of Service. Upon the expiration of the applicable exercise period or (if earlier) upon the expiration of the option term, the option shall terminate and cease to be outstanding for any vested shares for which the option has not been exercised. However, the option shall, immediately upon the Optionee&#8217;s cessation of Service, terminate and cease to be outstanding to the extent the option is not otherwise at that time exercisable for vested shares.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">2. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator shall have complete discretion, exercisable either at the time an option is granted or at any time while the option remains outstanding, to:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(i) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">extend the period of time for which the option is to remain exercisable following the Optionee&#8217;s cessation of Service from the limited exercise period otherwise in effect for that option to such greater period of time as the Plan Administrator shall deem appropriate, but in no event beyond the expiration of the option term, and/or </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;(ii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">permit the option to be exercised, during the applicable post-Service exercise period, not only with respect to the number of vested shares of Common Stock for which such option is exercisable at the time of the Optionee&#8217;s cessation of Service but also with respect to one or more additional installments in which the Optionee would have vested had the Optionee continued in Service. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">D. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">STOCKHOLDER RIGHTS. The holder of an option shall have no stockholder rights with respect to the shares subject to the option until such person shall have exercised the option, paid the exercise price and become a holder of record of the purchased shares.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">E. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">REPURCHASE RIGHTS. The Plan Administrator shall have the discretion to grant options which are exercisable for unvested shares of Common Stock. Should the Optionee cease Service while holding such unvested shares, the Corporation shall have the right to repurchase any or all of those unvested shares. The terms upon which such repurchase right shall be exercisable (including the period and procedure for exercise and the appropriate vesting schedule for the purchased shares) shall be established by the Plan Administrator and set forth in the document evidencing such repurchase right. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;F. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">LIMITED TRANSFERABILITY OF OPTIONS. During the lifetime of the Optionee, Incentive Options shall be exercisable only by the Optionee and shall not be assignable or transferable other than by will or the laws of inheritance following the Optionee&#8217;s death. Non-Statutory Options shall be subject to the same restriction, except that a Non-Statutory Option may be assigned in whole or in part during the Optionee&#8217;s lifetime to one or more members of the Optionee&#8217;s family or to a trust established exclusively for one or more such family members or to Optionee&#8217;s former spouse, to the extent such assignment is in connection with the Optionee&#8217;s estate plan or pursuant to a domestic relations order. The assigned portion may only be exercised by the person or persons who acquire a proprietary interest in the option pursuant to the assignment. The terms applicable to the assigned portion shall be the same as those in effect for the option immediately prior to such assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate. Notwithstanding the foregoing, the Optionee may also designate one or more persons as the beneficiary or </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">beneficiaries of his or her outstanding options under this Article Two, and those options shall, in accordance with such designation, automatically be transferred to such beneficiary or beneficiaries upon the Optionee&#8217;s death while holding those options. Such beneficiary or beneficiaries shall take the transferred options subject to all the terms and conditions of the applicable agreement evidencing each such transferred option, including (without limitation) the limited time period during which the option may be exercised following the Optionee&#8217;s death.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">II.   </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">INCENTIVE OPTIONS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;The terms specified below shall be applicable to all Incentive Options. Except as modified by the provisions of this Section II, all the provisions of Articles One, Five and Six shall be applicable to Incentive Options.  To the extent an option which is designated as an Incentive Option fails to meet the requirements of Section 422 of the Code, then such option shall be treated as a Non-Statutory Option.  Options which are specifically designated as Non-Statutory Options when issued under the Plan shall not be subject to the terms of this Section II.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">ELIGIBILITY. Incentive Options may only be granted to Employees. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">DOLLAR LIMITATION. The aggregate Fair Market Value of the shares of Common Stock (determined as of the respective date or dates of grant) for which one or more options granted to any Employee under the Plan (or any other option plan of the Corporation or any Parent or Subsidiary) may for the first time become exercisable as Incentive Options during any one calendar year shall not exceed the sum of One Hundred Thousand Dollars ($100,000). To the extent the Employee holds two (2) or more such options which become exercisable for the first time in the same calendar year, the foregoing limitation on the exercisability of such options as Incentive Options shall be applied on the basis of the order in which such options are granted.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">C. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">10% STOCKHOLDER. If any Employee to whom an Incentive Option is granted is a 10% Stockholder, then the exercise price per share shall not be less than one hundred ten percent (110%) of the Fair Market Value per share of Common Stock on the option grant date, and the option term shall not exceed five (5) years measured from the option grant date.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">III.  </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CHANGE IN CONTROL/HOSTILE TAKE-OVER</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">In the event of a Change in Control, each outstanding option under the Discretionary Option Grant Program shall automatically accelerate so that each such option shall, immediately prior to the effective date of that Change in Control, become exercisable for all the shares of Common Stock at the time subject to such option and may be exercised for any or all of those shares as fully vested shares of Common Stock. However, an outstanding option shall NOT become exercisable on such an accelerated basis if and to the extent: (i) such option is to be assumed by the successor corporation (or parent thereof) or is otherwise to continue in full force and effect pursuant to the terms of the Change in Control transaction or (ii) such option is to be replaced with a cash incentive program of the successor corporation which preserves the spread existing at the time of the Change in Control on any shares for which the option is not otherwise at that time exercisable and provides for subsequent payout of that spread in accordance with the same exercise/vesting schedule applicable to those option shares or (iii) the acceleration of such option is subject to other limitations imposed by the Plan Administrator at the time of the option grant. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">All outstanding repurchase rights under the Discretionary Option Grant Program shall automatically terminate, and the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of a Change in Control, except to the extent: (i) those repurchase rights are to be assigned to the successor corporation (or parent thereof) or are otherwise to continue in full force and effect pursuant to the terms of the Change in Control transaction or (ii) such accelerated vesting is precluded by other limitations imposed by the Plan Administrator at the time the repurchase right is issued. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">C. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Immediately following the consummation of the Change in Control, all outstanding options under the Discretionary Option Grant Program shall terminate and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof) or otherwise continued in full force and effect pursuant to the terms of the Change in Control transaction. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">D. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Each option which is assumed in connection with a Change in Control or otherwise continued in effect shall be appropriately adjusted, immediately after such Change in Control, to apply to the number and class of securities which would have been issuable to the Optionee in consummation of such Change in Control had the option been exercised immediately prior to such Change in Control. Appropriate adjustments shall also be made to the exercise price payable per share under each outstanding option, provided the aggregate exercise price payable for such securities shall remain the same (subject only to reduction by reason of rounding). To the extent the actual holders of the Corporation&#8217;s outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Change in Control, the successor corporation may, in connection with the assumption of the outstanding options under the Discretionary Option Grant Program, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in such Change in Control transaction.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">E. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator shall have the discretionary authority to structure one or more outstanding options under the Discretionary Option Grant Program so that those options shall, immediately prior to the effective date of a Change in Control, become exercisable for all the shares of Common Stock at the time subject to those options and may be exercised for any or all of those shares as fully vested shares of Common Stock, whether or not those options are to be assumed in the Change in Control transaction or otherwise continued in effect. In addition, the Plan Administrator shall have the discretionary authority to structure one or more of the Corporation&#8217;s repurchase rights under the Discretionary Option Grant Program so that those rights shall immediately terminate upon the consummation of the Change in Control transaction, and the shares subject to those terminated rights shall thereupon vest in full. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">F. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator shall have full power and authority to structure one or more outstanding options under the Discretionary Option Grant Program so that those options shall become exercisable for all the shares of Common Stock at the time subject to those options in the event the Optionee&#8217;s Service is subsequently terminated by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of any Change in Control transaction in which those options do not otherwise accelerate. In addition, the Plan Administrator may structure one or more of the Corporation&#8217;s repurchase rights so that those rights shall immediately terminate with respect to any shares held by the Optionee at the time of such Involuntary Termination, and the shares subject to those terminated repurchase rights shall accordingly vest in full at that time. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">G. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator shall have the discretionary authority to structure one or more outstanding options under the Discretionary Option Grant Program so that those options shall, immediately prior to the effective date of a Hostile Take-Over, become exercisable for all the shares of Common Stock at the time subject to those options and may be exercised for any or all of those shares as fully vested shares of Common Stock. In addition, the Plan Administrator shall have the discretionary authority to structure one or more of the Corporation&#8217;s repurchase rights under the Discretionary Option Grant Program so that those rights shall terminate automatically upon the consummation of such Hostile Take-Over, and the shares subject to those terminated rights shall thereupon vest in full. Alternatively, the Plan Administrator may condition the automatic acceleration of one or more outstanding options under the Discretionary Option Grant Program and the termination of one or more of the Corporation&#8217;s outstanding repurchase rights under such program upon the subsequent termination of the Optionee&#8217;s Service by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of such Hostile Take-Over.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">H. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The portion of any Incentive Option accelerated in connection with a Change in Control or Hostile Take-Over shall remain exercisable as an Incentive Option only to the extent the applicable One Hundred </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thousand Dollar ($100,000) limitation is not exceeded. To the extent such dollar limitation is exceeded, the accelerated portion of such option shall be exercisable as a Nonstatutory Option under the Federal tax laws.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">I. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The outstanding options shall in no way affect the right of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ARTICLE THREE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">STOCK ISSUANCE PROGRAM</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">I.    </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">STOCK ISSUANCE TERMS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;Shares of Common Stock may be issued under the Stock Issuance Program through direct and immediate issuances without any intervening option grants. Each such stock issuance shall be evidenced by a Stock Issuance Agreement which complies with the terms specified below. Shares of Common Stock may also be issued under the Stock Issuance Program pursuant to share right awards which entitle the recipients to receive those shares upon the attainment of designated performance goals or the satisfaction of specified Service requirements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">PURCHASE PRICE.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">1. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The purchase price per share, if any, shall be fixed by the Plan Administrator. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">2. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Shares of Common Stock may be issued under the Stock Issuance Program for any form of consideration as the Plan Administrator may deem appropriate in each individual instance, including, without limitation:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(i) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">cash or check made payable to the Corporation, or </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(ii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">past services rendered to the Corporation (or any Parent or Subsidiary), or</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(iii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">future services to be rendered to the Corporation (or any Parent or Subsidiary). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">B.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">RESTRICTIONS.  Shares of Common Stock issued under this Stock Issuance Program shall be subject to such restrictions on transferability and other restrictions as the Plan Administrator may impose (including, without limitation, limitations on the right to vote such shares or the right to receive dividends on such shares).  These restrictions may lapse separately or in combination at such times, pursuant to such circumstances, in such installments, or otherwise, as the Plan Administrator determines at the time of the grant of the shares or thereafter.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">C.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Forfeiture.  Except as otherwise determined by the Plan Administrator at the time of the grant of the shares or thereafter, upon termination of employment or service during the applicable restriction period, shares of Common Stock issued under this Stock Issuance Program that are at that time subject to restrictions shall be forfeited; </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">provided, however</font><font style="font-family:inherit;font-size:11pt;">, that, the Plan Administrator may (a) provide in any award agreement that restrictions or forfeiture conditions relating to such shares will be waived in whole or in part in the event of terminations resulting from specified causes, and (b) in other cases waive in whole or in part restrictions or forfeiture conditions relating to such shares.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">II.   CHANGE IN CONTROL/HOSTILE TAKE-OVER</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">All of the Corporation&#8217;s outstanding forfeiture restrictions or repurchase rights on any shares of Common Stock issued under the Stock Issuance Program shall terminate automatically, and all the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of any Change in </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Control, except to the extent (i) those forfeiture restrictions or repurchase rights are to be assigned to the successor corporation (or parent thereof) or are otherwise to continue in full force and effect pursuant to the terms of the Change in Control transaction or (ii) such accelerated vesting is precluded by other limitations imposed in the Stock Issuance Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator shall have the discretionary authority to structure one or more of the Corporation&#8217;s forfeiture restrictions or repurchase rights under the Stock Issuance Program so that those rights shall automatically terminate in whole or in part, and the shares of Common Stock subject to those terminated rights shall immediately vest, in the event the Participant&#8217;s Service should subsequently terminate by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of any Change in Control transaction in which those forfeiture restrictions or repurchase rights are assigned to the successor corporation (or parent thereof) or are otherwise continued in effect. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">C. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator shall also have the discretionary authority to structure one or more of the Corporation&#8217;s forfeiture restrictions or repurchase rights under the Stock Issuance Program so that those rights shall automatically terminate in whole or in part, and the shares of Common Stock subject to those terminated rights shall immediately vest, either upon the occurrence of a Hostile Take-Over or upon the subsequent termination of the Participant&#8217;s Service by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of that Hostile Take-Over.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">III.  </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SHARE ESCROW/LEGENDS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Unvested shares may, in the Plan Administrator&#8217;s discretion, be held in escrow by the Corporation until the Participant&#8217;s interest in such shares vests or may be issued directly to the Participant with restrictive legends on the certificates evidencing those unvested shares. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ARTICLE FOUR</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">OTHER STOCK AWARDS PROGRAM</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">I.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">STOCK APPRECIATION RIGHTS</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">A.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A stock appreciation right may be granted to any eligible person selected by the Plan Administrator.  A stock appreciation right shall be subject to such terms and conditions not inconsistent with the Plan as the Plan Administrator shall impose and shall be evidenced by a stock appreciation right agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">B.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A stock appreciation right shall entitle the Participant (or other person entitled to exercise the stock appreciation right pursuant to the Plan) to exercise all or a specified portion of the stock appreciation right (to the extent then exercisable pursuant to its terms) and to receive from the Corporation an amount equal to the product of (i) the excess of (A) the Fair Market Value of the Common Stock on the date the stock appreciation right is exercised over (B) the Fair Market Value of the Common Stock on the date the stock appreciation right was granted and (ii) the number of shares of Common Stock with respect to which the stock appreciation right is exercised, subject to any limitations the Plan Administrator may impose.  The exercise or base price per share of a stock appreciation right shall be fixed by the Plan Administrator but shall not be less than one hundred percent (100%) of the Fair Market Value per share of Common Stock on the date the stock appreciation right was granted. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">C.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Subject to Section I.B above, payment of the amounts determined under Sections I.B. above shall be in cash, in Common Stock (based on its Fair Market Value as of the date the stock appreciation right is exercised) or a combination of both, as determined by the Plan Administrator.  To the extent any payment is effected in Stock, it shall be made subject to satisfaction of all provisions of Article Two above pertaining to options.</font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">D.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Each stock appreciation right shall be exercisable at such time or times, during such period and for such number of shares as shall be determined by the Plan Administrator and set forth in the documents evidencing the stock appreciation right. However, no stock appreciation right shall have a term in excess of ten (10) years measured from the date the stock appreciation right was granted.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">II.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Dividend Equivalents</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Any eligible person selected by the Plan Administrator may be granted dividend equivalents based on the dividends declared on the shares of Common Stock that are subject to any Award, to be credited as of dividend payment dates, during the period between the date the Award is granted and the date the Award is exercised, vests or expires, as determined by the Plan Administrator.  Such dividend equivalents shall be converted to cash or additional shares of Common Stock by such formula and at such time and subject to such limitations as may be determined by the Plan Administrator.  Notwithstanding anything to the contrary, dividend equivalents with respect to an Award that is subject to performance-based vesting that are based on dividends paid prior to the vesting of such Award shall only be paid out to the extent that the performance-based vesting conditions are subsequently satisfied and the Award vests. In addition, notwithstanding anything to the contrary, no dividend equivalents shall be payable with respect to options or stock appreciation rights. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">III.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Restricted Stock Units</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Plan Administrator is authorized to make Awards of restricted stock units (a right to shares of Common Stock deliverable in the future) to any eligible person selected by the Plan Administrator in such amounts and subject to such terms and conditions as determined by the Plan Administrator.  At the time of grant, the Plan Administrator shall specify the date or dates on which the restricted stock units shall become fully vested and nonforfeitable, and may specify such conditions to vesting as it deems appropriate.  At the time of grant, the Plan Administrator shall specify the maturity date applicable to each grant of restricted stock units which shall be no earlier than the vesting date or dates of the Award and may be determined at the election of the grantee.  On the maturity date, the Corporation shall, subject to Article Six, Section V,  transfer to the Participant one unrestricted, fully transferable share of Common Stock for each restricted stock unit scheduled to be paid out on such date and not previously forfeited.  </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">IV.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">OTHER TERMS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">A.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Except as otherwise provided herein, the term of any award of stock appreciation rights, dividend equivalents or restricted stock units shall be set by the Plan Administrator in its discretion.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">B.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Except as otherwise provided herein, the Plan Administrator may establish the exercise or purchase price, if any, of any award of stock appreciation rights, dividend equivalents or restricted stock units.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">C.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">An award of stock appreciation rights, dividend equivalents or restricted stock units shall only be exercisable or payable prior to the Participant&#8217;s termination of Service; </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">provided, however</font><font style="font-family:inherit;font-size:11pt;">, that the Plan Administrator in its sole and absolute discretion may provide that an award of stock appreciation rights, dividend equivalents or restricted stock units may be exercised or paid subsequent to a termination of Service, as applicable, or following a Change in Control of the Corporation, or because of the Participant&#8217;s retirement, death or disability, or otherwise.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">D.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Payments with respect to any Awards granted under this Article Four shall be made in cash, in Stock or a combination of both, as determined by the Committee.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">E.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">All Awards under this Article Four shall be subject to such additional terms and conditions as determined by the Plan Administrator and shall be evidenced by an award agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">V.  </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CHANGE IN CONTROL/HOSTILE TAKE-OVER</font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">In the event of a Change in Control, each outstanding Award under the Other Stock Award Program shall automatically accelerate so that each such Award shall, immediately prior to the effective date of that Change in Control, become vested and exercisable and/or payable with respect to all the shares of Common Stock at the time subject to such Award and may be exercised or paid for any or all of those shares as fully vested shares of Common Stock. However, an outstanding Award shall NOT become vested and exercisable and/or payable on such an accelerated basis if and to the extent: (i) such Award is to be assumed by the successor corporation (or parent thereof) or is otherwise to continue in full force and effect pursuant to the terms of the Change in Control transaction or (ii) such Award is to be replaced with a cash incentive program of the successor corporation which preserves the spread existing at the time of the Change in Control on any shares for which the Award is not otherwise at that time vested, exercisable or payable and provides for subsequent payout of that spread in accordance with the same exercise/vesting/payment schedule applicable to those Award shares or (iii) the acceleration of such Award is subject to other limitations imposed by the Plan Administrator at the time of the Award grant. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Immediately following the consummation of the Change in Control, all outstanding Awards under the Other Stock Award Program shall terminate and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof) or otherwise continued in full force and effect pursuant to the terms of the Change in Control transaction. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">C. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Each Award which is assumed in connection with a Change in Control or otherwise continued in effect shall be appropriately adjusted, immediately after such Change in Control, to apply to the number and class of securities which would have been issuable to the Participant in consummation of such Change in Control had the Award been exercised or paid immediately prior to such Change in Control. Appropriate adjustments shall also be made to the exercise or purchase price payable per share under each outstanding Award, provided the aggregate exercise or purchase price payable for such securities shall remain the same. To the extent the actual holders of the Corporation&#8217;s outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Change in Control, the successor corporation may, in connection with the assumption of the outstanding Awards under the Other Stock Award Program, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in such Change in Control transaction.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">D. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator shall have the discretionary authority to structure one or more outstanding Awards under the Other Stock Award Program so that those Awards shall, immediately prior to the effective date of a Change in Control, become vested and exercisable and/or payable exercisable for all the shares of Common Stock at the time subject to those Awards and may be exercised or paid for any or all of those shares as fully vested shares of Common Stock, whether or not those Awards are to be assumed in the Change in Control transaction or otherwise continued in effect. In addition, the Plan Administrator shall have the discretionary authority to structure one or more of the Corporation&#8217;s repurchase rights under the Other Stock Award Program so that those rights shall immediately terminate upon the consummation of the Change in Control transaction, and the shares subject to those terminated rights shall thereupon vest in full. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">E. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator shall have full power and authority to structure one or more outstanding Awards under the Other Stock Award Program so that those Awards shall become vested and exercisable and/or payable for all the shares of Common Stock at the time subject to those Awards in the event the Participant&#8217;s Service is subsequently terminated by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of any Change in Control transaction in which those Awards do not otherwise accelerate. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">F. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator shall have the discretionary authority to structure one or more outstanding Awards under the Other Stock Award Program so that those Awards shall, immediately prior to the effective date of a Hostile Take-Over, become vested and exercisable and/or payable for all the shares of Common Stock at the </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">time subject to those Awards and may be exercised or paid for any or all of those shares as fully vested shares of Common Stock. Alternatively, the Plan Administrator may condition the automatic acceleration of one or more outstanding Awards under the Other Stock Award Program upon the subsequent termination of the Optionee&#8217;s Service by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of such Hostile Take-Over.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;G. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The outstanding Awards shall in no way affect the right of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ARTICLE FIVE</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PERFORMANCE-BASED AWARDS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">I.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PURPOSE </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">The purpose of this Article Five is to provide the Primary Committee the ability to qualify Awards other than options and stock appreciation rights and that are granted pursuant to the Plan as Qualified Performance-Based Compensation.  If the Primary Committee, in its discretion, decides to grant a Performance-Based Award to a Covered Employee, the provisions of this Article Five shall control over any contrary provision contained in this Plan; </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">provided, however</font><font style="font-family:inherit;font-size:11pt;">, that the Primary Committee may in its discretion grant Awards to Covered Employees that are based on Performance Criteria or Performance Goals but that do not satisfy the requirements of this Article Five.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">II.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Applicability</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">This Article Five shall apply only to those Covered Employees selected by the Primary Committee to receive Performance-Based Awards.  The designation of a Covered Employee as an Optionee or a Participant for a Performance Period shall not in any manner entitle the Participant to receive an Award for the period.  Moreover, designation of a Covered Employee as an Optionee or a Participant for a particular Performance Period shall not require designation of such Covered Employee as an Optionee or a Participant in any subsequent Performance Period and designation of one Covered Employee as an Optionee or a Participant shall not require designation of any other Covered Employees as an Optionee or a Participant in such period or in any other period.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">III.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#32;Procedures with Respect to Performance-Based Awards</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">To the extent necessary to comply with the Qualified Performance-Based Compensation requirements of Section 162(m)(4)(C) of the Code, with respect to any Award which may be granted to one or more Covered Employees, no later than ninety (90) days following the commencement of any fiscal year in question or any other designated fiscal period or period of service (or such other time as may be required or permitted by Section 162(m) of the Code), the Primary Committee shall, in writing, (a) designate one or more Covered Employees, (b) select the Performance Criteria applicable to the Performance Period, (c) establish the Performance Goals, and amounts of such Awards, as applicable, which may be earned for such Performance Period, and (d) specify the relationship between Performance Criteria and the Performance Goals and the amounts of such Awards, as applicable, to be earned by each Covered Employee for such Performance Period.  Following the completion of each Performance Period, the Primary Committee shall certify in writing whether the applicable Performance Goals have been achieved for such Performance Period.  In determining the amount earned by a Covered Employee, the Primary Committee shall have the right to reduce or eliminate (but not to increase) the amount payable at a given level of performance to take into account additional factors that the Primary Committee may deem relevant to the assessment of individual or corporate performance for the Performance Period.</font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">IV.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#32;Payment of Performance-Based Awards</font><font style="font-family:inherit;font-size:11pt;">&#32;&#32;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">Unless otherwise provided in the applicable award agreement, an Optionee or Participant must be employed by the Corporation or a Subsidiary on the day a Performance-Based Award for such Performance Period is paid to the Optionee or Participant.  Furthermore, an Optionee or a Participant shall be eligible to receive payment pursuant to a Performance-Based Award for a Performance Period only if the Performance Goals for such period are achieved.  In determining the amount earned under a Performance-Based Award, the Primary Committee may reduce or eliminate the amount of the Performance-Based Award earned for the Performance Period, if in its sole and absolute discretion, such reduction or elimination is appropriate.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">V.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Additional Limitations</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">Notwithstanding any other provision of the Plan, any Award which is granted to a Covered Employee and is intended to constitute Qualified Performance-Based Compensation shall be subject to any additional limitations set forth in Section 162(m) of the Code (including any amendment to Section 162(m) of the Code) or any regulations or rulings issued thereunder that are requirements for qualification as qualified performance-based compensation as described in Section 162(m)(4)(C) of the Code, and the Plan shall be deemed amended to the extent necessary to conform to such requirements.</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ARTICLE SIX</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">MISCELLANEOUS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">I.   </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">TAX WITHHOLDING</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Corporation&#8217;s obligation to deliver shares of Common Stock upon the exercise, vesting or payment of Awards under the Plan shall be subject to the satisfaction of all applicable income and employment tax withholding requirements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan Administrator may, in its discretion, provide any or all holders of Awards under the Plan with the right to use shares of Common Stock in satisfaction of all or part of the Withholding Taxes to which such holders may become subject in connection with the exercise, vesting or payment of their Awards. Such right may be provided to any such holder in either or both of the following formats:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Stock Withholding: The election to have the Corporation withhold, from the shares of Common Stock otherwise issuable upon the exercise, vesting or payment of such Award, a portion of those shares with an aggregate Fair Market Value equal to the minimum required percentage of the Withholding Taxes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Stock Delivery: The election to deliver to the Corporation, at the time the Award is exercised, vests or is paid, one or more shares of Common Stock previously acquired by such holder (other than in connection with the exercise, vesting or payment triggering the Withholding Taxes) and held for at least six (6) months (or such other period determined by the Plan Administrator) with an aggregate Fair Market Value equal to the percentage of the Withholding Taxes (not to exceed one hundred percent (100%)) designated by the holder.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">II.  </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">EFFECTIVE DATE AND TERM OF THE PLAN</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan was initially adopted by the Board on March 7, 2002, and became effective on the Original Plan Effective Date.  This amended and restated Plan was adopted by the Board on April 5, 2016, and will become effective on the Amended Plan Effective Date.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Plan shall terminate upon the earliest to occur of (i) April 4, 2026, or (ii) the termination of all outstanding options in connection with a Change in Control. In the event of the termination of the Plan, then all option grants and unvested stock issuances outstanding at that time shall continue to have force and effect in </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">accordance with the provisions of the documents evidencing such grants or issuances.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">III.   </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">AMENDMENT OF THE PLAN</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Board shall have complete and exclusive power and authority to amend or modify the Plan in any or all respects. However, no such amendment or modification shall adversely affect the rights and obligations with respect to Awards at the time outstanding under the Plan unless the Optionee or the Participant consents to such amendment or modification. In addition, certain amendments may require stockholder approval pursuant to applicable laws or regulations.  Except as permitted by Article One, Section V, Article Two, Section III or Article Four, Section V in connection with a transaction specified in Article One, Section V.D or V.E (including, without limitation, any Change in Control, Hostile Take-Over, stock dividend, stock split, extraordinary cash dividend, recapitalization, combination of shares or exchange of shares), the terms of outstanding Awards may not be amended to reduce the exercise price of outstanding Options or stock appreciation rights or cancel, exchange, substitute, buyout or surrender outstanding Options or stock appreciation rights in exchange for cash, other Awards or Options or stock appreciation rights with an exercise price that is less than the exercise price of the original Options or stock appreciation rights without stockholder approval.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Awards may be granted under the Plan that are in each instance in excess of the number of shares then available for issuance under the Plan, provided any excess shares actually issued under those Awards shall be held in escrow until there is obtained stockholder approval of an amendment sufficiently increasing the number of shares of Common Stock available for issuance under the Plan. If such stockholder approval is not obtained within twelve (12) months after the date the first such excess issuances are made, then (i) any unexercised Awards granted on the basis of such excess shares shall terminate and cease to be outstanding and (ii) the Corporation shall promptly refund to the Optionees and the Participants the exercise or purchase price paid for any excess shares issued under the Plan and held in escrow, together with interest (at the applicable Short Term Federal Rate) for the period the shares were held in escrow, and such shares shall thereupon be automatically cancelled and cease to be outstanding.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">IV.    </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">USE OF PROCEEDS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Any cash proceeds received by the Corporation from the sale of shares of Common Stock under the Plan shall be used for general corporate purposes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">V.   </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">REGULATORY APPROVALS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The implementation of the Plan, the granting of any Award under the Plan and the issuance of any shares of Common Stock under the Plan shall be subject to the Corporation&#8217;s procurement of all approvals and permits required by regulatory authorities having jurisdiction over the Plan, the Awards granted under it and the shares of Common Stock issued pursuant to it. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">No shares of Common Stock or other assets shall be issued or delivered under the Plan unless and until there shall have been compliance with all applicable requirements of applicable securities laws, including the filing and effectiveness of the Form S-8 registration statement for the shares of Common Stock issuable under the Plan, and all applicable listing requirements of any stock exchange (or the Nasdaq Global Market, if applicable) on which Common Stock is then listed for trading.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">C.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">All stock certificates delivered pursuant to the Plan are subject to any stop-transfer orders and other restrictions as the Plan Administrator deems necessary or advisable to comply with federal, state, or foreign jurisdiction, securities or other laws, rules and regulations and the rules of any national securities exchange or automated quotation system on which the Stock is listed, quoted, or traded.  The Plan Administrator may place legends on any stock certificate to reference restrictions applicable to the Common Stock.  In addition to the terms and conditions provided herein, the Board may require that an Optionee or Participant make such reasonable </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">covenants, agreements, and representations as the Board, in its discretion, deems advisable in order to comply with any such laws, regulations, or requirements. The Plan Administrator shall have the right to require any Optionee or Participant to comply with any timing or other restrictions with respect to the settlement or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Plan Administrator.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">D.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Notwithstanding any other provision of the Plan, unless otherwise determined by the Plan Administrator or required by any applicable law, rule or regulation, the Corporation shall not deliver to any Optionee or Participant certificates evidencing shares of Common Stock issued in connection with any award and instead such shares of Common Stock shall be recorded in the books of the Corporation (or, as applicable, its transfer agent or stock plan administrator).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">E.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">In the event that the Corporation establishes, for itself or using the services of a third party, an automated system for the documentation, granting or exercise of Awards, such as a system using an internet website or interactive voice response, then the paperless documentation, granting or exercise of Awards by an Optionee or a Participant may be permitted through the use of such an automated system.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">VI.  </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">NO EMPLOYMENT/SERVICE RIGHTS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Nothing in the Plan shall confer upon the Optionee or the Participant any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Corporation (or any Parent or Subsidiary employing or retaining such person) or of the Optionee or the Participant, which rights are hereby expressly reserved by each, to terminate such person&#8217;s Service at any time for any reason, with or without cause.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">VII.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">COMPLIANCE WITH SECTION 409A OF THE CODE</font><font style="font-family:inherit;font-size:11pt;">&#32;&#32;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">To the extent that the Plan Administrator determines that any Award granted under the Plan is subject to Section 409A of the Code, the agreement evidencing such Award shall incorporate the terms and conditions required by Section 409A of the Code.  To the extent applicable, the Plan and Award agreements shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the adoption of the Plan.  Notwithstanding any provision of the Plan to the contrary, in the event that following the adoption of the Plan the Plan Administrator determines that any Award may be subject to Section 409A of the Code and related Department of Treasury guidance (including such Department of Treasury guidance as may be issued after the adoption of the Plan), the Plan Administrator may adopt such amendments to the Plan and the applicable Award agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Plan Administrator determines are necessary or appropriate to (a) exempt the Award from Section 409A of the Code and/or preserve the intended tax treatment of the benefits provided with respect to the Award, or (b) comply with the requirements of Section 409A of the Code and related Department of Treasury guidance.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">VIII.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">FORFEITURE AND CLAW-BACK PROVISIONS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Pursuant to its general authority to determine the terms and conditions applicable to Awards under the Plan, the Plan Administrator shall have the right to provide, in the terms of Awards made under the Plan, or to require a participant to agree by separate written or electronic instrument, that: (1) any proceeds, gains or other economic benefit actually or constructively received by the participant upon any receipt or exercise of the Award, or upon the receipt or resale of any shares underlying the Award, must be paid to the Corporation, and (2) the Award shall terminate and any unexercised portion of the Award (whether or not vested) shall be forfeited, if (i) a termination of Service occurs prior to a specified date, or within a specified time period following receipt or exercise of the Award, (ii) the participant at any time, or during a specified time period, engages in any activity in </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">competition with the Corporation, or which is inimical, contrary or harmful to the interests of the Corporation, as further defined by the Plan Administrator or (iii) the participant incurs a termination of Service for Misconduct; and</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">B. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">All Awards (including any proceeds, gains or other economic benefit actually or constructively received by a participant upon any receipt or exercise of any Award or upon the receipt or resale of any shares underlying the Award) shall be subject to the applicable provisions of any claw-back policy implemented by the Corporation, whether implemented prior to or after the grant of such Award, including without limitation, any claw-back policy adopted to comply with the requirements of applicable law, including without limitation, the Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules or regulations promulgated thereunder, to the extent set forth in such claw-back policy and/or in the applicable Award agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A-5</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">APPENDIX</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">The following definitions shall be in effect under the Plan: </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">A. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">AMENDED PLAN EFFECTIVE DATE shall mean the date the Plan shall become effective and shall be coincident with the approval of the Plan at the 2016 Annual Meeting of Stockholders scheduled to take place on May 23, 2016.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">B.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">AWARD shall mean an option, stock issuance award, stock appreciation right award, restricted stock unit award or dividend equivalent award granted pursuant to the Plan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">C. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">BOARD shall mean the Corporation&#8217;s Board of Directors. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">D. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">CHANGE IN CONTROL shall mean a change in ownership or control of the Corporation effected through any of the following transactions: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(i) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">a merger, consolidation or other reorganization approved by the Corporation&#8217;s stockholders, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Corporation&#8217;s outstanding voting securities immediately prior to such transaction, or </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(ii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">the sale, transfer or other disposition of all or substantially all of the Corporation&#8217;s assets in complete liquidation or dissolution of the Corporation, or</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(iii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">the acquisition, directly or indirectly by any person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation), of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation&#8217;s stockholders. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">E. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">CODE shall mean the Internal Revenue Code of 1986, as amended. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">F. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">COMMON STOCK shall mean the Corporation&#8217;s common stock. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">G. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">CORPORATION shall mean Ligand Pharmaceuticals Incorporated, a Delaware corporation, and any corporate successor to all or substantially all of the assets or voting stock of Ligand Pharmaceuticals Incorporated which shall by appropriate action adopt the Plan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">H.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">COVERED EMPLOYEE shall mean an Employee who is, or could be, a &#8220;covered employee&#8221; within the meaning of Section 162(m) of the Code.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">I. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">DISCRETIONARY OPTION GRANT PROGRAM shall mean the discretionary option grant program in effect under Article Two of the Plan. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;J. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">EMPLOYEE shall mean an individual who is in the employ of the Corporation (or any Parent or Subsidiary), subject to the control and direction of the employer entity as to both the work to be performed and the manner and method of performance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">K. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">EXERCISE DATE shall mean the date on which the Corporation shall have received written notice of the option exercise.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">L. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">FAIR MARKET VALUE per share of Common Stock on any relevant date shall be determined in accordance with the following provisions: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(i) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">If the Common Stock is at the time traded on the Nasdaq Global Market, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question, as such price is       reported by the National Association of Securities Dealers on the Nasdaq Global Market and published in The Wall Street Journal. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(ii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">If the Common Stock is at the time listed on any Stock Exchange, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question on the Stock Exchange     determined by the Plan Administrator to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange and published in The Wall Street Journal. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">M. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Full Value Award shall mean any Award other than an option or a stock appreciation right and that is settled by the issuance of shares of Common Stock.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">N.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">HOSTILE TAKE-OVER shall mean a change in ownership or control of the Corporation effected through either of the following transactions: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(i) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">a change in the composition of the Board over a period of thirty-six (36) consecutive months or less such that a majority of the Board members ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the time the Board approved such election or nomination, or</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(ii)  </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">a Hostile Tender-Offer.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">O. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">HOSTILE TENDER-OFFER shall mean the acquisition, directly or indirectly, by any person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation) of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation&#8217;s stockholders which the Board does not recommend such stockholders to accept.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">P. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">INCENTIVE OPTION shall mean an option which satisfies the requirements of Code Section 422.</font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Q. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">INVOLUNTARY TERMINATION shall mean the termination of the Service of any individual which occurs by reason of:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(i) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">such individual&#8217;s involuntary dismissal or discharge by the Corporation for reasons other than Misconduct, or</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">(ii) </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">such individual&#8217;s voluntary resignation following (A) a change in his or her position with the Corporation which materially reduces his or her duties and responsibilities or the level of management to which he or she reports, (B) a reduction in his or her level of compensation (including base salary, fringe benefits and target bonus under any corporate-performance based bonus or incentive programs) by more than fifteen percent (15%) or (C) a relocation of such individual&#8217;s place of employment by more than fifty (50) miles, provided and only if such change, reduction or relocation is effected by the Corporation without the individual&#8217;s consent.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">R. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">MISCONDUCT shall mean the commission of any act of fraud, embezzlement or dishonesty by the Optionee or Participant, any unauthorized use or disclosure by such person of confidential information or trade secrets of the Corporation (or any Parent or Subsidiary), or any other intentional misconduct by such person adversely affecting the business or affairs of the Corporation (or any Parent or Subsidiary) in a material manner. The foregoing definition shall not in any way preclude or restrict the right of the Corporation (or any Parent or Subsidiary) to discharge or dismiss any Optionee, Participant or other person in the Service of the Corporation (or any Parent or Subsidiary) for any other acts or omissions, but such other acts or omissions shall not be deemed, for purposes of the Plan, to constitute grounds for termination for Misconduct. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">S. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">1934 ACT shall mean the Securities Exchange Act of 1934, as amended.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">T. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">NON-STATUTORY OPTION shall mean an option not intended to satisfy the requirements of Code Section 422.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">U. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">OPTIONEE shall mean any person to whom an option is granted under the Discretionary Option Grant Program.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">V.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">ORIGINAL PLAN EFFECTIVE DATE shall mean May 16, 2002, the first business day following the date the Corporation&#8217;s shareholders initially approved the Plan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">W.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">OTHER STOCK AWARD PROGRAM shall mean the discretionary stock award grant program in effect under Article Four of the Plan</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">X. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">PARENT shall mean any corporation (other than the Corporation) in an unbroken chain of corporations ending with the Corporation, provided each corporation in the unbroken chain (other than the Corporation) owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Y. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">PARTICIPANT shall mean any person who is issued an Award under the Plan other than an option.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">Z.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Performance-Based Award shall mean an Award granted to selected Covered Employees which is subject to the terms and conditions set forth in Article Five.  </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">AA.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Performance Criteria shall mean the criteria that the Primary Committee selects for purposes of establishing the Performance Goal or Performance Goals for a Participant for a Performance Period, determined as follows:  </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">(i)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Performance Criteria that will be used to establish Performance Goals are limited to the following: net earnings (either before or after interest, taxes, depreciation and amortization), gross or net sales or revenue, adjusted net income, operating earnings or profit, cash flow (including, but not limited to, operating cash flow and free cash flow), return on assets, return on capital, return on stockholders&#8217; equity, total stockholder return, return on sales, gross or net profit or operating margin, expenses, working capital, earnings per share, adjusted earnings per share, price per share of Stock, regulatory body approval for commercialization of a product, implementation or completion of critical projects, and market share, any of which may be measured either in absolute terms or as compared to any incremental increase or decrease or as compared to results of a peer group or to market performance indicators or indices.  The Primary Committee shall define in an objective fashion the manner of calculating the Performance Criteria it selects to use for such Performance Period for such Participant.  </font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">(ii)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Primary Committee may, in its sole discretion, provide that one or more objectively determinable adjustments shall be made to one or more of the Performance Goals.  Such adjustments may include one or more of the following: items related to a change in accounting principle, items relating to financing activities, expenses for restructuring or productivity initiatives, other non-operating items, items related to acquisitions, items attributable to the business operations of any entity acquired by us during the performance period, items related to the disposal of a business or segment of a business, items related to discontinued operations that do not qualify as a segment of a business under applicable accounting standards, items attributable to any stock dividend, stock split, combination or exchange of stock occurring during the performance period, other items of significant income or expense which are determined to be appropriate adjustments, items relating to unusual or extraordinary corporate transactions, events or developments, items related to amortization of acquired intangible assets, items that are outside the scope of our core, on-going business activities, items related to acquired in-process research and development, items relating to changes in tax laws, items relating to major licensing or partnership arrangements, items relating to asset impairment charges, items relating to gains or losses for litigation, arbitration and contractual settlements, or items relating to any other unusual or nonrecurring events or changes in applicable laws, accounting principles or business conditions.  For all Awards intended to qualify as Qualified Performance-Based Compensation, such determinations will be made by the Primary Committee within the time prescribed by, and otherwise in compliance with, Section 162(m) of the Code.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">BB.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Performance Goals shall mean, for a Performance Period, the goals established in writing by the Primary Committee for the Performance Period based upon the Performance Criteria.  Depending on the Performance Criteria used to establish such Performance Goals, the Performance Goals may be expressed in terms of overall Corporation performance or the performance of a division, business unit, or an individual.  </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">CC.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Performance Period shall mean the one or more periods of time, which may be of varying and overlapping durations, as the Primary Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to, and the payment of, a Performance-Based Award.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">DD. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">PERMANENT DISABILITY OR PERMANENTLY DISABLED shall mean the inability of the Optionee or the Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment expected to result in death or to be of continuous duration of twelve (12) months or more. However, solely for purposes of the Awards granted to non-employee Board members, Permanent Disability or Permanently Disabled shall mean the inability of the non-employee Board member to perform his or her usual duties as a Board member by reason of any medically determinable physical or mental impairment expected to result in death or to be of continuous duration of twelve (12) months or more. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">EE. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">PLAN shall mean the Corporation&#8217;s 2002 Stock Incentive Plan, as amended and restated and set forth in this document.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">FF. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">PLAN ADMINISTRATOR shall mean the particular entity, whether the Primary Committee, the </font></div><br><div></div><hr style="page-break-after:always"><a name="sbf6b4c24e9ea4917b070a0d8dd6584e2"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Board or the Secondary Committee, which is authorized to administer the Plan with respect to one or more classes of eligible persons, to the extent such entity is carrying out its administrative functions under those programs with respect to the persons under its jurisdiction.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;GG. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">PRIMARY COMMITTEE shall mean the committee of two (2) or more non-employee Board members appointed by the Board to administer the Discretionary Option Grant and Stock Issuance Programs with respect to Section 16 Insiders.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">HH.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Qualified Performance-Based Compensation means any compensation that is intended to qualify as &#8220;qualified performance-based compensation&#8221; as described in Section&#160;162(m)(4)(C) of the Code.  </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">II. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">SECONDARY COMMITTEE shall mean a committee of one or more Board members appointed by the Board to administer the Discretionary Option Grant, Stock Issuance and Other Stock Award Programs with respect to eligible persons other than Section 16 Insiders.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">JJ. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">SECTION 16 INSIDER shall mean an officer or director of the Corporation subject to the short-swing profit liabilities of Section 16 of the 1934 Act.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;">KK. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">SERVICE shall mean the performance of services for the Corporation (or any Parent or Subsidiary) by a person in the capacity of an Employee, a non-employee member of the board of directors or a consultant or independent advisor, except to the extent otherwise specifically provided in the documents evidencing the option grant or stock issuance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">LL. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">STOCK EXCHANGE shall mean either the American Stock Exchange or the New York Stock Exchange.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">MM. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">STOCK ISSUANCE AGREEMENT shall mean the agreement entered into by the Corporation and the Participant at the time of issuance of shares of Common Stock under the Stock Issuance Program.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">NN. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">STOCK ISSUANCE PROGRAM shall mean the stock issuance program in effect under Article Three of the Plan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">OO. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">SUBSIDIARY shall mean any corporation (other than the Corporation) in an unbroken chain of corporations beginning with the Corporation, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">PP. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">10% STOCKHOLDER shall mean the owner of stock (as determined under Code Section 424(d)) possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Corporation (or any Parent or Subsidiary).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">QQ. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">WITHHOLDING TAXES shall mean the applicable income and employment withholding taxes to which the holder of Non-Statutory Options or unvested shares of Common Stock may become subject in connection with the exercise of those options or the vesting of those shares.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div></div><hr style="page-break-after:always"><a name="sC7342DAAFE034E62DD75E760D596C606"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;"><img src="a02bffbligandpharmanotic001.jpg" style="height:869px;width:672px;"></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div></div><hr style="page-break-after:always"><a name="sC7342DAAFE034E62DD75E760D596C606"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;"><img src="a02bffbligandpharmanotic002.jpg" style="height:869px;width:672px;"></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div></div><hr style="page-break-after:always"><a name="sC7342DAAFE034E62DD75E760D596C606"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;"><img src="a02bfceligandpharmacommo001.jpg" style="height:869px;width:672px;"></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div></div><hr style="page-break-after:always"><a name="sC7342DAAFE034E62DD75E760D596C606"></a><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;"><img src="a02bfceligandpharmacommo002.jpg" style="height:869px;width:672px;"></div><br><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>a02bfceligandpharmacommo001.jpg
<TEXT>
begin 644 a02bfceligandpharmacommo001.jpg
M_]C_X  02D9)1@ ! 0( E "4  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0* Q\# 1$  A$! Q$!_\0
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MA/$EA:.DY/_:  P# 0 "$0,1 #\ _5.@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4!2@% * 4 H!0"@% * 4 H!0"@% 5H"
ME * 4 H"M 4H"M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * \V6>D7#S6O
MFHJ]L[\?O#[U >E * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M1"$* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M6@63^'[22\6S*6XELF7F_2KRQ8+?(,B/9V70@(BH</RMN&Y()'?U)W- =*T
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M[8W*L=DN$R/(2F=!92ASIK:/'[8@+)!V/+CV[B@-I>$(;^+KQ;]__LW:??\
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MW?X^Y_:LO[Q&XK1_PS,?WFR#_56^N(K>I;?.4/MK'G%QZEG\Y;?O5S6>%?\
M&&/?P.M/_GC%=7?>I6^?J_ZO([?B?XJX_K-;_59DHOG]Y/4G]Y87_FLZM1;_
M )8L?G)_W-(T5K^7^'?.U/[BB6%L_NSRK_K=H_\ ))E2:OQ.W_9J_P"L4R77
M^(6O[-?_ %JD7^6_WGXO\+;)_P"61*C6?Y5E\Q6_O:A$X?\ ER7]7N/[^J8-
MK_@F7?O_ )#_ *^VUL'ZUM\W0_=K&UEZ]I\S;?N5R7Y'_P 9:2_PBR3_ &EZ
MM+:_B^(_-6_[D3G;/\5Q7YFU_<B1/3#^Y/"?^BM?_F-SK<<6^-77MJ_W5 W_
M !SX[>^VM_<VYZ9U_:,:_P"R57^K-6\/]:O_ %W^)9PKUKG_ /4%]HN/]R[G
M[TN?_*[$JM+XROVU_K504?CB^<7^N53T\0?]W.K_ /U>Q?ZQJL?1KXEPWVU_
MLD6=$/R?PCVW'V2)*S_?#;_?X?\ RQKK62^(/YO_ &5&EE^3'\U_L:(HK^^0
MK_M8/^:MNOR?_P#LS?\ _)?_ /;R8:._W;X;_P V#_Y&]6DXY\3N?]/_ %B)
MSG2+\GWG]I_K4#4F,_W/8C^\V5?ZEVNSNOC%S\Y;?O1/0;[XS=_.V?[T3;D?
M_A6HG[R9+_K(U<9+U;+YRW^R9Y[+U.'_ #MI]E0@V _W16#^"U@_\VBUO^(_
M%ZWSU?\ N9G4\6^*U_G[G_5ZA?W;^\#J'^\]H_V^34>C^7++]NK_ '<"+;_G
M)P_YRO\ W5,D.F_]^N[?PDM?_E4RM;Q3\CT_FJO]]3-/QG\@TOF:W]_2.MQZ
M5XN?/A:SKK"M98$R8Q$+ZPTT'W4HZBSZ)3N>Y^\*S4Z-2MGJXMXW>%G"\69Z
M5O6KZNJ@Y867A-X7B\<D>C\V/&2ZIY]MI+2.HLK6$A">_M'?T'8]_O59&G.>
M%%9SM[RR-.<VE&+>7A>;\/:>;=VA.N1FT2V%KDH+C"4NI)=2/521O[0[CN/G
MJ]T:B4FXOL[/;D_/P+W;UHJ3<'B+P]GL_!^#]I27=X,!I3DF9'CMI7TRIUU*
M0%;;\=R?7;OM2%"K4>(1;?/9/EXE:=O6JO33@V\9V3>WC[#Y?OENBE\/3XS1
MCA)>"WDIZ85\GEN>V_NW]:NC;UIXTP;SG&SWQSQ[.\NA:UZFG13;U9QL]\<\
M>.._P/IB\0)+C#;4V.ZM]*EM)0ZDEQ([$I /<#WD525"K!-RBUCGL]O:6RMJ
MT%*4H-*.SV>S?+/@>L.='N#/6BOM26MRGJ-+"T[@[$;CYCVJR=.=)Z9II^>Q
M94I3HRT5(M/P:P>]8S$* 4 H!0"@% * 4 H!0"@% 8N\8O9LB?M[]UM,&YO6
MY\2H;DR,AU49X>CC94"4+'[9.QH!;L7LUGF7.7 M,&%+NC@>GOQHR&W):P.(
M4ZH %9V[;JW.U >=DP^PXU956>T66W6JTJYE4"#$;98//Y>[:0$^UN=^W?WT
M!CL/TKPO3V1*?Q;$K%C;\O\ X0Y:+:S%4]WW]LMI!5W[]Z ^<PTGPG4*5&DY
M3A]AR21&&S#MWMC,I;0WWV27$DCO\U 9*[X;8+_9&[-=+);;E:&^!1 F1&W8
MZ>'R-FU I''8;=NVW:@*Y%AUARYN*W?;);KTW$>$B.BX1&WPRZ/1Q 6#Q4/<
MH=Z ]+3B]FL,VY3+9:(-NEW)[S$Z1$C(:<E.;;<W5) *U;>]6YH"XN]G@7^V
MR+?<X4>XP)">#T66TEUIU/[52% A0^\10&&PS33$=.67V<4Q:S8RU((4\W9[
M>U%2X1Z%0;2-_4^M 9&RXK9<<3.%IM$"UB<^J5*$*,AGS#ROE..<0.2S[U'<
MF@,59]*L*QZ7!E6K$+#;),%3JXCT.V,-+CJ<&SI;*4@H*P!R(VWV[[T!E+KB
MEDOMPMD^Y6>!<)UL<+T&3*BH=<B+.P*FE*!*%'8=T['M0%;9B]FLMRN5QM]I
M@P;A<UI<G2HT9#;LM21LE3JT@%9 ) *B=J CMTT/TYO=RDW"XX#B\^?*<+K\
MJ59HSCKJSZJ4M2"5$_.3O0%Q/T@P2ZVFVVJ;A>.R[9;0L083]JCK9BA1W5TD
M%'%&Y[GB!O0&8QO$K'AMO\A8+-;['!Y%?EK;%;CM<CZGB@ ;_?H#+4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0$!UYC.R
M](<H98:6\ZN)LEMM)4I1Y)] *Z/H[*,.*T)2>$I?P9UG12<:?&[:<WA*7?[&
M:4R.T3EW;34IA2"&LRO3BR&E>PA4IPI4>W8$=P??7>VM:DJ5]VEO0HKFN:@L
MH]-LKBBJ/$LS6]M02W6[5..5[41+2.Q7*/AF&(=M\MI;9B<TK86"G:[R%'?M
MV[$'\!K<<9N*,KRZ<9IYU=Z_4P7VG0=(;NWG?WCC4BT]?>O\W@OMV]I[9E8[
MBY#PU*($I91IA*84$L*/%SRRAP/;LK?W>M66-Q14[G,UO=Q?-<M:W]GF8N&W
M5!3O&ZBWOH/FN6M;^SS/-=AN7V%AOX/E\_@1*./07OO]CP1MZ>O+V?P]O6KU
M<4?3,ZU^,?>O\YS]F_L+U=V_I^>LCCK7WK_/,^/AO[-S[\0UCN,S*]551X$I
M]+UFM"6RTPI061(8) V'?;8^GS59T9N*,+7A^N:6*E7.6MNS(MZ'W5"E9\+4
MZB6*E?.6EC,)\R3R+/..8E?DI'#X;6OET5;;?#T16^^WIQ!/X 36JC7I>B8U
M+\6N]?YO47V[>TT<+BCZ#C6L]4N]?YI57V[>W8C%XL=Q7J9<7$P)2FSJA;GP
ML,*VZ82[NO?;Y(W'?TK:T+BBN'03FL^B5%S7/L[>WR-Y;W5!<)IQ=19]!JKF
MN>8[>WR)?I!:)T;*L24]#D-)0[#*E+:4 G:W3P=]QV[J _"1\]:;C=:E.UN%
M&2>5/O7ZVE_N.=Z17%&=G=J,T\J?>OUU!_8G]!JJQ8]=$VG&@;;,!1'RP*!C
MK[%<501OV]Y[#YZZ^XN:'6UWK7.U[UW36?H[SO;J\MG6N6JD=W9=Z[JBSW]W
M?X&W+5:9J9>7$PY "[1?DIW:5[14W X@=NY/$[?/L?FKBZU:DX6W:6TZ'>NY
MU<_1D\]KW%%PM,36U2V[UW2K9^C*S[36^&6&YHG8^56Z6D)Q&U-DEA?90O3*
MBGT]0D$[?,-ZZF^N*+A6Q-?CJKYK]1)?;L=IQ*[MW3N$JD?C%9\UR]&FL_3M
M[=B3WNS7 Z,ZBLB#)+KEGAI0CHJY*(N<U1 &W?L0?P$5J;>O2^%[*6M84Y]Z
M_54T:.UN:'P[P^>M852>=UM^ HK[5@L+;8[B,PRA9@2@A<JTE*BRK8[666D[
M=O<H@'[Y J15N*/HE!:URJ]Z_7TW]FY*KW5#T&V76+*C6[UWW-)KZEGV%]E=
MFN"])8S28,E3OV5V9S@&5<N(MT5)5MMZ @@GYQ4>SKTEQ24G-8ZFLN:_6S?V
M$:PN:"XU*3FL>CUUS7-UJC2]ZW,*U8KEY7*__<^5NN^W]:?M"_:2I^W\2.W<
M'BK;Y]C\U3W<4=5OVUM3H=Z[HU<_1DV4KNWUVOX2.U*V[UW1KY^C*S[269#:
M)R[CI44PI!#609$MS9I7L)5(=*2>W8$=Q\]::VK4E3XAVEO3M\;K?$8Y^CO-
M!9W%%4N*9FMZ-KC=;XA'./9W^!%M-+%<F<5PQ+EOE-J0U;.04PL%.UPN1._;
MML%)/X"/GK<<5N*,KFY:FMW4[U^KH_[F;WC=U;RO+QQJ)Y=7O7ZFW7VI_0ST
MS>R7%QG'.$"4HHTJ4PK9E1V<Z9]@]OE?>]:LL+BBI5\S7QS/-<L\_9YEG"[J
M@I7&:BWOT^:Y9Y^SSY"X6*Y*QEQ(M\HJ^"W$\0PO??['XB=O3]L"G\((]:K3
MN**N4]:]==Z_SFH_LW]FXHW5NKM/K%^,7>O\[JO[-_9N?>O=DN,O-M65L0)3
MR'F+&&U-LJ4%[.-;\=AWVV.^U6='+BC"SX<I32PZV=UMM(MZ)W5"G8<*4ZB3
M3N,Y:VRI8S[21LVB<,_;<\E)Z?PX%\NBK;C]D*U;[[>G'VOP=_2M9*O2]!:U
M+/5^*_S9+[=O;L::5Q1^#7'6L]5XK_,TOMV]NQ%E6.X_IB*<\A*X?IIE_ET%
M;=/;Y>^WR?O^E;=7%'T#&M?$\<US\/;Y&]]*H?!FGK%GT#'-<_#V^1+M)+3.
MCYGB*W84AI"$PN2ELJ 3M97DG?<=O:('X>U:7C5:E*SN5&2>=?>OU\7]F_L.
M>Z07%&=A=J,TV^L[U_G,7]F_LW-4XWCUU18<42JVS I%GRA*@8Z]TE33H2#V
M]3N-OGKL+JYH.O</6MYVW>NZ4<_1WG?7MY;.YNFJD=ZEIWKNE'/?W=YM=BTS
MO,Z@'R4@!VS9&E'VE7M%3D;B!V[D[';Y]JXZ5:EIL^TMJEOWKN4\_1WG RN*
M.BP[:VJ6N=UMA5,_1W^!"<%L=R:R"Q*7;Y24IQBPH)+"P I-TC*4#V]0 2?O
M UO^(7%%T*R4U^-K]Z[Z,TOK.FXK=6\K:NE4C^/N'S7)T*B7TO8OKM9+B="=
M0&! E%YRT6E*&^@KDHB=)) &VYV!!/S;U'HW%'X;LY:UA3J]Z[Z<"+;W5#^<
M5A/K%A5*V7E8WI4TOI,_IY:)S.LMU><A2$,G(K8L.*94$E(M<L$[[>@) W^<
MBM=Q*M2EPBG%26>JJ=Z_74S4\8N*,N!4HQFF^IJK&5^OI/[-SJP>E>.G@AK/
M/(\&/E4R3?+#)OUOEV<0X;3$-<D%[J.%UGV0>F7 IG91XCV.Y'&NKX=*K*UC
M"VK*G*,]4FY*.V%B6^-2CB6RR]^6YVW"9UIV<*=G75*<:FJ3<E'LXBHRW:U*
M+4MEE[\GDM<DMC%CN>1W=_'9EV;D6JW*5"2') =D-ON<&]QR]E!X%02" -U$
M'<[YK6K*XIT+>%90:G4WVCB+BLONW>Z67SPLK&TBRKSNJ5O:PN(TW&I5[79C
MB,H1R^[>6Z66GG$4UC; BS^63BHM-MD2KVW(3+ZSMK=C,2 IU]2T!:D\HS;2
MW%JXD J2I(V5RK8]?K=QU\TJ;3CA34FL**3PGB<II)93>&F]L&U=SK=UZ344
M:33CA5(RE'$8)/">*DIJ*64WAIOLX,0YC%V@V>=\,6^X,SV[K*E1U1HB+DW+
ME+B- %P+:.R5K*P"$@#NGDC8$S5=T*E6'H\XN+A%/,G3<8J<N6)<TL-IO/)X
MEEFQ5];5:\/1:D7!TX1>9.DXP526T6I<XQPVF\O9Z99:,E;;;=H<G)79=G^$
MKHJ-<'G6';4%-H?5(0N*EMWA]O2H$$@E7'I#;AML8M6K;SC0C3JZ89II-3W<
M5%J>5GLM<ELLZGSSE0:U>VJ1MHTJVBGJI)-5,-Q4&JC<<]AKDL*.=3];.5\7
MS '+5E=MMD")*;C1H<>*QY2'OUD!N2EU\/@;-+07E*X;CF2-]^7:MOQ)5K6=
M>K)9E*3>9<GF#C'3SDFHI9P]*Y<B^UXO&XLZEQ7FG*4I2>9<GJIN,='.2DHI
M:L/2D\>J3'1*WSHT.[OOL(B0WG(Z8[+4)R&C=$="%J#2_:&Y3L2?>D@;@ G2
M<?J4ISIQB\R2EEN2D]Y-K=;<OM[LX7.=)ZU&<Z4(2U22EEN2F]YMI:H[<GE>
M3WPWA;,KE#B10"@% * 4 H!0"@% * 4 H#G2[ZLZPY3K-G^(:>V3!W+9B2X#
M+LK);A-8>>7)BI?]E++2T[#D1WVH"]\YXH/\3:1_SS=?]UH!YSQ0?XFTC_GF
MZ_[K0#SOB@_Q-I'_ #S=/]UH!YWQ0?XFTC_GFZ_[K0#SGB@_Q-I'_/-U_P!U
MH!YSQ0?XFTC_ )YNO^ZT \YXH/\ $VD?\\W7_=: ><\4'^)M(_YYNO\ NM /
M.>*#_$VD?\\W7_=: ><\4'^)M(_YYNO^ZT \YXH/\3:1_P \W7_=: ><\4'^
M)M(_YYNO^ZT \YXH/\3:1_SS=?\ =: ><\4'^)M(_P">;K_NM /.>*#_ !-I
M'_/-U_W6@'G/%!_B;2/^>;K_ +K0#SGB@_Q-I'_/-U_W6@'G/%!_B;2/^>;K
M_NM /.>*#_$VD?\ /-U_W6@'G/%!_B;2/^>;K_NM /.^*#_$VD?\\W3_ '6@
M'G/%!_B;2/\ GFZ_[K0#SGB@_P 3:1_SS=?]UH!YSQ0?XFTC_GFZ_P"ZT \Y
MXH/\3:1_SS=?]UH 9OB@'_V&TC_GBZ_[K0$Q\-VJ%TUCT?M.4WN!#MEUD29T
M23&@.+<82N-,>C$H4L!1!Z._< ]Z V;0"@% 4)"1N3L![Z A=CUIP;)+RS:K
M9E%NFW!]2D-,-/;J<4 20GW'L#Z?-6^N.!<3M:+KUJ$HQ7-M<O:=-==&N,65
M"5S<6THP6[;7+/CX%+KK5@UDO3UHGY1;8MQ9=#+C#CVQ0L[>R?<#W'O[4H\!
MXG<45<4K>3@UE/'-"AT9XQ=6ZNJ-K.4&LII<UXHNLKU7Q'!K@W!OV00K9,6V
M'DL/N;+*"2 K8#TW!_D-8K/@_$.(4W5M:+G%/&4MLF"PX!Q3BE)UK*WE.*>,
MI;9\#TO6I^*8[9K==KC?X,6VW$!4.2MWV'P4\MT;>HV[U;0X3?W5:="C1DYP
M]98W7=N6VW ^)WE>I;4*$I3I^LL;QWQOX;E&M4<3?Q1[)F[_  56%ESI.3P[
M]K2OD$\2?GW(&WKW%)<(OXW2LG1EUKW4<;XYY]@EP+B<+Q</E0EUS65'&[6,
MY]F$]SZQC4W%LS9G.V2^PKDW!2%R2PYOTDD$@JW]![*N_P!XU2[X3?6+A&YI
M.+ERRN?L^DI?<$XEPV4(W="4'/:.5S>VR^E&=M]TB76'&E0Y#<F/)93(9<;4
M"'&U %*A\X(([_?K7U:-2C.4*D<.+P_)KFC55J%6WG*G5BU*+::?<US3\RZK
M"8!0"@% * 4 H!0"@% * 4!3:@&U -J ;4 VH!M0#:@&U -J ;4 VH!M0#:@
M&U -J ;4 VH!M0#:@&U -J ;4 VH!M0#:@&U -J ;4!6@*4!6@*;4 VH!0#:
M@*T H!0"@% * 4 H!0"@% * 4 H#0&BGZZ'Q&?\ 7K#_ .5(H#2GC-S_ #^3
MG>86'"<BOMA3&L5MMC#ML==;2W,?<EW"0\GCL.:(EM".0.X$@C]EW UK#U%U
MGU@SE)@S<EA)RVZ6<0\>3>W[2B';F+<_.?1YAM*^@ZZVJ"IQ:025/E'N[ 2O
M)[QE^GBI&&:M:CY;:9-MQEVXXTSC%PE+EWNY2)4HHC(EI;#DUR*A,1H-K YE
MPK6@I] ,1:K_ *W95G%HGWN_7G'W'LHLV)*O,>^2$0($Z-"CNSTKMC;99D)D
MR!)8#BE! 6H [  D#-S+ME=DO.H*,<OFI5^O5ZR^=BV.6]F\2)IM]LCM1Q<[
M@VT^XEI2VW%O):4M0"5K:">PH"+O^(?5^TX-AN8PW;]<8V X81E=I?YJDW&7
M*E2;>VMT;[+>87#0^H]SLI9WV/<#=FG>G&2W#Q 8]9;SFV<R(^.8+:;C?$)R
M*6B-+O"W0VGF@*"2"B*^I:/19=W50&(R[Q"96_XF<<R-AG)H6DMJNTO'"^RR
M$VJZ*3"E*D2'"%\UK1*9;::]CALVXH*W6!0&G+=JGKFUB;&/7F]9 U>58PY?
MH=V:<<27W+\Y"BP&%'?D5PGI4T@'LD,-D;<1L!*K)K1J';<OL[^H.27?&,>Q
MC*K9B-_NKCKC<)]5OA3GWY2R.P1.=<@C=790 2?=0&+S_7'5J?I3<'K C-S<
M$2+CGMRDP&B'+;!5*<7:+<X7%H4VPY&9+SC: I80$IX_;30'2.B.NUJROQ :
MKV>=EI7+?O+%NQ_'9#J]TQXUO:6\\T@C8!;KCQ)'KT_O"@.9M=M8]7I>H^LE
MNQ>ZY%"MM[;,"S/1G7$-6E$"4W#><C['V'9$EQ+04GW+*M_9% 43K->XMRU7
MR.3G4J=.L#U[59K2G,KBW*2W!CF+&WM:6>@ZE;S0>*EN[J#O(C<;4!FH<J\R
M/"QG=VMVHM[O>8P8ULMT.=CFH-UN:U7)Y264+<0ZTT&N3KJ5EM'-*DC8G9(W
M KJ#*U5Q[4N^8=ISE^57!RTW2$U"5=KE)F><,"VOW2<A:UJ)(D.R84;]KMLG
M8@;4!B9>O.1W?'8]_P QOV4X_8+];KIEEBM3=\?L[UPD.W-QJ/;A,;0M2%1H
M;;3B(Z.SBW]R% =@-T:QZKY?AFDFBTA+^0Q[Q\'2LGO*)"MIKK,"SO/F-*+2
M$)*ER7(C:TA*0I6XV]U :)5E^O+?EM++G?K_ /97:&[5C7PTF<_%1=7;G-;F
M"4I] 6M"FH,20PIW92D%2R-R=J V'F]PN.FV2MXGJ5FN88=8T8\_>+:WC^47
M&Y2;U=G'UMB.S/6TAYQ3+3;"DQ0 "M\J*5I!H"#Q\AURRF[6V;?K[?<<>;NF
M-X=(OC%]D,1;3<TQ&7YSSUN:;+,H/.N^7*E*2A+A .R1O0&(LNM6JV47I$.9
MDF366P7/-H&5R[LI]U'D[/*0J0W;FB#NEI$:/)=<2-ALA"?V9% 3B/K'J!DD
M_5R^9:UG>+66]8++RBQ6TOJ@>4$&2/+(AK9<*TK=9=C*>Y!"E*6I/'BF@+6^
M7#4/2V1%M:\\S-%LM^.XZQF5_FW!^<NW/W.5_9TQL.<PWTF890DA)#/FE+V]
M] ?%XS_4OS?DM*\ER:^XA&R)[)+#-N\F1*?N]NMEO0N?##[GVQZ,_*>0TVI9
M(*@KB2D"@.MO"C?KUF.B-IRN_/3USLDF3;VTQ<%E2XL61+=<BL 'Y*6V"TD)
M'8;=J PW@<_6Y6G]^K__ .<S: WW0"@% >$[_@;_ /T:O\QK)3]=&6EZ\?:C
MGC';W;IFG>@T)B?%?FM7&#U([;R5.(VA2 =T@[C8UZ9<V]:%_P 7JS@U%QGA
MM/'XR'>>P7EK7I\3X[6G3:@X5,-II/-6')\BTR"\V^/I5K) =G1FISE^G\(R
MWDAQ6ZF=MDD[G>LUM0JRXGPRK&#<53I[X>.4N_D2+2VKSXQP>M&#<%2IY>'C
ME+OY&QV;W;K-K=EYN$^+!#ECMO#S+R6^>SLO?;D1OZBN7=O6K\&MNJ@Y8J5.
M2;[J?@<9*UKW/1^TZBFY8JU<X3>.S2\""81<(MLM.@DB9)9B,"SS 77W A()
MC-[#<G:NAOZ<ZM7B\*<6WKALEG]-G5<4HU*];CM.E%R?60V2;?KR\"DFX15X
MSD<U,EE4/],J&YY@. M\!(A[JY;[;=CWJL*4U<T*;B]7HLUC&^=-3N*PHU%=
MV]%Q>KT*:QAYSHJ[8YDTC2(V4ZJ9TW:Y<::'L8A1TN,.I6@++DP;$@G;U%:*
M<9VG#+25>+CBK-[K#QBGXG-3A4L>#V,KB#CBO4>&FGA*EW/V$:TIBY)9=4L;
MLM]LT6WKMF%^2#L>?YCJI;?93SVX)X[E/R=SM\];7C$[.OPVO<VM5R4Z^K#C
MIQF,GCF\X7?]1N^/U+"YX1<7=G6<U4N=6'#3ARC-X]9YPGSV]AO^O-SR04 H
M!0"@% * 4 H!0"@+.\7>'8+7*N,]],:'&;+KKJM]DI'KV'<_@'<^@K/0H5+F
MI&C2692>$B3;V]6[K1H4(ZI2>$O,C+NK6.,65NY+?EA"WUQO*B ^92'$)Y+2
MI@(ZB>*?:.Z=@G8^A&^U7!KR59T4ER3SJCIPWA-2SI>7LM^>QNH]'[^5=VZC
M'*2EG7'0TWA-3SI>7LL/=[<TRZ<U+QUN\0+:)Y=>FH:6TZTRM; ZH)9"G0"A
M!<V/$*(*MNWJ*PKA5VZ4ZVC"CG*;2?9];$6\O3WM+;O,$>"7[H5+AT\*#::;
M2EV?6Q%O4U'])I-+O+>/JUB\E%U<%Q*&K<VIYUUV.XA#C:5E!6T2G9Y/,<-V
M^7M;#WC?++@U]!TUHWF\))IM-K.);]EXW[6-M^YF:?1_B,'2BZ>74:22<6TV
MLXDD^P\;XEC;?N9YR-7L9BV=FXNR926W'7&3'\B^9+2FQN[U&0CF@(&Q45
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M>\IG)79R9#*XT1+! Z*"G8[$^M 9#GXI/\'TA_*+K]2@'/Q2?X/I#^477ZE
M"OQ2?X/I#^477ZE .?BD_P 'TA_*+K]2@*%?BD/K&TA_*+K]2@*\_%)_@^D/
MY1=?J4 ZGBD_P?2'\HNOU* IR\4F^_EM(=_^L77ZE 5Y^*3_  ?2'\HNOU*
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M=*_A0QFXS*GF45E*JFUNUAX64GC.-B#VJTS[58YMGEVV8W<,C:MSMN9,=PA
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M6I3H5)4JBQ*+:?M6S,E>C4MJLZ%58E%M->#3P_K+JL1@% * 4 H!0"@% 4-
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M6IUDJCU94ML+M16(O9+=(O&;% A^3\NPB,Y$C*AQEH'=IH\=TIW]WVM'KO\
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M;J8Z5SCIBE-R6-M+6WCG;.YF"U<U9D,]^ +J+>FX!'D/*_V;TO)%HN]'??\
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MX][[@F/:B,Y;I[$L>78E?+3:'8GPWU;<ANXH*V)#\H,[MMH2E7,A"N_$#U[
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M-Z,J0II!;VX%(*=AL-O=7GTLIO)Y9)--J7,^ZM+10"@% * 4 H!0"@% * 4
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M$%5SAW*X7^\.WJ8+7;$6V PXM"$!J-&2I0;;2EL=N1)))[>@ W30"@% * 4
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M8ZSU+C-:B@H<<2E9)6M*$\EE*1W5L.YV![4!DN0[^O\ )0%: 4 H!0"@% *
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MS>\&;AV*Z958K3"5$CQXEV\FN).#L;H3'G"XE12EIMX%8"U#D0$GJ&@-60M
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MMVZ2"=M^] 22'K-='\ QR_+@Q$RKEDPLCK(Y\$-?"#L;D.^_+BV#W[;D]MJ
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M/N2-@H*X)V VNGPTX2&[>V8TQ2(4"R6UI*I)(+-JD*D0PKMW(6H\C^R'8T!
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M'IV% 7! ^:@&P'NVH!L/F% -A0#8#W4!6@% * 4 H!0"@% * 4 H!0"@% *
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MPF[JIN%.YG)X67A8[D:XT*T!R?2F_P"0WJ_/6I,)=@FQ@8UP0ZLK4D$>R/\
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MI4:7E<U%QN3*Y;CD<R C@7&VB>+:E#;D4CVMD[^@V FM * 4 H!0"@% * 4
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MD*D2FNZCL%N*4=QW2/920D 4!2Q^%W3+&X[\>VXNW$CR!%3(81*?Z<A$>"J
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MXL,ME?M%#82"0"1V% ;/H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0'-.4V'%YFO\ J#=<OL3%YM5KQN'*XR(@D%.Q
M5R*$D=U;#;M774:MQ&PHT[:;C*4VN>#VNQN^(T^C=A;<+KNG4J5IQVEIYI8R
M_ U]D-AQ?2J6U(M&?YIBUMR9'PY'MMBMVS+3;A]E)2D^R0 $['N !6TI5;B]
M6FI1A.4.RW)[[>XZZSN^(\>@X75A0KSMWU3G4GNW'F\OGE[Y\3-Y%JC:\ST9
ME8V+K=;EC<-@(R'(+PP6KBE*G0IE3+2NSQ*AQ/?V0 :C4K.I;WBKZ4IOU8KU
M>6^7C8UEGP*XX;QV-_U4(5YO-&E!IT\J.)*4EZBP\KQ>2QF9KC6G-^R?"<BD
MS;X+GCW1^RQN*9-Q6V^D ,J">W!"3N-SZ@5EC;U[J%.ZHI1TSSHSB.W?[62J
M?#.(<9M[;B]A&-+JZV>I<M--.#WDL[ZI/F:ILV7Z=V?5"R*O-[O.78S;[0Y!
M0+U;^3D-P;AI#;7?8)[$?,:WE2WO:EK/JH*$Y2SV7S\6WYG>W/#N.W/"*RM:
M-.WKSJ*;ZN>TE^DY2\7R?BBYUSU7\[9\!.,7_)+C=L<\ZIZ^W.,N/)W=4CB>
M7W@%)]?0"K.&V6F5?TB$5&>GLK=;9_\ Y,/1;@'55[]<1H4H4[CJ\4X24H]E
M/.WMP_:;5GX7D6H#D; U9/<I]YM-J9S*W7F6]_9!EK3P;CE1[);2KN%#N-ZT
MD;BC:YN^K2C*3IN*Y86[?M."I<2L.$*7&E;0C2JU)6TZ<5V=">7/'?)K9KDS
MI[3>WWFU8%8(>0OJE7QB$TW->4[U2MX)]HE7[+O[ZXZ[E3G7G*BL1;>/8>'\
M:K6EQQ&O5L8Z:4I-Q6,8CG;;N]A)*B&E% * AV1ZD-X[J)B6)*L5YFN9$W,<
M1=8D7G!@^7;2LB2[O]K*^6R.QW((H#5%WU%S%IZ_9HQ?DM66S98SCPQ40FE-
MR(_FF8CBUN[=4/J6\74<5!'$(24*Y%5 2.3KW=(.B4#4"5B"F!/<;4U#\ZIU
MN/%</L29+K3*RVCCL5<6U\-QN=MU "S'B2E2+3=[W%QF*YCD!*&/A5Z_QVVE
M3%-QUE!(!!9_LGB'6BXI1;5Q;(*"H"RQ;Q3/Y-<+*A&(N-6^0]$BW"9Y_O%?
MD39<-L-MJ:2IU/5B$E2@V0AQ)X[@I &/U&UWSC$=2KC MUCA7.RV^4L)9\X&
M')+*;0N8X%J+:N!2M "=M^1(!XC=0 E>FWB.AZF9])L-OLDMNVA,@1[FH.'D
MMCI!P.IZ00V"7"$$.+*NFO<([;@0A[5/-&+/!SK[(D*M]VODZSIQ=4)D-Q&4
MKDL,.(<X]53R%QPXYR44%)<2$)XA5 7/A<U/R[.[W-C7FY7>YPF+%;YLLY%:
MXUODL2WP5CH(82GJ1U("CS4D[*1Q"B0L) RQ\2M\=L]MGQL 4Z+O">O5K0N\
MM)\Q;6FNHXXOV"6W]E- -$%)+R?MH"5E(&"O?BPFQ;K;[W%L2CA4N--9M[BG
MP7;E+3,@Q6BM"6U+80%R'>XZA*03QW"4D"=2_$(Q;=++1FLVPRX[$R2_#?C+
M4I"F76TOA!25H25H==90A"BE)(?;40.XH"#GQ.7?*IMB>QBT<&I[L%EQB?(0
M&TI<>C(DD*#95U6EOJ9VWXDMK.V^U 271_7._P"5Z8S;A>L<4<DM>.P;UT(T
MI"Q<DOQ%.H(V0 TXM33@*-E!.Z=E*![ >,GQ3QGY<AZSX\Y=;!#2B7+NGG$M
M[0E.-,]9I'$]50=6\"C=/:.L\N12@@7"/$A)N<S&8%GQ-<ZXWU$)QMIZX)9;
M92^9Q6I2^!WX(@.*[#=16D#;N: ]=4/$@-,LLNUHDXZX^S"M#MS8>=EB.Y<%
M(9<=+<9*V^#NW3XJV<YI*@2V4;K &(3XH+I#<NK-WPZ+:'8AEQVG7K\CH.R(
MTJ-'=!6604M_V6TI*@E2U<5I#94$!8&-C^*+(\N58AC>(1FF7I=K:N,JX7$I
M#7F9ST9;;2.B%*V$9Q06H(.RD>SON !:3_%#EDQ>)NV_#D195PCB\FU/W-LI
ME6YVWS)#2E/AH])T+BJ!0$J&Y1[1!44@9N=XLBU%%QAXB_,M$UQ46T/F>AMV
M7)0IA+C;C900RG=]7%?)6_17N$[HY >EK\5?G<QMF-O8I(1<?-I@W9$9]R1Y
M-Y4U^(DM%+'%UL*CJ6I:RUQ;4D@*/)( W]0%: 4 H!0"@% * 4 H!0"@% *
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M0&Y! W[#8"F.:28IB60N7NU6LQ)ZVBR-I+RVFPH-A9;:4LMH4L--\UI2%+X
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M2@*T H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MJ1^U&P&5;TQQ-NW^13CEL\ER*C',5);),<QCNDC8[L$M'_D';TH##(T"T[1
MM4/[#K2J-;'UR8J%QPKINJ4E:EDGNHE3;:MU$]VT'U2G8#-WS3?%\ER*WWZZ
M6*#/O$!!1&F/LA3C8._;?W[%2B-]^)42-B30%S#P?'[?#DQ(]FA,Q9,1N"^R
MAA(0Y';06T-*'H4)0HI ]-B10&*1H]A+=D%H&+VLVT,NL>65'24<'$H0XGO^
MV2V@'_F)^:@/1W2?$'L*;Q%6/POL=:6'40 WLA+@7U.H"#R#G,E?/?ER).^Y
MWH"U1HE@3=Q5.3B%G$E5O^"RKRB-C%Z?2+7';;8M@-^FY0..^W:@+>+H'IY"
M?M+S6'VE+UJ!$-PQPI31+A<*MSW*N:E*Y*W.ZE'?VCN!DAI-AR;]9[T,;MHN
MEGCHBP)(8 5':0E26TI]PX)4L)]Z0M0&W([@7LW3_&KC>Q>)5AM\BZAV._YQ
MR.E3O48#@85RVWW;#SO$^[J*V]30$;>\/.FTB#-AKPJS&-,E"8\@10-W0E:0
MH;=T[!UT )V #J^WM*W RC&D&%1;](O3.,6QJYOEE3DA$=()4TIM3:@/0$%E
MD[@ GI(WWXC8#RL>BV"XU>[?=[5BMK@7*WLEB)(8CA*F$'GV3\VP<6D'U"5J
M2" 2* FM * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MPT,U(S87F2Q:;],NWV(NMQFVW(=N:;+##B4\=U*4XTZ[]LW^6!Z "@.-\/\
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M^] 6%ITLPJPVURW6S$;%;K>Y,3<%Q(EL9::5*2H*2^4)2 7 H A>W($ []J
M^KWI;AF2P78-WQ*Q72&[-^$G(\VVLO-KE]O[(*5)(+O8>V?:[>M 29 2A(2D
M<4@;  ;;4!6@&XH!R_#_ "4 W[4 WH!O0#?>@*T H!0"@% 4WH!O0%: H3M0
M%: 4 H!0"@*$[4!6@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0&J+_ .*_1K%KW/L]XU0Q.V76 \J-*AR[NRVZPZD[*0M)
M5N"#V(- 6'QSM"?I?PK^>V/K4 ^.=H3]+^%?SVQ]:@*'QG:$@?WW\+_GMCZU
M ;AB2V9T5F3'=0^P\A+C;C9W2M)&X(/O!!!H#VH!0"@% * 4 H!0"@% * 4
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M4&?'CWIJW.K:D$;+<;2^TM:4_)*Q[@=@)U.\7V#VZ7DD!^)D2;Q9IL> FT?
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MME12E!5W45 ;;A6P&9O7B Q:S*Z&UPFW%4J1!;MT.(7)#DAF0B.6PG< %2W
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M [;B@/J1AFF,3((=B?L>*,WJ8PY)C6Y<**)#S392'%H;X\E)25I!(&PY#YZ
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M\3.;2L7O,ES,3;[='85.:R!RWQ)*DO&VK?:AJ0TV6DA;R%#I@K<'3+75*SN
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MKLR>Y8[O:5LJ;.-1XZOM5N:0HDI000\5@[.%P'OQH">^-_\ 6BZN?P;F?Z%
M;.T[_N!QO][8O^I10$BH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@*4
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0'P&4)*B$)!4=R0/4T!\IC-(>+P:0'2D(*PD
M<N(]!O\ -W]* )BLI=6X&D!Q9!4L)&ZB!L"3[^W:@*)AL)<4X&6PM0"2H)&Y
M WV&_P#&?Y30%C?\9MN40V8ERC"1':E,3$(Y%(ZK+J76U';UV6A)V/8[;'<4
M!?+AL.-I;4RVI"2DA)2" 1Z?R>[YJ ]."=B.(V)W/:@*.LH>0I#B$K0I)2I*
MAN"#Z@_>H#X3#82M*PRV%I2$)4$C<)'?8'YOO4!\H@1FT-(3':2AI16VD( "
M%'?N/F/<]Q\YH#T6PVXXAQ3:5.(WXJ(!*=_78^[TH W':92M+;:$!:BI02D#
M<GU)^^: HY&:>*2MM"RA06GDD'90]"/O_?H#Z#2$A0"$CD=U;#U/WZ J6TG]
MB/?[J \_*,=5+O1;ZB25)7Q&X)[$@_?H#Z+#9>#Q;274I*0O;V@#ZC?YNP_D
MH#X$&.&0T&&PT-P$<!Q&XV/;\!/\M 5,-@M(;Z+?31QXHX#9.WR=A][W?-0'
MTB.TVZMU+:4N+ "EA(!4!Z GW[;F@*I90DJ(0D%1Y'8>I^>@*-1VF H-MI;"
ME%:N(VW4?4G[Y^>@/,0(P0V@,-!#:N:$A V2KYP/<>Y[T!:W;'H%[M5QMTIC
M^QK@VMJ1T5J:6L*3Q)"T$*2K;T4""-AL1M0%AA>"VK!+4[!MJ9#H??7*D29T
ME<F1(>7MR6XXLE2CLE([GL$I V  H#-IAL("@EEM(4KFK9([JWWW/W]^^] 4
M$&.$< PV$A?5VX#;GOOR_#OWWH#Z<C-.K;6MM"U-[\%*2"4[C8[?-VH N,TM
M3:E-H4ILDH)2-TDC8D?-V)H#X-NBELMF.T6RKF4\!L5;\M]OGW[[_/0'N$A.
M^P W.] 5H#F>3X)41\HRJ\8_K%J7B#61WB1?)=ML5RC,Q4R7B"M24JCJ/[%(
M[DG8"@/OXG%\^Z+UC_GF)_NM /B<7S[HO6/^>8G^ZT!C,E\"<C,<?N%CO>OF
MK=TM%P85&E0Y5VB+;>;4-E)4/+=P: Z;LEJ:L5G@VYA2ULQ&&XZ%.$%12A(2
M"=O?L* O: 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M ^EK%_RX?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%_P N'YJ
M?'LT ^EK%_RX?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%_P N
M'YJ ?'LT ^EK%_RX?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%
M_P N'YJ ?'LT ^EK%_RX?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?'LT
M^EK%_P N'YJ ?'LT ^EK%_RX?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?
M'LT ^EK%_P N'YJ ?'LT ^EK%_RX?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'
MYJ ?'LT ^EK%_P N'YJ ?'LT ^EK%_RX?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q
M?\N'YJ ?'LT ^EK%_P N'YJ ?'LT ^EK%_RX?FH!\>S0#Z6L7_+A^:@'Q[-
M/I:Q?\N'YJ ?'LT ^EK%_P N'YJ ?'LT ^EK%_RX?FH!\>S0#Z6L7_+A^:@'
MQ[- /I:Q?\N'YJ ?'LT ^EK%_P N'YJ ?'LT ^EK%_RX?FH!\>S0#Z6L7_+A
M^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%_P N'YJ ?'LT ^EK%_RX?FH!\>S0#Z6L
M7_+A^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%_P N'YJ ?'LT ^EK%_RX?FH!\>S0
M#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%_P N'YJ ?'LT ^EK%_RX?FH!
M\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%_P N'YJ ?'LT ^EK%_RX
M?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%_P N'YJ ?'LT ^EK
M%_RX?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%_P N'YJ ?'LT
M ^EK%_RX?FH!\>S0#Z6L7_+A^:@'Q[- /I:Q?\N'YJ ?'LT ^EK%_P N'YJ
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M?#_]'S?\YS/ZZ@'ZGKX?_H^;_G.9_74 _4]?#_\ 1\W_ #G,_KJ ?J>OA_\
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M#\T"C2V'FL ;0XVXE:5"YS.Q!!'_ *6@.ZZ 4 H!0"@% * M;K_Q7,_Z%?\
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M3HRDJ=)-IS:DTEJWPHI;Y>_GC!A;!E^:Y7ATAF'*MS%RA7AZVS;^M" PW';
M)D)0H@$]]NW;MOM[QM+SAO!^'W\9U8R=.=*,XTEG4Y2Y0;6Z_P#B\GN;_A'
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MC2>13MTBDA*7-^)+?8T UATTRFYV#7IF)BUVEFYZGV:?$;:@.K,J.E"NH\V
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M?)[^M ;!U T/S!S$M1W[-8\@98Q[5YJ_QX]JCEN;+MK3 ;Z\(+24N*0"E22
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M2GN0>P [>\;=@N>4>&+4>U6>W2[M<Y,5M+$*"RIYYTB4THA*$@E1V!.P'N-
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MQ^:!GUU(B'\,*7_4T /C\T#/KJ1$/;;O"E^GXF@'Q^] C_\ %'AG_P#HI?\
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M!3KKG0')6R0/0>GWR2!/?C]Z _2-#_(9?]30%5>/S0)1W5J/$4?G,*6?_G-
M#X_- R=SJ1$)^_"E_P!30#X_>@6^_P"F/#W^?R4O^IH ?'YH$?74>&?PPI?]
M30%/C]Z _2-#_(9?]30#X_>@/TC0_P AE_U- /C]Z _2-#_(9?\ 4T ^/WH#
M](T/\AE_U- /C]Z _2-#_(9?]30#X_>@/TC0_P AE_U- /C]Z _2-#_(9?\
M4T ^/WH#](T/\AE_U- /C]Z _2-#_(9?]30#X_>@/TC0_P AE_U- /C]Z _2
M-#_(9?\ 4T ^/WH#](T/\AE_U- /C]Z _2-#_(9?]30#X_>@/TC0_P AE_U-
M /C]Z _2-#_(9?\ 4T ^/WH#](T/\AE_U- /C]Z _2-#_(9?]30#X_>@/TC0
M_P AE_U- /C]Z _2-#_(9?\ 4T ^/WH#](T/\AE_U- /C]Z _2-#_(9?]30#
MX_>@/TC0_P AE_U- /C]Z _2-#_(9?\ 4T ^/WH#](T/\AE_U- /C]Z _2-#
M_(9?]30#X_>@/TC0_P AE_U- /C]Z _2-#_(9?\ 4T ^/WH#](T/\AE_U- /
MC]Z _2-#_(9?]30#X_>@/TC0_P AE_U- /C]Z _2-#_(9?\ 4T ^/WH#](T/
M\AE_U- /C]Z _2-#_(9?]30#X_>@/TC0_P AE_U- /C]Z _2-#_(9?\ 4T ^
M/WH#](T/\AE_U- /C]Z _2-#_(9?]30#X_>@/TC0_P AE_U- :WU'\0?AEU
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MM^Q]WZ7*/S4P,+F!XJ[./3Q?V\?_ (N$?FH5*CQ6V@>GC @#_P#%RC\U4PO
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MOHHQ[\2OZ] /B!^'KZ*,>_$K^O0#X@?A[^BC'OQ*_KT ^('X>_HHQ[\2OZ]
M/B!^'KZ*,>_$K^O0#X@?A[^BC'OQ*_KT ^('X>_HHQ[\2OZ] /B!^'OZ*,>_
M$K^O0#X@GAZ^BC'OQ*_KT ^('X>OHHQ[\2OZ] /B!^'OZ*,>_$K^O0#X@GAZ
M^BC'OQ*_KT ^('X>_HHQ[\2OZ] /B!^'OZ*,>_$K^O0#X@?AZ^BC'OQ*_KT
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M@=P>9H##89X;-,=/8343'<,M=J9:N+5V1T6U<A*:2I+3G(DGV$J4E*=^*02
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M8\=^3Q]8K6G#X6L*M.ZU5'C,-$EISS[7)X\N9:6S*<OE6&Z2I>$^2N4<(\I
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M':@-O:):5773;(-49MQD17X^390J\P1'<4M:&/)Q6 '>21LODPHG;<;$=_<
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
MI0%: 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M MZA-:26%&JCL)_/ E[X2<MP0&">LOI\> "?[7PWV'KO0&PJ 4 H!0"@% *
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MOM(('4.G9NF-Z9Z=6_'6V<QMOE8L:7=I,Q40HCAL OMMJ0I2_O-DI(&P*NU
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M;@<IVB#J-CUNTRESO@R_/-8?;FK?"C61U@LK^$K1]JD*=>="E[ >V V4E"E
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MV2#0$,;\+ECSO&W,9?U+>R5FU.3(TH");WW67I(!?=< ;4$RRX"OK*'-/4=
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MZW<U7#<)2D!(+BBC;W( 'KWH"[MWAWLENTOOF#IN$YVW7?H]9]SIEQ(;CQV
M![/'NF,@G<>JE?>H#XUI\.]HUEM]O@2)SEIAQ69<<L1X<=YLB0E(4XA#J%);
M>24>PZD<DA;@'RMP!A9WA2LT_-F<C=O#SKR9[LM3<BW0WE!M4M4L,MN+:4IH
M!YQ[VT$+*'"DG=*5) VUA>,,83B%DQ^*\[(C6J$S";=>VYK2V@(!5L -R!WV
MH#-4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M7)&Z^[3AEL\#ZGEZ"@+^3XR#9KOF,6^Z:Y)8XF*38-ON4^3,MZVD.S'F&XP
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MBR+LX^@1CQ8:>4L+W[) >"3OL=TGMZ;@9&UZK8A>K:BX0LCMLB(M"%AU,@
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M8;!0I'11Q4OF4\1L5;[[_AW[[T!])8;0ZMU*$AQ8 4L#N0/3<_QF@/2@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MA[&Y2<=MDPRERI%R==N%J?EEWS+CQWX+8 ]M*E+"SN01N0.WDG< _/0%: 4
MH!0"@% 4WW- "=C[_P"2@*T!3>@*T H!0%* 4!6@% * 4 H!0%-Z K0"@% *
M 4 H"@.__P#R@*T H!0"@*4!6@% * I0%: IRW^?^2@*T H!0"@% 6SD.(Y-
M:EK895+90IMM]2 5H2H@J2%>H!XIW ]=A\U 8]S$K [-GS%V>W+EW!+:9CZH
MK9<DA'R XK;=83[N6^WNH#, @^A!_!0'A/M\6ZPW8DV,U+BNIXN,/MA:%CYB
MD@@C\- 0_5'2:SZIV@1)LN?9Y27&7&[G9WQ'E)Z:RM*"HI4%HY$GIK2I.^QV
MW ( KB.CF%X5C]FM%OL,%;-IM[=LC/RV4/R.@@* 2IU8*E;\UD[GN5J/O- 2
M(8S9-BGX+@;$J)'EF^Y4V&U>[WH 0?G2 /3M0'E;<+Q^SHM:(%CML)%K2XB
MF/#;;$1*_EAKBD=,*]_';?WT!DGK=%D3(\MV,RY*C!09>6V"MKD %<5$;C<
M;[>NU 8L87CB;@Q.%DM@FL.J?:DB(UU&W%<N2TJX[A1YKW(.YY*^<T!YL8)B
M\9EQIG'[2TTY-%Q6A$)I*52@=P^0$]W 0#S^5]^@$/ ,7@13'BX[:(\<A8+3
M,%I*#R2I*NP3MW2M0/SA1!]30&8BP(T)3RH\=IA3ZPXZ6T!)<4$A(*MO4\4I
M&Y]P ]U 7% * 4 H"@.] 5H!0"@% * 4 H!0%* K0%* K0"@*;T!6@% * 4
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M.M>3W.YOVMW*&;<U N]G>0BVMLEEJ-YUEDQG5ESJLK7U$(4A]&RR>32U(W%
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MENNMV0YY9,MN5PC3;?<H4=AOBQ$+B>[8W.ZE ^H^2* [@3W2* K0"@% * 4
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M =4)^2/P4!6@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MR]^Q0/X@/7)- X-YFRWK?<UV!EQ-J1'9M\9"!$$%;ZF^E[D[]?MVV3P'8^E
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M!N2@.=/$3X;\WU.U6PC/\"U"B8)?<9A382'95F3<0XF3Q"CQ4L)'LI([@^M
M1_\ 24\5'W25F_H'%^O0%M8_"MJ_>=9M.\VU'UEMV91,-ER946WQL7;@*47F
M"TO[8VY_S3W!^3]^@.LP-@!0%: 4 H!0"@% * IO0%: 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H"F] 5H!0"@% * 4 H!0"@% 4WH!O0
M%: 4 H"F] -Z K0"@*;T WH"M * 4 H!0$-UG9=D:09PTPA;KZ[%/2A#:2I2
ME&.X  !W)WH#G:1G&HV-LN.MWNYLV=Q<B ML6MI:+1#8<MZ3+:^U%2UI:=E*
M)<*TG8'C[!W MKGK)F\63*^!<LNMW>9:<%HC2;&VV+K;Q#DN*N:]F@2I#R$I
M"DE#:@VC[7]O30'G=M4]1,:N-^M5LS&[91DMJ2AM=JD69A7"(JSMRG)Q#3">
M3B)#@"4 [*W#?%2B#0%S,U5S=$.\3H&7WVXXK:(4YZ!>(]KB%V[)Z\5EMYU:
MF @(:+TG[8A*4D,API6$$+ C(U*S]AM-X5DDY$YZ.;6Y->*$16X+5[>;<G=8
MP>/)+*HPZW0X<'@X6]O: &:MU^R/5+)\"LN<763(7)E1P;+&MJFXL^ [:9B7
M9REJ80XE2G%E!/L(! '3!6DT!LW1K/\ ([KF6HUIN5QD79JV]1R&IMA*(\0)
M>?0A@I++;K3H0AO=M9>"DA+J7"'-J U'E.K>J.,8 TV]DMX=O,RUP[LQ<';?
M&8 E+MCK[D/<17 07FT]-E+2G5DJ1S2!O0$HFYGJ@]*D7IO)KJU&)N$MNU-6
MJ/T$IC3H+3+()9+G!QN3(Y;J*E!*2E2>!*@,)8]8-1)[T].292Y8;.NX(:O$
MN#$#\BP+*IH2QLN$E#:5J:C-E*R^L!85SV>2J@,SEV:9K@/AXT;:L4TV%+UC
M:$^YRFE-J;?;@)4PRM)C2"DN. CI],*44AL*2I0W LLIUBU1B7#(F#/<M]J;
MDPVHUS5"\LTTTMUI-S<ZRX[O%,5TI80M;1V0\I:@OIE:0/(ZS:A-8_*F3\DG
MQ\E8LK<FWV>WV,O1[E&\HMUR>KG'0XE0<3L3LE(* GI;NIH#TEYO>\XU$AW.
M+>9[T&=<'+?:4?!R%Q5QV[Q"2)*$K:[J;;<+B7-^X 4-QWH"RO\ K/J[\&6>
M<N4K'Q)5*BM(EQ"V'KA#$:.I@I3$?6ZE]\S5I;2&U.(0DH<2 =P-JZT9[E&.
MZDV>WVVZ2[<VXS!7;;<Q"0ZU>I+D[I2F''%-J*0TQQ7["D%(6IQ1*4$ #G;"
ML7R/2J,_D-D;FW"^N0$E,R;9H[K['*%/>==04,)65\R7"-R7%=E<BKN!L1K5
M_./L]M$"R98_?<?"FQ;9MRA!AR^M%^0F2H(:AJ#W10AL)=0N.@>RM25)7N0,
MAI_JCF5ASK#8V697<KS!F6!FXW!A<!IAQA2X3LEYUUE,5)+*5IX)=:=)0H(:
M6VI2^9 ZL:=2\TAQ!W0H!0.WN- ?= * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0%#0&A,(R>/;_$!>(S&5.7.RW&WRGE>8NZI 1-:N*6%M+86$IB=
M,NH8:2V/MNRBK=:05 8?6?52[V#7/'W+?\+JQO%C$%]<A$>02)[I95YSVP?M
M+00^G9*MN>YVWH# V+Q+YG>A9(CMZPR"]>W(J_A-49U4:UI=^$ IAU)D#J.[
MP4[$J1ONZ./L@D!!\2^>7^W-7%#V+XU"F]H[ETB/+;84U:&;@Z''.N@*ZI>*
M4 !/!MI2SS/8 9%_Q/9-<&W846%;[7=D)AJ6V_%7(4@W!<<VYM*"ZV%.*;7*
M"N:T(Y1]RI W% >FENNU[N^FVHF?R@B?*A62+<FK>V\3%2ZB(LK" %K"$*4W
MR5Q4K8$[*5MN0+S"<OR7.-?+%;[ED5MN=OQUF[!QZQMO,1+F[T;:I#@2)"D[
MM)G+;*5]4 @J'%2AP BU@U4SZS9A>;D[D$"_6^WRDQ)EN7&=YK0YD<V$AMH!
M[BTZAOA[12KD$-IXCY5 3;1OQ W_ "_ LMR')6+7;VK99F+ZRZTI'%IMV.ZZ
M6W6V9$A92WTA[9"%K!/VI)3L0((GQ.ZBO6*]JCIQX7"Q-W"9)7,@+1YAIB-;
M7T-=-J6Z&5*^$%)*BXH@(22@*W30&7/B4SF%FL?'GH-HF&VW#REQEH;;BMSD
MJN:H:2T'I84TI* E6R4R"I:DIV0% T!B;KXB=0'L29BS;CBUIGWJPM7QF\&*
M^U&A-.VZ7(\N09&ZG.4;V7>2=D\SP)1L0/NVZ^:CP;4'6)6/NVN!;Y+^TV(^
M[*=1"1;^IS=ZX!6]YQ?M<=D< =E\B !?V?Q(Z@Y/>W+;%@V2U&Y7=$& ]-:0
MZJ$WYV1&7U&6Y9<=5LQRY*2P L*1Q/8@"1:5:S7R[XOJ%EU_NUN2S LD"[-P
M0TYTK>3;^J\H\5*6II3B%J ">6P('(T!%+=XE=09T.[(2+"W)Q]$^9/7*@*0
MN2U'1;' T&VICB6%J3/<!47%D<$$H!*D@"8:.:F7_/M9I[ERND'R"[&\ZQ9(
M)<2N 47-Y@"0E2U!3O%K8K"4=PM/'9.Y B=D\2VH9GXJFXP\?>:N%MMEUE%M
M*(;);N"W@A"7'I?4'1#0W4AIWJ'D.+>PW Q<3Q*9@\Q;KI<KW:+;+B0[@U)M
MHMJG&GY*TVQ40(Z4MQ#W:65(4VX4K0M/(LDJ* /)GQ)9\Y-8E(EVYZ;,"+(B
MW)C-%#4E-WFQ5S.)FALDHCMH+?7X\W$ .'LE0&6;\1>I=\MC%PA?8K;&7&TL
MEIR,Y-V>%F<N2G0XU)"%()9Z82DG9+O+F2C90!OQ39U=KK<A!M%FA0WG4PX*
M9Q0I;#HD06BXM*976=2H3"K;HMA(+1YJ"MR!/-*]1LION?9*U>[E"G)M=F6W
M\%6Z*IHR),>Z7&*N0VE3JRD.)C-[H]K8E(Y';N!!\>U2RS5/---($N^6E4%Z
M=!ODKX"0^T@H>ML^0B"Z4R-RII<9*B5>RX%(*F@$\5 2:Z:F_!5IU>C.WA$N
MZP<E0B+;G+@M#S<<LV_LA*%I6E&[BU>R0-U'?U.X$05XI\L?#T9FY8T9\Z+%
MFPXL6"M]^"IQ<XN1'TKE-MJ<;;A;E:W&0-G?9W"$J ]$^*C-%XU]E'EK!\$R
MHX98B!EWDR^;/%G^8<>ZNRF4J?="D! /! 5SWWH"YO&49).\/>HS[M]5?+NU
MF!MS<JR3G8*76_A&*UT67.HI4<%*E(.RSQ*E=Z Q?PSJ3I'DAD+EB);6H,ZZ
MHQR\W.1>7&X8F6YH,^94XD]4E4A:5J+@;#@0.0WV RUD\26:93F#MAM;]@X7
M"XP1;K@_;W.#<-Y^<VM72$KJ.':$.*W P2I2CP*=C0%K:O$QGD*+;[SD#^+M
M69^! N+Z&($E*F&YD.:^D%8>62&3#220@EP.* 2DI!4![XOXELOO+[MMGW+&
M;%)M\B4[)N-WB%EJ0VTS;W1&#;4MWI.J$]7?FXH);22UR44I ]]/?%5D=[N%
MN>R&'9[19[D^VZEU]YEM<-E;%Q6&7 F4X>07"0.HXEKD>JGI@I&P$>M7B%RM
MVX-71^Z6IYV[>45%;6'D1K.F5!LA+CJ _LZTE<UUP<N)]D@*3R40!]ZC^)3)
MV8]PLT.]V.YL*@3;7*N=B86SPF?!\U]#S+RY 4%CRR#TVVW4IW5N\#QH#;6C
M6KMXS#/\DQZ\N0 B(VIZWIAM\^HPB0M@K\PEYP+.Z4A:'$,N(<YIX*2 J@-U
M4 H"AH#A73)_Q%>(7*-6)M@UWCX59L;SBZ8W#M:\0ASB&6%I*#U24D^RX$]]
MS[.Y)WH">G03Q1 $_&EB=O\ \'\+Z] 7_@WSG46]9CK)B6H>9(S>7B%\CVZ+
M<T6MBWA2%1^HH]-H;#<D>I5Z>M =/T!S'XSL[U"QZ^:08SI[EZ<*GY=DBK1)
MN:[8S/"&RPI8/2=&QV(W[%)^_0&-&@GBB(!^-+$[_P#X/X7UZ U]JTYXCO#O
M<M-KM>]>H^96F^YI:L>EVM&'PX14U(</,]4%1'LH([ 'VMP1M0'=PH 3L* X
M(\/C'B8\1FG[F9PO$-'QF,]=)\-NVKPN%*+26)"VA]LW3ON$_-_&: V7^D'X
MH=QOXI8FW_9_"_K* S?@6U'S?43 L[;S[(DY3>\=S6YX\FYHA-0PZS&#24GI
MM@ ;DJ/O/M;;G:@.DJ 4 H!0"@*;4 XC_P"@T!90;)!MLRXRXT9#,BXO)D2G
M$[[NN!M#04?OA#:$_@2* O=NW_\ &@'$??\ Y: ;4 VVH!M^'^6@&U .(_\
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MQ_<YK9_VK9!_IM4!U90"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MR#(8LLP[2(Z;='C]!+KL>ZW&(Y+0@N**>8CM\@-P"4C?L!0&^* 4 H!0"@%
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MU=AL* BCGA7XZD-Y,B]1GF7[G\(S8TJ&ZI7L7!Z:REKB^EL$*?*2IQ#GR0I
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* Q669)#PW%KQ?[AU/(6J&].D=)/)?3:0I:^(]YV2=A0''K'Z+EH9*CJ?:CY
M<XTGY2T63DE/;?N0YM0$OT5_1(](=>]2[/@V+F_&^73J^7\[;@TU]K:6ZK=7
M,[>RA7N]=J ZGWH"M * I0"@&] * K0%-Z K0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * U_XA?[P>I7\&;G_ +([0'Y7^"'.S@/A.@3/LDS+&VWM
M3BTXK#+6W/=E)\C&):?0LCBT?G 4=_V)H#$>&NPOXS^B\2+=)BV^"ZUD5]5Y
M:UG^QFDJBREI2WV&P 4!ML-NXV% =_\ Z(?%R.YZ58/;<1NBK-DL_.+1%M\T
M+*4MR%*<Z15M^QYA._NH#2FD?BBRW+KSF-TQ2+#M>4YSG-FQP-9&AYR)9)3=
MC0J<E304A2RAR*^A" I/)1!)]: DES\9&KETQY;5EA8A"OMFQS)KK>79462_
M&D/V::(ZQ%V>00V\"-N1)1R/=7'N!G/$!KDO4W1B1>K!8\CM^5X"U9]0$K7
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M4I[;@=(4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M "V<J/:+?;8[]BDHN\NSJ=N8,?D\4PI7-(:W*0A1V5MS5V[[4!KC$L[U.Q2
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MP!KJ\:B:D"!<E6:^9:_?TPWDP8<VQ);2NV"V%;5R6@,\1),OB./+N3P+0[@
M9I9U0MM\-L;RO*Y4*;>'K493T)A2XT1NZVYM#R%!@#FIB1+!<4""E.X'VO>@
M(U<,MU;QVQ1A+OV0/P)8C.7&YS8W0<@@.W%I(;6S"=4CGT(/,])>Y6#[ =)H
M#WS:1JA?\(R!^[WC(]YL&3 ?M\"W]%IM";%'E=9I'1ZJ7#*#J>Y)W6IOCN
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MD_&O_C#0_P#$77\] /*>-?\ QAH?^(NOYZ >4\:_^,-#_P 1=?ST \GXU_\
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M_P#C#0_\1=?ST!3R?C7_ ,8:'_B+K^>@'D_&O_A^A_XBZ_GH!Y/QK_X?H?\
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M_&&A_P"(NOYZ QD;#O&%#O\ -OC/Z1+=XFLM1Y$X1[L776FRHMH))[)25J(
MV[J)H#)^4\:_^,-#_P 1=?ST \GXU_\ &&A_XBZ_GH!Y/QK_ .,-#_Q%U_/0
M#R?C7_QAH?\ B+K^>@'E/&O_ (PT/_$77\] /)^-?_&&A_XBZ_GH!Y/QK_XP
MT/\ Q%U_/0#RGC7WW^$-#_Q%U_/0%/)^-?\ QAH?^(NOYZ KY/QK_P",-#_Q
M%U_/0%/)^-?_  _0_P#$77\] /)^-?\ P_0_\1=?ST \GXU_\/T/_$77\] /
M)^-?_#]#_P 1=?ST \GXU_\ #]#_ ,1=?ST \GXU_P##]#_Q%U_/0#R?C7_P
M_0_\1=?ST \GXU_\/T/_ !%U_/0#R?C7_P /T/\ Q%U_/0#R?C7_ ,/T/_$7
M7\] /)^-?_#]#_Q%U_/0#R?C7_P_0_\ $77\] 2?P=ZS9[JQ U'@:B-6!&08
MCE4C'5KQQIYN*YTFFR5#JJ4H[J4K8G;MMVH#=&?Y>QI_@N19/)C/S8]FMTBX
M.1HNW5>2TVI90C<@<CQV&Y W(H""Q_$IB*[U9X4EUVWQ+ABPRPW*6I#<>/&4
MZRTAMP\MPZI3VP2 >Z2/4@$"^N?B%P2$_8&(F00;K)O*XYCL0Y2%+##KBFQ(
M4"1LVE25@D^A2H>H(H#ZU"U]Q+3C';5>9LPRHMWAR9MN,8I*93;,5<I12HD#
M8MH.Q/8[CW=Z C[$[0VX9Y9M1FI&+.Y7<W5VV#? M'7>=0 RI(5^W2%I:Y$;
M@.)3OLL @32X:NXU9M2F<'N-Q8M]ZDQ(\N&B2\E'FNJX\@(;!.Y4"P>WOY)
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MI ^^D-DHX^A22D@@[4!,TI"$A*0$I V  V % ?5 * 4 H!0"@% * 4 H!0$
M\0?]X74C^#5R_P!E=H")^"G]:5I#_!B!_J10&ZZ 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0%%?)/X* Y6\,7Z[SQ7_O
MK8?_ "]5 3#QX?K/M6?WA?\ _F: V5HY_>EPK]Y(/^SMT!,* 4 H!0"@% *
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M[^Y+4?\ HA)H!^J+Z>_N2U'_ *(2: ?JB^GO[DM1_P"B$F@'ZHOI[^Y+4?\
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MI@?B:UA?TSU OKF<KD7)=@9G7F,9[<^7CTA5U:CR'FHR8Z1"2U&5(_L=Q2U
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MRH#MCPBY7?M1=&HV;W^5*><RJXSKU BRR"85O=D+\FPG;W)82V?PJ/>@-TT
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MS<'IR(C")KR VY)2VD.+2/1)5MN0/<": \6,>M49DM-6Z(TT?5"&$!)]OGZ
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M?MWH"@4"2 1N/44!]4 H!0%"0D$D[ =]Z  @C<'<4!6@% * 4 H!0"@% 4-
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M +20!IFV>*C5N9?(:5Y#,%V;M%JD2<>-@;1'#;V/N2ITIQXL[M+9DI;4$%8
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M5^;8[!=+X[)OEZBQ(V10I4BP-(7 DR<2N<AQEM*6@ $26VDCD"O=PH42%!-
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MIC6M++T]U$^:RA]TN0T)<:+3452U-+CJ:&[BFR' * G_ (<-8M6LOT&U)O\
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MB!)=\R[Q=<=4ZK@E 4I;BE*5LA"$@$[)2E(&P % 2U+K:RH)6"4>H"O3W]Z
MM[E<F+7#5)>#RVTE*>,=I;JR5*"1LE )/<CT'8;GT% 86TZC8[?E3DVVY)GF
M%&1+=\LVMS=M9="2G8>V26'1LG<^SZ=QN!GH<UF>PT\T5 .-I="7$E"PE0W&
MZ3L4G[Q&] 8:RYW8,BNTFV6VY-RYD=OJN(;"M@GKO,'96VQ(<C/)(!W' ^XC
M<#(W>^0;'9[A=)L@-08#+DB0ZD%730VDJ6=D[D[ 'L.] >T.XQ9L./+8>2MB
M0E*FED[<@H;C;?[WNH#W2I*O16^_?L: ^N(^_P#RT VH"M * 4 H!0"@% *
M4!SG<]$<\O3-PLKLW&85CCWJ\W^VR?MLM]^1*\V8[<AE;8;2VA4LE8!<Y],)
MV )H"+2/"IF%QM%Q;D7*U)E3Y$B0LN7)]YU +=K4VCS 805<G+84**4("4/
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M!K,>&#.48!(LCEC8FKD%MF8F3+MSG7E-PI+0GM(\NEH!;KR.;SR79)1W "T
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M5^8_%;\5&>.2F$I4ZREJ&5MA6_$J3QW .QVW]=C0'O\ %#U.^Z@U!_)HGU:
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M:@_DT3ZM /BAZG?=0:@_DT3ZM /BAZG?=0:@_DT3ZM /BAZG?=0:@_DT3ZM
M/BAZG?=0:@_DT3ZM :F\4&FVK/ATTG?S>%XB,WOK\2Y6^/Y&8U&0TXEZ4VTK
M<I3OZ*- ?H"* Y<\<N09;!=T;Q_$\ON>%/91FL>RR[E:N/6##C+N^P4"#L0#
ML?>* \OBAZG$?KH-0?R>)]6@'Q0]3A_]U!J#^31/JT ^*'J=]U!J#^31/JT
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M;7]WGAI_[38'^I=H#J@>@H"M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M&U -J ;4 VH!M0#:@&U -J ;4 VH!M0#:@&U -J ;4 VH!M0#:@&U -J ;4
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M2O*-"4J<><E%M+'/?R[_  [S+7*YQ+-;Y,Z=):B0XS:G7GWEA*&T ;E2B?0
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M;_@U#_S-5R-C^>+^=G]XX;AOY_OY^I]XT%HF?_@TZS_\R-_ZZ]&X]^<7#/\
M2/6.D_YU\']LOX#0P_\ P<M:_P#H(W^9=.D/YP<+]LOX%>E/YT<&]LOX&Q[2
M?_?1\-W\'O\ V=5<Q6_)O&_G?O(XRX_)'2/Y[[Z)EX3/[H]7/X2N_P"FY6CZ
M9?%^'?-+[$<Y_*!\5X3\POLB<_Z4D_'2/?\ ^V"Y?YGZ]'XQ^:']G3^Z>M\?
M_,/^QI?<*Z:$_'65_"&X?_/J<5_,_P#LJ?W2G&_S"7S-+[A)[\?_ 'KO$9_"
M9O\ VL5JK?\ *7!?FG^X:.T_*_1[YA_W9.7#_P#"$T'_ (,C_9W:YY?D'BWS
MOWHG+K\V>._/_?B0/Q_'_P"GS&OWK7_K55T7\G'Q*O\ MK[$=5_))^3KGYQ?
MNHP/B[/]B:7_ ,&6?\R:V'0KUK_YU_Q-K_)YZ_$_GY?Q-O[_ /OU^'S^#BO]
ME-<5_P C\9^=^^>>?\@\?^>_\Q&KB?\ X,&KG\+1_K6:ZW_G)P[YG^$CNO\
MG;PG^K_=F=M8'_<1C_[W1_\ 5)KP7B/QRM^U+[6?,G%?C]Q^W+]YF=K7FJ%
M:M\1BC]@<-E]7"SR+S;F+LHJX@0U24!P*/[4^R#]XFNNZ,)>G2E'\8J=1P_;
M47CW\VO,[KH:E\(SE!9JQI573_;4&XX\UNUYDBS6WXG%8QYR^MM140[G'1:B
MV%-J;E$\6D(Z??8^A3\DCU[5K+"K?SE6C:MO5"6OD\QYMO/ASSSSRW-/PRMQ
M.I*XC9-R<X2ZS.'F"WDWJVVYI\T^6Y+76^JTI 4I'($<D^H^^*TJ>'DY^+TM
M/&34&D>,0L0U9U$MT$ON-B+:77'I3ZGGGG5)D%;BUJ)*E*(W)_D ':NVXU=U
M+WA=E6JX3U54DDDDDX822Y)'HG2&^J\1X-P^O6PGJK)**44DG#"26R2[OKW+
M.18+7D\FU83AT'I6''[NW<+E>CR6AE]IWJEAEQ6Y<?4L[+5N0A)()).U9XW-
M>TC4XEQ&>:M:#C"')N,EIU22V4$O56.T\-+"R287=Q8PJ\7XK4S6KTW"%/9-
MQE'2I2BMHTTO46.TTFEA9/C6JQQY6GV9NXRFTO0G'G).3KZRE2B64MJ6EI7=
M*'4MH[!79)X[ ;[U7@-Q.%_:QO=2DDE1V[/:;2<ELW%M[XW>^65Z,W4Z?$[.
M/$'-324:&R4.VY).2V;@Y/?&[WR]L$7U]U'MN46:Z662;E#LK5A5<4#R$A8N
M$IQA2HS:EH04I;;W2M7)0!7Q![)56WZ.<+K6E:G<PTRJ.II]:*T1C+$VDVFW
M+=+"?9SWM&]Z)\&KV->E=T]$JKJJ#[<%HA&:4VDVFY3WC'">(Y[VB32(#FI-
MCTL=LE^MUM\LTY+2U=HBUO/*;C= K;CKX%? K5W) &Z5=P1OJHU(\*K<0C<T
M92U-1S&2269:L.:SC.%LM^:V9I(58\%N.*1O*$IZFHYA)))2GKQ*:U):DELM
M]FMGG$;S7([W=<4&-RXULD3[;FMOM,IUEDLP)R%<'6U.HW/$<E-!:-SW3L#W
M%;2PM;:C=>F4Y249T)S2;S.+68M)[9V3TO"YY[C<\,LK2WO/3Z4IJ%2VJ5(I
MO-2#68R47A9V4M,L+9Y:V-@86J9"U5R"R9$S:[E>'[3&F?"]OB*CA^/U7&PT
M\TI:P%)5RXJW[I/WJYN_5.IPRC<VCE&FIRCHDU+$L)YC)*.S6,K&S]IR7$U2
MJ\'M[NQE.%*-2<=$I*6):8R<HR48O#6,K&S7F4TSB1\KRS(<Y>8;3%CR'K/9
M4H;'%N,RKB^\G8?*==2OOZ\4)'STXK.=G:T>&1?::4ZF_.4EF,7Y1BU[VV.-
MU*EA96_!XR>J2C4J[\Y3681>>Z$&MN6IMFK<<C7)C$L#O4AJ&,#3DR+C#Z1)
MNR?,/K2PIY7R% K=]L)]KCL-R0:Z^ZG1E=7=M!OTGJG&6?Q?8BG)17-;1[.=
ML^X[N\G;SO;ZTIN7IG4.$L_BNQ!.:BO679CV,]G5EX2P9?.(MQQS&-8X1L+=
M\C79R7--^1*8Z,9/ET[-/@JZB5L\04)2D[[IVX[DU!X?.C=7/#*BK=6Z:C'1
MB69=I[QVTM3SVFVL;YR:[A=2A>7?!ZRKNE*DH1ZO3+,NV^U#"TN-3/:;:QAY
MSR)3IHV]=]3;V;^T'YJ,5L[24R4A1Z;@?,@;'W*<'M?/L-_2M1Q5QH<.I>BO
M$>NJO;Q6G3]"Y&BXVX6_":*LGB#N*[V\8Z-'T1>WM,_X;W77M%<9ZJBH(;=;
M9)._VE+[B6MOO=,(V^]M6NZ4J,>,5]/>TW[7%.7UY-3TSC&/'KG3WN+?[3C%
MR_\ %G/F;+KE3BA0"@% * 4!:W2YQ++;I,^=(;B0HS:G7GW5<4-H2-RHGW "
MLM*E4KU(TJ4<RD\)+FVS/0H5;FK&C1BY2D\)+FV^21K=]U#_ (D;.XVH+0K$
M92@I/<$&7'V-=3%./1ZJGSZZ/[DSLXQ<.BU:,N?I$/[N9C_$#BT7-;II]99C
MCK+,N\/)#S"REQI8A2%(<2?<I*@E0^^*D]&[R=A2O+FFDW&"V?)KK(II^364
MR9T1OZG#*/$+NDDW&G'9[IIU8)I^33:?M([CN7SK[K#@EFOP0UE5BC7:)<D(
M&R7MT1RU)0/VCJ1R'S'D/=6SN;*E;\)N[BUWH572E#RWGJ@_.+V\UA]YN+SA
MU&UX)?7=EO;UI490\MYZH/\ I0>S\5A]YO/(([3]HF=1M#G%AS;FD';V37G]
MM*4:L</&Z^T\MM)RA7AI>-U]I#?#]&:;T9PIQ+2$N&T1]UA(!/L#WUO.DDI/
MB]U%O;7+[3I.ETY/CM[%O;K)?:;#KF3CRA[T!JR)HF6941;MU4IF.L<4LA;*
MTH+B'5I2M"PI.[@<5N"/ECYN_7SX_JC)1I[OQPUG#BFTUAXCA>[S.\J=)U*$
MU&EO)=^&LX<4VFFGB+2P_#S,E+TQE2[)98 O!CKM#2RPZPT!U'^22VZX#OOV
M3[6VQ45*.XWJ+#BT(5JM7J\]8UE-\HX>4N7CMW));$&GQRG3N*U;J<JJUE-\
MHX>J*QCQ[.<I))89Z9%I[<;W?9LEFYMP(<QL-O\ ET+#JT% 0I*ARZ:CMN4N
M%/(=D]T]C;:\3HV]",)4]4HO*SC"><I\M2WYQSA\^9;9\8H6MO"G*DYR@\K.
M,)YRFGC4EGG%/2^?,Q3NC#[C@'PSS904-I#C&ZE--NEUE*B"!NA1]0 .WH*F
M+CL4OQ6^[Y][6F37M7F3X])8)9ZG=Y>S[Y1TR:YOM+S]YE+?IL_CR[,]:Y;;
MDF,P8TMV>IUXNH*4#V-U'@$\3LGY(Y'M42KQ6-RJL:\<)O,5'"P\OGMOG.[Y
M[$&MQJ%XJT+B#49/5%1TK#RWOMOG.[YO!2T8/=+-@[UH<>:F/-%A3/%YY74#
M10>)ZJU<>7#;9.R1OZ4K\0H5[U7"3BGJSM';5G?LI9QGF\LK<<4M[GB"NHQ<
M4]6=HK&K._92SC/-Y;P5ONEB+\[++\Y24/.S'4AI3C927FD-C<I4"0.))'H=
M_O52WXN[91TPY*"WP_5DWWI\\^XI:\>=HH*$-TH+?#]23EWI\\\^:/FUZ<S[
M7D$*:U<FDL-.*<=+:%H<<!6XKIJ 5P6G[9V*@2D@\=N7:M;BE*M0G3E!Y:6.
M32V2RMLI[=SP^_EO6OQFA7MITI4WEI)9::6T5E;:D]OT6E+;5RWMSI&Z_<5R
M7[Y*XRGU290CK4PL.?;@@LK00I&P?([D[A*1Z=JR_#48T]$:2[*26<-8[.=2
M>4\Z>['-]YF_G#&-)4X4%V4HQSB2QV,ZE)-/+AG9+&7W[GA!TJN<=,N(NYL-
M0I892\8O600E"64J2AHK+2>71]>).RB.]9*G&*$G&HJ;<HYQG2]VY-9DDI/&
MKEG&QEJ\>MYN%54FYPU8SI>[<FFY)*;QJY:L;&1GZ<2W[);(2;@U)<MS#L=M
M4IM7VQ!=;4WR4A0*5)2T!S3L0K90VVVJ+3XI3C6J5'!I3:;PUL\-/FFFFY9P
M]FMGXD*EQFE"XJU73:51Q;PUL],E+":::;DWI>4UL_$]+G@ETEV.QQ471LSH
M 4%S7 Z'1RV]I"TK"CMMMQ65!8^7O5M+B-"%:K-T^S/NVQMW--8W\5AQ_1P6
MT.*VU.XKU'2>B>,16G&W<TTUOXQPX?HX/FPZ?3[9 E07YS;C*IS,MI:5O*.R
M)/6*2A:RE&X[>P -^^WH*K<\2I59QJQ@\Z7%^KWPT\TDWX]K++KOB]&O4C6A
M!IZ91>T5SAHSE)-^/:;?F>^58+,OUW?=9FL,0I3;(?0XVI3@6UU"CB00-B7!
MOO\ M>WKVQV?$*=M2491;E%O&^V)8SGV8V]OEOAL.*TK2A&,X-SBY8PUC$M.
M<[9RL;8\?+>Z;P"-#PR?8XKSB79D?HNRY#BWEJ7TP@*)6HG8!(V&^P]U8GQ*
M<[R%S-;1>4DDEC.<;+'?SP8'Q>I4OZ=Y42Q!Y44E%8RWC9)=^[QN?$7#IL;(
M$R/-L&VLS'KBRWTCUNLZA2"E2M]B@<UGL-SND?L>]9WU.=#1I>MQ47OMB+3R
MEX[+RYOOVNJ<1I3MM&A]8XQ@WGLZ8M--+&<O"7AS??MA8&F%UL#R)5NO:)$L
MI47/A%CFCJN)*7EI"=NQV;(!W/LD$]]Q/J<6H7"<*U+$>[2\/">8K?/FF_/*
M6V^SJ\<MKN+IUZ.(]VEX>(O,4\Y\TVL<\I;8=XO!+NEOR[5RB>5BR3.A\XQY
MJ>+P=(=(.W'?F/9V/M _L=C@7$;=O7*#S):9;[8TZ=MN?+GX/QVC+BMJWUDJ
M<M4HZ)=K914=/9VYXP]\\G\K;%2M')$Z2]*=NK2)$MP/2DML'@I8=4\D)]K<
M)2X01OW['YZF0XY"G%0C3>([+??&%%YVYM<__8GT^D=.E!4XTGB*Q'+WQI47
MG;FXY3_]A;]'Y5GEQYL6YLN2H0'E$.L'II 4E?!6QWV*B^=QW!<3Z\>ZKQN%
M>+ISIM1ESP]^365MSQI7GA^.RMTBIW,)4:E)J,_6P]^365MSPH+STOQV]?TL
M+QM(;3=XK3<AWSKCJ(Z@XF3LO?A[6R4!2]P.Y]G;W[U9\+6^TG3;:6G&5C3M
MSVW>%[-S'\.6O9DZ3;BM*65C1MSVRWA8?=OGNP7)TJ=8LTVV,752XRH<V)&+
MZ-U-B0&3W*./9*VUGL!V6/>-SB^&(RK1K3I[ZH2>._1J\<\TUSSR\S#\/QG7
MA<3I8EJIREA[/1JY9SS4DM\[KP>"6XO;9=JM#<::XAUY*E'DAUYT;$[CVG5*
M6?XS^"M-=U:=:JYTUA;=T5]44E]1S]]6I7%=U*2PMNZ*^J*2^HR]0C7B@% *
M 4 H!0"@% * 4 H!0"@% * 4!0^AH#DM?]]3Q(_O"?\ 9J]F7Y,X)\Y]\^@5
M^1^CGSOWR8:5_K*U?P?N7^=^M)QC\\/[2G]TYSCWY^_VU+[AH#PF?W-ZN?P9
M=_T'*]'Z9?&.'?.K[4>M_P H'QKA/SZ^V(\)'_%&JW\&7O\ 173IG^-X?\ZO
MM17^4+\=POY^/VHDUN_N%\,G[]._[4FM55^.\=^;7[C-'6_*'27YI?W;-I:)
M?KEM9_\ I(W_ *ZY#C_YN\,]DCA.D_YJ<&]D_P"!H+,?U[;?\)8?^=JO1['\
MSG\U/[QZUP[\P'\Q/[Q3/OU[#?\ "2#_ )V:<-_,Y_-3^\5X3^8+^9J?>-D9
M#_=IXFOWG9_U-<M;?$^!?MO]XXNS^(=&OG)?O%BO_B_PM?\ 61_K&:DK\9Q_
MV?PD2E^-Z3_L_P )E_\ HA/_  /!/^EF?YF:C?R:>O=^R'WB'_)!^,OO9#[Y
MKS7K];UHE_U21_F:KINCOY>XI^U'[QV/1/\ .;C7[4?MD3MK^YGPO?OB/]-N
MN>?QCCW[/\)'*R^-])OV/X2,>O\ N \37[]?^T+J3_EW OF_NHEK\I=&OFON
M(VAF7ZR-K^#4+_,U7(V/YXOYV?WCAN&_G^_GZGWC0>B?ZVG6?_F1O_77HW'O
MSBX9_I'K/2?\Z^#^V7\!H9^MRUK_ .@C?_-TZ0_G!POVR_@.E/YT<&]LOX&Q
M[3_?1\-O\'O_ &=5<Q6_)O&_G?O(XRX_)'2/Y[[Z)EX2_P"Z/5S^$KO^FY6C
MZ9?%^'?-+[$<Y_*!\5X3\POLB<_Z4_KTS_""Y?YGZ](XQ^:']G3^Z>M\?_,/
M^QI?<*Z:?KUE?PAN'_SZJ<5_,_\ LJ?W2G&_S"7S-+[A)[]_>N\1G\)F_P#:
MQ6JM_P I<%^:?[AH[3\K]'OF'_=DY<_7":#_ ,&1_L[M<\OR#Q;YW[T3EU^;
M/'?G_OQ('X__ .[W&OWK5_K55T7\G'Q&O^VOL1U?\DGY.N?G%^ZC ^+O_@FE
M_P#!EG_,FMAT*]:_^=?\3:_R>>OQ/Y^7\3;W_P 6OP^?P</^RFN*_P"1^,_.
M_?/._P#D'C_SW_F(U>?UL&KG\+4_ZUFNM_YR<.^9_A([K_G;PG^K_=F=M8'_
M '$8_P#O='_U2:\%XC\<K?M2^UGS)Q7X_<?MR_>9G:UYJA0%K=+7#O=NDP)\
M9J9"DMEIZ.\D*0XDC8@@^HK-1K5+>I&K2DXRB\IKFF9Z%>K:U8UZ$G&<7E-;
M--=Z(?CVBN*8S=8EPBPY3\B$"(8GW"1*1$!&WVI#JU)1V[;@;[=MZW5SQZ_N
MZ4J,Y)*7K:8QBY?M.*3?O.BO.DW$[VC.A4FE&?K:80@Y=_:<8IO??#VR3JN?
M.6,7$QFW0;U<[LPP6[A<FV6I3P<5NXEH*#8VWV&W-7<;>M2YW=:I1IV\GF$&
MVEA;:L9]N<+F3JE[7JT*5K.684W)Q6%LY8S[<X7,A5H\/.$6*1&=@0;A&,9T
M/-H1>9G3"^7+<HZO$[J[D$=^^^];ZOTFXG<1E&K.+RL/L0SC&.>G/+EX'2W'
M3#C%U&4:TXO4L/\ !T\XQCGHSRV6^W<9.^Z.8KD=XE7"=!>4N8I"YL9J8\U&
MF*1L$E]E*PAP@ #V@=P #N*B6_'+ZUI1I4IKLYTMQBY1SSTR:S'W/V$*UZ1\
M2LZ$:%&:[&=+<8N4,\]$FG*.?)K'-8)1=[+#OMFFVJ:SU8$R.N*\R%%(4VM)
M2I.XV(W!([5J:->I;UHUZ;Q*+33\T\I_2:.WN:MK7A<T7B<&I)\]T\I[^9A[
M_IS8LCMULARHSK?P7L8,B))<8D1B$\/8=0H+&Z>Q[]QZ[U-MN*75K4J5(23U
M^LFDXRWSO%II[[K;;N-C:<9O+*K5JTY)]9ZZE&,HRWSO%IQ>^ZVV[CS9TPQE
MC$)&,?!:'+/)4IQ]IUQ:UO.%0475N$\U.<@#S*N6X&Q["KI<6O97<;WK,5([
M)I))+&,)8PEC;&,8[BZ7'.(2O8\1ZW%6.R:2222QI44M*CC;3C&,[;GOB6 6
M?"US';>W(<ES"@R)DZ4[*D.A(V0E3CBE*XI!.R=]AN>W<U9>\2N+]1C5:48Y
MPHI1BL\]HI++[WS,?$.+77$E"-=I1AG3&,8PBL\VHQ267WOFR_QK&K=B%DC6
MFTQ_*V^/RZ;7-2]N2BH]U$D[J43W/OJ-=75:]K2N*\LR?-\N2QW>2(E[>U^(
MW$KJYEJG+&7A+DDELL+DB.0-&<4MMX8N$> \GR\DS(\)4QY4-A\DDNMQROIH
M5N2=PGL22-C6TJ<=OZM%T9S6ZTMZ8ZG'P<\:FO:]^\W-7I)Q.O0E0G47:CI<
MM,=<H_)E/&MK;DWNMGE'I=](<7OM\>NDR"\MV0XV])C(EO(BRG$;<%O,)4&W
M%#8=U)/H-]]A5M#C=];T50IS6$FD],7**?-1DUJ2?DRRWZ1<1M;=6U*:2BFH
MO3%RBGS49M:HIY?)KF\<RYRW32Q9K,9EW%F2B6VRJ-YB#,>BN+94=U-+4TI)
M4@GOQ.XK#9<5NK"#IT6M+:>)1C))KE)*2>'YHP</XW>\,@Z5"2TMJ6)1C-*2
MY22DGB2\5N2&VVV+9[?&@08[<6'&;2RRPTGBAM"1LE('N  K6U:LZ]256J\R
MD\MOFV^\U%>M4N:LJU:3E*3;;?-M\VRYK$810"@% * 4!;W"WQKK DPIC*),
M22VIEYEP;I<0H;*21[P02*R4JDZ,XU*;Q*+RGX-<C-1K5+>I&M2>)1:::YIK
M=,C.%Z5XY@,I^5:(CZ93K*(W7ERW9*T,I.Z6D*<4HI0#^Q&PK;7_ !B\XC%0
MN)+";>%&,4V^;:BEEOQ9NN)<>O\ BT(T[J:TIN6(QC%.3YR:BEF3\7N9NZ8Y
M;[U/M4V8QU9-K?5)B+YJ3TW"VILG8'8^RM0V.X[UKZ-U6H0J4Z;PIK$O-93^
MU+D:RA>U[:G5I4I8C46F6RW2:ECRW2Y%M)PJRR\MAY.Y!0;Y$CKB-3 I04&E
M'<I(!V4/FW!VW.VVYK-&_N86LK*,_P ')J37FN_R]W/O,\.)W=.RGP^,_P #
M*2DX[<UR?BO/'/OY&8?91(96TX.3:TE*AOZ@C8U!C)Q:DN:-;&3A)2CS198]
M8(.+6.#:+8SY:WP64QV&N:E\$)&P&ZB2>WO)K/<W-6\K3N*SS*3;;Y;OV;$J
M\NZU_<3NKAYG-MM[++?/9;&1J,0RAH#5E]1FL60AJVIG3&OA22X7UNH2KB6R
M&DE) !:25;C;WI3O[]^OMWPV<7*MIB]$5C#YY[3_ &FE]#>#O+5\(J1<KC3%
MZ(+&&]U+M/._;:7?W-X[L>RA<#C\'S";XJS>>>YI:Z_GNCTU=/EQ^V[=7^/Y
M._L[U8NIZ^>C1UFE<].C.5G&>SZO\<;F).AZ3/1U?6Z8XSHZO5J6K&>QZONY
MX[6#&249P>:&A-4Q)7*CL(65(?9YAI*''7$DH 2"XH%*=@1VWJ5!\,V<L9CI
M;Y-/&IM)/#WV33>ZYX)T'P?9RTYBH2>,.+QJ;48M)[]E--Y:YX+=E6:Q+BS=
M78D]Q49*(RXP>>7U'4QUI[(WZ:FENA)+G'D-P?3<IRR7#9TW0C**U9><16$Y
M)\_64E'.(YP^7MRR7"*E)VT9Q6K,D\16$YI\_64HQRE'.'AKGSOK*S?XS\.#
MD"+\\]$"(\9Z ^M:'G.MNIQQP!*5#I*;!+@ ]EP#VJCUY6DXRJVC@E++:DDF
MEIV26[3U)^KOO'.Q&N964XSK6+II2RY*22:6G"48Y;3U)O$7G>+?9/GX%N5J
MO=F27+R81ES2[U7I\D$"6@,;EM9V'2!VY^P1N2#WJ[KZ-:C5:4-6F&,*G']!
MZN:^5ST]K/(KZ3;U[>LTJ>O33QA4H\Z;<_6COV^>GM9V7<8;X/RV#9%HFJO
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MO_U= 7-M\?\ X?;O<8L&'J?:9$N4ZAAEI#;^ZUJ4$I ^U^\D"@.@@=Z 'T-
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M?.2_>+%?_%_A:_ZR/]8S4E?C./\ L_A(E+\;TG_9_A,O_P!$)_X'@G_2S/\
M,S4;^33U[OV0^\0_Y(/QE][(??->:]?K>M$O^J2/\S5=-T=_+W%/VH_>.QZ)
M_G-QK]J/VR)VU_<SX7OWQ'^FW7//XQQ[]G^$CE9?&^DW['\)&/7_ ' >)K]^
MO_:%U)_R[@7S?W42U^4NC7S7W$;0S+]9&U_!J%_F:KD;'\\7\[/[QPW#?S_?
MS]3[QH/1/];3K/\ \R-_ZZ]&X]^<7#/](]9Z3_G7P?VR_@-#/UN6M?\ T$;_
M .;ITA_.#A?ME_ =*?SHX-[9?P-CVG^^CX;?X/?^SJKF*WY-XW\[]Y'&7'Y(
MZ1_/??1,O"7_ '1ZN?PE=_TW*T?3+XOP[YI?8CG/Y0/BO"?F%]D3G_2G]>F?
MX07+_,_7I'&/S0_LZ?W3UOC_ .8?]C2^X5TT_7K*_A#</_GU4XK^9_\ 94_N
ME.-_F$OF:7W"3W[^]=XC/X3-_P"UBM5;_E+@OS3_ '#1VGY7Z/?,/^[)RY^N
M$T'_ (,C_9W:YY?D'BWSOWHG+K\V>._/_?B0/Q__ -WN-?O6K_6JKHOY./B-
M?]M?8CJ_Y)/R=<_.+]U&!\7?_!-+_P"#+/\ F36PZ%>M?_.O^)M?Y//7XG\_
M+^)M[_XM?A\_@X?]E-<5_P C\9^=^^>=_P#(/'_GO_,1J\_K8-7/X6I_UK-=
M;_SDX=\S_"1W7_.WA/\ 5_NS.VL#_N(Q_P#>Z/\ ZI->"\1^.5OVI?:SYDXK
M\?N/VY?O,SM:\U0H!0"@*4!6@*$@>IVH #O0"@&_>@*T H!0%/2@*T H"E 5
MH"E 5H"E 5H"E 5H!0"@% * 4 H"A[4!J+].N>^U;VVK8RW)?2H/D!U_HK\P
MEM(#:$\E[MJZFP[]TUVOP#2BYN51X6,<EE:6WNWA8DM._F>A_P V:,'4E*JW
M&.,>K'*T.3WD\+$EIWVYF>5JDB-!P]Z6PPPN^*!<!>[(:.R4K3VW.ZW&NQV(
M"COW3M6N^"'.=S&FVU2\N;YM/V)2W6<M+&S-2N!.=2\C2DVJ/+;FUEM/V*,M
MUE-I8V9YW[4R589U\;>BQD-QFE"$EU2T^8<!;2G[9Q*""IS90!Y(X[D$'M=;
M\)A<0I.,GF3[6,;+=O;.K.%L\8EG":P7VG!*=W3H2A)MR:U8P]*[3?9RI9Q'
M*;6F6<)K&^.D:U**U>6M[3S;BX:XZNL1U&76@MQ9[=B@D)V_Y2:E1X"L=N;3
M6O.W)Q>$O]);^YDR'1E8765&FE/5MRE&6(KG^DM_<R[QS4VYW*!+>FVM#1:M
MCEQ:="'6DO<4H/$)<2%  K*>7H=MQ][!=<)HTIQC3J9S-1:V>,MKG%M=V<=W
M>1[W@EO1J0C1JYS-0:[+:RVLYBVN[..[.&>TO4F59M/A?IS#)EN.H;:86R]%
M2K<!1&SJ>79(6=]MCL-JLAPJ%>_]%I-Z4FV\QEY?HO'/'FC'3X+3N>)>A49/
M2DVWF,WME?HO'/&V<K):/:M2Y%S7;8<*,)3LHM1'77%%MYDK:0AX #?;DXH$
M>XI'[85FCP:G&FJU23PEF2264\2;C]"33\WX$B/1^G"DKBK-Z5',DDLJ6)-Q
MW\HII]Z;\#(/:C.6N-95RH++:)$N7$FJ:<)2TIGJ)Y([#D%.)2.^WR_GJ-'A
M<:TJJA-[1A*.5S4L/#\,1;?N(D>#1KSK*G-MQC"4<K=J>EX>^S46WMX>!8X/
MJC<<IO5OB2+<S&$EGFXVD.[M$,-N*/4*0A>RG CB#R&X)&V]2.(<(HV=&=2$
MV]+\M^TTMD\K99R]N[F2N*<"M["A4JTZCEI>S[._;E%+2GJ65%RR^R]USP75
MOU15?,:NL^W1V7Y,6<([;;94[NTI0X.\$^TH\"5=-/<E) WK%4X0K>XITJS:
M4HY?=NENLO9+.VI[8>61ZW E:W=*C<2:C*.6WA=I)YCE[):MM3V2:;,9<-:5
MQD/-QHD.;+;MC<Q+;;ZQU'BI/-H I"ALA8(W .^X(&U2J7 5)J4Y.,7-QRTM
MEAX>S:YK&SQC#3W)U'HU&;C*I.48N;CEI;1P\2V;7-8V;6,-/<+U?N$S('8E
MLM3<R,A]8:* ZXJ2T.@.0*4E+>_56=U^SLD=^YV+@E&%!5*]32\+/)8;U;;O
M+]5;+?<+H[0IVRJW%5QDTL^JE%O7MAO,O52Q'?+Y;;YH9Y/E7+&(\>*VENYP
M6YKRO+OO< I2!Q!0-D#91]I>P[?AJ#\'4H4Z\YRWA)Q6\5RSON]^7);FM^"J
M%.E<SG)YIS<5O%9PGOVGE\N4=RTNNK7DK[=[?&AMS50)$9O@TZ2ZXA2PE\A.
MWJCD"!^R].U9J/!NLH4ZTY:=:D]ULFEF._A+&[[C/;]'^MMZ5>I-QUJ;W6R:
M3<%GPEC=]W,^L=U*F7R=#?3&AKLTJ2F(VZRXHNE2FU.)<';8H(2.WKWW]VU4
MNN%4[>$HN3ZR*U--+&S2:\4]_P"!2\X)2M:<X.4NMC%R::6,)J+7BFF_9W&+
MG:RS6U-1V;8UYI4B2PYN7'.F$R$-,J"$#DKFA95Q'?=) WJ73X%2:<Y5'C$6
MN2SF+E)9;PM+6,OQRR=2Z-T6G.=5Z<0:Y+.8.4EEO"TM)9>V^6921JNBWXYC
MUREMQVS<Y1:5R6I">@E92IY(4.0[<%<% $<MCW%1(\&=6XK4:;;T+/<^TUE1
M>-O%96SQE;,@PX ZUU<6])M]7'/)/M-)J+P\>*U+*>,K9GOD6HLC'KS=6GX\
M9N%&CJ4PXZI:>NX&TJ "PDHWY*XE!(6 .6Q![8[7A<+FC3E!O5)K.,;++7+*
M?)93WBWV=F8K/@T+RA2E"3<Y-92QLFVN65+DLJ23BWV=F8A6M*RP%-P&'5N,
MP'&>#QV6IUTHDC?;_P!$!OO[]_=4U<!6<.;6'-/;Y*S#_K<O(V"Z,K5B51K#
MJ)[<E&.8=_Z?+R\S(87J/<K^MD3;:AEMZ(Y+:?0AUM*N*6U% #B03MU-BH;I
M/;;WU%ON%T;9/JYY:DHM;/FVL]EOGCES7?W$3B7!K>T3ZJIEJ2BUV7C+DLYB
MVM\;)[KO[BD;4F:UIR_D<R,PF4H->6CK:?C(4MP(XI*G4[D;J^4D$; [56?"
MJ4N(*SIR>-\O,9/"SE]E^"Y/<K/@M&7%(V%*3T[ZGF,GB.<O$7A;+D]RRFZR
MK4ZZS!A,J4\M)@.O+/!]I4=#A6=AN"A:TI4GYE)/OK/3X$L*563VSJ26Z:DU
MCWI93\FNXD4NC:45.M-[)ZTEO%J;CC?NE%-I^*:[B<XK>G[S"D^;:;:EQ)+D
M5[H**FU*0?E))[[$$=CZ'<=]MZT%Y0A0G'JWF,DFL\]_'_YOS.8O[:%M4CU3
M;C**DL\\/N?L^M;F:J :P4!C\@O]OQ6PW&]7:4B#:[=&<ERI3N_%EIM)4M9V
M]P2"?XJ P^F^IN+ZNXK'R7#[S'OUCD+6VU-B\N"E(44J Y 'L01Z4!** 4 H
M!0"@% * 4 H#\^?T:DD>&O$MCM_]-C/^R2J _%[FK]L?Y: EFDJB=4L/[G_C
MF%[_ /[X10']/*?3^,_YZ J?0T!R6O\ OJ>)']X3_LU>S+\F<$^<^^?0*_(_
M1SYW[Y,-*_UE:OX/W+_._6DXQ^>']I3^Z<YQ[\_?[:E]PT!X3/[F]7/X,N_Z
M#E>C],OC'#OG5]J/6_Y0/C7"?GU]L1X2/^*-5OX,O?Z*Z=,_QO#_ )U?:BO\
MH7X[A?S\?M1)K=_<+X9/WZ=_VI-:JK\=X[\VOW&:.M^4.DOS2_NV;2T2_7+:
MS_\ 21O_ %UR''_S=X9[)'"=)_S4X-[)_P #068_KVV_X2P_\[5>CV/YG/YJ
M?WCUKAWY@/YB?WBF??KV&_X20?\ .S3AOYG/YJ?WBO"?S!?S-3[QLC(?[M/$
MU^\[/^IKEK;XGP+]M_O'%V?Q#HU\Y+]XL5_\7^%K_K(_UC-25^,X_P"S^$B4
MOQO2?]G^$R__ $0G_@>"?]+,_P S-1OY-/7N_9#[Q#_D@_&7WLA]\UYKU^MZ
MT2_ZI(_S-5TW1W\O<4_:C]X['HG^<W&OVH_;(G;7]S/A>_?$?Z;=<\_C''OV
M?X2.5E\;Z3?L?PD8]?\ <!XFOWZ_]H74G_+N!?-_=1+7Y2Z-?-?<1M#,OUD;
M7\&H7^9JN1L?SQ?SL_O'#<-_/]_/U/O&@]$_UM.L_P#S(W_KKT;CWYQ<,_TC
MUGI/^=?!_;+^ T,_6Y:U_P#01O\ YNG2'\X.%^V7\!TI_.C@WME_ V/:?[Z/
MAM_@]_[.JN8K?DWC?SOWD<9<?DCI'\]]]$R\)?\ ='JY_"5W_3<K1],OB_#O
MFE]B.<_E ^*\)^87V1.?]*?UZ9_A!<O\S]>D<8_-#^SI_=/6^/\ YA_V-+[A
M733]>LK^$-P_^?53BOYG_P!E3^Z4XW^82^9I?<)/?O[UWB,_A,W_ +6*U5O^
M4N"_-/\ <-':?E?H]\P_[LG+GZX30?\ @R/]G=KGE^0>+?._>B<NOS9X[\_]
M^) _'_\ W>XU^]:O]:JNB_DX^(U_VU]B.K_DD_)US\XOW48'Q=_\$TO_ (,L
M_P"9-;#H5ZU_\Z_XFU_D\]?B?S\OXFWO_BU^'S^#A_V4UQ7_ "/QGYW[YYW_
M ,@\?^>_\Q&KS^M@U<_A:G_6LUUO_.3AWS/\)'=?\[>$_P!7^[,[:P/^XC'_
M -[H_P#JDUX+Q'XY6_:E]K/F3BOQ^X_;E^\S.UKS5"@,'F]ROEIQ6XR\:LS5
M_OK;8\I;GY8B-O+*@/;=*5<$@$J) )V!V!.PH#4WA#S;,LWP?+',[N46YY#;
M,OO%I=<@M=.,A,>1TTML@@*Z:=B$E6ZB-N1)H"YSG.K[:O%=I?BT6XN,X_=K
M!?)<V"$I*7G6%1.DHDC<<>HOT(^5WWH#U3G%\/C%<P_X07]C8P-%V$#BGCYH
MW%31=WVY;\ $[;[?>H""^+_4&XXMJ/HW8?TRWM*\:O\ ,NK=WOK3L1D(2S#Z
MK(+DI"VT[N;)[CORV]=J \/#EJA<[IKSD6%6K5 ZT8/%QYFYKR-28CJK;/5(
M+8B&1$0AISJ-[N<2"I/#UV- 3_Q*9!E^F=KM>I..S'9ECQA2W\EQK9'&X6Q0
M'6>;41NE^.!U4@* 6$K2024T!\^';+\FU@^%-3)\YV%AE\2EO%,?"4>Q 23M
M.?('+K2#[01OLVV$)(Y%5 ;KH!0"@(AFEGR&]W.WLP;ZK';"VVZ[/E0^F9:U
MCCTT(+B%(0CY:E*VW[) V&YK=6%>TMZ<Y5:/656THIYTI;Y;TM-ODDN7-^!T
M/#+FQM:52=:AUU9N*@I9T);ZF],HMRY**Y;M\\%AHMDESRC$7Y5QE?";35PD
MQX-U+26S<(J%[-OE*0$^UW&Z0 >.X'>I/'K6C:72A1CI;C%RCG.B36\<O?;S
MW6<=Q+Z365O8WL:=".AN$92AEO1-K,H9>7MX-MK.'R)'EUCG7^V(CP+],QUY
M+@<,N"AI:RD [I(<0H;'<'TW[5J[*XI6U375HJHL8Q+*7M[+3--P^ZHVE9SK
M4(UEC&F3DEGQ[+3S[\;D#T+>O]Z1>;Y.R6=?<>D/EBS^?:80MQILE*Y&[:$^
MRM0/$?M0#^R[=#TAC:T'2MJ5"-.JEF>ERPF]U'M-[Q7/S>.XZOI5&RMG1LZ-
MM&E6BLU-+DTG+=0[4GO%8U/Y3:[B6:J9BO -/+]D#3:'7X,92V4.G9!<)"4<
MO^3R4-_O;UI^#V*XE?T;23PI/?'/'-X\\+;S.?X#PU<7XG0L9/"G+#QSQS>/
M/">/,@NF&52IN8L03FD^^I?@+D/QKU:S#ZR@I(#\$]%L*9[J!&ZM@4$'ON>@
MXM9PIVCJ^BQIXDDG">K'/LU.U+$O!X7>L'4\<L*=*QE6]#C2Q-).G4UX6'V*
MJURQ/DT\1WRL=QN16_$[#<^X&N'/.5YFE)TS,\.N^'.7'*%W3(;W=41Y6.L,
MM&$(Q)+JF=FPZD,HV5U%*.^VQ'M 5WM.'#KZE<JC;Z*5*#:J-O5J_14MW%N;
MVTI;=W(],I4^$\1HWD:%MHHT:;<:K<M>M8TJ7:<&ZDMM*2QS7)FZ]^V]<$>9
M&@LBSB_KBZDY*,K58UXE+=8AV,ML%AY+325I+_))<5URHA/%2=NW'<[UZ/;<
M/M5*QL_1^L](BG*>993DVGIP]*T8R\IY[]CUFSX79*?#N'^B]:KJ*<JF9:DY
M2:>C#TKJ\9EE/.^<(W=8+LF_6*W7)""TB9&;D)0H[E(6@*V_\:X&YHNVKSHM
MYTMKZ'@\QN[=VEQ4MV\N$G'Z'@U_?IUZS/4VX8Q;<@E8W!M%L8F.OP&FEO/2
M'UN!L*+B%CIH2WN4@ J*NYV%=);T[:QX="]K455E4FXI2;PHQ2SC2T\MO&>[
M'(ZZTI6G#>$T^(W%NJTZLY12DY**C!1;QI<7JDY8RVTDN669[2'+IF<:>6F[
MW!+:;@OJL2>D-D*=9=6TM0'N!4V3M[MZUW&[*GP^_J6]+U=FL\\22DE[D\&I
MZ1</I<+XG5M:&="PXYYZ914DG[$\&5S*5?HUG(QR'%E7-U8;2N<Z4,L)(.[J
MP 5+"=A[*>YW'<#<U#L86LZW_#)-06_966_)=RSXOEYD#AL+*=?_ (?.4::6
M>RLRD_DK.RSXO9>#Y&$T1O\ /RG2?%[M=)*I=PF0D.OOJ2$E:CON=@ !_$*G
M\?MJ5GQ2XH4(XC&327@O>;3I/:4+#C-U;6T=,(2:2\%[]R<5H#EQ0%#0$ :R
M' 8_D94=N,X[(W>C"-"6MU90XAC<)2DJW"TMI]-_9'N%=([;BLM<)MX6SS))
M+*<N;>-TV_?YG6RL^-3UTZC:4=I9DDEF+GNV\8:;?O\ %F39=Q%<&VA#4-,:
M[\H<5!8*>KN5NJ;XD>SW"R0=MCV]=A422X@ISRWFGVGORY13SW[8Y9V\B#*/
M%%4J-N6JEB4M^7**><[[-)-9VWY%K)EX7!OMVGOL,-SX*%2I4LQ5\4EL)*E!
M?'BI:04;A.ZOD[^@K-&'$JE"G2BVXRV2RN_.-LY2>^,[<R1"GQ:K;TJ$)-PG
MB,8ZE^DWA-9RD\/&=N>#SD3\"B/2$NHMZ7&GFVG/[')(<D!+J!Z=^?!*MQV]
MGOZ5=&GQ6:3BY8:;6_=#,7W]V6O?YE\*7&JD8N+EAIM;]T,Q??\ HY:WWWVY
MGTBY87E0;?6RVXNVQ%NI1)B.M+9C\4D^PI(/$I*3MMW'IO5'2XE9YBGC7)+9
MIIRR^]-K.<^PHZ/%[#,$VE4DEM*+3EEXW3:RGGV=Y[VJ3BEAQE%S9BJMEIC/
M!:%2HCS)0M82V%)2M(5L0H)W VV)^_6.M"_N+ET)2USDNZ47E++QE/&V,F*X
MAQ.[NW;SEKJ26^)1>4LRPW%XV:SC.?J+*<]@(B+AN18KR(;SL$1V(BUK;=Y-
M%;:4H25;DED[#U]DCTK/3CQ75UBDUJ2EER236))-MO&,:EORW)-*/&M:JQDU
MK2EER236))-MO&,:UORW7>9%N1B+]OL<0,Q/*2BXU 87'(2%-@K<3Q(]@IZ9
M)"MCND^^HKCQ"-2K4R]4<.3SX[)YSNGG;&=GX$*4.*0JUZN9:HX<WGY6R>4]
MT]6%C*P_ M[!?,-O3T)BUM-.)=/7C.)A.(:4M4<'V5E(3R+*ANG??COV[&LU
MS;\1H*4J[:QLUJ3>%+O6<XU+GC&3/=VO%K:,YW#:QM):DVDI]Z3;QK7/&,^T
M]IC^(S+%.<6RQ(@,NHMCJ&6%*5U&G.+;24I'(J2M7L\?>=Q6.$>(4Z\$FU)I
MS66N4EEMM[8:6^?>8J<>*4[B$5)J;3FLM)8DLN3;>$FEVL^QEJ]=\%M=M0EU
M,./$C,MW8(,90#:">DAW;CN#N D^\>^LT:/%*U1N.7)MPYK=^LUS]_@^XSQM
M^,UZK<=3E)NGZRW:[3CG/+O\'W'U'R3"L<N;L2*EF+)CDQ'C&AN%+ 2&O96I
M*>*$@+9&Y('IW[':V5KQ*ZIJI/+3[2S)9>=7)-Y;VERW^DMG9<7O:*JU&Y1E
MVEF2R\ZMTF\M[2V6_P!*/!FU81#EV1N+:PMYY E0O*PWG.#:E(V42D$-IWX?
M*V';[QK)*MQ.<:KG4V6TLRBLM9VW>[Y\LLS2K\8J0KRJ5=D],LRBLM)[;OM/
M&>6692=<\3A7$M2C$;EV^4T/;:.[+\IS=!WVV!6OW_/MO42G2OZE/53RXS3[
M^<8+?_JKZN1!I4.)U:6JGJ<:D7W\XTUOMGE%?5R+"PKPAC(HZ;7"88N"08[+
MS<);;:2$J/32LI" OB%>R#RVW]U2;A<3E;MUY-QYM:DWS6[6<XSC?EGS)5VN
M,2M9.YFW#FTY)OFMVLZL9QOC&?,^7[Y@L5;,DMQ5ONO.I:Z,-:W5NL/!M8 2
MDDE+BP/PJW&]5C;\4FG#+PDLYDDDI1RN;QAQ7U;E86O&:B=/+PE'.9))*<=2
MW;QAQ3?L6YD1.Q95NC/J;8;CW)]VWH2['4@K=>6>JTI!&Z2I:%<@0.X[U%ZN
M^5244VW!*6S6RBNRT\[X3VQW<B&Z7$E5E!-N5-1F\-/"BEIDFGAI)K2TWL]B
MWGJP]C));\J*R+E%;#KTE<992GIH2Y\O;B5I0$*VWY<0/=66FN(2MXQA)Z)/
M"65^DVN6<X;RO#.>\S4EQ6=K&%.3ZN3PEJ6>TW'EG.EO*SZN<]YX/7/!%J?E
M.)@E6T>2XXJ.=SYM?%I7R>_44/=\W?:KXTN*+$(ZOTES_5K,ES_17_L98T.-
M+33BY?I12S^J69+G^BG_ +CTB7##LN5;VD,H<7 :+T1M^*ZRIIH)1[20I*3P
M(X;'T.W;?8[6SI<1LM<F\:WAX:>7OL\-[YSYKWEE2CQ7AZJ2;PIO$FI1EEY>
MSPWNGG/>O>?-DD8=:<8=N\2&;=9HBA+ZLB&\R$[(V2XA*T@D<5; I'OV%5N(
M\1K7*MZDM5279PI1??R;3QS6^2ZZAQ6XNU:U9ZZLNSA2B^_=-Q>%NM\OS/*Z
M.8$Q&EQI4:"M$-];+K+<52U(=<9#B@ E).ZFRD]O7T'<;5?17%92C.$I=I)I
MYQE*6.]XVEGGR+Z"XU.<*E.4DYI--R2349.*RV\=F6>?+F]B38JY:EV9I-F;
M2S!;4M :2TIHH6%'F%(4 H*Y;[\AOOZUJKQ5U6;N7F3QOG.5C;#6S6.6-C27
MZN57;NWF;P\Y3RL;8:RFL<L;8,O4(UY9WB[Q+!:9MSGN^7@PF%R7W2DJX-H2
M5*5L-R=@">U <6:]?HBOA[S+0W4&Q6?4)N7=KKCL^'#C?!<U!=>=C+0VG=3(
M W4H#<D >^@-2?H=_C=T5T1\+U@Q3-,V;LM_C3)KCL-5OE/%*5OJ4@\FVE).
MX(/8T!^B6F>IF-ZPX3;<NQ&Y"[X]<@LQ9@9<:#@0M3:O9<2E0V4A0[@>E 2B
M@% * 4 H!0"@% ?GS^C5?K:\2_A8S_LDJ@/Q=V_!_+0$LTE'_OI8?^_,+_7H
MH#^GI/I_&?\ /0%3Z&@.2U_WU/$C^\)_V:O9E^3."?.??/H%?D?HY\[]\F&E
M?ZRM7\'[E_G?K2<8_/#^TI_=.<X]^?O]M2^X: \)G]S>KG\&7?\ 0<KT?IE\
M8X=\ZOM1ZW_*!\:X3\^OMB/"1_Q1JK_!E[_173IG^-X?\ZOM17^4'\=POY^/
MVHDUN_N%\,G[]._[4FM55^.\=^;7[C-'6_*'27YI?W;-I:)?KEM9_P#I(W_K
MKD./_F[PSV2.$Z3_ )J<&]D_X&@LQ_7MM_PEA_YVJ]'L?S.?S4_O'K7#OS ?
MS$_O%,^_7L-_PD@_YV:<-_,Y_-3^\5X3^8+^9J?>-D9!_=IXFOWG:_U-<M;?
M$^!?MO\ >.+M/B'1KYR7[Q8K_P"+_"U_UD?ZQFI*_&<?]G\)$I?C>D_[/\)E
M_P#HA'_ \%_Z69_F9J-_)IZ]W[(?>(?\D'XR^]D/OFO->OUO6B7_ %21_F:K
MINCOY>XI^U'[QV/1/\YN-?M1^V1.VO[F?"]^^(_TVZYY_&./?L_P9RLOC?2;
M]C^$C'K_ +@/$U^_7_M"ZD_Y=P+YO[J):_*71KYK[B-H9E^LC:_@U#_S-5R-
MC^>+^=G]XX;AOY_OY^I]XT'HG^MIUG_YD;_UUZ-Q[\XN&?Z1ZSTG_.O@_ME_
M :&?K<M:_P#H(W^9=.D/YP<+]LOX#I3^='!O;+^!L>T_WT?#=_![_P!G57,5
MOR;QOYW[R.,N/R1TC^>^^B9>$O\ NCU<_A*[_IN5H^F7Q?AWS2^Q'.?R@?%>
M$_,+[(G/^E/Z],_P@N7^9^O2.,?FA_9T_NGK?'_S#_L:7W"NFGZ]97\(;A_\
M^JG%?S/_ +*G]TIQO\PE\S2^X2>_?WKO$9_"9O\ VL5JK?\ *7!?FG^X:.T_
M*_1[YA_W9.5_KA-!_P"#(_V=VN>7Y!XM\[]Z)RZ_-GCOS_WXD#\?W]WN-?O6
MO_6JKHOY./B-?]M?8CJ_Y)/R=<_.+]U&!\7?_!-+_P"#+/\ F36PZ%>M?_.O
M^)M?Y//7XG\_+^)M[_XM?A\_@XK_ &4UQ7_(_&?G?OGG?_(/'_GO_,1J\_K8
M-7/X6C_6LUUO_.3AWS/\)'=?\[>$_P!7^[,[:P/^XC'_ -[H_P#JDUX+Q'XY
M6_:E]K/F3BOQ^X_;E^\S.UKS5"@*4!K#033"Z:76W-(]T?B/KO.77>_1S$6I
M02Q*DEUM*N21LL)/M ;C?T)H##:Y:6Y;><[P;43 7+0]E&+(FPUVJ^NN,1;A
M#EI;#J.LVE:FG$J90I"N"AZ@C8T!;Z2:89M(U=O^J>HHLMNOLRSQ\?MUDQ^2
M[*8APVWEOK4X^XALN.K<<_8H2$I0!W).P%[K#H@_JAK#I%D;[-KF8_B<FZ/7
M*#<4=0OB1#++7304*2HA>Q/(C8#<;F@-K6>QV['X:8EL@QK=%!W#$1E+2 ?G
MXI % :PUFTHOFLN48Q9+A)AL:71'/A*^04N+,J\2&UA4:(M/'B(H4.HYNHE9
M0A'$)W) \='-(+UHOG&5VRT283FE=T<5=K7;"M0DV><ZLJDL-(X\?*K)ZJ0%
M H4I:0D@[@#<= * 4!J[67$,PS1^UP;.FTR,<0%.7&WW":]&\ZK]@VM3;:B6
MAZE.XY'8'MZ];P.]X?81J5;C4JNRC*,8RTKO:U27:[D^[FMSN>C?$>%<,C5K
M7;FJ[PH2C&,M"[VE*26I\D\/3S6_*9X6F^-V1+=_A6N!+;44-L6=U;C"6@ $
M@%:$D'U&P&P %:.^=LZVJUE*47S<TD\]_)OZ<G-\2=G*X<K*<YQ>[<TE+/?R
M<OISD9Y:[E?,*OUNL[S4>Z3(+T>,\\HI0VXM!2E1(!(VWW[ TX=6HV]Y1K7"
M;A&2;2[TGG X37M[6_H5[I-TX2BY)<VDTVM\<_:7>,6-C&,<M=HC)"(\"*U%
M;2GT"4("1_FK#=W$KNXJ7$^<VV_>\D>^NIWUU5NJC[4Y.3][R8_47#6=0L'O
M6.ONF.BXQE,AX)Y=-7JE6WOV4 =O?M4GAE]+AE[2O(K.AIX\5WKWHF<&XE/A
M'$*-_!9=.2>/%=Z\LK*(K9<2RN_9ICU\RIFTV]./QGVF$6J0X\9;SR4H6XKD
MA'30$I[(]H[GN>PWW%>]L+>SK6UBY2ZYQ;U)+2HMM+9O+R]WMMW;F^N>(<,M
M+"XL^&N<^OE%MS2CIC%MI+$I:I9>\MEA;+<V2^7 RLM)2IT)/%*SL"=NP)[[
M"N5CC*U<CBHZ=2U<C3& X9J1C^2N7>]0L7N=RN#J4S[L;C)4^B/SWZ+#99"4
M(2#V0" HC=1).]=UQ&^X-<VZM[:56$(+LQTQPY8]:3U9;;YO&RV2P>E<6XEP
M"[M%:VDZT*<%V(:(:7+'K3>O+;?.6'A;16-C=5<&>9FF=0-*+YEU]O"?@O&9
M2+BGH1\CE-<;A;(ZD<'&TH#9ZJ@"LH65IVY]_3OW7#>,6ME1I/K*BT;NFGV)
MR3RFWJ[*Y:EI><;<STGA''[/A]O1?6U8NGNZ2?X.I)/,6VY=E/;5'2\XVY[;
M>MEO8M-NBP8R>$>,TAEI/S)2 D#^0"N*JU95JDJL^<FV_:]SSRO6G<595JCS
M*3;?M;RR!Y'B^2VG/'\HQ9BV3UW"WMV^9#N4A<<)4TM:F7DK2A>^W46%(V&X
MVV-=#:W=G6L58WSE%0DY1<4I;224HM-QQR33W[\HZNRON'W'#H\.XE*<53FY
MQE"*EM))2BTY1QG2FGEX><HSVFF&G ,(M=B7)\X]&0M3\@)XAQYQ:G'% >X%
M:U;#YMJU_%;[X2O*ETHZ5+&%X)))+Z$C5<;XE\+<0JWBCI4L87A%)1BOH2SY
MDE<3R0H#U((K5+9FD3P\D3TFQ*7@FG&/6">XR[,M\1+#JXY);*AO\DD [?Q5
MN.,WM/B/$*UW2349R;6>?\3?](.(4N*\4N+VBFHU)-K//WXR2ZM,<^* H>]
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * MKG;(EZMTJWW"*S.@2FE,2(LEL.-/-J!"D+2>R
MDD$@@]B#0%ABN'V'!;,U:,;LMOL%J:4I:(-KBHC,(4H[J(0@  DG<]NYH#,4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H"FX^>@&X^<4 W'ST !WH"M *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@*;4 H!M0%: 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
0@% * 4 H!0"@% * 4!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>a02bfceligandpharmacommo002.jpg
<TEXT>
begin 644 a02bfceligandpharmacommo002.jpg
M_]C_X  02D9)1@ ! 0( E "4  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0* Q\# 1$  A$! Q$!_\0
M'0 !  (" P$!              4&! <! P@""?_$ %40   & 0,# P$%!P,"
M! $ &P ! @,$!08'$1(($R$4(C$5(T%1E=06%Q@R5UAA"3-")%(E-$-Q4X%B
M=H*1&2@U-SESL;/1-D1456-E=86AHK33\O_$ !H! 0$! 0$! 0
M   # 0($!0;_Q  K$0$   8! P,$ P$! 0       0(#!!$2,04A41,B811!
M4H$C,J%3<8+_V@ , P$  A$#$0 _ /U3
M
M
M
M
M
M
M               !ULL]HW#YK7S4:O>>_'_!?X =@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M6L)+[L8Y$1TG$$ZTXIMU&Y?>E:5),ON,C(!*@
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M^GR;1- Y]7H:_')?K91E"K7B=:4WWU]MTU$E/N<3Q6HMO"E&6Y_("S
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M 0&JO5]ISI?3OR57;%W/1#B6#<"N4IU3D60XVAI_FE*DDA1.DHCW]Q)/CN9
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MRQ:R^EW-*<Q,Q#:U-(>:<:>2226VXVM*B,TD9>2,O&YAM8
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MGTGYD>)X@VRY&7.QO&<:A^DA6SL%4N57OR5OM)D-HY-$I$C=#A%_.DMR(MS
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MF/>GK*YF&4=A$=2D$;SI&V@U&HDI/FK;^4MP]#E\>0'(
M                                           ..);[[>?C<!R
M              #@RW <@                .#+<MC\D Y
M  !P1;%L7@@'(
M
M
M
M
M                   XW(OO -]P'(
M
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MH\UZT<NC8QJ8\DW=/[%$C':;'OVRB1XI094UIQ;TE[92TFUP;6LN1GMP^"^
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M;KV72<K&8$HED25%Q4Y'EM,*/?RI+J-]R,]PJQZRZXQ\(P)\L\N[^SR?(KV
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M*EK5$<CK4MY&W'RXE)[<3VW,]@K6H.N^H>.]0NI;,2?>/8?A54BS*J@4,5Z
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M,!TS>CS2.RQ>+CTO%%2JR+*>F,$]:3%O-K=0EMXB?-[N]M:$)2IKEP41>4F
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M&CW]F_\ L[<OYO;\_P"1.-M9PM/6A<?R_AK'S^7''?\ Q&-I80L?7A=?S?\
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M_P 98V/2Z\DT;J]].,(QA"'IS39AY[1[9\<KF/AOS8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                        (C+Y-Q"Q.ZD8]$9L+]J$^Y71)"N+;\DFU&TA
M9[ELE2^)&>Y>#^2 >-2U=Z[=BWT.P/?;S_XPC]: ?O<Z[/Z'8'^<(_6 '[W.
MNS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U
M@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@
M?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z
M[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6
M '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!
M_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SK
ML_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8
M ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'
M^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.N
MS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@
M!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?
MYPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[
M/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6
M'[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_
MG"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL
M_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8
M?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^
M<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS
M^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!
M^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?Y
MPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/
MZ'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '
M[W.NS^AV!_G"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G
M"/U@!^]SKL_H=@?YPC]8 ?O<Z[/Z'8'^<(_6 '[W.NS^AV!_G"/U@!^]SKL_
MH=@?YPC]8 [HFK77.N4PF1HC@K;!N))Q:;=!FE.Y<C+_ *S\-P'ML
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M_P 0$)HWU/X)KME^<XUBLR0_9X?-]%8%(9)M"U<W$<V3Y'S1R:67+8ON\>2
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M@#8 V -@#8 V -@#8 V -@#8 V -@#8 V -@#8 V -@#8 V -@#8 V -@#8
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MQV]@'Z:=0)8HYH3G+.<3W:K$9%+)CVDYEM;BV([C9H4M*4)4HS+EN1$1_'P
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M235N9%^&P#[Z/B075MU8?2":+&OKE9P[/^WZWL.>JVV\<N>_+_.VX#V,
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MZJ0[NXIUV0\HB)3KCBS-2U&1$6YGX(B(MB(B 7T
M                                          $1F$ZUK,2NYE% 1:W<
M>"^[ @N+)"9,A+:C;;-1F6Q*424[[EMN \7%U$=:6Q?_ %-=-^>M?J #^(CK
M2_MKI?SUK]0 ?Q$=:7]M=+^>M?J #^(CK2_MKI?SUK]0 ?Q#]:.^_P##72[_
M /\ '6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /
MXB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOY
MZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI
M?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU
M!_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE
M_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.
MM+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^
MH /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VU
MTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$
M1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6
MOU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^
MVNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /
MXB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOY
MZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI
M?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU
M!_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE
M_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.
MM+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^
MH /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VU
MTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$
M1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6
MOU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^
MVNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /
MXB.M+^VNE_/6OU !_$1UI?VUTOYZU^H /XB.M+^VNE_/6OU #NB=0O6:[+80
M_P!-],TPIQ)..%>-'Q29EN?_ )C[BW >X@         !QL7X$ ;%^! &Q?@0
M!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &
MQ?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%
M^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X
M$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0
M!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &
MQ?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%
M^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X
M$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! &Q?@0!L7X$ ;%^! .0
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MD1$1^ &\NF#.\WS>3D:LHU&TTSZ+%2PEC]WRU+5%6HU\N^9N+(B41%Q^/Y5
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M(X&I2C,R(C(SWVW(!?P
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M :>U$JM9]-^K3+L]P323]X51=XU7U+,A>01*Y##[3CBS-1.&:U$1J+<B(O\
M!@*;B_2!J%A;N@;;L./<RZ2%F,O)IT62VEIF=:13[3:"6HE+3S,F]TD9>TS/
M8C 1NF'1CDVA4/I_U%Q'!819Y4,MU6<TG<C&N1%>W)V2AQ2N'J&?GDA9&HCX
M[F1&1AT:?:1Y_I?FV7+G=)5%J))EYK8W<#,9EQ5-26V'97-E22<2MQ/ BYD7
M(C(S^",!>+K$=>= ,QU=J=*\&BY=5:AW#M_59&NV8C)H9TAM*)"I#+OEQ*5)
M)Q/'<C))$>YF9$&R-;M)\ZS"1T[+)",DLL6RN#99'9,FU&1P;BN(>D$V9I\&
MXKPA!&9<B\> %6SG&-6M!^H[.-1=/, 1JC0Y] @(L*QJV9KY-?/B-FTTO=WP
MII:#\[>2,S^-BY!K6CZ&LDG_ +G6<\QZNRAF9EM_E>=14NMG$B.SHWV;9$I1
M*=)*T-)W1R]Q;_!$8"7Q70W6G0S2O4#37!L8IKG'JC(&;7'BLDPU-9)4/*,Y
M59(Y[FEY);)[SB2Y%X)6Q$ M?1CHIDF'ZKZBYO)TTC:+8M?1(<2)AL:Q;E\W
MVC6;DM1-?9M[\^))+;[_  7R8<Y7CNL73[U ZC9CIYIXUJGC>H+<.2N(BW9@
M/U5A'9[)&ON_SLK3L?M\E\>-O<%%Q'H8O46>@,3.\?JLQKX<_)KW-B<-MR&U
M,GM(4R@FUGNX27$(21I)7E&_@M@'N/$<0I<"QR%0X[5Q*6EA)-$:!!:)IEDC
M4:C)*2\%N:C/_P!S,!,
M                .-@'(   .-@'(   (W)+Z'BN/6=U8*4B#7179CZD)-2B
M;;0:U&1%\GLD_ "KU^LN-V>C!:HL/2%8H=*J_)TV#)[TJ6C=,^W\\N)'[?Q
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MO/CP ],?(#D!QL  .0'&VX#D  <;; &VX#D
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MY#89OHOTOZ9TV"RM1XL)BTS*[QJ%*:CJ>BMS)4:+R4X9))'==6>Q_/ MBW^
MEL*SV72Z.Z"M:@1W:N'H[J7]!R9N>9*.N032R@/O<=RX()U".X7MW1X/R VG
MU=ZTZ:ZO: =2+>"UT:UL:BLJ6+3,ZYAER+/-4EHVV$RT'R=-HB/QY27+P?D!
MAY78+RSI_P!:*>-U-P-=+![#)CS&/0XL%MZ.37%:WDE'4:U>"X;&6WN 2M+J
MIB6L743T>-X7D$#(WJ2DMY5JS7OI=77H55M-))\B_P!I7<(T\5;'O]WD@&P-
M(R_^JOZQ/_N&/_?_ /NIP!YNZ3LJIM*<JZ;<NSBQBT6(V&FEC35UM9NDS$CV
M)6:W7"4ZKVH4IDR(C,RW^ %XZB-<,9UET*B8KI%A<B66H.?OURX4!EB$K(V(
M;B9,^8RYN1+2[VT(-QS8_*B46Q>0U%E^2VF/=)O4WIG?XQ(P1ZLOZS**O'IS
M[3BX==/LXZ^VA;9FA2&W$GY+X[A$?D!ZUZI-<M#=6.GS(X$C-"R&E8D5YS;#
M")S$F72*5)03$Y9$OVMMNDGD?D]CV(MS(!7>B[/;5_J%SK#)6?8_K7"A8_#G
M,ZAU<!A$M)&\I"($F0T:NZ9$9K+=2C+97G<S(@U/U2UD6ZU/ZI:^<UZB'+>T
M\8?:Y;<VU2T)4G<OC<C,@%2I\2S.DURU)T5./*E6^*:3Y'1XS.-9J=L*]]Y#
ML B/_O2ASL^/@T$7R0#T=H7U(Z,7&G/3AA<2%!RW+7&(<*)3PF&94O'I;$0T
MO2GD+,E,$V:5D:_"C)1FDE%N TEA&L&!:??Z?6IVEN76,.+J=%7>TTW&Y2MK
M";92)#OIW&VC][A'S9/FDC(N'SX(!\*QC7/%\MS@].<B:I<QQG2S%BN*N36M
MRG[)QN*XEQMM;F_;<3P=,O:KDHR+Q\@.-/Z9^3F'2]$Z?LEB5[7[#73D6QR>
M(<O92I"5RT.MMJ+9SO*<+P>Q&7WD M]QI3$Z.]4>G2]SR^1:T17N22\@R9UC
MT\*/<6+*#:=-'E+2/8:2,S\<5*]I>""@=5&45&JUAU3YEA$QBXP^)A=)23;>
M LG(DRR*P:<+@Z7M<-#7M,R,]O'GR0#:6)6=]IGU?RIG4'FBLAM<8PV9;8;9
M1*YFO@2H9M\K#DA);^H0ELRXFHRXD:OP :3T+R?,M.]2-(=8LFT[LL:K\NOK
M!&09<_+9<CV;%TXE<0C0E7<;0T:&C(UEML1_&Y$ ]::);'U&=81[_P#YW4^?
M_P"5* :9Z ,H9AXMI-&D]45:ZV<9+!:7JCP$N\E=Q*(W<)7>Y$HR66Y<CV(O
M@P&LZ[4;%,A_TY&M*:N\@6.J-IE*H]5CT5]+D]$A5X;J'.TG=2"[9*5R,B+8
M_GR _6IHC2VDE'NHBV,_Q,!]@
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M$HDGX(RWVW 85/I#@N/,SV:K"\>K&K!GT\QN'5,-)DM?_#<)*"YI\G[5;EY
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M$$KS]_GR M@
M
M
M
M
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M6C3S0I"^1*+;_C^![@)NFZ@\2O,[+%8ZK%$Q<AR"U->KGD0G9K;7==B)?-/
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MI1A=+30.JN<5U"HI-C,2SE]HJW7(8XH=A/\ ;CI;4T>QD9H7%;<+D1^?!D9
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MQ=3N:"6HC)9^0&U\[T6@YR2$NV4J,E&-6>-)V(G%=J8EA*G34KR:T^G3MO\
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M+&C'8%)8C,1I3D=#;*2:;[:2[6VQ\C49&LS+EQ(-S
M
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M]Z;*.2M2_9R^S6I9(XF6R5GRY'L9!;0
M
M
M
M                      < .0 !QN Y      '&X#D
M      ' !N0!N Y  '&X#D                   ' !N0!N ;[ .0
M <;@.0''R Y
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MTYNIMXO(K-VK0B=/>E>H>7(2I27"=69F?,C+8R,]R^\!O0
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M-8=+^#V>+Y=1/1YQ1<FEQ+"4\U-6V^Q)C,L-1WF'$[*:6@HS*B,O^23/X,R
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M"J:/ 5.6J,IM3Q/*=6UX2I\U%_NF7+8S+[P&S
M
M
M                                   !QN $>X#D!QN Y      ' #D
M < .0   < .0' #D!P Y <? #D  < .0        ' #D  <  #D  <  !N Y
M
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MTEPD*\I):);A%OY-)-D>YD ]9
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M0#"KNEO2ZJS6ERV-B49.04T:/%A2UOO+X)89[+"U(4LT..H:]B75I4X2?!*
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M6HHY>/N:W,S-0#:P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
1                   /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>a02bffbligandpharmanotic001.jpg
<TEXT>
begin 644 a02bffbligandpharmanotic001.jpg
M_]C_X  02D9)1@ ! 0( E "4  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0* Q\# 1$  A$! Q$!_\0
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ML5NW1[EIY1^C7OXJ5LM6K?N*CS8_1-1W?SJ4V<F/C&,)/?<W5:UDGF?)^7(
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M0*!0*!0*!0*!0*!0*!0*!0*!0<>M! M<H"'-%<_0S'2IU6/7%*4H1NHDQ7
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M7HIJN6L3<JIIIIS7/6F.&(C%$3CUU9F>D*MQ2^QELX=+BR[PWJ#*OJ(]PO\
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M>X=HKNKUM54::NY75.(YS3,S,1CNSRB?!H=);/F.&.L0)&#PH[4QX.W6^NY
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MS;_"]$=,W]L+6C_&-7^T[7,^U?Z!M?S7W4N/=M_@S9OF8^RE6KW_ !-ZG?\
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MU_*J_"^.UGQFV7Y57VTO0-P_N)4?XJ-?]FFN;6_CC_33]LN1V?C]/^T3_%*
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M_C7TO?X-_P"X:JI1^C;]\O\ %4HT?H?:;Y?XJDYUP_NAM$_[XF?[+=5_L_\
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M[?$&/F;?X3 ?[MAS_&2=_K>IN7Q/CYJC\)NWQ!CYFW^%Z(Z9O[86M'^,:O\
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MFW5RIXND^C^U\GGUZ(#H<27M1-R3ME\X>?\ HLU8^T'31?,4?;4MG:CIM_\
ML]O[:EGU4U'*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0<&@\N77!KD[=)JTL
M6_93[BAO=[0#L5GX*MQ(_D))^LGUKKMG<+,6Z8S5TC]2_P"'JOQ'U1'L=UL;
MIIZ;-$355TC_ ">H\(\-3$?5$1X1#%^\.Y_^@MW^>+-_^K:R^^-GQJ_\E_\
M]=G]]M/^U5_P]3__ &5XZ+VI^SX@MB0EE#AE.*V8D1GT[$)_?1V64;_9QW^L
MGQMS_?;U-_5Q51G&(ZQ5'CW5UUS^_'J<N[2ZBC4ZV*Z)G'#'6*Z?'NN5W*O_
M *L>$0GM5U5"@4"@4$6U.PHZB8)=L=$L0#/;2CV@M]SALM*M^.XW^CMZ_&I?
M:=?[V:VWK.'BX)Z9QGE,=>?BG=CW/WGW&UKYHXN"9G&<9Y3'7$^/@C>6Z-JR
M=W4!8NPC_?5;8MO ,?E[-V0X.?TASW[GIXVV]:E-%OD:2-''D\^0KJJZ^EQ8
MY=.6,>M-;?VDC0QH(\EGW-777UQQ<7#RZ<L</7GU?>2Z0+R![,'!=0Q\OV!J
MR &/R[!0'?QGTARW[OT?'T?7S7SI=[C31IH\GGR5R;G7KGAY=.7H]>?7H^-%
MVBC24Z.GR6?(7IN]>N>'S>G+T>O/KT?5QTA5/GWJ3\J!'RCBR<;X]C?MD%W\
M=]+S^Z?1^SU\TM;W%NBU1Y/T+WE>O7T?-Z>KK^XL]HHM6[-OR6?)WYO=>N>'
MS>G\WKZ^CY:T>4U-9?\ E4'MXG][''V?U.X/>^E]GT?]->U;W$T31Y/K>\KU
M_P#IZ?O_ '/:NT456ZJ/)==1Y?K[?-Z>OK^XLVCZK3+QUXW4._).+JQPI]GV
M[I/:_'?2\?N7T?/KZ^*\O[W%ZF]3Y/'E+T7>O3TO-Z>OK^XU/:*-11J*/)8\
MK?B]UZ8XO-Z<_2Z^KH8OH^K'9>#/&ZA_[VK*]:2D1^/M!6&AW/I'CMVO3SZ^
MOBFKWN-53JZ?)X\M<BOKTQQ<NG/KUY&N[11K*-=1Y+'NB[3<Z^CCBY=.?I=>
M73HZ<0T75BPT[!NPD_>G$EQ3M'X^U=Y*1R^D>&W'T\[[_"LFMWV-9[M_)X]T
M543U]'AF?5SSGU,FX]I8U_OA^2Q[JJHJZYX>"9G'3GG/JPXQ3156,M:?H-W$
MC[U7)RR?9^/M/M"5C;Z1X<>?V[[?"O=9OT:N=9/D\>7BCO\ 1X,>KGG'JP]U
M_::-;.OGR6/=,6XZ^CY.8]7/./5AS8-%U6.%AK'RL'OO>NTVYE7L_'OA\O\
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M4"@4"@4"@4"@4"@X-!Y5NLBV?*LWEG]A:5[0YNVJZWH%/OGP0F8 "/3P /J
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MH\ZW;JHF8GTIJBJ.*?7BJ,^,QGO2&UVV2G+KY<WD=MEUJ-$8&_E:6PXLK_\
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M^G[2VK=FBCW=C$1R\M>CNCPT\_;/MEB?,E-_-ZK^;UO_ /UC6?W_ +7^F?\
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ME*>V3],;A;U H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MJ+ODY\VF8C\EP])XOVIYQGJG^N%WT-7C!U$G66%E-SO2%*@!;TE@W LJ0TL
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MK!V]U0V/G8GBK8-F]U'::QX4F6O,+<(\>5[(XL*4=E\5**ALGRV$MN*+HW0
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M$+WH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M?G:RS]2U_6H'X&/'/SM99^I:_K4#\#'CGYVLL_4M?UJ!^!CQS\[66?J6OZU
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M!.Y'@^@H*&UHZJ[QHMBFK61W33R0Y:,*?MC5ODJN:$)O:92T(6I&R%%KM*6
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M=PMJ[A%N,21 1ORE-/H6T-O7=8.WC^6@[H5UAW%<A$66Q)7'7VWDLNI66U;
M\5;'P=B#L?KH/.6?]<N,XSI?K!F%BM$C(!IO=F[-,B.2$QA+?+C+:RVK99"$
MJ>VY%/O%!V&VQH/0MDR"%?6"J-(9<>;2@OL-NI6IA2DA02L#R#L?CM0=MOO,
M"[+D(A38\M<=?:>2P\E9:7_!5L3Q/V'S09M H% H% H% H% H% H% H% H%
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M[)/T]S%&*1<@;QB1F:H:46]$Y:@G8!2@M;840.8&Q]0"-MPU.HOW1#'\!O\
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M+J2X$N%2D<^7(!"=CN>(;;3GI[U)MN4X-,?PF.\W T(5B4B+?'D>Q+NG>/\
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MDV]NZGWTN8';,EA9%?H=Z^^.?DLMB/;60F,)+#MO:<1WW$F.HM*3[I*T%9'
MA02O3K17.,>ZC?OBCXW&PRUJN5RF9!<K-?W3;,E:=2X(Q^2U%09DA2VEN.^[
M[S;FQ7W/ 975#H[G>I^:/,P+6[DV*3,<<MT*"<G>M,*W7-2W>4J8RT0J4V4+
M:"4^_MVU#@.?(!'X/3+G#6C.J>.N,0A=,BP:Q6*$DRD\3+BV]3#P60-DI"R-
ME>A'F@S,AT:U+AWF9B-HL%MGXE-U&AYRK)'[J&W&H_R@S+?B^SE)474N(7Q5
MOP*-O(5[M!8/4Y@F4Y-=--;[B^)VS-G,9O;\^59+K<$0FGVG($B./QBVW!NE
M3R5;<3]'X>M!%LBP34#6;2ZX:?W?3.PZ96:_W)B)>';7>6)Q^3.)7)<;"8[8
M#ZBVAE&Z5<>X7-_< (:ZS8#K'IS<K'DD+&[/EU^BXXYA;\=-R;@M%N/)4Y N
M(W20$+0H]YD *2=N 4!M0960:!9[>\$U<@W!RW7&_93<[!-;DL.=AF0J+&MR
M)2PD[]H%<9_BD[G;C]=!$;OT\ZE9+K!:;U=K,JXOVC4!%^^^:=E3SK"[0)"U
M,1H=NW[;"VVEMI7ND$]M1"EE?@,F\]-5^:T'TZQ[(9,:TPL=LN21K_-9<+YB
MLR[=+92XVA(W=*>\#Q2-_%!7D^WY3U7Y([BCJL49>9TQ<9C2;'>53XTAXW*W
MO,NO.-H0J.U(]D(0CRXE(<5ZI H/0_3)I!-PS)LHR&=I_#P!,^+%@L1%9#)O
M<][MJ<6XMU];BFTM<G!VT)2%?34HCD$@.N=C^J>C.>9R]I_A]JS:PYE<1>FC
M-O0MZK1/4PVP_P!Y*D*+K"^RVZ"W[X)<3Q.X-!%KII)J_@OR^+5'MVH]WS7%
M(-DNU\GST6\0KDPU(:5+6UVSW(ZDR>00W[X+6VQYE0#M:Z8,DL>&Y=CL QIC
M#^08A)M[[SP07HML9M3;ZUC]ZK^PG2$_'Q]=!(_F/R?Y^?OK[,7Y(^_W[X>7
MM Y^R_>U\G[\=OI>T>./\'S01I[IQS%>!85:4L0O:[5>\MG21[2.(:N#-U1&
M(.WDDS&.0_>[J^J@BRNG'42WY7A+UIQB%9+] A8_$.>6/(7(BF8L5IA,V+<(
MGE,[?MOI:/$CBZ@$HX$J#KN'3;J-.RG-TV?&(.%Q[O;\A9N\FTY"Y\D9*N5'
M>;A*3;5%0C/!;C3CCIX[%"]BL.> W%[T&U,:Q3-=-K?8[9+QW4!R%(F9([<T
MI59O["B1IK:F"GD\K:(5,E!VW< 44A&Y"7#0;*_D=F,68G=3JVO,"/:!M\GF
M8IT*]/I\2/<^N@LK-\"NU]UNTPR>*AI5JQ]F[(FJ4X L&0RRAKBG]]Y0K?ZJ
M#S_9M"=5&V<0PZ18+7&QS#KED,AJ^?*J5KNB)T.Y-1BA@(W:XF8A+@6=]QNG
MD-S012[]&V4P6DL+P:U9O*OF+V6TN2)N32H$2S2XL%$1\26&%H]KCJ2D+'#W
MR0I!V2H* 6&]H3G$'J)@WVPXW$QAEN\QY$W+K+?WF(UTM#;(08<RVJ4H/23M
MP#I&VP0OF"GC0>@M,\SFYKIS$OV0VMBP27?:1(B>T=YI#;;SC86'%)3R0M"
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M4NLW*(ZTJ/[6E:'T%)8_]*"#]#_G>GVT'>S<X<EU#;,IEUQ;(D)0AQ*BIL^
ML 'RD_7Z4$0QC6;%LIE9JU'N3$=O$;D;7<WY3[;;;;@9;=*M^7A [O'DK;WD
M+'PH)?'ND.5;D7!F4P[!6WWDR4.)4TI&V_(*!V(V\[[[4&DS+,DXUC$BYP(R
M+W+]G,B+ :F,L*EI''?@MQ01L H'<G;;^44&S<R6TLW<VIRYPV[F&3(,)4A
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M=0UWQ^! L692+M=LG1/MUPL;D;);%WFI*G5RG4*4W-@NJX(;[P\I>C\.11L
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M]9I$Q,DBYY4U)9D2&^'M*!:8""X-DA)W6EP$I''D%  ;; +AH% H% H% H%
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MZD)&R1N#LO<C8!01"]=5-PP/6O4745B/,O&(MXGB5R<M,B<M"(42:]Q=DH0
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M=UZ7"U9!B]JL.G[]^5G]LMMPP-_VI33=S4^I DM2B&U>S*CI45J(Y@I ]-_
M;RY=9=QM,V_8Z_B+!S6#J#!PB-:TSU=N2U*0EYF:5]O="2QW7"G8[=OZ7G>@
MG/4;K[>M&+EI_:\?Q)O+KME]W79XT9RX"&EMSL*<0HK*%#CND<CMN$[D G8$
M*CTHZ[<HSK)\%C7O3)JPV#(;],Q-VZM7H2%-76.EQ2@AH-CDR>&P6HA6_+QL
MD%08">NO+9V5Y-ALC"[)9\H5CUXN=FA0\ICW"9&D0T%2&9[;:"B.M:/? Y*'
MN['?R0$/P[KUR_!M%-+8-ZQ^TWC.KKC#N1RI&094U;VY-O;(2T\'5H(5)D*Y
M<6!]'B=SMZ!:D3K'OVI&?V+','P$7C'[MB<#+9M[D7A,1=O@R2XEP%'!7)U!
M2 $I)W(5Z!-!6=BZS;YH_P!+>FV26K$8UPL4C'Y-S?G9IG#3<EU;<AQ/L;"U
MM]V7)4D%0 ;2-N*1N?%!]Y#U7RM.]6M5M1FV9UWL"<*Q:? LDN<MJ-'7.=XA
MUP@*2TD=U)6M*2?&WG<4'J3IRUBNFM.%3KS<[99H1CSW(;$S';\S=[?.;2E)
M#S3R %)^D04.(2H%/IYH/#F9=0&KUWL.=S+M&F(^1-;[;:[:U O"4+=0A82J
MU@)"0&N"6E<U>%E]7(;I-!Z.A]7V9KP?/G)>G5L@YKA^0L62XP963,L6J,R\
MVEU,QV:ZA'%I*%>0$%1/'8>3Q"K7>M34'5B[:&2L-Q^&VW<,SNEBOL"!?6W(
MDUR(SN U)[8[C!:<4^% ;*+:4['<&@]3=16KU]T=Q*WW2R6.TW,R)@CR)V0W
MYFSVVWM<5*[K[[FY\D!(2E))*OAMY"BK#UXY7J'9](_O%TQCW^^9[#NCRH;U
M]2PS!<@24LO$O%LA;9'-:5#8GW!MN:#/TT^Z!0=0M9K5C0L=LCXK?KO-L=GN
M;-^:>N*I$?GQ<DP0D+99>+;@0K<GPG<>\#06'U4]1.0: 6JW3K1C=EN<)UF3
M(E7'(LC8L\5HM)"D,-E84MU]S<A*4IV\>3YH*\F?=!(=KQB_WR?BXB,)P"WY
MS8653B5W(25!A456S>R%(DJ::W3RW#@5L/2@^]8^MC)]$<LLD+)L&LD"TO"U
MMRU/Y2RBXON2N ?,*'P+CS<=:^*E+X;\20 /-!6-UU+G3]4K1&M,V_6UMGJ#
M<LTY$F]N2426Q"W*$)XH#3!.Q#'O)!!.YW\!.)G6M?KMJ+=]-;YBEKQN9=+3
M?56[Y.RAF=<X*X<=;B3-CLC:.7$)*T>^2-MO.QV"#Z0]4N:Q-",,P[,,9DVK
M[Z=.KE)QS*A>C*ESI$* IQU;R>(4TI2/QB5<U'P-_)/$.K%NOB9H_I!IQ:%6
MF%E4NU8):\AR.?>LE;A2W$/)\-14.@JE2"A*G"G<>.(WW507KURZQY+A?1_>
MLWTZDEJ3*1 4U=&GDMN1HLAUL=YOD#NHA:4>/([A4#NF@C6;]:N;XG,R-B#I
M0B\HP"SP;EGRF[\A)MCC[7>7'BDM[25-M!2RK=(.Q'CU(6WK?U"MZ6:'PM4;
M7:Q?\>4Y;Y$HEXLJ:M\EQM*I*0$JW*$NH5Q.WC?R-J"NLRZUIMFNV8VVPX8G
M(943+X6"XVE%Q#2;M='8X>D!U100PVR" 5#EO_S=Z#IM'6S="NQV6_8,BR9G
M\X4/ [Y:?E,/-0S)8<?:F,NI1^-0I#8(20D^3N? )"V-#M;W=8+SJ;!=M"+6
M,.RJ3C:%HD%WVH-(;4'B.(X$\]N/G;;UH*?L_7'=[GEMMN2M/%-Z0W7+#AD'
M+TW1*I#DSN%E#ZH@1[K"GDJ0%<]QZD?"@P<-ZZLGO^58H+EIFU;,-OF9RL&3
M>D7D.O"<A;H;4ECM#=LAL;DJ!!Y; A(*@D_57JGJ'A&LV@5DPV )MKOU_D-W
M-CV]$7VH(CDAE1*20E*%..^/"BTE)'D4%0Z!=4>78+<D6V]XY(O>&WO5>[8D
MG*)MYY2&9+TEPQT-QRE1[* D))*QMN0![OO!/=%ON@<'5O5JQ8Z;';86.91)
MN$.P3X]]:DW N1>1WF0@ J,EU+;BD$D^@!^D#0>OO6@YH% H% H% H% H*DQ
MK08X]K=JAJ#\M]\9M;[=!^3_ &7C['[*TXWR[G,\^7/?;BG;;U.]!7V#]%YP
MZQ:%VXY<)ATQC7>.71;N'RC[=&<8WV[I[7#N<MMU<MMO&^]!";U]S\O\K2##
M]/H>I,!^SVBQO629%O>+,W"*XIQUQ?MT5M;O*-*2'"D+"U#9*?3;R%[9QTWV
M/.>FE6C,J?,19DV6-:&+@2%R&S'2WV'C\%*"VD*(\;[$>*"KI71MF.:X+DD/
M/]8KED>739MMN%FN\>W)CQ+)(@$JCNLPRM2"M:E*[IW',$#QL#0=$/H=NMUE
MHR/+=1#D&>2\QLF4W2\(M*6&'F;9R$>$TPES\4G9:MU[GR=^)H-G+Z*525WY
M7WWA/RIJA%U''^]N_:#*D'V/]U\[\/W7QMO] [>0[8/1@J']Z7_RN"_D'4:;
MGQ_WNV[X?6ZKV7]U]WCW0.YYWX_1&_@-$]T,WFT.VB[XOJ,FS99:,UO.5PKD
M]9DR&4-7)/!Z,IDN^\4HV 7R )W]T;^ V.DO1"[IC?M+KF]F[E[=PFZ9#<E*
M=MH:7/-T2$[*(<V06]MR0"%$^ F@ZK%T'PX3V -W3*?E.W8T]E9DQ4V_M>WM
M7L*2MOEW#V^TE9&^RN7U)H-%#Z#,OG:;W[!<DULN]WQO[V3BV/P(UO$5F#'#
MB%MNR4)<VDNI#2&]SQ]PK'CEX#H=^Y]WBYX7J?:[GJ%!-RS:VV:*'K9C;<*+
M;7;:_P!UDM,(=V+9V0"@['<*._D !O[]T,S\P>U!N]\U 4YEN4*QVX1[S"M*
M6?DZZ6EE2$2DM%Q25I<4I1+?N[ D ^A <L=$-WO$"[W3+-1#?L\OF366_P!T
MO:;2EAA;-L7NQ$:CI<_%IX\@5\CY5OL=O(7!IIHH=.]4]5,R-X]O^_B=#F"$
M(W;]C[$4,<>?(]SEMRWV3MZ;'UH/*6!=*N8:O9GK#%O>33\9T[F:J2+I/QF1
M9AO>&V#'>9=8D**2AMQ02E1 4%=D<2#O07/=.BJ!?=*-6,,GY(XI6;9?*S"-
M<6H20JUR7'6G6D\%*4'0A3(WWX\TJ(V'K08+721FITSNEH=U,@(R.?=F;BZN
M-BD5JS.QVT%'L+L '\:RO<K5NYOSV(V\@A$H7W.H8_AN-_(F76V)FUEO=SO3
M<V3C;+]G(GH0B1%1;BOBVR$M-< %DI*2?CX"T,*Z59.*YAAF02\Q<O,FPXI/
MQQ]3MM;95,=E/H>5(V;*4-@%) ;"3X(W42"2$+P?H=O6G:M)E6/4IR$[A]AG
MXW<9#-J2EVX19+I=*F2IQ7L[B5[$*]_RD?:"&YT!Z.KCI5J\]J%D>76[)+TB
MSN65IVU8\S:7):%NI<5)G*;6KVB0>"1S\?$^2? 9.N/2=D6H&H%ZRG!]1W<
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M[A"G>D/);;J]=;WC6JMSQC KWDC66W?&($-*)$F<D)[B4S L*2RZ4(+B.)W
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M-R" P+IT'95.NUMO;&I\")D$NS0K-D=P5BD>0J6F*HAE^('%D1G>T0T3LH$
M*VW\4$Q^Z!X7=,HZ4KK8+!#N$^<JX6A#;=LCEV0E*9S'):4(2?HI!42!L-M_
M2@TLOHBOV56[-9>8:E_?#E^2W*RNN7D65$=IB%;9"7FHZ6$.;<ED**E\MMU
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M'U(79AO38<1U#N.3??(NX"7AD+$>T["0VX3'4ZHRE*00@E9<W*$H2 0=CYV
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M1R\D;'8([U8=3UGZ6<%L^0W9M+R;E>8MJ0' YQ;0M6[[QX)43VVDN+X^JBD
M>309%XZQ='L?SZV87<<WAQ,CN*8RF8SC#X0CVA(6PEUWAVV5+2I)2EQ220H>
M/(H)QJCJQBFC&)/9-F-W;LUF:<0QWE-K=6MQ9V0VAMM*EK63Z)2DGP?J-!!)
M'61H]%TOB:@N9DR,7ESE6QAX0Y"I#DM._)@1@WWNX-B2GAN!Y]/-!\9-UGZ,
MXG@V,Y?<<XB_(.2)<7:GXD:1)<DI:_=5!IIM3B0V?"RI(X'PK8^*#(S#K"T=
MP.XXS"O6=V^,[D<1F?;G&DNOLKC.J"6GW'6T*0TTM1V"W"E)._GP:#*R+JLT
MLQ34UG3^Z96U%RAR2Q",?V20IAJ0\GDRRY(2V66W%@@A"U@G<>/(H%KZJ]++
MSJDO3N'E;3N5"6] $?V20EA<ID;NL(DEL,K=0-]T)65 @C;<;4&TUEZAL T
M@6V5G5_%G3<G%M0V6XK\I^04)Y+*&F4+64I!!4K;8;C<^101;+NM71?!K?:9
MMXSB,S'NUI1?("F(DB09,-2R@.H2VVHG8@[IVY)"5%0 !(#JU8ZQM+],L6M<
M]_,+?[9D%H<NMB2&GGVY+7;*FW5EM)[;15Q'-92-]QN"#L&WTJUQ:O/3#C>J
M^;/1;2R_CC5]NST1EPLL)[7<=*$ K7Q'G8>\?Y:".R^O+0J%B;.2N9XRJSOW
M!ZV,/LP);BGGF6T./=M"6BM:$(<05.)!0.0W5O03EKJ(T[>?O+2,GC*%HL#6
M4RW0VYVA:W$J6B4ASCQ<00A7T"HCP" 2*"O+/U:8\UDFH=XOF78[&TYL=ELM
MXB/-Q)K5P9;FM%:524N-A*N[NCM-M K\[*2"0*"9X7U2Z7Z@HQE5ARIF;]\<
MF9"MR51GVE+D16N[(9<2M ++B&_>XN<21Y&]!DX9U*:;ZA##3CN3-73[\!.5
M9.U'>'M0AG:2?*!P"#XW7QWW&V^XH,#5OJOTJT,R.%8<URQJS766RF2F.(K\
MCM,J7P2Z\IIM0905;@*<*1X/U&@H[53K,S+"\TU>M-LM]C?AXCD&)VNWNO,N
MJ4\Q<T!3ZG"'0%*&_N%.P'Q"J#U#J9JIBVCF'R\HS*\,V.R1E)0N2ZE2RI:C
MLE"$(!4M9/HE()/U4'F#J2^Z%8KB.D.)Y)IKD]DGR<EOHM+<^[0);K%O:;V,
MMU]A"4NA306U^*("SW 4I4!065U'=5]KZ9,!P6]9&8\QZ_W6%;I$AEMY#++*
M@%RI24!*UE*$<E);WY'=(\D&@BNG'79BLK4[-<+SN^VNQW.-F+F/X^RQ%D?V
M1'+;197(<]Y#:EK6I(4LMA6VP&Z306NQU0Z7R=7EZ8-9;%7FJ'%,& &7>WW@
MCF60_P .T70GR6POGZ^/%!QJMJC.P;4K3"R,72Q0;?D4V:S-8N;,E<N0VS%4
M]M$+22A*DE.ZBZ0"GPG=6PH(.S]T.Z?9$9QYK4..ZE$1,U(1;YA4\V2!LTGL
M[NK3O[S: 5(V)4!Q.P;W,.MC1;!+?9YMXSB.S'O%J1>[>8\.3(,F&I90'4!M
MM1.Q"N2=N20E14  309NH/6!H_I?9\;NN19O"C0<CC";;'8K+TLR(Y /?XLH
M64M^1[Z@$_#?<&@Z\_ZQM'M,;K:;=D.:1XTV[06+G;VHT61*]JBO*4EIULLM
MJ"DDH5Y!\  G8$;A7.E?W1;2_+=$K9G^579O%W)MTE6SY)9C2ICZ'6R5I0E+
M;14[^(+3BUH3P27-B0?%!/<HZU]%L.M5GN-TSB.W$O%J%ZMZF(<E]4J(7.WS
M0EMM1)"M]T;<DA*B0 DD!H?]VUA<WJ+P732VRV)L/*[!\M0[PV'5)>6Z08S*
M $;#FVEU96H@)XA)V)VH)1J+KB-.]8K;:+I>[%;\41BURR&Y,OQI;ER"(I25
M/-%M!:[24<N22>X3MQ!\T$3R/KYTB1@&?7S&,LBWZX8M93=C#$:0A+X7LAC@
MHMCN(4\MMM2T;A!5[Q&QH(MI%UZX? T*PS+]7,YL$6\9,'GF6K%:IR4-);4$
MN(6T4N+ :7R0IX[-DI]TD>2%NY9U:Z381DV/8_=LQC-7?(8T69:H\>._($QB
M2M2&7&U-(4DI4I)\[^!Y.P(-!$F?NA73[(;6XUJ+&= B":D(@2RIY'( I:':
MW<<!(W:1NM(W)2 #L&^S+K0T:P+&L:OUXS:.W:\CB&?;'8D21*4]'&W)Y2&F
MU*;0"=BI82 00?(( 5UJ!UVV*W:DYQ@F/W*S,7"T82<FMUZNB)3T)Y\L&2 X
M&&R>RB/VW2I!*E!SBD<D[$)O=.LW2[3NW89#SW.;3;LAOMIAW$B%'DKC!+R$
M[/%7 EAE2B>)?*?'KZ&@V.H769HWI7D\O'LHS:-:[O$5&$B.8LAWM)?0%M.*
M4AM20V4D;N;\4\@"02!069F6=X_I]A]QRK(;M&M6/6]CVF3<'E?BT-^-CXW)
MW)  &Y)( !)%!6]IZQ='KUIG><^CYK%1C%G?3%G/R8[[#[#RMN#9CK0'BI6X
MX@()5YVWV-!\,]96C;VGL#./OXB-XQ,NALK<UV.^@HFA"G.PZV6^;2^*%'9:
M4_#^$-P@&I/W0_3'$\/P7)['=F[[9<BR<6&1*5'DLJM[;8"I;KC1:[G-L*:V
M;*0I7=21N :"RH'5II1<]65::Q<O8=S$25PO8Q&?[)DH3R6P)'#LET#U0%\M
M_&V_B@@>%=:V&V+3>S7G4S-,?9N=VD740EX] GJCRFH<KM*2VAQHN*<2%-A2
M=O>/(HW2-Z"891UEZ.8=@^+Y?=,VBM6#)FUNVF0Q&??7);1^ZK[3;:G$I1Z+
M4I("#X5L:#7Z\]8VG6C>,*4YE=M.1W.P/WFPQNV[(9E([2E,.+6T"E#2UA*0
MM:DA6^P-!VR-;[V.C6%JLN18[-D$C$8U^<=N3$A5MCON1T.*YML\WBV%*(V3
MR5Z>M!CWSK:TBT_<C6K,LX@6[($1X+DQEB%+4TV9+*7&W-^V>+)"@>:B GDD
M*()VH-UU5=14#IHT0NN>N1479YM;$:!#[BDHDO.K 2"M*5;)">2R?B$; [D4
M%46S[H3@UJU8S&V9=D5MM&%-0;%-QNXI@RN_,1.CJ=<<> 2HMMI/:]Y:4!/,
M!1W(H+CRGJGTLPK4JVX#><PB0\IN!82S$[3JT)4]^XI<>2@MM%S]Z%J25;C;
MU&X275+6##]%<?C7S-;VS8+3(F-P&Y;[:U([RPHI2>"3QW"%>3L!MY-! $];
M.BITZ;SE><1V<95=#952WH<EM;4T-J<[+C2FPXVHH0I0Y)&_C;?<4'S=>MS1
M2QW/&K?<,ZBPY60PXUPA)>B2$A+$@ L+?5V]HW,$$!XH.Q!VV-!O+OU3:86&
M_7:QS\G$>]VN\0[#)MJH4@R?;98WC-H;#?)P.#<A: I.P)) !H,N#U(Z=7*S
MV.YQ\B2Y%O5_5C$'^Q'PX[<DK6A4<ME'))!;7NI0"0!OOL02'WJ]U%:>Z$.6
MMK.,B19'KHW(=@M&*^^N2&>'<" TA1*AW$;)]3OX!V.P:'!.L?1O4S(FK'CF
M=P+C<';>JZ(';=::4PA 6X0ZM"4<D).ZV^7-&QY ;'8(7DOW0?21O3'/\HQ/
M($9-,Q2V?*"K:J+)B&3S<#+'!3C(Y-K>4A'=0%)3R!/B@VT;KKT>M^'8+><A
MS*):G,KMZ)T9OV62H(1S[3CCGXLEEH/!2.X[Q2>)\D F@SM5.KW3S";ODF%Q
M<OML74:%;GY$:WSX<MV.VXF$J6VX\IEL_B>V M2DGTW ][84&O;ZV-,L,QS!
M&L]S>TQ,EO\ 9(%T<5:X4Q<("2A/%[D6R8[*U$\"^4'CMO\ &@PK7U>0,;S_
M %IA:@S8%CQO#KY;;/:GXL5]V5+7*BAT-EM'-3SA5OQ2V@'8'QX)H+GTPU5Q
M;67$V<EP^[(O%G==<8[P:<:6VZ@[+;<;<2E:%I/JE20?3ZZ"6T"@4"@4"@4"
M@4"@4'RX"4* ]=C0> ^E/IOS[![UH0[DV*/06L=QK)X=Q4\XRL17Y5R<<80>
M*SN5M+W\;C8[';TH(UIGTXZHXE8-![;-P^X,K3AN0XE=Y$=]DJLCTV0M3,AW
MW_* E05[A)\;>NP(:C .F/4MS3/);)=<(S%&06/36Z8O"DWC((;L%^6\@-B-
M 8;0"IA80E86XX.!V'O'S0>C+5HMDD36/I=NOWO*:M.'XC<+?=7@IL)@27(4
M=I"".6Y)*7$[I!'@^:#S3:^E_5? <*TLNXQ?+7WK;9<AL%PLF(W2'%G1U2+J
M_)C*4IWF@QW4+0E?'WD@)/PV(73ISI;G6A&MF$72V:=W&[61K25&.%MF[,R!
M GQWWY@BNOJ".842AE+B4;;K!VV2:#TU<[3<-8]")UKR.Q*QRY9-C[L6?9GW
MTOF$X_'4A;)<2 %\2HCD -]MZ#\Z%=&6LZ^B%ACY&E?/ K*ERW(RI#/?%O7
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M4274CQMRW^-!?>L6FM^R?JHT)RF#:5S+#CD3(DW":%("8KDB*TVQN"025$+
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MD8Y<3:KF$-J"690;0XIO<C91"7$[D;@$[;[@T$FV&_I0-A]5 V&VVU (!^%
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M"+?=$9T*SZYO7NX7^TWEBSXPQ)^].Y9!-L%QA[/N*]JM+Z=F7GUD<2G9Q8X
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MO:=*>HK'-([Z]?\ 1V+:L8EH7\I.SXL6[.71@.(8><4HDK: 6M(4=E #8;
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MUC$[(G(57X6> +XIOLFY^RM^TEO^!W=N7'[-]J#%EX/:%6EJ%!MUOMRHI6[
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MD IWWVV\;4&[H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!TRYC,%
MA3TAQ+3:?52C01B9J"PVHIC15O#^&XKB/T>308?SA/\ Y&W^L/\ 10/G"?\
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M_P C;_6'^B@?.$_^1M_K#_10/G"?_(V_UA_HH'SA/_D;?ZP_T4#YPG_R-O\
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MQO\ 5G^F@?-Z_P#EC?ZL_P!- ^;U_P#+&_U9_IH'S>O_ )8W^K/]- ^;U_\
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M6"YQ;Q9YJ.Y&G0G0ZR\G<CDE0\$;@^?LH,]<V.W+:BJ?;3)=0IQMDK 6M*2
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M86I^W_.Z-4Q@I>$%/:]CY=[VSL[[<>Q\?\M!8'W3G(KC9NE&ZP8$MR S?+I
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M4N*Z1NIA["IW-!^H\4D;C[":#L_W>N"__174?^9,_P#J4#_=ZX+_ /174?\
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M :1[&MW?NJ9V3^+*]SR*=N6YWWH-A=,?M=[=@NW&VQ)[L"0)41<IA#BH[P!
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MU,-">D[[A\)0.X#N=PK?U-!*(<./;HC$6*PW&BL(2TTPR@(0VA(V2E*1X
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M;5JK;;D]!AW*T7&U3# N5FO,?V>;!?"$K"'$<E#92%H6E25*2I*@03YV"O\
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MR,Y)N"X#R)"V^ )X<4J^F2-@D[;DT&KSC6AK&M"INIMFLLK)X4:UHNXMT)U
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M;6S<FKM!=M[RPVU+1)06EJ)V"4K!V)W\; ^M!%=6=8;7I=HYD6HB6_EZU6>
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M@4"@4"@4"@4"@4"@4"@PKS>(&/6F9<[I-CVZVPVE/R9<IT-M,MI&ZEK42 D
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MH8@K2W)<M4I+Z65*!*0HI]"0#^B@V>49[C>&':_7N#:=H<FX_P!F/AO^QH_
MON^?WB.XWR/PY#ZZ#?)4E0!!W!&XV-!R0#08]PN,2SP7ILZ4S"AL)*W9$AP-
MMH3]:E$[ ?RT&/:<AME\?N3%OGQYCUME&%,0RX%&.^$(<+:_J5P<0K8_!0/Q
MH,\) )V]:#7R,@M<.^PK,].CM76:R])C0EN .O-M% =6E/J0DNM@GX<T_70;
M  >:#HD7")"=BLOR66'93A:CMN.!*G5A)44H!^D>*5'8?!)/PH,CP?C0<;)
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M#R5S0$<>)H,O0#4#423==$[[D&>3\CCY^+Q&GVB5$BMQ8HCMO.QW&.VTE86
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MM)V'D (+<NLFQM8]C-SM=AG7IV^X[%O;$*,\A+J7Y<IB)"A'EL.XZ^\XDJ)
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MRZL:N7#!KUCF-XUC#F89=?A)?BVWVY$)EN/'""^^Z^I*N"076D !*BI3@'@
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M^GF[8'E6,7^XS;"E^!:;Q#E0<?M*+?$0Y-F17T(8;0 .VTB-V^2]W%^%*/P
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M;DN[<!NLJ23QX^\%B:B]*%WNEPQ:]6*/A%]N\#%F,6F1\VLYG14)9W4U+C@
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M?8!M0967SLK;G:LZA,YYE<:XXKK!"M=MM3=Y=]@:CO/1$/LJ9WXK2H/<=CN
M$> .2MPV%MU%ON'=7+UQO.0WC*[=<L^G66VW3&LQ*V&7%I6ABSS;,Z#LAKB
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M)V$['Q"Q,.079;\5;=N:26')0(E+00GW2Z"0LCZ>_G>@^K3I5A=A+)MN)62
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MFAUZ_/\ V[^84;]IH'S0Z]?G_MW\PHW[30/FAUZ_/_;OYA1OVF@?-#KU^?\
MMW\PHW[30/FAUZ_/_;OYA1OVF@?-#KU^?^W?S"C?M- ^:'7K\_\ ;OYA1OVF
M@?-#KU^?^W?S"C?M- ^:'7K\_P#;OYA1OVF@?-#KU^?^W?S"C?M- ^:'7K\_
M]N_F%&_::!\T.O7Y_P"W?S"C?M- ^:'7K\_]N_F%&_::!\T.O7Y_[=_,*-^T
MT#YH=>OS_P!N_F%&_::!\T.O7Y_[=_,*-^TT#YH=>OS_ -N_F%&_::!\T.O7
MY_[=_,*-^TT#YH=>OS_V[^84;]IH'S0Z]?G_ +=_,*-^TT#YH=>OS_V[^84;
M]IH'S0Z]?G_MW\PHW[30/FAUZ_/_ &[^84;]IH'S0Z]?G_MW\PHW[30/FAUZ
M_/\ V[^84;]IH'S0Z]?G_MW\PHW[30/FAUZ_/_;OYA1OVF@?-#KU^?\ MW\P
MHW[30/FAUZ_/_;OYA1OVF@?-#KU^?^W?S"C?M- ^:'7K\_\ ;OYA1OVF@?-#
MKU^?^W?S"C?M- ^:'7K\_P#;OYA1OVF@?-#KU^?^W?S"C?M- ^:'7K\_]N_F
M%&_::!\T.O7Y_P"W?S"C?M- ^:'7K\_]N_F%&_::!\T.O7Y_[=_,*-^TT#YH
M=>OS_P!N_F%&_::!\T.O7Y_[=_,*-^TT#YH=>OS_ -N_F%&_::!\T.O7Y_[=
M_,*-^TT#YH=>OS_V[^84;]IH'S0Z]?G_ +=_,*-^TT#YH=>OS_V[^84;]IH'
MS0Z]?G_MW\PHW[30/FAUZ_/_ &[^84;]IH'S0Z]?G_MW\PHW[30/FAUZ_/\
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M*4@)*P-E;D@;C;<A4L+[FQ=G<4O5JN>I%O6[<,)3A32K=B[<-F,RW+9DMO\
M!#WOK):5S*CNI3F^XX[$)OJ/T/7+4O4BWW6[9U&E8Q%N$"Y-PY6/LNW6"8W
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M?X;4$9U2^Y]S<KDYO;\0U%5AF(9A8[7:+G:#9T3%[V]H-12AU3B>*."4A20
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M/:4THJ2..ZR/@0 [,/ZN](<_SNXX=8<UAW'(("7UN1D,O)0Z&02]V75(#;_
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M &]!=W1)C.5X#I]DF)95BTS'W[9DER>C2WW6ULW%B1+=?0ZUP43Q 6 =]O\
M6 %&-:#:DX9CV*Y?&PN1D%PQ+5*^Y&YBR)+*'IUOEN.I;D,E2N!<0%)6E)(/
MD^AH,G3KI]U!E:A8+FE[POY%8NFJ-WS2=9N^TX;+%=M_9CE[BK8NJ<;2I7#?
M8J3OL0=@OGK%MVH$[3['$8%!N4T-7^*N](Q\1A=V[>$K#BH*I X(>"BC97A0
M!.Q'DT&@Z'-*LKTZTFSBS9;:[GC]QN>6W6X,)N4YN;*5'D!LMNK?0HAQ?KR4
M3N5)4?C04OI5H]JU(T@AZ#733"WV"-8\=R"S.Z@SWV70M<I+J8Z[<4$N)[I<
M!>Y >Z"#L=A013*M.]1K]IJJYY-IR]IO:]+=(;_CTF2Y+8<^5Y+MN[ #"6E'
M=E(:+H4K;RK;R?-!(M)=),HUV8PQ[*L)&!859M)7,3?NK\IA3=U5,8:2VM@(
M42&D( =W7L4K5MMN-Z">?<Q;)>KUIGD6I&3NMR[YD,B-9F931Y(=@VJ.F$TI
M*OB%.(?62/!)W^-! M;-*-:L[USN#C^-9+/L]MSRT7FV.VJ;"BV/Y*:<9*G5
ML@I=DS 0K<N;\4I/'8!((;C1G1_4_".IBWN6#&LIPS$DWNYRK_;KE=XUQQA4
M9SN%MZV;[/MNNK4E2D\$E.^Q.VZ:#WL/0;^M!S0*!0*!0*!0*!0*#Y6D+24D
M!0/@@^AH/Y_NHS3R^]$_5G>(D1+L6QOS6[G;7FD<4R+>92)"$))W\MK:"-_4
M*:W^J@_3[&9^>PH6L-NTQOF)622UJ"].D7G*TN*8C6^=;HDWO,I1L%N%;Y("
MU!.V^_P "G,MS73FYWD1=1.I_.M9+TW[OWK:81U1(CZSN"CA 20KXCWG@?M\
MT&PP[3BUV]J*]I=T0R9KL@%0O6J,V,PZA1]7%MR%ON^I^'$D>FU!9S<7J6Q]
MMMBU6O0+3&$&^:F"N6XZT$@>H0EM&WCU'H/Y*"/:S0LAR33K2";J)E.):@7>
MW:N6)YYW&6PB&S'>664LG<J*B%.<MSMN-M]]O(>ZAZ4'- H%!&M1\\@:8X5=
M<GND:?+@6YM+CK-LBJE2% K2D<&D^5'=0]/AN?A0;]A]$IAIU*5!*TA0"TD$
M;C?R/A0:W+,4L^<X[<;!?[>S=;/<&3'E0Y*=VWFSZI5]E!K]/LRQC,[(\YBD
MQB?:[;*=M)7&2KMH=CJ[;C:21[P21QW&X\>":"3^/7;T^R@XW /V_7M01_"L
M_P ?U"M\V=CMR:ND.).?MSK["5<.^RO@ZD$@<N*@1N-QX.Q-!(-P/.WK]E!$
M-)=5+#K3@<#+\:6^[9YCDAIE<EDM+Y,O+97ND^GOMJV^L;&@EXV\^/\ 10<@
M@T$'S/6C$,#FWRWW2Z)%TLV/OY1,M[#:G'D6]HE*GM@-O*@0!ONH@[>AH-_A
MF5V_/,0LF2VI3B[9>8+%PBJ=1P6676PM!4D^AXJ'CX4&Y&Q]!Z?90<;C?T\_
M7M0<[@__ (*!X&_C_10<;CU_^% \$[;>GV4'.X/B@X.R1MM^@4$7QO4.VY3E
M65X_%BW!J9CCS#,MV5#6TPZIUON)++A\.@#P2GT/B@Z</U2L.<95F./6Q;ZK
MCBDUJ!<DNL\4AUQE+R>!_?#@L>?KH-*OINTO=U,&H2L%LBLS#HD"\F(GO]T#
M8._5SV_?[<OMWH+(&V_@>?Y*#G<$^G^B@'8'?;S]@H(A?-),,R3/;+FMUQN!
M<,JLS2F;==9#/-Z*DDDA!/@'=2O.VXW.VU!\Y1JM8,1U#PO"[@M]-[RWVSY,
M0VR5-J]E:#KW-7[W9)&WUT$P)!&^V_\ DH*WRO7S',4U>QO31<2\7/*+W&,Y
M+5KMZY#4.*'.W[1)6/#316./([^=M]MQN%D @^=OTB@YW'K_ /"@CNHF=VK3
M#!K[EU\4ZW:++#<G2UL-]Q8:;3R5Q3\3L/2@IV\]=.E-BTLP?4"1<9QL&935
M0+5VH2E/K=2M2%A:-]TA*DD$GZQ]=!=!PJPKS5O+3:HYR5N JU)N?#\<(I<#
MA9Y?P2L!6WUB@W8V\;#_ $4%0:V=5FG73]>+;:<NN,MF=-CJG*9@6]Z68L1*
MPVJ4_P!M)[;(6H)Y'U.^P.QH+:ARX]QAL2HKK<B*\A+K3K2@I"T$;I4"/!!!
M!!H*;RCK TRP_5EO3VXW64B]"5&@2)34!U<&'*D#>.P_)">#;C@VV!/Q\[4$
M4S#4SI_ZC]3UZ/93;HN4WFW39#,9-SMCGLJIS" J2PQ)("2\VA0YH2?3Z]J"
M>:>ZI:86.ZY7IQBCT&TQM.H+#ESC0VDM0K<TXEQ?'D/=Y)#:U+'J"?/G>@^=
M#^J+ .H.9=8N(SIBY5O::E*9N-O=AK>C.[]J2TEQ(*VE\3LH?9OMN-PG5IS[
M'[]F%_Q:!<FI=^L#<9VYPVP2J()"5*9"SML"I*%*VWWVV)VW&X2#PKX?I%!3
MF%ZC8!;M>LST\QBP7!.3\F[QD=RA6QPP6Y+K*"V'Y'T0\MH)*4_$)/Q!H)MA
M>DN&Z=WC(;MC6.6^S7/(91FW67%9XNS'BI2N3BO4^5K.WINHG;R:#XS35.SX
M)D%BL]QCW%;UX9FO,OQ82W6&DQ6>\YWG!X;W2-D\OI'P*"&XSU78%DUFB7AM
MZY0;'(Q=>7F[3H#C41F ATMJYN^4AT%)/;\JV\B@M>T7:)?;5"N4)?>ARV$2
M&'.!3R0M(4D[$;C<$>#0:NSY[C^0Y7D.-VZY,R[WC_L_RI$;!*HI?07&4J.V
MVZD)Y; [@$$[;B@D V]=O]%!6]UU_P /MXDF)(EWM43)&<4F"T0W))BW!Q*5
M<'.(\)0%IYK\A.^Q\@B@L?<'?Q_HH'C;T_T4$,DZMX]$U>AZ:K6_]\TNS.7Y
MML,$M>RH>#*B5_!7(CW?JH)IX/C;_100'7C.,2T]THO]VSIA<K$UMMV^X1T,
M%[NMR7$Q@@H!&X470#]A-!O<#P+&]+\7AXWBEFB6"QP^08@P6N#:"I14H[?$
ME1))/DD^:"#8-U,X?J'.QV+9&;Q(%]G72W1W_DU?9:=@'9_O+&X;!/A!5]/T
M%!;/CZO]%!SN"/\ ]E!QN"/3T^L4&%?;' R>R7"T76(U/MEPCN1)45Y.Z'FE
MI*5H4/B"DD'^6@6*Q6_&;);[/:XC4&V6^.W$BQ64[(9:0D)0A(^ "0 /Y*#.
MV'U4#8;[[>:!L!0-AMMM0-A]5 (!]?- VVH&PWWV\T&OR#'[=E5AN5EN\-J?
M:KE&<B2XCR=VWV7$E*T*'Q!22#_+0:N\Z;8QD&!.85<++%E8JY#1;U6I:3V3
M'0 E+>P.^P"4@>?@*#88KBMGPC';?8;!;8UGLT!H,18,-L-M,H'P2D>GQ/\
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M%KK'N]LA/.6XO1W"X$.LGMK;*CY*DD;&@DM H% H% H% H% H% H% H% H%
MH% H% H% H% H.#Z>:#\E[)G+FB&J^K<"R:R-:?WRYY)-MPQV#ASV174MQYT
MMZ.IAO<-H;4W,Y KW.X\>E!LLD^=2_6:3=KQ-U@58-A[5?=1LQB8):>1^C_8
MC:%.%*O(XAP'T\ ^@599NDO)]:(R481CEIO?MCBER;];+3(3;%HWV*DWB[J6
MX\H'QO&CJ!V)Y;4'I#2/[CIC4=]JZ:L9;.RR6-B+1:"8D)KSY07#^,6G;XI#
M7\E![MTXTFP[2&Q)LV&8U;<;MH(*F+='2WS5_"61Y6K_ )RB3]M!+:!0*!08
M%\L-LR>U2+7>+=$NUMDI"7X<YA+S+HW!V4A0(4-P#Y'PH-?+P#&)\>ZL2<<M
M,AB[.-NW!IV"TI,Q: D(4\"G9PI"$ %6^W$;>@H.E>FF(NYBG+5XM9594E';
M3?%6]DS@G;CQ#_'GMMXVW]/%!\Q-+\.@71ZY1L3L<>XO3OE-V6U;64O+E\5(
M]H*PG<N\5*3SWY;*(W\F@^+WI5A637AZ[7?$+#=;H]'$1R;-MC#SRV0H*#:E
MJ224!0!XD[;@&@R9.GF+3,LCY2_C=H?R:,WVF+RY!:5,:1L1Q2\4\P-B? /Q
M-!@R]'\$GQ+W%DX7CTB-?'Q*NK+MJ84B>\/1Q])1LZH?!2MS095QTTQ&\62V
M6:?BUEFVBV+;=@6^1;F7(\1:/H*:;*>*"GX%(&WPH-O9K%;<<MZ(%IM\6V04
M*6M$:&REEI*E**U$)2  2I2E$_$DGU-!IK3I=AMAD7E^VXG8[>_>@H7-R+;6
M6E3@K?D'RE([F^YWY;[[GZZ#/B8;8($NVRHUCML>3;(I@P7FHC:5Q8YVW9:(
M&Z$>ZGW4[#W1X\4&/?M/<6RFZQKI><;M%WN49AV,Q,G0&GGFFG$E+C:5J22$
MK22%)!V()!]:#O8PVP19,*0Q8[:S(@PS;XKK<1M*X\8[;L-D#=+?NI]P;)]T
M>/%!TXC@&,:?Q)$7&,=M..1I+I?>9M,%J*AUP^JU!M(!5]I\T&;%QNT09-SD
M1K7"COW-8<G.M1T)5+4$! 4Z0-UGB G=6_@ >E!K\8TXQ/"K5+MF/8Q9K%;9
M:E+D0[9;VH[+RE#916A"0%$CP21Y%!]3M/<6N>))Q:7C=HE8PEM+*;*] :7"
M"$^4H#)3PXC;P-O%!V0,&QRUN6E<.P6N(NT,KC6Y3$)I!A-* "FV2$_BTD
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MVXK16?510VD#<_70?-RP'&;RS>F9^.VF:U>TH3=$2(+3B9X0GB@/@I_&A(
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M]DQZU8U%<BVBVP[5&<>7(6S"CH90IU:N2UD) !4HDDGU)\F@V% H% H% H%
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M0*!0*!0*!0*!0*!0*!0*!0*#C<?70-Q]8H&X^N@;[T'- H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>a02bffbligandpharmanotic002.jpg
<TEXT>
begin 644 a02bffbligandpharmanotic002.jpg
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M]!W_ ,3G^1<>@[_XG/\ (N/0=_\ $Y_D7'H._P#B<_R+CT'?_$Y_D7'H._\
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MJJ2Y)ZGU'VK3:_39U+U>V3?9&_\ 3*]O]DC6%JDI*68S ]=J1&0>%B</D3*
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M1%/E,_0:@OJ?8]>631VT6Z@-^I&27$E#)%3;56S%3%5Y(2%1).>45%1??/Q
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M-PFT1MUT4:4 !4^93]^>$S(O>O7<2STEI7'(FW1D@[-85UKL%7J48MAF5H,
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M.P6(U<"LUR&$F6Z^3)NHG@3@>WBV7T7,7I[W+ZYU-BT;]-3[ /QUE,J)[4R
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MW4,NZ"TM[>BNGY+MD];L;"Q4159.O*F2.,1V>3OK>/J<M+$0%3R1'47CE<K
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MU'GCWXYSSING7/?.GEZ?3.UV=V;L;UDUZ&S5.LK,F.1"@/22;9@->0F\CK!
MBJBBC:J1(I#RNU;?J3MLKM9:W'6W86S;0_5QWQET<!V0TXA& O2&8A*+AD#:
MN.)'7YE(/3]URM]$^OH2?AX=AO$;J3!M;]JCJ[2-7)7V,6041^0XS81%%OT?
M%(Y>)("$2&B*/LI+)W'>)KU:"/Q]7V.Q@QXRS[*9':CHW71!G/PB><\GD4D1
MV.9>+:$7A\W'LJ)E=-.K%OM'6JWUTK$IM+%K)SX^O#;8<&0S=S(:I\JKR @P
M("JKR2"AJ@D2HFGHW<9M'_%6VAQNIE79W+&_+KK'3-*M@I+E?\6#)/>JVJ/-
MJ#)&_P"J?((C:HJ<+EVZF]XDS7M>V5NHTFXA;'!8C3:^+<#&%9L4[%B&XXK*
M/HXP2>N)"#Z-DJ&*\>Q(F5U+[O(5;K^^Q:6!.K[&OK;MJGNY:1G(LFS@1GG'
MF4:1TG$\"9=1",$ U9<055/'R]#44IR=2P)+JHKKT=MPU1.$55%%7_\ 7F=C
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8RO=0M)@]2-&OM6LC=:A6\)V$ZZPJ(XVABJ>8*OMY"JHJ<HJ
M<HGMFH_S;=@.P';7=XBN=3&[0)[5^M&B1$:&&4/X8HGK\J"MF9JJ.HOJ%Y)P
M*(&6IKH6%=T1@Z!5;+9U4R"#3L?8(_BD@9C;R2/7(/N$A/(JDTJ>)"1!]%RF
M/]L>R6=DYM=EU C2>HHV<"?&MV=?%J T$1J2R#)1$?4C0@FR?(U>\N3'A40$
M'.*[M#9AZ-?:\_MLJ:Y;Z^M&]/=A@A\E.E2R?44)$55*60^*<)\J+^/"730N
MA3&C=0K+:0N')CDV/-86*3" @?$6DFP5?+R7GQ62K?T]T!%_'A+!TXZ;-=/&
M-C;;G'-6YO)UT1$TC:M+)<\U;3A5Y0?IS^/ZLT#7]B(P:JPBM[?%C/N4Q5,>
M5"U]IEQQQ)L:8U-F%ZBE*D>I&%'"4A0T(N$!555F9?9?'E2]M ;ZMAUM\Q<>
M\36XP3PD633@O*Y+4E-QD#>><;:3Q)/(1)PQ%$ST=60DK:Z+$0_41AH&D)4X
MY\11.?\ \V96,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8Q
MC&,8QC&,8QC&,8QC&,8QC&,8QC*-UPWR3TRZ1[9M$)IMZ?6USKT4'D56U>X\
M6_)$]U'S(>>./;GW3-%;;MV_:C1]1JRQZGV#,K2 B6@W<:E@')M&93!HW#5I
M6_3$_B&R$"$454-M"YX4EV3LTCJAIW;,KPRBV7J=&KF%F2H$!HS)TG ^)-B.
MGB#AMMDXK8>R&38HJ?-QFI-:[A=CKTHHU/MZ=28$[=JZBD.W%8-7=UC#L=YR
M0W,C$W'0%16A)LT;12!33W445;72]\FMW=;8S6->LI _!LV-1'A2XDF1:1G)
M;,421L'55@_.2P7IO>*^+J+]4,1P]D[J]BK=KKFXFCW$F170KP-AU=I^)ZL9
MZ(E>\+WQ!&@$'H2E(/%?G5T45$5%\;)'[QM4G;[5T46(ZY5S9$&!]KG,BAZ<
MN8PV_';^&5SUB%1>9$G!%1$W$3W1#49GHQW'L=7KAJ">J6^L?'TK6P5+EFXP
M7QT(S1M3\6S)6R$U'Y3]U0Q7\51)[HCM]KN-1M#]M)22["VFXK6%1L0\8[$Q
MQMH/E1.> %$Y7W7\57,;N+OMMUOIJ],T]N>DQ)D5N9*J8 SYT2$3J)(?CQB1
M4>= .50/$OQ5!-4\5UCI_<5-U[IG*M6[8NK4<+A^'&MC%BC?B,@R#A-VGKBP
MU'D":D B@"KB$TOBG)*G5J_=A/F[K:6+])9S.GDJ/K<IBR1(S8U 6;*>'JIY
M^;JJZXWY^'D@"7/*I[8Z+=U%]/Z<5;VX:E>2[Z542[*!(CC%3[;^&DHR\C;8
MFB,JGJLDBN((JVJFJH@EQM[HGUBB]9:"VFLP/LV74V3E5,CA-8FM(Z+;;G+;
M[)$#@J#H+RG"HO(JB*F;$QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,9PB\YSD!ONF5_432KS6+7U$K[>&["?
M)DD%P!,5'R!5140DYY1>%]T3-:5O;F<JNL#V3:Y.PWMG=U=O8V20VXXR KW&
MCCQO2%500Y:Y)>552,U]D5!38/4O1 ZC:=+I/M6=1R#<9DQ;.M,1?B2&71=:
M='R11+Q,!51)%$DY%45%7-5)VPV5I*2\V'?I-WNGVM66/VM]E1V(_HPO71N,
MD85X\"&7*0B4U+EWE%1!$<IM[VCV^G=.K6IU38Y4IP4K:^ECPZZ'$<@Q6K*,
M^KKKB"GQ3S3;2(AGPBBWPHD1$2[%I>VMJ),L;6VV65;;!;1;9BSG_# R+YS@
MB->0-HJHV+34%D 'E?;E2557G(G5>TF+IVV4]E7;,XW615@R)<,JJ,4B5)BQ
M&HPDDI1]1MHQ8:(VAYY(?8A0B1;AT^Z$0>G]SJUC'M),LZ#5 U5L'6Q1'6A<
M;/U2X^A<M(G">WNN1>J=$=KTK;+V;5]2Y;.N6EC8VGV$=-%(67Y2F?*/JGFJ
M Z:&B+]?'Q7V7+5U"Z;3=[TVMK@VB?2[#6/QYT._A-MH8RFD5/,V53TS T(T
M)M4X5#7CA414U98=H;]U*B7=MNIVVX+9N6,ZTFTD5V.]YQ6XHHU$7D&C:::#
MTW%4R%2<4O-#5,^Z+M 2B^S*\-XLI.M!&I(UG4R(3!+8)5H/PRJ[QRWY*V'J
M>*+Y(*(GA[JN G9:,S4'-<MM[L;>#"KG:ZD&17L<00=E,R7O6'Z21,X[3:@7
MB/I(0+RI*6;3Z*](/^$-?L#*V_VL]=67VH]X06H;+!_#LL>FRTW\H-HC \#[
MJG*\D2^Z['QC&<<I^O.<8QC&,X543ZKQA%Y^F<XQC&<?3.<8QG&<YPJHGU5$
MPB\YSC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QF#>MV#M)8!
M4O,1K0H[@Q'I(*;0/**^!&**BD*%PJHBHJISFE^WFPOEW'>*=W<;'?==J4B1
MBN[06>?MC]+\>PP338"K0)\/R/OZ9D8(ORD([VR@]?[ZPU;H3U%N:J4<*TKM
M<L9<62WQY-.MQG" TY]N4)$7_P!L\X])^KEW4['>2Z*UWS<:*EU<["_KNH#;
M-:<><:M+"]!R0TR0 8)*(S+EI ;147R3A9.Q[KK_ &QS7RIHU4W6A=7%1=RJ
M"]"<P\$>E*<VY#DK'^?[XKRH#P;7BO(JJY$:UUUNJ+>;C;-JL;[\D*_X-B%%
M8M670)D=;=LW"?8^&#S=/A24A,>34$3@ 7RVK?=PNWZEJK=CL>AU.L2GI++;
M4B[VQB+5(TXP3J><HFO-'D(?25H&3^=45"4.22@TG=%;;;MC-I-:DT^E2XNJ
MV4$8DQM'FOC6Y;CXOIZ)>;?#*H2"2*J-#XJGFO%K8[L+ABCC2['IZ[$G6\&N
MM*" %L#A38TN:Q$!'C5M!8> I4<S#YQ07/8R451+E1]?VEZ2[?N&Q4AU$S4W
MY\2UJX4E)B*]%7W%AU1#U$-%!14A#[_!(G"YJ_J7UAZA;'8Z]I'V&>E;(>SU
M+-LE7?"?G7269+P*S)6,ONIPWFW!\!5/25!)1<0T[>ZON/\ ^$G4O3(3>TPJ
M&'5-#?W4&7(:;.TAN2FXB,-":HID@'*?X'WYC GXY>KSN(L*'>+& _J*_DK7
MWD?7'KY;%$,IC\5M]E0C^FO+7D\VT1^:*)&BH)#Y*E;J^[>TD5E6,_0EK[_8
MZ^MLM:J_M<7$FMS'4:$9#B-(D<FU5#/A'$0%114BY!,2P[HYE?9/2'M9LRV*
MO:=JI>LQ[1E8BS?M6##%1<)I%+E)C3@.+XIZ9DA A?=BKONQVJ!L<%][6(\.
M)1PMJ+9ZABR%]5?K&8SK?P[RL"K@D#PJ/*-KRZODB>'O.Q.[>Z@;3]F;-H#=
M##B6T*KM)K=V,GX59D?UXI@",BKGR^SJ<CX*J>"NIRJ1FK=\T3;*:1)K]<@V
M<]^-6S:NOJMA8EFXU-FM0VVY1"'$5\"?:,VE\T\27@B421)_1NO6W;QUFU:@
M>H(M+ 2)L,:^B!8I)1J;!D0VQ)IST15QOQD J>S:JCY>0HK:(4_>]P=A6[K-
M@Q-4^-U>#>Q=7E7A6*-N!92 ;5H4C^FJJPAR([1N^7DA.*J-D(JN:OJ-^WJN
M[$K7>K*YFM[C.C.6J3"F#)5A7) H(M<- ( @^PM^*^*?VB7WRTWG>"6IVMQ(
MN]-=B:A!G758S;M60.2)$FN9=?-$C>"((. RX(DKG/F/"BB*A+7)7='LVA;I
MLS6Z5%91SI+])6U=58[$TU5QW7XTR0\\Y-)E% $!A4+]&2^;:"*$A(2SK/>+
M(M=>;V"GT@[&D@TGV[>2TMFT2*R$R1%?"/X@0R2$HKS@KY +C8\H2*HBN(_W
MTT35OL335;!GP(#-T4((5VR[8ONUK;ANH_$\?*,VZC+WI.$1<^(^0AYBBSL'
MN;V*5<+JKN@LQM\=M(L.+4E>"L4X[T-V8C[DE&.04&F'A($;+YT%!4A+R36^
MD=[BZSJ>MQMG:AR[08+%A=K8W;$>>V,F<^RVU%C>*K+<;%I2-!4$\4'Q4B)!
MRQ=3^Z_:JO5-V.JU!JK-JNV4:"X=M =5Z74D8/$;'I< "H!N-JI%Y*WXD(<H
MJV7N;W&ZI.G_ $X<<G[#K[MOL,*):IIP%,L/ XDAPVF$%HB<_2 '*BWRHBJ\
M)^&OM#[GY>D:>LA^T>V&FO=C?K=2L^H=BS2O%'8BH<LIC_H_HQ"0V^TVAM>J
M2^*$/">66X.\IRYU^/L6NZ4[;Z]'B5;]Q)<LP9=ANSG_ $0;:!&R%]&^/,S0
MA3Q45#SY7CZI>Z%:S;-;U$( SGK6;* 9.P7S$67)1+>3#((8JT+<HF49\R:\
MP,6B:1/5)?>BZWWT6&KZ%5/;C!II-^D2PNK$7KUF"106K*1&:"(V32?$R%%A
MSAI/%%1I.3\C1,O>S]X;FOV\^(>N54"&=\YKU3:7VR-U\66^RT3TAUXB9+T&
MA;04%?G,S+Q\$3YEKF[]VUON_3:18Z%2.,M1X-5+M;1;%L7:TY4[T$;:! (9
M"(C+I$:$*>! H>:EPEC[T>M\WI32ZW"IMF@:Q=2G95PCUA):9"5'@,J\<1%<
M5$59#A,,<)[\.$J?3+0QW'O;%L0CJ>L'L6K1(E;-MKE)XL.1FIP>JV33"@OK
M(VRHNN<F"H))X(9<CD77]RNT6%%13QZ;&V>VG#35$.X#TI@2!==_YLT:YC&$
M=DGS$1>3Q5$$B+D4XC]VC7V'MLJ7JK\2PU>D>LK&#\:)^,AF;)B/1Q- X)$.
M*I"YQ\PF/RHO*9$[?W4[!$<V2)!TT8<4';^GJ+AZS B?L:Z*\_\ .QZ7RLD+
M#G!^1+Y J*'"H2X6C=P^UNP:F(QK[VT;G=G7QEA2[AN- 8?*C;GN$#@Q_(&U
M1%Y3Q-?4/VX'Z24/O EW=177U-HKTW6_&D:M9;UF+3T*19$T@-@UZ9(Z+2/-
MJX?D/WT\4+YE'I[I-JLJ[J=H5,U;=0:^IF55O+D,=.HB29KKS+L(6U<'TG%]
M-!>=3GA/F(??WS*I^L-KJ=_&U2DK+_<[:5:0:AO\J+-J*;(_9(3'7W51CR O
M!"\P\24G5]O%%X&NN=[EXW4.7!=,E"J2C/:1<.^!'%JFI'H/N*'H^SW*B8-(
MJB8K\SC9)XKZP%?).4^F<XQC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&
M,8QC&1^PU)7U#95H3I=8<R,Y'&=!- D1U,5'U&R5%1#'GE%5%X5$]ES6O2KH
M$[THUZ'15_4':+"HA'$^%B2PKQ!AIE24F4]**"J+OEPXI<DO'*$BJJKMK(+?
M-/A]0M(V'5K%QYF!=U\BMD.1B071;>;)LE!5140D0EXY14Y_!<H'4WMJUKJ@
MXP_,FV-=*;IRI''H1M?\PPCK3[/JB8$)JT\R+@<IQR3@DA"9"L27:G5RD<?G
M;=L<ZTD6[EQ*GO'&\WG':Y:YYI 1E !HV.$\1%%%1115/?F1_-<T]V"L&6[8
M3H)N ;T=]X/%U!IRJ? O$47A8YJ2\*B^?NBHGMD2G:FTLVIMWNH6V2MGJWO^
M5O)!Q''FHWH*Q\.+:L>D/R*JJZ@(ZI*I*:_3.RB[1]6H':06KBZD0:N%5PDA
MRG&7 DI )]8YNDK7DI*$EULN%1"147CR3G.W7>U2CI6XS<S8[^\&N"NB5*SW
M6.:Z%"F-2V8K:@T/F*N,-(9N>3A"V">7MSEN'HGKCFI[MK<KXJ;5[=+F3+%M
MUU$)"DB@N(V0HBBB>***^ZHOOSD#KW;C75MO'N[C9[[:-C:LXEB5M9&P+KJ1
MF'V(["@TT (V(R7B7Q%"(S(E+WXR?F=$M9M;7=I]FPY:N;9':A30E^)BU';C
MDR++7R\B/!NFONJ^3I+SQPB:KU?M<GU][L#]GL=U8U$6QB3*BIER&#8G/1:F
M+$CRY"HVA^HCC1JHH0@1 !J/M[_?3OM(;A]-Z"-LNRWTC;8-/40X5BKT<W:(
MX?BZ 1E1KP<1'O+R)U'%<%!$E44RT0>UC7(ZL2)5Q<V%IZ_QDRP?<91R;)6Q
MC6!.N(+:"G+D-D$$$$1;3Q1$]E3JV/M0UK8IUM*^VKN"Y:R+=V:D=QE4=;LH
MK4>2S\S2^(\,,F*I\R$'WE1519>Z[<=9OKZQM9<FP-V?;UEP^SYMJT3D%I&F
M@X4/N$*?.B^Z\KPJ9':WVQU]'6,ULO;]FNZV"5:%7$G26?3KX\&4W)89 0:%
M'%\FFP)USR<4!0?)/=5F:;H)4Z]O\7;8%M:,S6YUK,>CJ31,R$GHPKS1HK?D
M@"<5@Q450D4%155%5,QK/MXJ;/J >Q%>7#-8_:Q[^5K;3C20)-DP  S))?3]
M5%1&FB4!- (F@)1Y1><Z7T'H9G1%.EQR[!*'X(8/Q".!\3X":$B^7AX\\I_V
MY&7O;)J.RP?@;-R?*@E:VUL[')T4%URP8D,/@JH/* @R34>%0D5!7E>/>%C]
MJ<=HY5F]O^US=M*5"F1MCDE$*1$<BL/1VT!M&$:429D.@8D"^?FI>Q+SD)/[
M5I=QNYQIFV;(YJ)ZU&J;!QR>TZ_=E\=*D2&I*DVI")>J/NUZ? F8#P/LEHD=
MK]5)_*& 6U;&WJ]JQ9MMZXS(9;APCL$/XEQOQ;0S]W7" '2,&R<)1'[OCG;-
MVZ55YM$S9X%_<T.RN2(,J-9028(HAQF'XZ> .-$)"XU)= Q-"1>45.%%%R$I
MNTRIUIBIC4VY[761&(D:#9@Q*9%RX:8D./M>NZC7F!^3S@D;*MD0&HJO''$Q
ML/;)J^S4WV9+FV@QE2_1?2=;$E2W5U92?<]O'UB\./IPG/EELLNFD:]@Z4U:
MVD^?+U>:Q8LS3](');[<=UCR>000?F1XR5 04YXXX3VRG77;/4R=AL[^CV&Y
MU>ZDVWVY'DUZ1G!A2SC?#22;;=:,%%]OQ5P#0D4Q0T\2Y5=4]4.VW:9^RU]%
MKPW;M#,:I&K&^>OV3&6D&7ZQ'8-.MJ\XZ@HJ L<A%SS07$$6QS9UIVMU%FY"
MCKM&PMT03?CIE&KK#D68XE@[/!5\VE)DA>>)%-E0(@01(E\45,!OM(K:\' I
M]WVJB%])<645>]'!Q^ _*<E?!^?HJ0(VZ\]Z;H*CPH\:>:^RC8KKMXJYK)/U
M=[;4-ZW?2=BB7,3T''HLB0VK3P(#K9-FT39$*@8E^"\\HBI!W?:93W,>/&3<
M-JC1W8<*';HDMEYVY2)(61'<DNN-$:&AD:*K:@A 7@J>(BB;&?Z8TLWJ&_N,
MP#FV)585+;$A!-AAH7B>-0%1Y0C(A\E55Y1H.$3A>=<4':70:PL&+5;-L,2C
M;&,U.IP?9]&Q:C/&[$:=+TO4$&D<1KALA\VFVP/R1%YXB]IU=#KXK+>Z;0LJ
MG^&'6I9OL$5"TPI^FVR'I>#J>+A-D3XN$3? JOMSF);]F^OVM8D$=KV:&$R%
M(@WCT=^/ZMV+THY9F^1,KXEZ[KA<M>">)J''APB6V=VY:S9)'&3(L7&FKBUN
ME;]4$0W;!B0P^"J@\^"!*<\>.%14'E5X7G'T/MNH]%GT4\+BWM;"I=:>"1-)
ME%>)NN2O'S1ML4_Z*(ORHGS)S^[-,[#VM[!5[11:OJ\:V8TUN10/2K0;J,D:
M2%<^+BE,CDSZROH+0@'H*C9HH*[PK2<^H)NCP9^^U&VN.OI8UE?,K66A)/2)
MN2Y'<<4DXY4D6,''"HG"ERB^W$$G1BE3J&FY))G?:?VE]J>EZ@>CZOP'P/''
MCSX^E[\<\^7OSQ[9497:9J4K62I#L;@8JZH_I_F+S7G\(ZZ+I'SZ?'JH0IPO
M''']G-N4]4[5?&^K92[%)$DY )*\/^7$N.&@\!'Y!X]O+DO=>57)'&,8QC.,
MYSCE/UXY3CGE.,<ISQS[X543ZKQG.,8QC&,9QY(OXIG.,8QC&,8QC&,8QC&,
M8QC&,8QC,.W8ERJJ8S EC G.,F$>4;7JBRXHJ@FH<IY(B\+X\ISQQRF:/[=K
M&\J>H'4/2[N[V"T;IQKWXA[20%,E>H+POS&2#V^%=<:^0.>0('$\0%0'-^9'
M[!>0]9HK&XL'?0@5\9R7(=XY\&VQ4S7_ -D%<\== ^ZZTD]/]P?*RB]2-D&9
M3VL6&Q9 (QPN7VVDA*X@D@)%?)P%1454%!3\4S8K_<ONCLF915VAUL[;*9+0
MKJ.MV3<1I(0PW/T#JL*1J^W.:4/( \20D+V3E?L.Z6]V":ZNLZ=#F5<V=74]
M)*GVI,'+FS(+%@A/-BR7HL-QG34B0B)3;01!?+R3EKNUE1XMC%L=0]#88S9Q
M&(#$_P!1N79MV0U[L8'%;1?#S?AN"YX\J$CW 5!46E=6^ZVW?B=2M7@?9-78
MP*6WE09E)>I,GP7(3S3?_- #?ILFX+J&(BZ9!QXFB+SQOCJCU(O]:V#7=9U'
M7X>P;+<M2Y@-V5@4**S&C(WZI&X+;A>1&^R B@\<FJJJ(*\Z\Z!=1+WJ[UBV
MG9WCDQM577J8ZFM*S-18^):5YSU8J-HWZOFA"KOF2H@(@^Q+FJ=;[D>J=0V]
MLMC70=@9K-=OK>TA%;E'9&/#NG6O)KQC+YO^B!-@*B(JC:*1HI<9MBB[O8-_
MUJ33HT&O<JSN': 'F[ RLADMLDXKYQ$:\1C*0DVA^IY>7BJBB%[2G63N3=Z4
M]1*2A*!2/0Y;L ' E7:-64A)4I(ZE%B V:D+2J)$;I-"7*B*JJ*J4VX[M]UA
M1[&=%Z=U3U<U77=O&-[83!QR+4RO0F*8I&7Q<<Y F1121?)?,@XS+D=ZT%>H
M5A30ZROEU<66_6(B69?:?Q#4,I*NE&1E1&-Y#Z/J>HI(7!>/CG94]U>TS6HE
M;+T:MA;7>,TLJA@#=FY'-FQ&20_%._#HK1,C#?4T 7$+Y4%5Y]JM [J-UTG2
M)TJ?J;-W.KF]AV&Y^*NU!8L2)=/Q5BQR1DO5- 1/3\O3%1;X)1]LG-H[Q[/3
MITC6KFAURHW1BV?A&W/V!QNK1AN'&EHY\3\,IJ9#,9;\/2X0T-?+Q%%60J>[
M>VV"UJ9<'26V=1D3**!*G3;-6IK3UJTT3*#'1E45&W'@!SDQ]B\A\N%3)OI!
MU>VE[M9#?=HC0+#8&6)LAP%LVHL=Q DNB"N/N V#(H(IY$J+P(\IY+[96]:[
ML=EW:'"@:WK&N7NPRKJ=3A)C; \E221X#4WUQ?6+ZA"0O"WPC?L?ORH_-D98
M=T.Q=3Z77+'4:,:W72M]59M;$K-1EQW9[\1XV :1OQ<:%I\&S)3%55U?$505
MYVAUAZ[SNE^T-06=?9L:F'0S]FN;!V<K)QH450$Q9:1LO5>)7!\14@'V+DD]
MN=5-]\<E=4L)KM+KS<J+*@@]9M74A^D@L2@?(3E2@B*31 ;'I&B-J*$ZR7D@
MDJIG#W+[= O-QMY</7&=?:H];F01L-D89A0G9WQ'JN.2A;476_D]E:5PC\&D
M ?TA>$#*[S+V&Y4;A(K:Y-376+1Z3!CV2^#MBS<L5K1@Z<<2]$C,>#)!5 =,
ME!2!!*RP>[R_OJJ/'H=4I+O8%FV$1QZ/>NI5$,6&U,5UJ0L;S<0@=1OCTT47
M$5%^5/+,.1WLSJVCCOV^L55'.N6:>;1K.NR2+\+8LRG0*8Z+"JR;8PGO(6Q<
M15)M!)>55/N9WHW+VL_;U5H\296UE&Y?WCSMR3:-,-3GHCPQ/T"^NJ^@;K9%
MZ8F''/BJHF7SICU9NV]<ZP[!N?I'6:KL5LW%6$?J.) C-B:#X^F"(2"B\>Y<
MJ2\KFM.IW6CJ+L])6:H]1QM0O+:PH)BG5;(Z!%5S9BM$VDD(WFT^)@+;G@BI
MXN>0&ONF;HF;!8L=R5'1C.?2H<U"?,.(I_HS>";# '%3_N03-.?_ *)<H-EU
M\OZ3:=PI=7UH]FLZ^;:6,IJXNU9;")#CPE((ZHP7B3AR1$&E^5%1PB-$5$SI
MJ^[YVPW_ $JE=IZ2/$V1( #%&^1ZU9*5!24#Q1@:5 80E]+EPP,N%- \?'RP
MZ7N\V.?40#G:/ K[79*VHL=9B#=$Z#R3Y*1P"6?H)Z*@2HX7@CB*'*)\R<+G
MTF_;=*[>^N%S:R7*[8ZB7L;<9&):OC"5AHO21EU1%5!%1"%5$51%3E$7E,TX
MWNNYZWJ$^XTVTZGVM,-)7NRW-Y;?B^=HY90!9:B.RF@<\7&3E"XHH3:"K:_5
M??:VU]V]_J&N6AV>O:M5WU/<3:F<%CLY-0G#8C,26PC%\/Z[[CK<D.!1G@%$
M_)4^5"RS[K=CM7G)%#HL254D_1U\=Z?=*P\Y,M&8SS2* L&@M-#)^<_)27Q^
M42Y]OF@[K-G>;?.[T>L@"M==N1E9V(?$YE3("/+%QQYIMMF.1&I \1<H($I
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MUDZA]9&[&$[7:]J=XM+6PW*5YAXO3!%,RD$:BZ9+ROI""* JVJJOJ)FHJ/\
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M-?K-HAIK4C7->KF&+.O-YU)U.XJQW'%%P4)ET#=%P$X+Y^1)/'WW)T;[>F-
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M>4)%5,MD/M$ET'49+?7NHEK1:G.*N>O=:BPF0^U'8488S?Z</'T6G&P;1UH
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MQ^?ET/\ [XR/]"LOY?'Y^70_^^,C_0K+^7Q^?ET/_OC(_P!"LOY?'Y^70_\
MOC(_T*R_E\?GY=#_ .^,C_0K+^7Q^?ET/_OC(_T*R_E\?GY=#_[XR/\ 0K+^
M7Q^?ET/_ +XR/]"LOY?'Y^70_P#OC(_T*R_E\?GY=#_[XR/]"LOY?'Y^70_^
M^,C_ $*R_E\?GY=#_P"^,C_0K+^7Q^?ET/\ [XR/]"LOY?'Y^70_^^,C_0K+
M^7Q^?ET/_OC(_P!"LOY?'Y^70_\ OC(_T*R_E\?GY=#_ .^,C_0K+^7Q^?ET
M/_OC(_T*R_E\?GY=#_[XR/\ 0K+^7Q^?ET/_ +XR/]"LOY?'Y^70_P#OC(_T
M*R_E\?GY=#_[XR/]"LOY?'Y^70_^^,C_ $*R_E\?GY=#_P"^,C_0K+^7Q^?E
MT/\ [XR/]"LOY?'Y^70_^^,C_0K+^7Q^?ET/_OC(_P!"LOY?'Y^70_\ OC(_
MT*R_E\?GY=#_ .^,C_0K+^7Q^?ET/_OC(_T*R_E\?GY=#_[XR/\ 0K+^7Q^?
MET/_ +XR/]"LOY?'Y^70_P#OC(_T*R_E\?GY=#_[XR/]"LOY?'Y^70_^^,C_
M $*R_E\?GY=#_P"^,C_0K+^7Q^?ET/\ [XR/]"LOY?'Y^70_^^,C_0K+^7Q^
M?ET/_OC(_P!"LOY?'Y^70_\ OC(_T*R_E\?GY=#_ .^,C_0K+^7Q^?ET/_OC
M(_T*R_E\?GY=#_[XR/\ 0K+^7Q^?ET/_ +XR/]"LOY?'Y^70_P#OC(_T*R_E
M\?GY=#_[XR/]"LOY?'Y^70_^^,C_ $*R_E\?GY=#_P"^,C_0K+^7Q^?ET/\
M[XR/]"LOY?'Y^70_^^,C_0K+^7Q^?ET/_OC(_P!"LOY?'Y^70_\ OC(_T*R_
ME\?GY=#_ .^,C_0K+^7Q^?ET/_OC(_T*R_E\?GY=#_[XR/\ 0K+^7Q^?ET/_
M +XR/]"LOY?'Y^70_P#OC(_T*R_E\?GY=#_[XR/]"LOY?'Y^70_^^,C_ $*R
M_E\?GY=#_P"^,C_0K+^7Q^?ET/\ [XR/]"LOY?'Y^70_^^,C_0K+^7Q^?ET/
M_OC(_P!"LOY?'Y^70_\ OC(_T*R_E\?GY=#_ .^,C_0K+^7Q^?ET/_OC(_T*
MR_E\?GY=#_[XR/\ 0K+^7Q^?ET/_ +XR/]"LOY?'Y^70_P#OC(_T*R_E\?GY
M=#_[XR/]"LOY?'Y^70_^^,C_ $*R_E\?GY=#_P"^,C_0K+^7Q^?ET/\ [XR/
M]"LOY?'Y^70_^^,C_0K+^7Q^?ET/_OC(_P!"LOY?'Y^70_\ OC(_T*R_E\?G
MY=#_ .^,C_0K+^7Q^?ET/_OC(_T*R_E\?GY=#_[XR/\ 0K+^7Q^?ET/_ +XR
M/]"LOY?'Y^70_P#OC(_T*R_E\?GY=#_[XR/]"LOY?'Y^70_^^,C_ $*R_E\?
MGY=#_P"^,C_0K+^7Q^?ET/\ [XR/]"LOY?/MGOMZ(OO-M!N#Y&X2 *?85BG*
MJO"?_@_ZUS?N,8QC&,X\4_?_ (X\4_?_ (X\4_?_ (X\4_?_ (X\4_?_ (YP
MJ(GU7C_WSGQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3
M]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\
MCCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3
M]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\
MCCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3
M]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\
MCCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3
M]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\
MCCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3
M]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\ CCQ3]_\
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MRO[LF.S,)&IVW6KIX^8>AK&\S':]A%^9F%. )K0JGZN7G.%_'W_5GI?/(_\
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MIG:5=%)U]Q8[2N/@@.DK:<N"GLB$O'NGNOLOZ\QV:"LCU2UC5?%;K5%06&#
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M)I%1?_W8YSG&,8QC&,8QC&,95NJFM2-SZ9;=K\0A"5;5$R T1?1#=8,!5?\
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MJHA)RG(K[IG2QN>ORI-I'9O*UZ15F+<]IN6V1Q"+[HNHA<MJOX(7'.=-1O\
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MK6\K:P?B B<S)C;*>L8^0-?,2?.2+R@_54]T3.^/+IXDB4K+L%E]Z6C<A6R
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M"!YPG&WE?! 4N"$O%"(D-%&[GUP;G],]ZV"%16,&^U1B5\;KUJ#82F9#<9)
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M]R>/'XYK#8^Z+9:CK#8:TQIMI9P*[9RI C5D9IR38-K2).3P4WA$21Q>54E
M?34$]R542Y5G=AJ%U(IS@0;J533@K?B+P8H#$K79Z(L1F3Y.(8F2D"+X 8@K
M@>:CY(N9_43KA"Z:;L]"G)8VJ'$K@C4M77"X^[)E2GV&E%TG11?(F_%15!$.
M/)2X5?&-H^ZR@V2RJ*^MUK9Y4^4/E81&X;)/TZ)-."7Q+:/*9>+[3@DK".H(
MBIDJ J$M(U#OC@.:7!L]HU*^CV!QYEC-&LBM.,0H;5@]#;=<)7_[1-(/"<DJ
M\KXH*<ILW<>XFEU2_G4$:DO=CV&)+**M53QFS><0(;<MUT5-P!\ :>;154D5
M3,0%")41=<57=XR_<WLZYCSJ.AJK6=$BQUJO-^S9;@PWV^$5WS;=4Y2(@*WR
M2N ' JA<6FP[M::M_P"2<TS;W-G!^4Q(UEF''.='6.PU(,C7U_14%9> Q(7%
M0O<4Y/Y<G=0[CJ#?-MBT]#4W=G">;C$=W'C 4..<B&,QD'41SU6_)DP7U";]
M/R) \_+VRO6G<P_KW5[<=/F:O9625[E3$I6JEILY%I*ELOO.-BKCPB* VP9J
M1^ B+1JI<J*+-;5UM"9TCI-SUE2CMSKZKK'F[./X.1D<M&8<MIT%7Y'&_)X%
M]U1"'E%5$]XN-W=:J_7',.DV2.$J,U,HFWH((>PLN20C-%"'U/?R==91!=],
MD%T#5$!?)))[KW V'I%O.SP6[35Y.M.RH$T+2N!Y^')8$%/]"+OBZB>:<*+B
M"7U0N.%7)U?N-H=IZAKJ;5/>PC<EV-?$MID0 A3)4%Q0E,M$CBFJCPI(I @D
M@EXDJBJ)D;'U\K-6W5JAGZ_L#4-R8E:-^L1L8!3%C%(%@5)Q'#Y %3U!;5M"
M^53147BKT_=]K=W!:-C6-I;L)P5SU/52(;+<JX9F^JL=V.BO>*#PP\I>L3:@
MC:J2(BIS(Z'U[;D]#)/4+9(TMIL+2PB-P68:C+-0LW8D6,C//_6)4:;XYX4U
M^J)[YAS.[C6:M]B'8:_LL&U!V:%I7NQ&E<IFX@,.R'Y1"ZH(T+4EEU#;)SS$
M_D0B^7(>F[K2E;C=QIFJ[#$:*)2MTNOOPV6[*=*FK-/Y%];TD!68PFJFX'IH
MVXA^)(HY<=)[D*'J#MM5KU+2W\B7+@E.F/'# &:E!>D,$U*)7.1=1Z*\UX@A
M^Z(OW5\LD&^N->O4F'J+^OW\(9TR170KN5$!J#+E,,*^ZTWRYZJH@"?#BMHV
M2@2":KQSLG&,8QC&,8QC&,9Q]<@$T2D7=ORM.%ZVP)#^SVI;SIGZ#'EY$#0J
MJBWY%PI**(I^(>2KXCQ8,T9W$]LQ=>K )0[$E)XZM>:WXK"]?WL!8'UO^H/_
M $_0^[_:\OJ/'O4MW[-)VP[9:[-5;HU6W#UQK5S"5^K]=J.[4M.M<&/JBK@N
MB\2^RCXJB?7*/'_HVH4*BWBBA[)30JNYKY==6R6=792Q8"1,"212I?J>I(4$
M#T105;107YD)43C:?4SM-7J%;=3IP[.E>NZ-ZXV@? >I\']E2ED<_P#43S]7
MGQ_L^/U^;Z906?Z/2"Q;=0_3OJABKV2#>18;C&M,)9QCLU525^:IJ;P,^1B
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M7V6NL=VNJ38[S<*EVB;=#-^$9H6:DOCY(+'22,EMI21/15E4-")17W0%1#5
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ML&[6J@6\&+ KR>D26YCPLQ@!M%Y5PW#$?'\.>55$Y7,S2.XK6]ZVABDBP;J
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MB7P)"7DD1.>:WN@V#J)*HX&E4]6U(O/L^+%FW#CA,1I;D!ZPF Z#?!%Z+(L
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M5^LT=.YLD.#>R9<X9TJ+&*-";9078WFRCHN.%+:\4-$0?3->2115>[4N[^9
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MN37E51%(O'Q0E1>K8.W'6=CWEW9I$VZ9<>LX-V[6QK FX3D^)Z:,R2;1/F)
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MA"J*V^M[-V1;JR0QZV<_$\6A1DO-UTF4)$)1$44N27A/*-G=X]CKFY0M;O\
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MGG10//E!!M% 3$#](/,2\<PNJ_;E1=7+2PFV%U>U"6E/]@V;-/*;9&=#1PW
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M*VDZU;A.$RV;WJOQ_!Q";-U&R)43GE"X'C9NY3JE7VT_3:L6[38-;^U'9=Q
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8,8QC&,8QC&,8QC&,8QC&,8QC&,8QC/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!X17AI9@  34T *@    @ !@$Q  (
M   1    5@,!  4    !    : ,#  $    ! @   %$0  $    ! 0   %$1
M  0    !   .Q%$2  0    !   .Q     !-:6-R;W-O9G0@3V9F:6-E
M 8:@  "QC__; $, " 8&!P8%" <'!PD)" H,% T,"PL,&1(3#Q0=&A\>'1H<
M'" D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_; $,!"0D)# L,& T-
M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,O_  !$( ,8"$P,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
M         0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @, !!$%
M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U
M-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*
MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:
MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!         0(#
M! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q
M$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8
MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?H
MZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /?Z*** "BFR2)%&TDCJB*,LS'
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M - %(1H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:H4= ,5Z63I\LWTT/+SIJ\%UU%HHHKV3Q HHHH **** "BBB@ HHHH ****
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M$5SFL>!-&U1&:*$6=P>DD(P,^Z]#73T4 >#:[X=OO#]UY5VF8V/[N9?NO_\
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M4PI_Z"*0BS7B?CJ\-WXNO.<K#B)?P'/ZYKVROGW6)OM&M7TN<[YW.?\ @1H
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MK2_\(1X<_P"@8G_?;_XT >(45VOQ"T73M&ET\:?;+ )5D+X8G.-N.I]S7%4
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M %%%% !1110 5P/Q3_Y!=A_UV;_T&N^K@?BG_P @NP_Z[-_Z#0!Y=70>"/\
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MG7D&#]E?W:(_T-<?10!VR_%#60?FM;$_1''_ +-4R?%+4!]_3[5OHS"N#HH
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MN,C_ -!I"/2:XWQ7XYM])1[/3W2>^/!8<K%]?4^U<1JWCO6M51HA*MK"W!2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.KZ5;
M:SILME=+E''##JI[$>]7J* /"->\-W_A^Z,=S&6A)_=SJ/E8?T/M6/7T7-!%
M<PM%/$DD;##(ZY!_"N1U/X;Z1>%GM'DLW/93N3\C_C0!Y%4D5Q- <Q321_[C
M$5V5W\,M7A)^S7%M.O;DH?U_QK,E\">(XNNG%AZK*A_K3&9:ZYJRC"ZI>@>@
MN'_QJ.75-0G_ -=?7,G^_,Q_F:T?^$.\0_\ 0+G_ $_QJ2/P1XCE/&F./]YU
M7^9H Y\DDY/6BNRM?AKK<Q'GM;6X[[GW']*Z33?AEIUN0]_<2W3#^!?D7].?
MUH \VTS2;[6+H6]C;M*YZD=%'J3VKV#PKX3M_#ML78B6]D&))<< ?W5]OYUM
M6=C:Z? (+2WCAB'147%6*0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
***** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image1a01.gif
<TEXT>
begin 644 image1a01.gif
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9A0 PH-MNL_UD0@,'O+?0  Q\H-@& 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image2.gif
<TEXT>
begin 644 image2.gif
M1TE&.#EA'@ > /8  (^/CY"0D)&1D9*2DI.3DY24E)65E9:6EI>7EYB8F)F9
MF9J:FIN;FYR<G)V=G9Z>GI^?GZ"@H*&AH:*BHJ.CHZ2DI*6EI::FIJ>GIZBH
MJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^OK["PL+&QL;.SL[2TM+6UM;:VMKBXN+FY
MN;JZNKN[N[R\O+V]O;Z^OK^_O\# P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(
MR,G)R<K*RLO+R\S,S,W-S<[.SL_/S]#0T-'1T=+2TM/3T]34U-75U=;6UM?7
MU]G9V=K:VMO;V]S<W-W=W=[>WM_?W^#@X.'AX>+BXN/CX^3DY.7EY>;FYN?G
MY^CHZ.GIZ>KJZNOKZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T]/7U]?;V
M]O?W]_CX^/GY^?KZ^OO[^_S\_/W]_?[^_O___X^/CX^/CX^/CX^/CX^/CX^/
MCX^/CX^/CX^/CX^/CX^/CX^/CX^/CX^/CX^/CX^/CX^/CX^/CRP     '@ >
M $8(_P!EV,!!L""/'CE2>+A0@8*%#RUV]-!1D. -&D-XK(%P0 $"!$.^@!A@
MP( %*&O,))DA04J5!QT1).CBA4<%"0H,=, 2 0$!$FS:+#F 0('1HP<D=(%!
M0,&#!#UPM&F#!4*!HP8T^,#214N6*S\Z&.CHD8#4-EEXG&U3A0*!!$9]%F#P
MH$$! D6-&D  9"I:'ALJ>&10Y<8 !0D,#)D*!,&##@Z*%@#AQ4)'"2* ^$C2
M5$&!'%8D] C3I4N;%P:P)F!2A8%D$E)^Y/!+>PT1%!PF1-@M <,(&UMH^_6R
M8^U4-#TF%"AP .[1! <('"AA17A:J6<^=$9P@(46,$I\X/_($<3*%AP+4N>$
M$#RMC157#U@8X^*P @(W_'+IDN8"@ QBG!!?!TL H5M.'F@!05$$^#!5#/8=
M-1@5-#0%P0(^F. !@T,T44 "3DQ5AA(HY'74 #U4@9@"$80 Q&PXV)>   UL
M,<, ""QG %X@3/&%")T5@ $;7*A%FQ4;X'@4=P<0]1P!"_ 0U%1IS2;<5$Z\
M(,(%$O#FVPVF74F<<5R$0-)S'\GTW  .%$';=5-M,4%G"13@@ I!3(%%%4*P
M8%5>1!U!)0^SY3  7 <L0$09.%100  (=-"!!2UP 04$Z@V 0AM:\."#$D'6
M,,8&32' @!0B8J$&!0I@H82: ]S[P$4/&A8U  XJ%F5 !F-,]0009OP@$P%$
M2)' L1+<$,1-.67@!0BI&;#!&9P^4$".@$JPA0I712 !$!1$X-D'6#S '01:
MM $&!>I)B( #5U2H  10!:;  1%<@0(!!EA966<22MN%!AU%X, /[UUE  AD
MC"  $5-)D4:N1Q4P@1@Q-)6 !#L$P8,:,'FTP D>1-$!"5?PH&8" RQPA!@;
MI,8R$E\8:08'=![@@AA1T$ """/D$$481E!PE4<(+/'76I<";("=$U @@0/+
M(47 #'[!2=L8,S1 P+42(A:= 2&@^B8/ E4TWD$TC)!!0Q1<\ $+$E%4T45#
$! 0 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image3.gif
<TEXT>
begin 644 image3.gif
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MB0]"3O# M:O7KUP16 R00J)&@08K/%"@@(*)LP)_#KP DFC(!64AUI1@MR\
M!"OB7I"9H82'#D)U,EBA@45=  PD(AUI40*+$1D.F$ A(D'(JB$I;.! N 0(
M#78%G"#A.&0 LRQ(^R5:(#!L@B8X]FU@VV=&%7R)$L"@42X)L;,M"B#NF\4*
MW<E=OXW+ G7TH98EIB ,E ';[^#90HD@0<*S1:,;H"<E$$(%])"6*\"4*4 R
M8<H )K 8#("G^\\X6;#!9!8YP((#"JC  @D#<* "<J!9)%I6(24%6 9#"4#"
M"?7A=-4*CV&T0@44E&CBB118\,$'YD%FE@F/72=3!=0)))^,(7$PD%PK3!!
;= @\U%Q$&A PE %N%;?!DDPVZ>234"X9$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image4.gif
<TEXT>
begin 644 image4.gif
M1TE&.#EA'@ = /0  )F9F:"@H*BHJ*^OK["PL+:VMK>WM[V]O;Z^OL3$Q,O+
MR\_/S]'1T=34U-?7U]W=W=[>WN#@X./CX^;FYNGIZ>SL[.WM[>_O[_3T]/KZ
M^OW]_?___YF9F9F9F9F9F9F9F2P     '@ = $0(_P W"!Q(, ,%!@@9.+A
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:&7K@A0'Z3>150YL-U-H!^0$@0 *0:180 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image5.jpg
<TEXT>
begin 644 image5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (/ _ # 2(  A$! Q$!_\0
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M +)5X7_]-%K7T!0!\_\ _#IW]EG_ *-I^ '_ (;S2/\ Y'H_X=._LL_]&T_
M#_PWFD?_ "/7T!10!\__ /#IW]EG_HVGX ?^&\TC_P"1Z/\ AT[^RS_T;3\
M/_#>:1_\CU] 44 ?/_\ PZ=_99_Z-I^ '_AO-(_^1Z/^'3O[+/\ T;3\ /\
MPWFD?_(]?0%% 'S_ /\ #IW]EG_HVGX ?^&\TC_Y'H_X=._LL_\ 1M/P _\
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M/7T!10!\_P#_  Z=_99_Z-I^ '_AO-(_^1Z/^'3O[+/_ $;3\ /_  WFD?\
MR/7T!10!\_\ _#IW]EG_ *-I^ '_ (;S2/\ Y'H_X=._LL_]&T_ #_PWFD?_
M "/7T!10!\__ /#IW]EG_HVGX ?^&\TC_P"1Z/\ AT[^RS_T;3\ /_#>:1_\
MCU] 44 ?/_\ PZ=_99_Z-I^ '_AO-(_^1Z/^'3O[+/\ T;3\ /\ PWFD?_(]
M?0%% 'S_ /\ #IW]EG_HVGX ?^&\TC_Y'H_X=._LL_\ 1M/P _\ #>:1_P#(
M]?0%% 'S_P#\.G?V6?\ HVGX ?\ AO-(_P#D>C_AT[^RS_T;3\ /_#>:1_\
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MT!10!\__ /#IW]EG_HVGX ?^&\TC_P"1Z/\ AT[^RS_T;3\ /_#>:1_\CU]
M44 ?/_\ PZ=_99_Z-I^ '_AO-(_^1Z/^'3O[+/\ T;3\ /\ PWFD?_(]?0%%
M 'S_ /\ #IW]EG_HVGX ?^&\TC_Y'H_X=._LL_\ 1M/P _\ #>:1_P#(]?0%
M% 'S_P#\.G?V6?\ HVGX ?\ AO-(_P#D>C_AT[^RS_T;3\ /_#>:1_\ (]?0
M%% 'S_\ \.G?V6?^C:?@!_X;S2/_ )'H_P"'3O[+/_1M/P _\-YI'_R/7T!1
M0!\__P##IW]EG_HVGX ?^&\TC_Y'H_X=._LL_P#1M/P _P##>:1_\CU] 44
M?/\ _P .G?V6?^C:?@!_X;S2/_D>C_AT[^RS_P!&T_ #_P -YI'_ ,CU] 44
M ?/_ /PZ=_99_P"C:?@!_P"&\TC_ .1Z/^'3O[+/_1M/P _\-YI'_P CU] 4
M4 ?/_P#PZ=_99_Z-I^ '_AO-(_\ D>C_ (=._LL_]&T_ #_PWFD?_(]?0%%
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M_P##IW]EG_HVGX ?^&\TC_Y'H_X=._LL_P#1M/P _P##>:1_\CU] 44 ?/\
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MD=(VM].UFSOIU!1&/F-%;N$! !8J"RC+#R#]L?\ 8Y^)_P 2_B'\3;GX?R>
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MH **** "BBB@ HHHH **** "OG__ (*Q?\HLOVEO^R5>*/\ TT75?0%?/_\
MP5B_Y19?M+?]DJ\4?^FBZH ^@**** "BBB@ HHHH ^?_ /@D[_RBR_9I_P"R
M5>%__31:U] 5\_\ _!)W_E%E^S3_ -DJ\+_^FBUKZ H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *CO+R+3[26>>1(8($,DDCG"H
MH&22>P J2O/OVJ?@C=?M)_L^^)_ 5MX@G\,1^+;8:9?:A!;^?,ME(ZB[BC&Y
M=KRV_FQ+)D^69 ^UMNTS/FY7R;^>WS\BH<O,N?;J?/\ ^PI^V)XW^)_QCGB\
M?WEJ/#?QATBY\<_"^$6J6\EMI%O=M;M;/A5=W:TETJ]_>;I U]<*2JQJB]I\
M+?\ @I9X8^)'PMU[Q]=^"?B1X6^'6E>&KKQA8^*M3T^UGTS7]*M@6DGMVL[F
MXDB?8%=;>[2WN&5CB(E)0E75O^"5/PB\'>+_  9XI^$G@7X<_!KQEX-UR#48
M]:\->$+.TGOK/:\-W83>0(3)'/;RR*-[,J2>5(4<Q[3SGP(_X)CZU\(OC5XP
M\>2?$'PY8>)_$F@WVB+J_@[X?V/AS4-4FNKA)_[6UK]Y/:ZIJ431J8Y?LT$0
M,UU^Y(FVI3LXVCI922OOHFX/S?PQ;=KM2E)/F31"U^:?5Q=NBN_?6SLK7DM'
M9-*.UCN-'_X*#6*?#P>(?$_PQ^*?@1)M9T'1[6UUFTTZ8WPUF\AL[2YAN+.]
MN+22(2S#S5$_G1*N6B^>+S%^)7_!17PO\.]3US3HO"OCOQ'J^C>.[;X=II^D
M6=J\^HZK<:5%J<7DF6XC00F*9$,LK1A'W%]L:F4>0> _^"/-QX-^%_CW3[;Q
M?X#\+^(?%FH>'M7TX>!_AZOAWPOI-_HMZ+ZVO7T<7LPGN9Y@JW,@N(_-BBA1
M1&8PY[OP+_P3QU^P\4'Q%XI^(FGZ[XAO/BA:_$R_ET_PTVG6DDD.AQZ3]BAA
M:[F>.,B,2!WDD89VG>?G.C4'.VRNO_ 7*E?YJ/M6]-=++9$QTIMO65I6\WRR
M:ZZ)RY5OWN^KM?#+_@J)X<^(OC3P]I-S\.OBGX5M==\0WW@Z;5]:LM/CT_2-
M>M%N7FTR=HKR1V?9:N5N+=)K1BRJ+C?N59O"'_!4KP#K^DZQJ^K:'XU\)>&;
M;PI?>.M#US5K.V:S\8Z%98:YO[!;>>:;:B26\GE7,<$[)<Q,(B-VVS!_P3^1
M;/2H)?%/FQ:=\5=0^)CC^S=OGK=B\!L?]=\NW[7_ *[G/E_ZL;N.!_9%_P""
M16F_L?ZAJS>%M4^'7ALP^'KGPUX>UGPO\+]*TOQ/!%*R&.ZU/4IC<G4KJ-8H
MN1%;PRL9'FAE8IY?/!SE3;FK2Y>G?V:;^ZHW%;KEB[[J9K:"J63O&Z\M.>2[
M=::C)Z7YI:;<J]]_9N_:0N?VA-.OI;WX=?$+X=7%I';W,4'B:"Q=-0MYT+13
MV]S875U:R#Y6#()O-CPI>-0\9?YX^#G_  4SU+P]X7L=%U_PIX^^*/COQ!KO
MCR;3;7PU9Z7"1IFA^(Y;$([W-S:0(8[>2W +-F01-EFE90_H7[ W_!/\_L7:
M]XTU>34? HN?&:6,4ND^!/!:^#O#EN;43?Z4-/%U= WLQG(FG\P!TAMU"+Y6
M6C^"O_!/#_A3_P 3-)\1?\)?_:/]EVOC:V^S_P!E>3YO_"1ZY#JV=WG-C[-Y
M/E8P?-W;_P!WC8=<1I)^QVL_OY6XK6V\K)O3=[+:*5O9VJ;\T?+W;2YN_=:7
M>RWL>9?''_@JW_8?AK3?%/PNT+QOX]?Q':_#W48=&N+33+>RMM+\1:I<6Z30
MF:XMIQ>R)&\1669HHY39MM$?VEQ["W[8Z:!>_$5=)\)_%[XCZUX>\:VOA8^'
MM,TS3'EL[F72;*]*V\WFP016:13^8\]_<+^^:2-78-!&?*K+_@D-?>'_ (26
MFA:5\2X+?6=(\)^ ?#^F:C<>&C/;PW?A34)KZ&[EMQ=J9([AY55H%E0H$.)6
M+<:WQT_X)=:K\8;?Q4__  F_A:Y/BWQ_;^.=2T7Q'X,?6O#&K+'H5MI7V"_T
M[[=";N(2VR7D>Z=0DJ195_+#':I[-3J*&W,^7_#S4K?^2JH]5Z;V'[O7^5?^
M!<FO_D^FFG?N:GP3_;JO/VD_VK_AQ9:'!X@\-^%]9\*^,CKGAS7+&VCU"RUC
M1]9TK3RDKQ-* T32W:_N9FB<2!LMA2,V#_@H7??"7XR_$S0O$>D>+?'<]S\5
MH_ O@K1_#]G8BXC)\*V6K>0SS2V\>UI/M9\V:3Y6E4,RQKE+_P"Q3_P2\@_8
MV\6^$-0M/%ECJ5IX1L?%5E#867AJ'2+<C7-5LM1(CCAD\J".W:T:-8XXPI61
M<;-F&Z.+_@G_ .5^T@/B#_PEN<?$M_B)]@_LO^]X6'A_['YGG?\ ;QYNW_IG
ML_Y:5,.2T4_Y)7_Q.JI:;ZJ%TGK9::[-75JGSY?.T)*-[6WERWVUUTZ4_ O_
M  52\ ^-?!7B36)M!\;Z#)X7\.WGB"ZT[4K.U6\G-GJ-WIEY8PB*XDCENH;R
MT\I@K^4QN;8I(XDR-OP+_P %#O#/CCXO:=X9_P"$6\;Z5I.N:K>^'=(\5WL%
MD=#U76;))&N],C,5R]RL\1M[Q=\L"0.UE,(Y9/DW\I:?\$OM.-AX%ANO%UT_
M_")>/-:\7WQM]-2+^W;+4-7GU@:3+N=RD4=\-/D,@.9/L&-J"5@N9\'_ /@D
MQX=^#'[6EW\1=+C^&,5F^NZIXEM[A?AM8MXS^V:AYS31S:_+)([VJ2W,S1I%
M;PS*JPQM.\:.DN4=7KVEZ7NN6VM]4VM7O&]TG9E1)<Z@[Z^[Z:K7SNE+9+EF
MUNO=S_BG_P %8+Z?]BOXC_%/P%\)OB')!H7@V[\6^$=5UJST]]$\46\1VBX5
MX-0+0HH9)FM[HVMT\6_RXG='1>S^+G_!3"Q^";"TU7X4?%C4=8T_P5'X^U^R
MTNWTF8^'-,+3),]Q(VH+"\D30/F*WDFD<$>4)MK[?-K3_@CC/K%S\6;C7O'/
MA2/4/B?X,U?P==:CX5^']OX;O-8.H.';5-<\FX:'5-0C*#9+'%:(/.NL1@3
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MR1X6X$K37$]S(SJZ@I&8TBW2@W)-Z7=O-*=D_64+R>EKM6M9Q>";Y+M:VO\
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M)?"N3X7> /#'BW7?B4/$$$GVCQPMOH6F7&BSQ07134+>SN3=VLCL_DSPP$R
MPDQH'<Q<9XJ_X*:^,OB]^S/JM[<?#Z3X=6'Q&^$WB7Q1X0UBS\6?:]6M+O3K
M./SHYX8K>-;<AYS)!-%<2EEB4NL#MY:_4/A']D72O#7BKP#KUYXG\:^)==\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5\_\ _!6+_E%E^TM_V2KQ1_Z:+JOH"OG_ /X*Q?\ *++]I;_L
ME7BC_P!-%U0!] 4444 %%%% !1110!\__P#!)W_E%E^S3_V2KPO_ .FBUKZ
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M2?"T%O'!I7B34=,MY?W.CQN96@LHRY+E"[N51055?K6OG_\ X)I_\FZ^(_\
MLJOQ'_\ 4WUVLA'H'_"F_$7_ $5CQ_\ ^ >A_P#RNH_X4WXB_P"BL>/_ /P#
MT/\ ^5U>@44 >?\ _"F_$7_16/'_ /X!Z'_\KJ/^%-^(O^BL>/\ _P  ]#_^
M5U>@44 >?_\ "F_$7_16/'__ (!Z'_\ *ZC_ (4WXB_Z*QX__P# /0__ )75
MZ!10!Y__ ,*;\1?]%8\?_P#@'H?_ ,KJ/^%-^(O^BL>/_P#P#T/_ .5U>@44
M >?_ /"F_$7_ $5CQ_\ ^ >A_P#RNH_X4WXB_P"BL>/_ /P#T/\ ^5U>@44
M>?\ _"F_$7_16/'_ /X!Z'_\KJ/^%-^(O^BL>/\ _P  ]#_^5U>@44 >?_\
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M >?_ /"F_$7_ $5CQ_\ ^ >A_P#RNH_X4WXB_P"BL>/_ /P#T/\ ^5U>@44
M>?\ _"F_$7_16/'_ /X!Z'_\KJ/^%-^(O^BL>/\ _P  ]#_^5U>@44 >?_\
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M >?_ /"F_$7_ $5CQ_\ ^ >A_P#RNH_X4WXB_P"BL>/_ /P#T/\ ^5U>@44
M>?\ _"F_$7_16/'_ /X!Z'_\KJ/^%-^(O^BL>/\ _P  ]#_^5U>@44 >?_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(^&G_!(#]G[Q#X@U*RT;0M#^#_AN^U"_O)1%!9P1Z-;/)([GA55022?2N_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP _\,WJ__P T]?0%% 'S_P#\*Y_:F_Z+)\ /_#-ZO_\ -/1_PKG]J;_HLGP
M_P##-ZO_ /-/7T!10!\__P#"N?VIO^BR? #_ ,,WJ_\ \T]'_"N?VIO^BR?
M#_PS>K__ #3U] 44 ?/_ /PKG]J;_HLGP _\,WJ__P T]'_"N?VIO^BR? #_
M ,,WJ_\ \T]?0%% 'S__ ,*Y_:F_Z+)\ /\ PS>K_P#S3T?\*Y_:F_Z+)\ /
M_#-ZO_\ -/7T!10!\_\ _"N?VIO^BR? #_PS>K__ #3T?\*Y_:F_Z+)\ /\
MPS>K_P#S3U] 44 ?/_\ PKG]J;_HLGP _P##-ZO_ /-/1_PKG]J;_HLGP _\
M,WJ__P T]?0%% 'S_P#\*Y_:F_Z+)\ /_#-ZO_\ -/1_PKG]J;_HLGP _P##
M-ZO_ /-/7T!10!\__P#"N?VIO^BR? #_ ,,WJ_\ \T]'_"N?VIO^BR? #_PS
M>K__ #3U] 44 ?/_ /PKG]J;_HLGP _\,WJ__P T]'_"N?VIO^BR? #_ ,,W
MJ_\ \T]?0%% 'S__ ,*Y_:F_Z+)\ /\ PS>K_P#S3T?\*Y_:F_Z+)\ /_#-Z
MO_\ -/7T!10!\_\ _"N?VIO^BR? #_PS>K__ #3T?\*Y_:F_Z+)\ /\ PS>K
M_P#S3U] 44 ?/_\ PKG]J;_HLGP _P##-ZO_ /-/1_PKG]J;_HLGP _\,WJ_
M_P T]?0%% 'S_P#\*Y_:F_Z+)\ /_#-ZO_\ -/1_PKG]J;_HLGP _P##-ZO_
M /-/7T!10!\__P#"N?VIO^BR? #_ ,,WJ_\ \T]'_"N?VIO^BR? #_PS>K__
M #3U] 44 ?/_ /PKG]J;_HLGP _\,WJ__P T]'_"N?VIO^BR? #_ ,,WJ_\
M\T]?0%% 'S__ ,*Y_:F_Z+)\ /\ PS>K_P#S3T?\*Y_:F_Z+)\ /_#-ZO_\
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M!10!\_\ _"N?VIO^BR? #_PS>K__ #3T?\*Y_:F_Z+)\ /\ PS>K_P#S3U]
M44 ?/_\ PKG]J;_HLGP _P##-ZO_ /-/1_PKG]J;_HLGP _\,WJ__P T]?0%
M% 'S_P#\*Y_:F_Z+)\ /_#-ZO_\ -/1_PKG]J;_HLGP _P##-ZO_ /-/7T!1
M0!\__P#"N?VIO^BR? #_ ,,WJ_\ \T]'_"N?VIO^BR? #_PS>K__ #3U] 44
M ?/_ /PKG]J;_HLGP _\,WJ__P T]'_"N?VIO^BR? #_ ,,WJ_\ \T]?0%%
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M ,*Y_:F_Z+)\ /\ PS>K_P#S3T?\*Y_:F_Z+)\ /_#-ZO_\ -/7T!10!\_\
M_"N?VIO^BR? #_PS>K__ #3T?\*Y_:F_Z+)\ /\ PS>K_P#S3U] 44 ?/_\
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M;Z[0!] 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#WACQGX3\1Z_X.G6VU_3-+U>WO+S0Y6+A8[J*-R\#DQN L@4G8WH:%KMVO\
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M_P"9BC_A8_[4W_1&_@!_X>35_P#YF*^@** /G_\ X6/^U-_T1OX ?^'DU?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?,?[=_P"W-<_!B[L_
MA[\/;7_A(?BMXFQ!9VD*B7^R@X^661>F\CE5;@ %W^4 -OAL/4KU%3I[_EYO
MR*A!R=D0_MU_MT7GPKU>V^&GPUMCXA^*_B+;!!! @E&D*XR))!T\S;\RJW"C
MYW^4 -N_L)?L-6?[+7AZYUK7)UU[XC^(LS:SJ\C&5D+G<T,3-SMW<LW5VY/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\-D?$7_HT[X__P#@W\$?_-#7T!10!\__ /#9'Q%_Z-.^/_\ X-_!'_S0T?\
M#9'Q%_Z-.^/_ /X-_!'_ ,T-?0%% 'S_ /\ #9'Q%_Z-.^/_ /X-_!'_ ,T-
M'_#9'Q%_Z-.^/_\ X-_!'_S0U] 44 ?/_P#PV1\1?^C3OC__ .#?P1_\T-'_
M  V1\1?^C3OC_P#^#?P1_P#-#7T!10!\_P#_  V1\1?^C3OC_P#^#?P1_P#-
M#1_PV1\1?^C3OC__ .#?P1_\T-?0%% 'S_\ \-D?$7_HT[X__P#@W\$?_-#1
M_P -D?$7_HT[X_\ _@W\$?\ S0U] 44 ?/\ _P -D?$7_HT[X_\ _@W\$?\
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MW\$?_-#1_P -D?$7_HT[X_\ _@W\$?\ S0U] 44 ?/\ _P -D?$7_HT[X_\
M_@W\$?\ S0T?\-D?$7_HT[X__P#@W\$?_-#7T!10!\__ /#9'Q%_Z-.^/_\
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M'Q%_Z-.^/_\ X-_!'_S0T?\ #9'Q%_Z-.^/_ /X-_!'_ ,T-?0%% 'S_ /\
M#9'Q%_Z-.^/_ /X-_!'_ ,T-'_#9'Q%_Z-.^/_\ X-_!'_S0U] 44 ?/_P#P
MV1\1?^C3OC__ .#?P1_\T-'_  V1\1?^C3OC_P#^#?P1_P#-#7T!10!\_P#_
M  V1\1?^C3OC_P#^#?P1_P#-#1_PV1\1?^C3OC__ .#?P1_\T-?0%% 'S_\
M\-D?$7_HT[X__P#@W\$?_-#1_P -D?$7_HT[X_\ _@W\$?\ S0U] 44 ?/\
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M_!'_ ,T-?0%%>48'S_\ \-D?$7_HT[X__P#@W\$?_-#1_P -D?$7_HT[X_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\L^'7_0N?'__ ,,3XW_^5-'_  \L^'7_ $+GQ_\ _#$^-_\ Y4U] 44 ?/\
M_P /+/AU_P!"Y\?_ /PQ/C?_ .5-'_#RSX=?]"Y\?_\ PQ/C?_Y4U] 44 ?/
M_P#P\L^'7_0N?'__ ,,3XW_^5-'_  \L^'7_ $+GQ_\ _#$^-_\ Y4U] 44
M?/\ _P /+/AU_P!"Y\?_ /PQ/C?_ .5-'_#RSX=?]"Y\?_\ PQ/C?_Y4U] 4
M4 ?/_P#P\L^'7_0N?'__ ,,3XW_^5-'_  \L^'7_ $+GQ_\ _#$^-_\ Y4U]
M 44 ?/\ _P /+/AU_P!"Y\?_ /PQ/C?_ .5-'_#RSX=?]"Y\?_\ PQ/C?_Y4
MU] 44 ?/_P#P\L^'7_0N?'__ ,,3XW_^5-'_  \L^'7_ $+GQ_\ _#$^-_\
MY4U] 44 ?/\ _P /+/AU_P!"Y\?_ /PQ/C?_ .5-'_#RSX=?]"Y\?_\ PQ/C
M?_Y4U] 44 ?/_P#P\L^'7_0N?'__ ,,3XW_^5-'_  \L^'7_ $+GQ_\ _#$^
M-_\ Y4U] 44 ?/\ _P /+/AU_P!"Y\?_ /PQ/C?_ .5-'_#RSX=?]"Y\?_\
MPQ/C?_Y4U] 44 ?/_P#P\L^'7_0N?'__ ,,3XW_^5-'_  \L^'7_ $+GQ_\
M_#$^-_\ Y4U] 44 ?/\ _P /+/AU_P!"Y\?_ /PQ/C?_ .5-'_#RSX=?]"Y\
M?_\ PQ/C?_Y4U] 44 ?/_P#P\L^'7_0N?'__ ,,3XW_^5-'_  \L^'7_ $+G
MQ_\ _#$^-_\ Y4U] 44 ?/\ _P /+/AU_P!"Y\?_ /PQ/C?_ .5-'_#RSX=?
M]"Y\?_\ PQ/C?_Y4U] 44 ?/_P#P\L^'7_0N?'__ ,,3XW_^5-'_  \L^'7_
M $+GQ_\ _#$^-_\ Y4U] 44 ?/\ _P /+/AU_P!"Y\?_ /PQ/C?_ .5-'_#R
MSX=?]"Y\?_\ PQ/C?_Y4U] 44 ?/_P#P\L^'7_0N?'__ ,,3XW_^5-'_  \L
M^'7_ $+GQ_\ _#$^-_\ Y4U] 44 ?/\ _P /+/AU_P!"Y\?_ /PQ/C?_ .5-
M'_#RSX=?]"Y\?_\ PQ/C?_Y4U] 44 ?/_P#P\L^'7_0N?'__ ,,3XW_^5-'_
M  \L^'7_ $+GQ_\ _#$^-_\ Y4U] 44 ?/\ _P /+/AU_P!"Y\?_ /PQ/C?_
M .5-'_#RSX=?]"Y\?_\ PQ/C?_Y4U] 44 ?/_P#P\L^'7_0N?'__ ,,3XW_^
M5-'_  \L^'7_ $+GQ_\ _#$^-_\ Y4U] 44 ?/\ _P /+/AU_P!"Y\?_ /PQ
M/C?_ .5-'_#RSX=?]"Y\?_\ PQ/C?_Y4U] 44 ?/_P#P\L^'7_0N?'__ ,,3
MXW_^5-'_  \L^'7_ $+GQ_\ _#$^-_\ Y4U] 44 ?/\ _P /+/AU_P!"Y\?_
M /PQ/C?_ .5-'_#RSX=?]"Y\?_\ PQ/C?_Y4U] 44 ?/_P#P\L^'7_0N?'__
M ,,3XW_^5-'_  \L^'7_ $+GQ_\ _#$^-_\ Y4U] 44 ?/\ _P /+/AU_P!"
MY\?_ /PQ/C?_ .5-'_#RSX=?]"Y\?_\ PQ/C?_Y4U] 44 ?/_P#P\L^'7_0N
M?'__ ,,3XW_^5-'_  \L^'7_ $+GQ_\ _#$^-_\ Y4U] 44 ?/\ _P /+/AU
M_P!"Y\?_ /PQ/C?_ .5-<S\4?^"N_P +?ASX<N93IOQ0AUEK:273=/U[X;^(
MO#2:FZE042XU&Q@AX+J6PQ8+DA6/![/]JS_@H+X _92@:SU"\.N>*7&(-"TU
MA)=,Q^[YIZ1*<C[WS$'Y5:OD_P"('['OQL_X*9:@_C?QC::%\.K6RL7B\/Z9
M<6I^USJ271)3_K%4L>6DZ$DK$ QKU\!E\9-5L6^6GY]?3K\SHI4D_>J:(])^
M'W_!=GX-6WP\TRZ^(EWX@\*^))]T=S8Z;X4UC782R8_>))8VLX1&SPLA5LAA
M\P&XZG_#^[]E_P#Z&_QS_P"&N\5__*VN>_8__P""-7A+P_\ #D7?Q;TO^WO$
MVH[9#8Q:A-#!I*_\\P\$B^8_/S-DKP O3<WK?_#IC]G[_H0/_*YJ7_R16F*A
ME:K24)2MY)-?)MCFJ"D[-G"_\/[OV7_^AO\ '/\ X:[Q7_\ *VC_ (?W?LO_
M /0W^.?_  UWBO\ ^5M=U_PZ8_9^_P"A _\ *YJ7_P D4?\ #IC]G[_H0/\
MRN:E_P#)%<]LN_FG]T?\R?W/G^!Q-K_P7D_9AO)@B^,/&H)[O\,O%*#\VTX"
MK?\ P_,_9G_Z'/Q7_P"&[\2__(%=A9_\$I/@#8W D3X?Q%ES@2:QJ$B_]\M.
M1^E7?^'87P(_Z)WIO_@7=?\ QVBV7=Y_='_,/W/G^!P7_#\S]F?_ *'/Q7_X
M;OQ+_P#(%'_#\S]F?_H<_%?_ (;OQ+_\@5WO_#L+X$?]$[TW_P "[K_X[1_P
M["^!'_1.]-_\"[K_ ..T[9=WG]T?\P_<^?X'!?\ #\S]F?\ Z'/Q7_X;OQ+_
M /(%6;/_ (+;_LV7T1=/&OB( ''[SP)XAC/Y-8@UVG_#L+X$?]$[TW_P+NO_
M ([5JQ_X)M_ W3HBD?PXT-@3G]ZTLI_-G)I?\)W>?_DHOW/G^!PW_#ZK]F[_
M *'?7/\ PB=>_P#D*C_A]5^S=_T.^N?^$3KW_P A5Z!_P[K^"/\ T3?PY_W[
M?_XJC_AW7\$?^B;^'/\ OV__ ,51_P )W]__ ,E#]SY_@>?_ /#ZK]F[_H=]
M<_\ ")U[_P"0J/\ A]5^S=_T.^N?^$3KW_R%7H'_  [K^"/_ $3?PY_W[?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !14&I:E;Z-I\UW=SPVMK;(99IIG"1Q(!DLS'@ #
MJ37R!\:?^"H,_C#Q<_@;X">'I_B'XLES&=26,_V;9]BX.1O /\;%(AP=S#BN
MG#82K7=J:VW?1>K+A3E/8^F?C)\=/"?[/WA&37/%^N66BZ>F0AF;,EPPYV11
MC+R-[*":^/\ 5/VJ/C1_P4&U.?1O@OI%SX#\"[S#=>+=2_=7$J]#Y3#.QNOR
MQ;G!QET!-=+\&_\ @F#=^._%Z>.?C_XBG^('BF3#II0E/]FV7.0AQMW@'^!
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MOG__ ()I_P#)NOB/_LJOQ'_]3?7:^@*^?_\ @FG_ ,FZ^(_^RJ_$?_U-]=H
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M_AP](_\ DBOH"B@#Y_\ ^'L7[+/_ $<M\ /_  X>D?\ R11_P]B_99_Z.6^
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M^2*^@** /G__ (>Q?LL_]'+? #_PX>D?_)%'_#V+]EG_ *.6^ '_ (</2/\
MY(KZ HH ^?\ _A[%^RS_ -'+? #_ ,.'I'_R11_P]B_99_Z.6^ '_AP](_\
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MH"B@#Y__ .'L7[+/_1RWP _\.'I'_P D4?\ #V+]EG_HY;X ?^'#TC_Y(KZ
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M_P#)%'_#V+]EG_HY;X ?^'#TC_Y(KZ HH ^?_P#A[%^RS_T<M\ /_#AZ1_\
M)%'_  ]B_99_Z.6^ '_AP](_^2*^@** /G__ (>Q?LL_]'+? #_PX>D?_)%'
M_#V+]EG_ *.6^ '_ (</2/\ Y(KZ HH ^?\ _A[%^RS_ -'+? #_ ,.'I'_R
M11_P]B_99_Z.6^ '_AP](_\ DBOH"B@#Y_\ ^'L7[+/_ $<M\ /_  X>D?\
MR11_P]B_99_Z.6^ '_AP](_^2*^@** /G_\ X>Q?LL_]'+? #_PX>D?_ "11
M_P /8OV6?^CEO@!_X</2/_DBOH"B@#Y__P"'L7[+/_1RWP _\.'I'_R11_P]
MB_99_P"CEO@!_P"'#TC_ .2*^@** /G_ /X>Q?LL_P#1RWP _P##AZ1_\D4?
M\/8OV6?^CEO@!_X</2/_ )(KZ HH ^?_ /A[%^RS_P!'+? #_P .'I'_ ,D4
M?\/8OV6?^CEO@!_X</2/_DBOH"B@#Y__ .'L7[+/_1RWP _\.'I'_P D4?\
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M<M\ /_#AZ1_\D4?\/8OV6?\ HY;X ?\ AP](_P#DBOH"B@#Y_P#^'L7[+/\
MT<M\ /\ PX>D?_)%'_#V+]EG_HY;X ?^'#TC_P"2*^@** / /A?^UC\+/VH/
MVIM"_P"%:?$OP!\1/[#\*ZQ_:7_",>(;35_[/\V[TGRO.^SR/Y>_RI-N[&[R
MWQG::3_@K%_RBR_:6_[)5XH_]-%U7H'B/_DZ;P;_ -BKKW_I7HU>?_\ !6+_
M )19?M+?]DJ\4?\ IHNJ /H"BBB@ HHHH **** /G_\ X)._\HLOV:?^R5>%
M_P#TT6M?0%?/_P#P2=_Y19?LT_\ 9*O"_P#Z:+6OH"@ HHHH **** "OG_\
MX)I_\FZ^(_\ LJOQ'_\ 4WUVOH"OG_\ X)I_\FZ^(_\ LJOQ'_\ 4WUV@#Z
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HJCXE\3Z=X,T*YU35[^STS3;)#)<75U,L,,*CNS,0 /K7QS\3?\
M@I3XF^.WBVX\$_LY^&KGQ-J@^2Y\274&VQL 3CS%5\+CT>7 )& CY%=6&P56
MNWR+1;MZ)>K+A3E/8^EOC_\ M.>"?V8_"W]J^,=;M]-1P?L]L/WEU>L/X8HA
M\S=@3]T9&2!7R7-\7/CM_P %*)FM/ =G<?"CX6SL4EUVZ)6^U&/H=C+AFSS\
ML6%X*M*>E=W\ /\ @EMI]EXI_P"$U^,>LR_$[QO<$2.MX[2Z=:L.@"OS-CMO
M 0 X$8P#7UI! EK D<:+''&H5$4850.  .PKM]MAL+I17//^9[+T77U?W&O-
M"'PZON>+_LJ_L#_#_P#9,LEFT;3_ .T_$;J1<:YJ $EY(3]X(<8B4^B8R,;B
MV,U[7117FUJ]2K/GJN[,92<G>04445D2%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%8FN?$GP[X8S_:6O:+I^WJ+F]CBQ_WTP]17&Z[^
MV-\-?#X/F^*;.9AT%K%+<9/U12/UKBKYEA*/\:K&/K)+\V2YQ6[/3:*\#U3_
M (*)^"89O)T^Q\1:M,WW1!:*H;_OIPW_ ([5;_AL3QIXEX\/_";Q#.I^[/=&
M18_TBV]Q_'7FOBC++VA5YG_=4I?^DIF?MX=&?0M%?/7_  FW[0GBP_Z-X6\-
MZ!"WW9)Y59Q]096/_C@ZT?\ "F_CKXJ_Y"OQ&TS3(V_AT^'YD'I\L4?J?XCV
MYJ?[?E/^#AJLO^W>5?\ DS0>U[19]"UDZYX]T/PQG^TM9TG3]O7[3=QQ8_[Z
M(]#^5>'_ /#"M_X@_P"1D^)?BO6=WWE#,@^@WO)[=NU:VA_\$^/ASI.//MM6
MU/'7[3?%<_\ ?H)_DT?7<WJ:4\-&/^*HORBG^8<U1[1_$SOC1^W+HG@GQOX;
ML]#O['5].>YWZS/;GSEC@/RA48<%ADOQ_<4?Q&MZ]_;S^&5KNV:W<W.!D>7I
M\XW>PW(*\/U__@G'XRU/6[NXM;OPA8VLTS/#;)=W++ A)VH"823@8&223CFO
MH+]GWX I\/\ X<V6F^)='\)WFK6+NBW=I:K(98R<J69HU._D@\= .22:\#+<
M7Q'7Q52-6*IQ>J<HMI6LK+WD]=]>O8QA*LY.^AS%[_P44^'UKG8NO7.%S^[L
MU&3Z?,XY_2J8_P""B?AR_P ?V=X8\77F[A?]&B&YO3Y9&_SVKWBQ\/6&F;?L
MUC9V^PY7RH53;],"KE?0?4LWE\6*BO2G_G(WY:G\WX'SV/VY-4O\?V?\+O%U
MYN.T?(XRWI\L;4J?M8?$;4MOV7X,Z]#SM/VB649/'K N![U]!T4?V7F+^+&2
M^4(+]&')/^;\CY\7XY?&[4=OV;X8647.&\^XQGTZR+2#QG^T7J(_Y%+PE8[3
MWF0[O_)AJ^A**/[#K/X\75?HXK\HB]D^LF?/9T_]HO4 ?].\(V.TY^ZIW?\
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MOG__ ()I_P#)NOB/_LJOQ'_]3?7:^@*^?_\ @FG_ ,FZ^(_^RJ_$?_U-]=H
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M .'3O[+/_1M/P _\-YI'_P CT?\ #IW]EG_HVGX ?^&\TC_Y'H ^@**^?_\
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MX3_#V!5GUG66 &#'I-I:Z9$W/=1&YQ]&_&O;O!O_  2D^!7@W:P\%KJDR_\
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M'_\ "/M/_BZ/K.(_Y\_^3(/['R?KF"_\%U/\C]-:*_.H?\&X7PMQ_P AZ?\
M\$EI_A5[1/\ @W7^%6E2NS:_JHW#'^C:;9P'\3L;-'M\3_SZ_P#)D']DY+_T
M'_\ E*7^9^@]%?!7_$/G\*/^A@\3_P#?FS_^,UN6O_!![X26]K&A\1?$/**%
M.R]LD7@=A]E.![9H]OBO^?2_\"_X ?V9D?7'2_\ !+_^31]IWVHV^EP^9<SP
MV\>=N^5P@SZ9-4_^$RTC_H*Z;_X$I_C7R%8_\$+?@_:3[I-:^(-RN,;)=0M0
MOU^6V!_6KG_#D#X,_P#/SXU_\&<7_P 9H]KB_P#GVO\ P+_@!_9^0+?&3?\
MW!_^Z'U'=?%CPM8SM%-XET"&5.&1]1A5E^H+57NOC=X,L+=I9_%WAB&)/O.^
MJP*J]N26KYQM?^"*OP1MX%1K;Q/.PZN^JD,WUVJ!^0JQ:_\ !&'X&V\ZNVEZ
M_.HZH^KR!6^NW!_(T>TQG\D?_ G_ )!]4X>6^)JO_N''_P"3+/[??_!0^U_9
MU^#>GZU\/=9\"^*=;NM8BL9;62\%ZL4#0SNTFR"97X:-%R3CY_<5XW^PU_P5
ME^(G[3'[4?AGP1K^B>"[72];%WYLVGVES'<(8K2:==I>=UY:, Y7H37=_&?_
M ((D_#/QGX6@M?!MS=^"=42Z662^E,VJ"6$(X,7E/,@&6*-NSD;,8YKF/@U_
MP0E\*^"_B1IVI>-M>T#XF^&;;S?MGAK6_"$,UAJ6Z)UC\Q)II8SY<A209C/S
M1J1@@$<$XYB\3&6T;J]GI;KO9GU.&K<(4\FJTKN5?EGRN<&I<UO=^'FCOMKZ
MGWK17S__ ,.G?V6?^C:?@!_X;S2/_D>C_AT[^RS_ -&T_ #_ ,-YI'_R/7O'
MY8?0%%?/_P#PZ=_99_Z-I^ '_AO-(_\ D>C_ (=._LL_]&T_ #_PWFD?_(]
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M[;?1;T<CM\\2C)_+WKEM9_X+?_!G2PWD6WC74<8Q]GTR)=V?3S)DZ5]%:/\
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M&_2.B^1\L6'_  1L^!5G&1)H6LW1)R&EUB<$>WRE16M:_P#!(_\ 9^MH45O
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M:U] 4 %%%% !1110 5\__P#!-/\ Y-U\1_\ 95?B/_ZF^NU] 5\__P#!-/\
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MZMX'F>"&24:KO:.-[FX9%)(4SRD %VSH?\.T_AU_T,?Q_P#_  ^WC?\ ^6U
M'T!17S__ ,.T_AU_T,?Q_P#_  ^WC?\ ^6U'_#M/X=?]#'\?_P#P^WC?_P"6
MU 'T!17S_P#\.T_AU_T,?Q__ /#[>-__ );4?\.T_AU_T,?Q_P#_  ^WC?\
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MBN91QC$;WMJIR<_OEP#SCQG_ (=I_#K_ *&/X_\ _A]O&_\ \MJS[G_@E/\
M"6\\56>NRZA\;Y=;TZTGL+34'^-WC5KJUMYWA>>&.4ZKO6.1[:W9U! 8P1$@
ME%P ?2%%?/\ _P .T_AU_P!#'\?_ /P^WC?_ .6U'_#M/X=?]#'\?_\ P^WC
M?_Y;4 ?0%%?/_P#P[3^'7_0Q_'__ ,/MXW_^6U'_  [3^'7_ $,?Q_\ _#[>
M-_\ Y;4 ?0%%?/\ _P .T_AU_P!#'\?_ /P^WC?_ .6U'_#M/X=?]#'\?_\
MP^WC?_Y;4 ?0%%?/_P#P[3^'7_0Q_'__ ,/MXW_^6U'_  [3^'7_ $,?Q_\
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M>-__ );4 ?0%%?/_ /P[3^'7_0Q_'_\ \/MXW_\ EM1_P[3^'7_0Q_'_ /\
M#[>-_P#Y;4 ?0%%?/_\ P[3^'7_0Q_'_ /\ #[>-_P#Y;4?\.T_AU_T,?Q__
M /#[>-__ );4 ?0%%?/_ /P[3^'7_0Q_'_\ \/MXW_\ EM1_P[3^'7_0Q_'_
M /\ #[>-_P#Y;4 ?0%%?/_\ P[3^'7_0Q_'_ /\ #[>-_P#Y;4?\.T_AU_T,
M?Q__ /#[>-__ );4 ?0%%?/_ /P[3^'7_0Q_'_\ \/MXW_\ EM1_P[3^'7_0
MQ_'_ /\ #[>-_P#Y;4 ?0%%?/_\ P[3^'7_0Q_'_ /\ #[>-_P#Y;4?\.T_A
MU_T,?Q__ /#[>-__ );4 ?0%%?/_ /P[3^'7_0Q_'_\ \/MXW_\ EM1_P[3^
M'7_0Q_'_ /\ #[>-_P#Y;4 ?0%%?/_\ P[3^'7_0Q_'_ /\ #[>-_P#Y;4?\
M.T_AU_T,?Q__ /#[>-__ );4 >S>*?B)HO@K7/#>FZIJ$-G?>+]1?2-'A<'-
M_=):7-ZT2X&,BWM+F3G Q$W.< [5?-^L_P#!*?X2^(]1TF\U#4/C??7>@W;7
M^F3W'QN\:RR:=<-!+;M-"S:J3'(8)YXBRX)2:1<[78'0_P"':?PZ_P"AC^/_
M /X?;QO_ /+:@#Z HKY__P"':?PZ_P"AC^/_ /X?;QO_ /+:C_AVG\.O^AC^
M/_\ X?;QO_\ +:@#Z HKY_\ ^':?PZ_Z&/X__P#A]O&__P MJ/\ AVG\.O\
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M\.T_AU_T,?Q__P##[>-__EM0!] 45\__ /#M/X=?]#'\?_\ P^WC?_Y;4?\
M#M/X=?\ 0Q_'_P#\/MXW_P#EM0!] 45\_P#_  [3^'7_ $,?Q_\ _#[>-_\
MY;4?\.T_AU_T,?Q__P##[>-__EM0!V?BKQ%96W[9'@/27N$74;WP9XDNX(#G
M=)%#?:"DCCMA6GB!_P!\5QG_  5B_P"467[2W_9*O%'_ *:+JN@^#O[#'P_^
M!OQ3C\:Z0_C_ %3Q-;Z5<Z);WOB?X@^(/$_V2SN9K::XBA34KVX2+S)+.U9F
M158^0@)P,5S_ /P5B_Y19?M+?]DJ\4?^FBZH ^@**** "BBB@ HHHH ^?_\
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MX!;UBEIRI>7]/Y[]NR2)J6]K+EV]VW_@$;_^37"BBBD(**** "BBB@ HHHH
M**** "BBB@ KGOBUXAU_PG\+_$.I^%?#W_"6>)K#3YY])T4WL=D-4NE0F* S
MR?)$KOM!=N%!)P<8/0UQ_P ?XO'-Q\%/%$7PS;PY'\0)=.ECT"37Y98M,@NV
M7$<DYBCD?8A.XJJ'=MQQG(BJ[0;UVZ;_ "\RZ6LTG;?KM\_(^4?%?[=_Q?\
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M=BY7YI&O[OFM/:RV[<T.:WFH<SUUN[1U2.^^,7[9?C'PC^US\$_!&A^ I?\
MA!/B)JT]CJOB[5)XEB<_V->ZA!;V$"3><TN;4&66:-8D7Y$\QW8PY'[4O[4O
MQ,_9Y_:$\(V:ZO\ "*?0_&/B/3M"T#P((+N?QCXHMI9(8[_4(;G[1'% +-9G
MG>+['<)Y-J2]S$9@(O2/C=^SMJ/C[XF? G4]&GT^WTOX5^)YM7OX[J5Q--;-
MHFHZ>BPX1@T@DNXB=Q4;5<YR IX[]I/X&_%K]HWQ?'X0U*U^&H^%R>*-$\36
MGB&#4KRW\1Z2NFW=K?BV%@UM+!<2/<6I3[4+R#9%<?ZAFB_?;1Y/;0_EYM;_
M ,O,KW](W2[I?SV9C[WL_>W]FKVZ3]_Y_P M[:_*Y](T445D,**** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %?/_ /P5B_Y19?M+?]DJ\4?^
MFBZKZ KY_P#^"L7_ "BR_:6_[)5XH_\ 31=4 ?0%%%% !1110 4444 ?/_\
MP2=_Y19?LT_]DJ\+_P#IHM:^@*^?_P#@D[_RBR_9I_[)5X7_ /31:U] 4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% '@7[2OQ2^)_\ PT_\._AG\-=;
M\!^&)?%'A?Q%XGU#5/$WAB[U]0NF7>B6T<$4-OJ%CL+_ -K.S.TCX\E0%^8D
M,_X5S^U-_P!%D^ '_AF]7_\ FGH^(W_*4WX-_P#9*O'G_IW\&5] 4 ?/_P#P
MKG]J;_HLGP _\,WJ_P#\T]'_  KG]J;_ *+)\ /_  S>K_\ S3U] 44 ?/\
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M )IZV/@Q\<M1^)_[4GC'38[R9_"</@OPSK^DVDUJL,EO)?2ZKYKM\HDW,EO
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ME3?/"$X*_,DTNNKLK_/]+:GMG_"N?VIO^BR? #_PS>K_ /S3T?\ "N?VIO\
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M\ /_  S>K_\ S3T?\*Y_:F_Z+)\ /_#-ZO\ _-/7FOAC_@J3XEUO1KSQ)/\
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ME=^2NH_G);7W\F*_NN739>=U?3[GJ[+3S5^J_P"%<_M3?]%D^ '_ (9O5_\
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ME#IW_"P)O^$<:U;3WOQ,VI#3#.)_*C8?9Q8LV<-N,1,@7X+?\%&-1^+'QO\
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MN04EC=2)K:&0%2&C0@BI6JNO+\;V_)_TT5M;S_2W^:_I,\]_X5S^U-_T63X
M?^&;U?\ ^:>C_A7/[4W_ $63X ?^&;U?_P":>OH"B@#Y_P#^%<_M3?\ 19/@
M!_X9O5__ )IZ/^%<_M3?]%D^ '_AF]7_ /FGKZ HH ^?_P#A7/[4W_19/@!_
MX9O5_P#YIZ/^%<_M3?\ 19/@!_X9O5__ )IZ^@*\C^,7[9WA7X)^,Y-"U2RU
M^YO8HDE=K2VC,8##(P7D7/'H".V<@UR8W'X?"4_:XF:C':[[DRFHJ\CF_P#A
M7/[4W_19/@!_X9O5_P#YIZ/^%<_M3?\ 19/@!_X9O5__ )IZA/\ P4J\"_\
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MW\$?_-#1_P -D?$7_HT[X_\ _@W\$?\ S0T ?0%%?/\ _P -D?$7_HT[X_\
M_@W\$?\ S0T?\-D?$7_HT[X__P#@W\$?_-#0!] 45\__ /#9'Q%_Z-.^/_\
MX-_!'_S0T?\ #9'Q%_Z-.^/_ /X-_!'_ ,T- !\1O^4IOP;_ .R5>//_ $[^
M#*^@*^,?CY<WW[2?B?P_K?B7]DW]JZUUKPO:WECINH^'/B3H'AF[AM[Q[9[F
M%I=-\5V[R1R/9VK%)"RY@0@ BN._X4Y_U;E^W_\ ^)&__AQ0!]_T5\ ?\*<_
MZMR_;_\ _$C?_P .*/\ A3G_ %;E^W__ .)&_P#X<4 ??]%? '_"G/\ JW+]
MO_\ \2-__#BC_A3G_5N7[?\ _P")&_\ X<4 ??\ 17P!_P *<_ZMR_;_ /\
MQ(W_ /#BC_A3G_5N7[?_ /XD;_\ AQ0!]Z:=H%CH]W>SVEE:6L^I2B>[DAA5
M'NI JH'D(&6;:JKDY.% Z"K=? '_  IS_JW+]O\ _P#$C?\ \.*/^%.?]6Y?
MM_\ _B1O_P"'%%[[@?6?Q:_8M^#GQ]\;6GB7QW\)OAIXU\1Z?$D%KJNO>%['
M4KVVC1RZ(DTT3.JJ[,P . 6)')KS/XN?\$I?A=\7_P!H_P ._$JYCN=*U#P]
M=Q7ZZ=8:9I/V:YN$O)+UI!/-927MKYUQ([SK9W-NMR7?SA)YDF[QC_A3G_5N
M7[?_ /XD;_\ AQ1_PIS_ *MR_;__ /$C?_PXHC[KBUT=UZ@]4T^NC^6WW'UG
MH?[%OP<\,>*-?UO3?A-\,]/UKQ69CK>H6WA>QBNM9,VXR_:9%B#3;][[MY.[
M>V<Y-6_BK^R;\*_CO<QS>./AI\/_ !E-#="^CDUSP[9ZBT=P(UB$P,T;$2"-
M$0-UVJHS@"OD'_A3G_5N7[?_ /XD;_\ AQ1_PIS_ *MR_;__ /$C?_PXHZ)=
MMOEM]P[N[EU9]VWG@[2-0N=)FGTK39Y=!E,VF/);(S:=(8GA+PDC,;>5(Z97
M!VNR]"13-;\#Z+XFN9)M2T?2]0FEL9M,>2YM(Y6>TF*F:W)8$F*0HFY/NML7
M(.!7PK_PIS_JW+]O_P#\2-__  XH_P"%.?\ 5N7[?_\ XD;_ /AQ0]=Q+38^
MK==_8<^"GBCX@77BS4O@_P#"W4?%-ZL27.LW7A2PFU"X6(((@\[1&1@@BC"@
MM\OEIC&T8[K5/A[H&N7MS<WNAZ/=W%X;4W$L]E'(\YM93-;%V(RWDRDO'G[C
M$LN"<U\,?\*<_P"K<OV__P#Q(W_\.*/^%.?]6Y?M_P#_ (D;_P#AQ1=VL'6Y
M]8:_^Q-\&?%?Q'B\8ZI\(_ACJ7BZ"1Y8M<NO"UC-J4;LS.S+<-$9 2SNQ(;D
MNQZDTFM_L1_!CQ-XJ\3Z[J7PB^&&H:WXVM6L?$6HW/A6QENM>MV:-C#=RM$7
MN(RT41*R%AF)#CY1CY0_X4Y_U;E^W_\ ^)&__AQ1_P *<_ZMR_;_ /\ Q(W_
M /#BE9)<O2UOD]UZ,=VW?K_EL?4LG[ WP*E\'Z#X>;X+?"5M \+74M]HNF'P
MAIYL](N)6#236T7D[(9'*@LR %B!DG%=*W[-OPZ?Q/>ZV? /@LZSJ4D4MW?G
M0[;[5=/%:R6<322;-SE+6::!22=L4KH,*Q!^-?\ A3G_ %;E^W__ .)&_P#X
M<4?\*<_ZMR_;_P#_ !(W_P##BGNFGU$M-CZ4M?\ @FO^SI8Z7IUE!\ O@K#9
M:1>2:C86Z>!],6*RNI!$))XE$&$E80P@NN&(BCR?E&.HD_9%^%$OQ/T_QNWP
MP^'C>,])97L=?/ARS.J63+"ENIBN?+\U"(8XXP58?(BKT %?(?\ PIS_ *MR
M_;__ /$C?_PXH_X4Y_U;E^W_ /\ B1O_ .'%.[3N@Z6/N3Q3\-/#GCFZ$VM^
M']$UB865QI@DOK&*X86EP8S<6^74GRI3#"73[K^4F0=HQD?$S]G7X??&KP[J
MFC^,O O@[Q;I.N3PW6I66LZ+;7]OJ$T*JL4DT<J,LCHJJ%9@2H4 8P*^,O\
MA3G_ %;E^W__ .)&_P#X<4?\*<_ZMR_;_P#_ !(W_P##BDTFK/\ KK^8[M;'
MUKHW[&/P>\.>+[+Q#I_PH^&MAK^FZ4N@VFIV_ABRBO+73EA\A;*.58@Z6XA_
M=B($($^7&.*J77[$WPOU3XUV7C[4?!?AK5_$.B65A9:#)?Z1:7 \,+9F8Q/I
MY:+?:N?.PQC8<118 V\_*O\ PIS_ *MR_;__ /$C?_PXH_X4Y_U;E^W_ /\
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M^']EX^U1'CO?$MOX=LX]8NU=0CK)=B,3.&554AF.0 #P*^0?^%.?]6Y?M_\
M_B1O_P"'%'_"G/\ JW+]O_\ \2-__#BAZN[]/D+I8^L/AA^Q)\&/@C::[!X+
M^$7PP\(P>*;4V.M1Z+X5L;!-7MR&!AN!%$HFCP[_ "OD?,W')KNM0\"Z)JU[
MH]S=:-I5S<>'I&ETJ66TC=],=HFA9H"1F(F)WC)3&4=EZ$BOA7_A3G_5N7[?
M_P#XD;_^'%'_  IS_JW+]O\ _P#$C?\ \.*-U9AY_P!?UHCZF^%?[!/P+^!7
MCJ+Q1X(^"_PG\'>)H%D2/5]#\(:?I]]&L@*R 3PQ+( P)!P>03FN@\4_LP_#
M7QS\6])\?ZW\// VL>.] 18],\27V@VMQJ^G*I8JL-TZ&:, NY 5A@NWJ:^.
M?^%.?]6Y?M__ /B1O_X<4?\ "G/^K<OV_P#_ ,2-_P#PXHN]'VV\O0'K>_7?
MS]>Y]?Z?^R?\+-(\9>)_$5K\-? %MX@\;0O;>(M4B\/6B7FOQ.06CNYA'ON%
M8@$B0L#@>E+\;/V9/!GQ[^'GB/PYKFBV @\4;I+R[@LX/M:W!M_LRW2NZ,/M
M"0@1K(02% 7H,5\?_P#"G/\ JW+]O_\ \2-__#BC_A3G_5N7[?\ _P")&_\
MX<465E'HMO+K^8=6^^_GZGU:W[#OP5?X1R^ #\'_ (7'P'/??VI)X;/A2P_L
MB2[X_P!(-KY7DF7@?.5W<=:V/#O[+_PT\(?$6#QAI/P[\#:7XMM=,CT2#6[3
M0;6#48;"-51+1;A8Q((%5%41AM@"@ 8 KXZ_X4Y_U;E^W_\ ^)&__AQ1_P *
M<_ZMR_;_ /\ Q(W_ /#BC^OPM^6GIH#U=W_6M_SU]=3ZKUG]ACX)>(_#>H:/
MJ'P=^%E_I&K"R6^L;CPG82VUZ+*+R;,2QM$5?[/%^[BW ^6ORK@<5WW@?P%H
M?PQ\':?X=\-Z+I/A[P_I$"VMCIFF6<=I9V4*\+'%%& B(.RJ !7PM_PIS_JW
M+]O_ /\ $C?_ ,.*/^%.?]6Y?M__ /B1O_X<4;W3Z[_E^0/5W9]C^-_V9OAO
M\3?A39>!/$GP^\$>(/ ^FK"EIX=U+0K6[TJU6$;81':R(8D$8X7"C:.F*Y_Q
M;^P;\#?'UA<6NN_!CX4:U;7;6;SPW_A'3[F.9K. VUH65XB"8(&,46?]7&2J
MX4XKY8_X4Y_U;E^W_P#^)&__ (<4?\*<_P"K<OV__P#Q(W_\.*.K??5^H[N]
MS[>\*_"3PKX%9CHGAGP_HY>QBTQC8Z=#;[K2)Y7BMSL4?ND>>=E3[JF:0@ N
MV9K7X:^';&;0I(= T6&3PM UKHK)8Q*=(A:-8VCMR%_<H8U5"J8!50.@KX;_
M .%.?]6Y?M__ /B1O_X<4?\ "G/^K<OV_P#_ ,2-_P#PXHO?<7]?U]R/J3PS
M^P)\"?!?B%M7T?X*_"72=6;4H=9:]LO"&GP7#7T+.T5T9%A#>>C2R%9,[E,C
MD$;C6K\//V/OA)\(GG;PG\+?AUX8:YODU.8Z3X:L[(RW:'<EPWEQKF5220Y^
M8$\&OD;_ (4Y_P!6Y?M__P#B1O\ ^'%'_"G/^K<OV_\ _P 2-_\ PXHC[ME'
M2VW]?)?<$O>OS==_Z^;^\^SO%W[//@#X@>%9="U[P-X/UO1)TN8Y=/O]&MKF
MUD6YE$URK1.A0B64!Y 1\[ ,V3S6WX&\":'\,/!^G>'O#6C:5X>T#1X%M;#3
M-,M([2SLHEX6.**,!$0=E4 "OA;_ (4Y_P!6Y?M__P#B1O\ ^'%'_"G/^K<O
MV_\ _P 2-_\ PXH_K^OO ^_Z*^ /^%.?]6Y?M_\ _B1O_P"'%'_"G/\ JW+]
MO_\ \2-__#B@#[_HKX _X4Y_U;E^W_\ ^)&__AQ1_P *<_ZMR_;_ /\ Q(W_
M /#B@#[_ **^ /\ A3G_ %;E^W__ .)&_P#X<4?\*<_ZMR_;_P#_ !(W_P##
MB@#[TUO0K+Q+I<MEJ-G:W]E/@2V]S$LL4F"",JP(/(!Y[BHO#?A/2_!M@;72
M-,T_2K5G,AAL[=((RY !;:H S@#GV%?"'_"G/^K<OV__ /Q(W_\ #BC_ (4Y
M_P!6Y?M__P#B1O\ ^'%1[.'-SVU[]0MU/O\ KE/$OP(\#^,_#MOI&L>#?"FJ
MZ39W<]_;V5YI%O/;P7,XF6:98V0JLD@N+@.X&6$\N2=[9^*_^%.?]6Y?M_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
